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ABSTRACT

Double-strand breaks and stalled forks arise when the replication machinery
encounters damage from exogenous sources like DNA damaging agents or ionizing
radiation, and require specific DNA helicases to resolve these structures. Sgs1 of
Saccharomyces cerevisiae is a member of the RecQ family of DNA helicases and has a
role in DNA repair and recombination. The RecQ family includes human genes BLM,
WRN, RECQL4, RECQL1, and RECQL5. Mutations in BLM, WRN, and RECQL4 result
in genetic disorders characterized by developmental abnormalities and a predisposition
to cancer. All RecQ helicases have common features including a helicase domain, an
RQC domain, and a HRDC domain. In order to elucidate the role of these domains and
to identify additional regions in Sgs1 that are required for the maintenance of genome
integrity, a series of systematic truncations to the C terminus of Sgs1 were created. We
found that ablating the HRDC domain does not cause an increase in accumulating
gross chromosomal rearrangements (GCRs). But deleting the RQC domain and leaving
the helicase domain intact resulted in a rate similar to that of a helicase-defective
mutant. Additionally, we exposed these truncation mutants to HU and MMS and
demonstrated that losing up to 200 amino acids from the C terminus did not increase
sensitivity to HU or MMS, whereas losing 300 amino acids or more led to sensitivity
similar to that of an sgs1∆ cell. These results suggest that the RQC domain, believed to
mediate protein-protein interactions and required for DNA recognition, is important for

xv

Sgs1’s role in suppressing GCRs and sensitivity to HU and MMS, whereas the HRDC
domain that is important for DNA binding is not necessary.

RecQL5 is a RecQ-like

helicase that is distinct from the other members through its three different isoforms,
RecQL5α, RecQL5β, and RecQL5ɣ. It has a helicase domain and an RQC domain, but
lacks the HRDC domain that other RecQ-like helicases possess. In contrast to Blm,
Wrn, and RecQL4, no human disorder has been associated with defects in RecQL5. For
this reason the role of RecQL5 in the cell has remained largely unknown. To try to
elucidate the pathways RecQL5 may be involved in we performed a yeast two hybrid to
identify RecQL5-interacting proteins. We found that RecQL5 interacts with Hlp2, an
ATP-dependent RNA helicase, and Ube2I, a SUMO-conjugating enzyme. These novel
interactions shed light on a potential role of RecQL5 in the cell as a transcriptional
regulator.
Saccharomyces cerevisiae, Rrm3, is a 5’-3’ DNA helicase that is part of the Pif1
family of DNA helicases and is conserved from yeast to humans. It was initially
discovered as a suppressor of recombination between tandem arrays and ribosomal
DNA (rDNA) repeats. In its absence there are increased rates of extra-chromosomal
rDNA circles, and cells accumulate X-shaped intermediates at stalled forks. Rrm3 may
be involved in displacing DNA-protein blocks and unwinding DNA to facilitate fork
progression. We used stable isotope labeling by amino acids in cell culture (SILAC)based quantitative mass spectrometry in order to determine proteins that deal with the
stalled fork in the absence of Rrm3. We found that in the absence of Rrm3 and
increased replication fork pausing, there is a requirement for the error-free DNA
damage bypass factor Rad5 and the homologous recombination factor Rdh54 for fork

xvi

recovery. We also report a novel role for Rrm3 in controlling DNA synthesis upon
exposure to replication stress and that this requirement is due to interaction with Orc5, a
subunit of the origin recognition complex. Interaction of Orc5 was found to be located
within a 26-residue region in the unstructured N-terminal tail of Rrm3 and loss of this
interaction resulted in lethality with cells devoid of the replication checkpoint mediator
Mrc1, and DNA damage sensitivity with cells lacking Tof1. In this study we describe two
independent roles of Rrm3, a helicase-dependent role that requires Rad5 and Rdh54 for
fork recovery, and a helicase-independent role that requires Orc5 interaction to control
DNA synthesis.
Our data provides novel insight into the role of DNA helicases and their role in
protecting the genome. Through yeast genetics it was possible to determine the
importance of the C terminus of Sgs1 and elucidate new RecQL5 interacting partners
that shed light onto roles for RecQL5 distinct from other RecQ like helicases.
Quantitative mass spectrometry allowed us to take on a more global view of the cell and
determine how it responds to replication fork pausing in the absence of Rrm3. Using
both proteomics and yeast genetics we were able to better understand how these DNA
helicases contribute to maintaining genome stability.

xvii

CHAPTER ONE:
INTRODUCTION

Helicases have a role in numerous processes in the cell from DNA replication
and repair, transcription, to translation. Defects in their function have been linked to
several diseases, including neurodegenerative diseases, cancers, and developmental
defects [1-4]. They were first discovered through multiple alignment and sequence
conservation of three related sequence motifs within the ATPase domain [5]. Helicases
were initially characterized by these conserved motifs, but it has become clear that
these motifs characterize proteins, specifically translocases, which possess the ability to
move along DNA [2, 6]. Helicases and translocases are characterized by their
processivity, likely due to their interaction with other proteins, and polarity. Since DNA is
double stranded and asymmetric within the duplex, it is important that the ATPdependent helicases move along the nucleic acid with some direction or polarity [2, 7-9].
Helicases can be classified within six superfamilies with the largest groups being
Superfamily 1 (SF1) and Superfamily 2 (SF2), which contain seven signature motifs [5].
They can also be distinguished based on their affinity for DNA, RNA, or DNA-RNA
hybrids and ability to move on DNA with either 3’-5’ or 5’-3’ polarity [7]. The activity of
these helicases is often altered by accessory domains, which may direct the helicase to
a specific substrate or enhance its catalytic activity [10].

1

SUPERFAMILY 1 HELICASES
Superfamily 1 helicases are the best characterized, with roles in DNA or RNA
metabolism, and can be subdivided into Superfamily 1A (SF1A) and Superfamily 1B
(SF1B) helicases. The first crystal structure determined for a helicase was of PcrA, a
UvrD-like enzyme from Geobacillus stearothermophilus [11]. SF1 helicases possess a
four-subdomain structure with 1A/2A subdomains forming the helicase core and 1B/2B
interacting with the duplex DNA substrate [11, 12]. After ssDNA binds to a helicase a
conformational change allows the 1B/2B subdomains to interact with DNA. With the
addition of ATP, an additional conformational change occurs and allows subdomains
1A/2A to encircle the nucleotide [13]. These core domains constantly open and close as
ATP is bound, hydrolyzed, and released, resulting in translocation along DNA [14]. SF1
family of helicases are divided into three families (Rep/UrvD, Pif1/RecD, and Upf1-like)
based on their polarity on ssDNA with SF1A moving 3’-5’ and SF1B moving 5’-3’ [2].

SUPERFAMILY 2 HELICASES
Superfamily 2 helicases contain a more diverse group of helicases than the SF1
family and are involved in DNA or RNA unwinding and have a role in DNA repair,
transcription, RNA metabolism, and chromatin organization [9, 15-18]. They include the
following families: RecG-like, Swi/Snf, Ski2-like, RIG-I-like, NS3/NPH-II, DEAH/RHA,
DEAD-box, Rad3/XPD, type I restriction enzyme, and RecQ-like [10, 18, 19].

2

Figure 1.1. RecQ-like helicases from various species
RecQ helicases have several domains in common. The most conserved domain
amongst RecQ- like helicases is the helicase core. Most RecQ helicases also share a
conserved helicase and RNAse D C-terminal (HRDC) and RecQ C-terminal (RQC)
domain. WRN, BLM and RECQL1 contain a nuclear localization sequence and
interestingly WRN and FFA-1 in Xenopus has an exonuclease domain.
THE RECQ PROTEIN FAMILY
RecQ-like helicases have 3’-5’ polarity and have been implicated in
recombination, telomere maintenance, and DNA repair [20]. They bind to specific DNA
substrates and prevent unscheduled recombination. In their absence there is a higher
level of recombination, chromosome missegregation, and meiotic defects [21, 22]. The
first RecQ helicase was discovered in Escherichia coli as a mutant that was resistant to
thymine starvation in the RecF pathway and in its absence there was increased
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sensitivity to UV damage and genome instability [23]. Saccharomyces cerevisiae and
Schizosaccharomyces pombe contain one RecQ helicase. Others contain multiple, like
humans who possess five homologs; WRN, BLM, RecQL4, RecQL1, and RecQL5.
RecQ helicases from different organisms are defined by their sequence similarity to the
E. coli RecQ helicase. They possess highly conserved protein domains, the helicase
domain, the RecQ C-terminal (RQC) domain, and the helicase and RNAse D-like Cterminal (HRDC) domain (Figure 1.1) [5, 24].
RecQ helicases belong to the SF2 family of helicases and contain seven
sequence motifs [25]. Functions of these motifs have been studied based on their
structural similarity between motifs of other helicases. The function of Motif 0 was
determined by looking at the crystal structure of E. coli RecQ and was found to facilitate
ATP binding [2]. Motif 1 and Motif II are conserved amongst many helicases and have a
role in binding and hydrolysis of ATP [10]. The crystal structure of the helicase domain
of RecQ has revealed that there are two lobes that are separated by a cleft, which is
thought to play a role in ATP and ssDNA binding [26-28]. Mutations to these motifs
result in deleterious effects in the cell as seen in BLM, where mutations adjacent to the
cleft of the helicase domain have resulted in reduced catalytic activity of this protein [2,
27-31].
The RQC domain is not a common feature of all RecQ helicases like the core
helicase domain, but it is a unique characteristic of the RecQ family and has been
implicated in DNA binding [32]. The structure of the RQC domain was initially resolved
using X-ray crystallography [26, 27, 33]. This domain possesses a zinc-binding motif, a
helix-hairpin-helix, winged-helix, and a β-hairpin motif [26, 27, 33]. The winged-helix
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domain of both WRN and BLM shows affinity for DNA and the crystal structure for WRN
shows that the winged-helix domain interacts with the phosphate backbone of a 5’
single-stranded DNA overhang [28, 32]. Mutating the residues in WRN that interact with
the phosphate backbone results in loss of DNA-binding and helicase activity [33, 34].
RecQL1, which is a much shorter protein than other RecQ like helicases,
possesses a conserved RQC domain that has been shown to bind dsDNA through its
winged helix [35]. Additionally, the β-hairpin motif in the RQC domain of RecQL1
coordinates its ATPase activity and ability to unwind DNA through dimer formation [31].
The helicase and RNAse D-Like C-Terminal domain (HRDC) of RecQ-like
helicases is seen in WRN, BLM, E. coli RecQ, and S. cerevisiae Sgs1 and its crystal
structure has been resolved [24, 28, 36]. RecQ and Sgs1 have been shown to bind to
the HRDC domain but interaction is not needed for their catalytic activity [37]. In human
WRN and BLM, the HRDC domain is important for recruiting the protein to methyl
methanesulfonate (MMS), mitomycin C damage as well as dsDNA breaks [38].
Although this domain is not needed for catalytic activity of these RecQ-like helicases, it
is important for recruitment to damaged DNA [39].

SACCHAROMYCES CEREVISIAE RECQ-LIKE HELICASE, SGS1
RecQ helicases are highly conserved from bacteria to humans but, only one
RecQ helicase is present in bacteria and yeast. Sgs1 was initially discovered as a
suppressor to the slow-growth phenotype of a yeast strain lacking Topoisomerase 3
(Top3), a type IA topoisomerase capable of relaxing negatively supercoiled DNA [40].
Sgs1 is 1447 residues long and has a helicase domain, RQC domain, and a HRDC
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domain (Figure 1.1) [41]. It is involved in repair of double strand breaks by homologous
recombination (HR), restart of stalled replication forks, resolving aberrant intermediates
during meiosis, and telomere maintenance [37, 42-46]. Cells lacking Sgs1 show
increased sensitivity to DNA-damaging agents hydroxyurea (HU) and methyl
methanesulfonate (MMS), accumulate gross-chromosomal rearrangements (GCRs),
and have defects in chromosome segregation during mitosis and meiosis [21, 46-50].

Figure 1.2. Requirement for the RecQ helicase, Sgs1, during end resection
Double-strand breaks are recognized by the Mre11-Rad50-Xrs2 (MRX) complex and
the ends are partially resected by the Mre11 nuclease with help from Sae2 leaving a 3’
ssDNA overhang. The ends are further resected by Sgs1 and Dna2 (left) or by the Exo1
nuclease (right) resulting in ssDNA that is coated by RPA. This image has been
adapted and modified from Gobbini, Cesena et al. (2013).
6

Figure 1.3. Double strand break repair
The RecQ helicase, Sgs1, of S. cerevisiae is required during double strand break repair
by HR. After a double strand break has occurred the MRX complex and Sae resect the
5’ ends. Sgs1, Exo1, and Dna2 then further resect resulting in a 3’ ssDNA strand. This
strand can invade the sister chromatid and be extended by DNA synthesis and aberrant
structures can be prevented by the activity of Sgs1. A double Holliday junction (dHJ) is
then formed and can undergo dissolution by Sgs1/Top3/Rmi1 resulting in non-crossover products. The dHJ can also be processed by other resolvases to create either a
non-cross-over product or crossover product. This image has been adapted and
modified from Ashton and Hickson (2010), Brosh (2013).
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Repair of double strand breaks by homologous recombination
HR is important to repair double strand breaks (DSBs) and DNA crosslinks by
utilizing two homologous DNA sequences [51]. In the presence of a double strand
break, the MRX complex (Mre11-Rad50-Xrs2) is recruited to each end of the break and
initiates resection of the 5’ ends (Figure 1.2) [51]. Sae2 interacts with Mre11 and its
absence has shown reduced nuclease activity similar to a Mre11 deficient strain
suggesting that these two proteins work in coordination with each other to produce a
substrate for Sgs1 or Exo1 [52-56]. Sgs1, Exo1, and Dna2 are then needed to further
resect the DNA in order to create a substrate for HR (Figure 1.2) [42].
After extensive resection, ssDNA is coated with Rad51, which searches for a
homologous sequence to use for error-free repair [57]. Efficient resection during DSB
repair requires not only Sgs1 but also its interacting partners Top3 and Rmi1 (STR
complex) [58]. Rmi1 may have a role in recruiting Sgs1 and Top3 to ssDNA so that
Top3 can remove any torsional strain caused by the helicase activity of Sgs1 during
resection [45]. Cells deficient for any member of the STR complex results in increased
rates of recombination [59].

Restart of damaged replication forks by Sgs1
In S. cerevisiae the intra-S phase checkpoint is activated in the presence of HU,
which depletes dNTP pools, or MMS, which alkylates DNA, and results in slowing of
DNA replication (Figure 1.5) [60]. Upon activation of the intra-S phase checkpoint,
proteins involved in DNA repair are activated [61, 62]. When cells defective in intra-S
phase checkpoint proteins, Mec1, Mrc1, Rad9, and Rad53 are exposed to DNA
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damaging agents HU or MMS, the replication forks are unable to proceed and stall [63].
Therefore, it is thought that the intra-S phase checkpoint serves to stabilize the forks in
order to resume replication after repair has occurred (Figure 1.4) [64].
DNA checkpoints are complex signal transduction pathways that require sensors,
transducers, and effectors [65, 66]. The sensor, ATR-like Mec1 kinase and its binding
partner, Ddc2, are required to sense and detect lesions [66]. The transducers Mrc1
which functions in the intra-S phase checkpoint, and Rad9, which functions in the DNA
damage checkpoint receives, and transmits the signal [67]. Lastly, the effector kinase
Rad53, functions in both the intra-S phase and DNA damage checkpoint, and is
required to start downstream events [63]. Sgs1 interacts with Rad53 in vitro and in vivo
and activates this kinase in the presence of HU [68, 69]. This activation is independent
of Sgs1’s helicase activity and suggests that the physical interaction between these two
proteins is what is required [68]. In MMS, sgs1∆ cells accumulate HR intermediates that
are not observed in the presence of HU, suggesting Sgs1 has several roles at forks
upon MMS treatment [70-72]. Top3 and Rmi1 also activate Rad53 in a MMS dependent
manner, which is independent of Top3 catalytic activity but dependent on protein-protein
interaction with Sgs1 [72-74]. Sgs1 seems to have a HU dependent role in activating
Rad53 through protein-protein interaction and a MMS dependent role, which requires
Top3 and Rmi1.
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Figure 1.4. Checkpoint response
The sensor kinase, Mec1, detects lesions and helps to activate Mrc1 or Rad9, which are
mediators of the checkpoint response. Mrc1, the replication stress checkpoint and
Rad9, the DNA damage checkpoint can both activate Rad53 under replication stress.
Activation of Rad53 leads to numerous downstream events that stabilize the fork and
allow for repair to take place. Rad53 has roles in DNA repair, preventing late origins
from firing, regulation of transcription and maintaining dNTP levels. In addition to
Rad53, Rad9 can also activate the effector kinase Chk1, which functions during G2/M.
This image is adapted from Fu et al. (2008).

Figure 1.5. Regulation of dNTP levels
Sml1 inhibits Rnr1 from associating with the RNR complex and prevents production of
dNTPs. Upon exposure to replication stress, Dun1 is activated and phosphorylates
Sml1, targeting it for degredation by the 26S proteasome, allowing production of dNTPs.
This image is adapted from Andreson et al. (2010).
10

Role of Sgs1 in maintaining genome stability during meiosis
Cells lacking Sgs1 show reduced spore viability and tetrad formation [75, 76].
The meiotic defect in sgs1∆ mutants can be attributed to missegregation of
chromosomes during meiosis and unscheduled separation of sister chromatids [76].
Disrupting meiotic checkpoint genes, RAD17 and RED1, results in rescue of the poor
sporulation phenotype seen in an sgs1∆ mutant suggesting that this defect may be a
result of accumulation of aberrant recombination intermediates that require Sgs1 to be
resolved [77]. A sgs1∆C795 allele sporulates just as well as a wildtype suggesting that
the instability seen in sgs1∆ is due to loss of interaction with Top2 or Top3 which both
interact with the N terminus of Sgs1 that is present in a sgs1∆C795 mutant allele [78].
Additional work has revealed that Sgs1 is also able to disrupt D-loop structures and
promotes formation of a Holliday junction intermediate that is dissolved by Top3/Rmi1
activity further supporting its role in meiosis considering similar substrates are present
[37, 72, 79-82].

Sgs1 facilitates repair at telomeres
Telomeres are composed of protein-DNA complexes at the ends of
chromosomes that help to maintain genome stability. In humans, telomeres contain a 10
kb TTAGGG repeat, the shelterin complex, and a 3’ ssDNA overhang [83, 84]. In the
absence of telomerase, the DNA ends shorten after each cell division and if left
unchecked the cell will eventually die [85]. To avoid this, the cell can use telomerase or
it can go through alternative lengthening of telomeres (ALT), which is a process that
utilizes recombination [86-89]. The ALT pathway uses recombination to elongate
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telomeres and is used in 5-15% of human cancers, including osteosarcoma and
glioblastoma [88, 89]. RecQ helicases have been shown to co-localize with other
components in this pathway, but their role remains unclear [90].
The G-rich regions of telomeric DNA may lead to the formation of Gquadruplexes, which if left unresolved can be toxic to the cell [91]. Sgs1 has been
suggested to resolve these secondary structures and has been shown to resect
telomeric regions that have a higher incidence of G-quadruplex formation [92, 93]. By
inducing a site specific DSB in an sgs1∆ exo1∆ mutant, the presence of telomeric
sequences in non-telomeric regions was observed suggesting Sgs1 and Exo1 work
together to prevent these events from occurring [94, 95]. It was recently reported that
Sgs1 is sumoylated at K621 and that this modification is important for its function in
telomere-telomere recombination and is dispensable in its role in DNA repair [96]. If
components at telomeres are disregulated, unwanted intermediates may arise, which
require the function of Sgs1 to be resolved and if they persist, can lead to cell death
[97].
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Figure 1.6. Conserved protein-protein interactions with Sgs1 and BLM
Sgs1 and BLM have several protein-protein interactions with proteins involved in DNA
repair and recombination. Sgs1 interacts with Top3, Srs2, Top2, Rad16, Rpa70, Rad53,
Mlh1, and Rad51. Many of the protein-protein interactions in Sgs1 are conserved in
BLM with some additional interactions like WRN specific to BLM helicase. The colors for
Sgs1 and BLM are the same as those in Figure 1.1.

Sgs1 interacting proteins
Sgs1 physically interacts with Top2 and Top3 through its N terminus (Figure 1.6)
[76, 98]. In yeast, Top2 has a function in decatination of DNA molecules that form as a
result of DNA replication [99, 100]. Without this function chromosomes run the risk of
fragmenting and may not separate properly during mitosis [99, 100]. Top3 also interacts
with Sgs1 and forms a complex that is required to resolve aberrant structures that result
from Sgs1 activity [40, 101, 102]. Sgs1 has also been shown to interact genetically with
Srs2, a DNA helicase involved in displacing Rad51 filaments. sgs1∆ srs2∆ double
mutants show a growth defect suggesting the inability to displace Rad51 filaments may
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be causing toxic intermediates, which, if left unresolved are deleterious to the cell [46,
103]. Rad51 of S. cerevisiae has a role in HR and repair of DSBs by recombination
[104]. rad51∆ mutants have mitotic and meiotic defects and are sensitive to ionizing
radiation (IR) [104]. Interaction between Sgs1 and its human counterpart, BLM, with
Rad51 has been shown through yeast two-hybrid [104].
Apart from its role in DSB repair, Sgs1 also has a role in mismatch repair and
nucleotide excision repair. Sgs1 interacts with Mlh1, a member of the MutLα complex
that works with Pms1, required for ATP binding, during mismatch repair [105]. Through
yeast two-hybrid analysis interaction with Rad16 has been observed. Rad16 belongs to
the Swi2/Snf2 superfamily of DNA-dependent ATPase and functions during nucleotide
excision repair [106]. Interaction between Sgs1 and Rad16 was confirmed by coimmunoprecipitation and the interaction was found to be between amino acids 421-792
[107]. sgs1∆ rad16∆ cells show slow growth in the presence of DNA damaging agents
suggesting a role for Sgs1 during nucleotide excision repair [107].
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Table 1.1. Comparison of helicase activities of E. coli RecQ with human and S.
cerevisiae RecQ helicasesa

This table has been adapted and modified from a review by Croteau, Popuri et al.
(2014).
a

The data presented here is from the following studies: [44, 108-118]

b

DNA is represented as red and blue; RNA is represented as green.

c

Helicase activity: +, weak; ++, moderate; +++, strong; -, no activity; ~/-, partial activity;
ND, not determined.

d

Activity of RECQL4 is shown in the absence of ssDNA

HUMAN RECQ-LIKE HELICASES
Humans possess five RecQ-like homologs BLM, WRN, RecQL1, RecQL4, and
RecQL5. Defects in three of these five RecQ-like proteins (BLM, WRN, RECQL4) result
in genetic disorders for which there is no cure as of yet.
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Bloom Syndrome is an autosomal recessive disorder caused by a mutation
in

BLM

Mutations to BLM (15q26.1) result in Bloom syndrome (BS), also known as
Bloom-Torre-Machacek syndrome, and patients have a predisposition to cancer,
diabetes, and pulmonary disease [119-122]. Bloom syndrome is extremely rare and
most patients are of Central and Eastern European (Ashkenazi) background [123].
Patients are characterized by having short stature and rarely exceed five feet in height
during adulthood [123]. They are sensitive to sun exposure and suffer from
telangiectases and hyper- or hypopigmentation of the skin (Figure 1.7) [124]. Other
distinctive physical features include high vocal inflection and a long narrow face with
prominent nose and ears [125]. Men usually do not produce sperm and are infertile and
women have reduced fertility with early onset menopause [112]. BLM is expressed in
the spleen, thymus, testis, and ovaries during embryogenesis [126]. Mouse models
containing mutations in BLM found in the general population have been generated.
BLM-/- mice are smaller than BLM+/- or wildtype mice, show developmental defects,
have increased incidence of SCEs, and have a higher incidence of cancer upon
inactivation of the helicase domain [120]. Additionally, inactivating the helicase domain
of BLM in a cell with a mutation in the tumor suppressor gene APC results in higher
levels of tumor formation [125]. Cells deficient for BLM are characterized by high levels
of SCEs, increased mutation rates, inability to resolve DNA intermediates leading to
slowed replication, and presence of quadriradials [20].
In mammalian cells, the central kinases ATM and ATR regulate the intra-S phase
checkpoint, which responds to replication stress and inhibits cell cycle progression,
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induces genes involved in the DNA damage response, restricts HR, and inhibits late
origin firing [127]. Both ATM and ATR phosphorylate BLM at threonine 99 and 122 in
the presence of UV irradiation, and phospho-defective mutants cannot recover [128].
Although phosphorylation of these residues inhibits recovery of BLM from replication
stress, BLM is still able to suppress SCEs and localize to DNA damage foci [128]. In
addition to being phosphorylated by ATM and ATR, BLM is also modified by Chk1 and
Chk2, which are downstream of the checkpoint response and lead to localization of
BLM to sites of DNA damage [129]. Cells depleted for BLM have checkpoint defects,
cannot activate CHK1, and are more sensitive to the DNA damaging agent
camptothecin [125, 130].
As it is a member of the RecQ family of helicases, BLM has a core helicase
domain with ATP-binding and DEAH motifs, a RecQ helicase C-terminal domain (RQC)
adjacent to the helicase domain that promotes protein-protein interactions, and a
helicase and RNase D C-terminal domain (HRDC) that is on its C terminus [2, 10, 24,
32]. The disordered N terminal tail of BLM contains several sites of post-translational
modifications (PTM) that mediate interaction with RMI1/2, TOP3α, and RAD51 [40, 73,
104, 131-134]. BLM has a role in resolving recombination intermediates similar to that of
Sgs1 in yeast and is able to dissociate D-loops in vitro with specificity for invaded 5’
ends by preventing the formation of RAD51 filaments [135, 136]. It has been further
shown that BLM and TOP3α in combination with RMI1 and RMI2 are required for dHJ
dissolution [125]. RMI1 and RMI2 are thought to help recruit TOP3α to the dHJ [137].
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Figure 1.7. Individuals with Bloom syndrome
Patient on the left and center have facial telangiectasias, a hallmark of the syndrome.
The patients on the right are siblings with the brother to the left positive for Bloom
syndrome. Images are from the Bloom syndrome registry, Weill Cornell Medical
College.

Werner syndrome is an autosomal recessive disorder characterized by
premature aging
Werner syndrome protein, WRN, like BLM is a RecQ-like DNA helicase and
defects in this protein are associated with a predisposition to cancer with a majority of
patients with this syndrome linked to a founder mutation in Japan [138]. Cells from
individuals suffering from Werner syndrome have increased sister chromatid exchange,
shortened telomeres, and genomic instability, specifically chromosome rearrangements
like translocations, inversions, and deletions [139-141]. In addition to these cellular
defects, patients with Werner syndrome show distinct clinical features such as type II
diabetes, cataracts, atherosclerosis, arteriosclerosis, osteoporosis, and accelerated
aging [142, 143]. Patients develop normally until adolescence, then symptoms manifest
in early adulthood and death occurs around 46-54 years of age (Figure 1.8) [138]. BLM
manifests different clinical symptoms and these differences in physical features of
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patients with this syndrome compared to BLM show that WRN and BLM cannot
compensate for each other, suggesting they have independent roles in the cell.
WRN is 1432 amino acids in length and contains an exonuclease domain on its
N terminus, the RQC domain, and an HRDC domain (Figure 1.1) [144]. Both WRN and
BLM possess the helicase core and HRDC domain, but the ATPase domain of WRN
and BLM is only 30% similar while the RQC domain and HRDC domains are 10% and
20% similar [145]. The RQC domain of WRN is critical for DNA strand separation and is
linked to the Zn binding domain by a short linker sequence resulting in a winged-helix
motif [33, 146].
The function of the HRDC domain, unlike the RQC domain, is not well
understood. In human RecQ helicases only WRN and BLM possess the HRDC domain.
The HRDC domain was initially discovered from studies of bacterial DNA helicase PcrA
and Rep [11, 12, 147]. Studies of S. cerevisiae Sgs1 have shown that the HRDC
domain weakly binds DNA via its attraction to its positive surface [24]. Notably, the
surface of WRN does not share the same characteristics as that of Sgs1. The HRDC
domain of WRN is linked to the RQC domain by residues 1065-1141 which is
unstructured and contributes to the distance of the HRDC domain from the RQC domain
[142]. This flexibility might allow for protein-protein interactions that may help recruit
WRN to sites of damage.
WRN has several roles during DNA repair. During base excision repair (BER),
WRN, through its exonuclease activity is thought to have a role in post replication repair
[148]. WRN interacts with poly (ADP-ribose) polymerase I (PARP1), which adds
substrates into chromatin-binding proteins allowing for modification of chromatin
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structure [149, 150]. Cells depleted for WRN are unable to activate PARP1, which
results in an inability to resolve oxidized and alkylated DNA demonstrating an important
role for WRN in BER [148]. During double strand break repair, DNA can be resolved by
non-homologous end joining (NHEJ) or HR. NHEJ requires 53BP1, DNA-PKcs,
XLF/XRCC4/LIG4, and Ku70/Ku80 (Ku) [151, 152]. WRN is a substrate for DNA-PKcs
and physically interacts with Ku [153-156]. Cells depleted for WRN show increased
chromosomal deletions and are sensitive to IR [155]. Even though WRN possesses
exonuclease activity it has been observed that this activity hinders proper resection
during HR and that BLM has a more important role with its interaction with EXO1 and
DNA2 [157]. WRN lacks anti-recombinogenic activities like BLM but has been thought to
suppress recombination [104, 158]. This may be mediated through its interaction with
several HR proteins: BRCA1, MRN, RAD51, RAD54, and RAD52 [159-162]. WRN
depleted cells are defective in telomere replication and these cells have increased sister
telomere loss (STL) which suggest that WRN may prevent deletions during telomeric
replication and that it may resolve secondary structures that may lead to telomere
defects [163]. If the damage cannot be resolved then there is a risk of cell cycle arrest
and chromosomal instability.
WRN also undergoes post-translational modifications, which are critical for
regulating its catalytic activities, protein-protein interactions, and cellular localization.
WRN undergoes phosphorylation by DNA-PKcs, ATR, ATM, and c-Abl tyrosine kinase
[164-167]. Phosphorylation of WRN occurs when the replication machinery encounters
a block, and both ATM and ATR kinases have been shown to activate WRN in the
presence of HU [164]. Experiments have shown that inhibiting ATR mediated
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phosphorylation prevents WRN from localizing to nuclear foci and can result in
collapsed forks [164]. Acetylation of WRN by p300 allows WRN to move from nucleolar
foci to nuclear foci and may enhance its helicase and exonuclease activity shedding
light on its role during BER [168].
Mouse models, constitutively expressing Wrn, have been generated to study the
phenotype seen in Werner patients. One specific model has the helicase domain
disrupted resulting in a truncated protein [169]. Although this particular model did not
exhibit the premature aging phenotype of Werner patients, it is sensitive to
camptothecin, an inhibitor of topoisomerase I [170]. WRN has an important role in
maintaining telomeres and mouse models with telomerase RNA, Terc, depleted in
combination with a Wrn

-/-

mutation showed premature aging phenotypes and early

development of type II diabetes and osteoporosis [41, 171].
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Figure 1.8. Patients with Werner syndrome at various ages
These images show patients who suffer from Werner syndrome and specifically
premature ageing that is associated with this syndrome. A and B) Patients from
America that suffer from Werner syndrome. C) A patient of Japenese descent that has
Werner syndrome and premature ageing is most evident in this patient. Images are from
University of Washington and a review by Bohr et al. (2008).

Rothmund-Thomson syndrome is caused by a mutation to RECQL4
Mutations

in

RecQL4

result

in

Rothmund-Thomson

Syndrome

(RTS),

RAPADALINO syndrome, or Baller-Gerold Syndrome (BGS). Patients suffering from
these syndromes display growth retardation and radial defects [111]. RAPADALINO
patients are most commonly found in Finland and are distinct from those suffering from
the other syndromes in that they do not show clinical features such as poikiloderma.
RTS is the most common of the three syndromes, and patients age rapidly, are
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sensitive to light, have skin and skeletal abnormalities and, at the cellular level, cells
depleted for RecQL4 have increased chromosomal instability (Figure 1.9) [172-174].
RecQL4 can be found in the cytosol, mitochondria and nucleus, has peak
expression during S phase and highest expression is found in the testis and thymus
[175]. RecQL4 has a role during replication, particularly in its initiation, and work has
been carried out in Drosophila, Xenopus, and Chicken DT40 cells to explore this
function. In Drosophila and Chicken DT40 cells, RecQL4 binds to origins of replication
during G1/S phase of the cell cycle and physically interacts with MCM2-7 helicase,
MCM10, GINS, and CDC45 [35, 176-179]. Additionally, RecQL4 in Xenopus shares
sequence similarity to S. cerevisiae Sld2, which is responsible for initiating replication
and DNA Pol α loading onto origins. RecQL4 interacts with TRF1, TRF2, and POT1
(shelterin proteins), which help unwind telomeric D-loops by stimulating RecQL4 activity
[180-182]. Cells depleted for RecQL4 have telomere defects, specifically in telomere
replication, and it has been shown that RecQL4 localizes to telomeres during S phase
[157, 180, 181, 183-185]. RecQL4 may also play a role in the intra-S phase checkpoint
response as cells depleted for RecQL4 are unable to arrest in S phase following
treatment with HU, UV light, or IR [186, 187].
Mouse models have been generated to study RTS and most mutations in
patients who have RTS syndrome map to the helicase domain [188]. One such mutation
has exon 13 (motif III) deleted and mice have reduced lifespan and those that do
survive are smaller and have skin abnormalities [188]. Another mouse model to study
RTS was created by mutating the helicase domain in exons 9-13 of RecQL4, which
results in a truncated protein. These mice die rapidly, within 24 hours of birth, and have
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skin and skeletal abnormalities. Additionally, in these mice if the mutated tumor
suppressor gene APC is combined with the RecQL4 mutation, the mice have a higher
incidence of cancer and increased chromosomal instability [189, 190].

A

B

C

Figure 1.9. Patients showing clinical features of Rothmund-Thomson syndrome
A) This patient is a 4 year-old girl who shows chronic poikloderma on the cheek. B) This
is another patient who shows poikloderma on the cheek more visibly. C) X-Ray of a
patient showing bone defects. Images are from Bartyik et al. (2013) and Wang et al.
(2001).

RECQL1 and RECQL5
RECQL1 has no associated human disease and is the smallest of the RecQ like
proteins with a molecular mass of approximately 71 kD [173]. Several studies have
implicated RECQL1 as being an important component in regulating genome stability
[35, 191]. Studies have revealed that RECQL1 possess ATPase activity and is capable
of unwinding short lengths of duplex DNA in vitro [192]. RECQL1 has been shown to
interact with RPA and mismatch repair factors Msh2/Msh6, Exo1, Mlh1/Pms2,
Topoisomerase III, importin homologs, and Rad51 [191, 193-195]. The functional
significance of these protein-protein interactions, however, remains unknown.
RecQL5 consists of 19 exons and encodes three alternatively spliced isoforms,
RecQL5α, RecQL5β and RecQL5γ [196]. In human tissues RecQL5 isoforms are
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expressed with high abundance in the testis [196]. RECQL5 possess DNA dependent
ATPase activity and contains a DExH and Zn binding domains at its N terminus [197].
The helicase possesses 3’-5’ polarity and has a unique C terminal half that has been
implicated in DNA strand annealing activity [197]. RecQL5 has also been found to
interact with RNAPII, which may implicate RecQL5 in transcription [197].

Table 1.2. DNA helicases involved in maintaining genome integrity
Gene

Disease

BLM

Bloom
syndrome

Metabolic
Pathway
DSB repair and
repair of
damage during
replication

Biochemical
properties
3’-5’ helicase,
HJ branch
migration, G4
structure
resolution, fork
regression and
strand
annealing
3’-5’ helicase
and
exonuclease,
HJ branch
migration, G4
structure
resolution, fork
regression and
strand
annealing

Type of
Cancer
Leukemia,
lymphomas,
adult epithelial
tumors

Melanomas,
sarcomas,
meningiomas,
osteosarcomas,
thryroid
neoplasms,
lymphoid
neoplasms

WRN

Werner
syndrome

DSB repair and
response to
replication
stress

RECQL4

RothmundThomson
syndrome,
Baller Gerald
syndrome, and
RAPADILINO
syndome

BER,
mitochondrial
genome
stability, DNA
replication

3’-5’ helicase
and strand
annealing

Lymphomas
and osteogenic
sarcomas

ND

DNA replication
and oxidative
DNA damage
response

3’-5’ helicase,
HJ branch
migration and
strand
annealing

Pancreatic
cancer

RECQL1
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Table 1.2 (continued)

PIF1

ND

FANCJ

Fanconi
Anemia (FA)

XPD

XPB

Xeroderma
pigmentosum,
xeroderma
pigmentosum
with Cockayne
syndrome, TTD
and COFS
Xeroderma
pigmentosum,
xeroderma
pigmentosum
with Cockayne
syndrome, and
TTD

Fork
progression,
telomere
maintenance,
and
mitochondrial
DNA
metabolism
DSB repair and
intercross link
repair

5’-3’ helicase
and G4
resolvase

Breast cancer
predisposition

5’-3’ helicase
and G4
resolvase

Acute myeloid
leukemia and
breast cancer

Nucleotide
excision repair
and
transcription

5’-3’ helicase

Skin cancer

Nucleotide
excision repair
and
transcription

3’-5’ helicase

Skin cancer

5’-3’ helicase,
Maintenance of
and
Dyskeratosis
RTEL1
telomeres and
disassembly of
congenita
D-loops and THR
loops
This table was adapted and modified from a review by Brosh (2013).

Adult glioma

NON-RECQ LIKE DNA HELICASES AND THEIR ROLE IN THE MAINTENANCE OF
GENOME INTEGRITY
Among nuclear proteins in S. cerevisiae, there are 23 with helicase activity and
evidence for functions in DNA repair. Of the 23 proteins with helicase activity, non-RecQ
DNA helicases with a role in DNA repair were selected and will be discussed here.
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Chl1 has a role in sister chromatid cohesion
S. cerevisiae Chl1 is a DNA helicase that is important for sister chromatid
cohesion.

Mutations

RAD21/Mcd1/Scc1,

in

the

SMC3,

human

cohesion

HDAC8/Hos1,

subunits

APRIN/Pds5,

(SMC1A/Smc1,
NPBL/Scc2,

BACH1/BRIP/FANCJ/Chl1, ESCO2/Eco1/Ctf7, and ChIR1/DDX11/Chl1) result in
Cornelia de Lange Syndrome, Roberts Syndrome, Warsaw Breakage Syndrome and
Fanconi Anemia [198-210]. Chl1 has recently been shown to play a role in recruiting
and regulating the cohesion subunit Scc2 to chromatin during S-phase [211]. It has
been proposed that Chl1 may be removing DNA secondary structures to allow for
recruitment of Scc2 during S phase and thereby promoting sister chromatid cohesion
[211].

Irc20 functions during DSB repair
IRC20 was found in a screen for gene deletions that increase the formation of
Rad52 foci [212]. Irc20 is part of the Snf2/Swi2 family of helicases and has a C3HC4
domain that is part of the RING subset of E3 ligases [213]. Cells lacking Irc20 have
reduced SDSA events, shows decreased crossover events, and inhibit activity of Srs2
and Mre11 [214]. It was found through crossover assays that Irc20 may function prior to
the formation of a D-loop, followed by disassembly by Srs2 to promote SDSA over dHJ
intermediate formation [214]. It was found that irc20∆ suppressed the defects of mre11∆
cells (inhibition of SDSA, NHEJ, and crossover events) and that this suppression was
partially dependent on Exo1 [214]. This suggests that Irc20 is important in shuttling
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DSBs to be processed by Mre11 to initiate end resection and that the absence of Irc20
results in formation of more 3’ ssDNA at DSBs [215].

Mph1 is involved in preventing crossovers and has a role in error-free
bypass of DNA lesions
Mph1, a 3’-5’ DNA helicase, is related to human FANCM, and has been shown to
disrupt Rad51 D-loops, suggesting that it has anti-recombination functions [216, 217].
The absence of Mph1 results in increased crossover frequency, and this role is
independent of Sgs1 and Srs2 [218]. Mph1 has been proposed to play a role in errorfree lesion bypass repair by template switching and cells lacking Mph1 have a mutator
phenotype and impairment of sister chromatid cohesion [219, 220]. Mph1 can form and
unwind D-loop structures during SDSA repair of DSBs, and may be involved in
reversing these D-loop structures at stalled replication forks [218].

Pif1 has a role at telomeres, double-strand breaks and promoting fork
progression through aberrant DNA structures
Pif1 is a 5’-3’ DNA helicase that is found in the nucleus and mitochondria, and
has roles in telomere maintenance, resolving G-quadruplex DNA, Okazaki fragment
processing, and unwinding duplex DNA [221-226]. Pif1 was initially discovered from a
screen for mutations that affect recombination between rho+ and rho- mitochondrial
genomes and it was found that Pif1 deficient cells had reduced mitochondrial DNA
recombination resulting in a greater loss of mtDNA compared to wildtype [221, 227,
228].
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In the absence of Pif1, the length of telomeres increased by ~75 base pairs and
this was not only at chromosomal ends but also at intrachromosomal DSBs [229]. Pif1
directly disassembles telomerase from telomeric ends in a helicase dependent manner,
thereby reducing the processivity of telomerase [226]. Pif1’s role at telomeres is further
evidenced by the fact that it binds RNA-DNA hybrids with greater affinity than DNADNA, supporting the notion that Pif1 disassembles TLC1, the RNA portion of
telomerase [230-232].
Using ChIP analysis it was found that Pif1 has a strong affinity for G4 structures
in vivo during late S/G2 phase of the cell cycle and fork progression is hindered in its
absence [233]. Pif1 also has a role at the replication fork and is thought to pause the
fork at the rDNA region. During HR, Pif1 works with Pol δ to displace the newly
synthesized DNA strand and promote D-loop migration [225]. Although mutations in
mice show no visible phenotype, defects in human PIF1 results in breast cancer
predisposition, suggesting a possible role for PIF1 as a tumor suppressor [234].

Rad5 is involved in error-free PRR
DNA lesions can be resolved by post replication repair (PRR). PRR is dependent
upon Rad6 and Rad18, which form a ubiquitin ligase and conjugating enzyme complex
[235]. In S. cerevisiae, the Rad6-Rad18 complex promotes replication through DNA
lesions through several pathways. DNA polymerase pol ƞ and pol ƹ allow for
progression through DNA lesions in an error-prone manner [236]. Alternatively, an errorfree mode of repair using Rad5-Mms2-Ubc13 can used. Rad5 belongs to the SWI/SNF2
superfamily of proteins and contains seven conserved helicase-like motifs [237, 238].
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Mms2 and Ubc13 interact and promote the assembly of polyubiquitin chains linked
through lysine 63 [239, 240]. Pol30 encodes PCNA which is the proliferating cell nuclear
antigen, a sliding clamp on DNA, which is important for modulating different lesion
bypass pathways and possibly providing support for TLS polymerases to bind [240]. In
the presence of DNA damage, PCNA is monoubiquitinated at lysine 164 by Rad6Rad18 [241]. The lysine is then polyubiquitinated by a lysine 63-linked ubiquitin chain in
an Mms2-Ubc13-Rad5 dependent manner [241]. Monoubiquitination of PCNA results in
activation of TLS (Pol ƞ and Pol ƹ) whereas polyubiquitination of PCNA results in PRR
[239, 242]. In PRR, it is thought that the lesion is bypassed by template switching and
fork regression where the newly synthesized strand encountering an obstacle uses the
sister duplex as a template to ensure error-free repair (Figure 1.10) [236].
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Figure 1.10. Mechanisms for DNA lesion bypass.
Lesions at the replication fork can lead to fork stalling and genome instability. The cell
can bypass these lesions using translesion synthesis or template switching. In the
presence of such lesions, Rad6-Rad18 have a key role in shuttling the damage to a
particular pathway. Rad6-Rad18 monoubuitinates PCNA, promoting error prone
translesion synthesis. Rad5-Mms2-Ubc13 can promote polyubiquitination of PCNA
which leads to an error-free mode of repair using template switching. The lesion can be
bypassed using the nascent lagging strand as a template for synthesis past this lesion.
Image adapted from Cimprich and Chang (2009).

Rrm3 has a role in replication fork progression
Rrm3 is a 5’-3’ DNA helicase that is a member of the Pif1 family of DNA
helicases and is highly conserved from yeast to humans [61]. S. cerevisiae RRM3 was
first discovered as a suppressor of recombination between tandem arrays and
ribosomal DNA (rDNA) repeats [243]. In the absence of Rrm3 there are elevated levels
of extrachromosomal rDNA circles, suggesting a role in maintaining rDNA stability. The
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cells accumulate X-shaped intermediates at stalled replication forks, which are detected
by 2D gel electrophoresis. This has led to the possibility that Rrm3 facilitates in
displacing the DNA-protein block and in unwinding of DNA to help fork convergence
during replication termination [244]. Additionally, in the absence of Rrm3 there is an
increase in replication fork pausing at the ribosomal DNA, centromeres, telomeres,
tRNA, HML/HMR loci, inactive origins, and RNA polymerase II (Pol II) – transcribed
genes [243, 245, 246].
Rrm3 has an important role in fork progression and maintaining genome integrity,
because in its absence there are broken replication forks within rDNA, tRNA, and
subtelomeric DNA [61, 245]. The mechanism by which Rrm3 aids in fork progression is
poorly understood, but it is thought that Rrm3 removes aberrant structures during
replication [61]. S. cerevisiae rDNA is composed of 200 tandem copies of ~9.1-kb
repeating unit on chromosome XII [247, 248]. Within the coding regions of these RNAs
there are two intergenic spacers, IGS1 and IGS2, that contain two tandem Ter sites
[249]. The two Ter sites are bound by the replication terminator protein, Fob1, to
promote fork arrest in order to prevent unscheduled transcription [250, 251]. The Ter
sites also require the intra-S phase checkpoint proteins Tof1 and Csm3, which form a
complex at the replication fork and antagonize Rrm3 function [252, 253]. It is thought
that Rrm3 removes Fob1 and X-shaped intermediates from Ter sites during fork
movement and other non-histone proteins on DNA ahead of the replication fork [244].
Type IA (Top3) and type II (Top2) topoisomerases have a role in replication termination,
but Top2 resolves the strain created at TERs as evidenced by the fact that in the
absence of Top2, there are increased levels of breaks and rearrangements [244, 254-
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258]. Direct evidence for Rrm3 in facilitating fork merging has not been shown, but
recent evidence shows that fission yeast Pfh1 has similar functions to Rrm3 and
promotes fork merging at replication termination sites [259]. Rrm3 also has a role in
replicating telomeric and subtelomeric DNA and in the absence of Rrm3 there is
increased pausing within telomeric repeats [246]. It has been shown that the ability of
Rrm3 to promote replication through these regions is dependent on its catalytic function
[260]. Taken together this data suggests that Rrm3 helps to prevent aberrant
chromosome segregation and helps to maintain genome stability.
Further evidence indicating Rrm3 has a role in fork progression is shown by the
fact that rrm3∆ shows growth defects with rad53∆, srs2∆, sgs1∆, mrc1∆, and rtt101∆,
components involved in maintaining the stalled fork [261-263]. Srs2 is also a 3’-5’ DNA
helicase that has been implicated in resolving lethal recombination intermediates at
sites of DNA damage and this function becomes crucial in the absence of Rrm3 or Sgs1
[261, 262]. Cells lacking Rrm3 and Sgs1 or Srs2 have increased doubling times and
rrm3∆ srs2∆ cells accumulate in G2/M [261]. In the absence of Mrc1 there is a slower
rate of replication and it has been shown that Rrm3 is important in repairing the damage
[264]. The sensor and effector kinases Mec1 and Rad53 are important in the absence of
Rrm3, as there is a severe growth defect in their absence [245, 262]. Upon activation of
the checkpoint response in the presence of DNA damage in rrm3∆ cells, Rad53 is
constitutively phosphorylated [245, 265]. Rrm3 is hyper-phosphorylated by Rad53 under
replication stress, and it has been proposed that this inhibits its activity in response to
DNA damage to allow for repair [265].
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Srs2 functions in multiple DNA metabolic processes
Srs2 is a DNA helicase that shares homology with the bacterial Rep, PcrA, and
UvrD [266]. It was first discovered as a suppressor of sensitivity of rad6∆ and rad18∆
mutants (Suppressor of RAD Six mutant 2) [267, 268]. Srs2 has 3’-5’ polarity, strong
ssDNA dependent ATPase activity, and can resolve D-loops and forks [269]. RPA
enhances Srs2’s ability to resolve long substrates and in its absence cells have higher
recombination events, cannot accurately complete post replication repair, and have
problems with the DNA damage checkpoint [270-272].
Srs2 is thought to function early in HR and displaces Rad51 presynaptic filament
[273]. This is supported by experiments in S. cerevisiae where SRS2 deletion resulted
in a hyper-recombination phenotype [272]. A srs2∆ sgs1∆ cell was found to be slow
growing, suggesting that improper regulation of HR can be deleterious to the cell. Srs2
may also have a role in PRR as shown by increased sensitivity of srs2∆ cells to UV light
[274]. Srs2 may be deciding whether a lesion should be repaired by HR or PRR [235].

HYPOTHESIS AND AIMS
Helicases have important roles in DNA metabolism and maintaining genome
integrity. Defects in many helicases are associated with cancers and genetic disorders.
Studying helicases involved in maintaining genome stability in S. cerevisiae has helped
elucidate their functions in humans, but the complexity of the DNA damage response
leaves us with many unanswered questions. Here, we functionally characterize RecQlike (Sgs1 and RecQL5) and non-RecQ like (Rrm3) helicases and hypothesize that
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defects in these helicases, with roles in DNA replication and repair, will result in genome
instability. This hypothesis will be addressed through the following aims:

Aim 1 (Chapter Two) – We seek to identify the role of the conserved functional domains
of Sgs1 of S. cerevisiae in the maintenance of genome integrity.

Aim 2 (Chapter Three) – We seek to identify human RecQL5 interacting proteins and to
test the ability of RecQL5 to complement Sgs1 functions in yeast to shed light on
cellular pathways that RecQL5 functions in.

Aim 3 (Chapter Four) – We seek to identify DNA metabolic pathways that respond to
stalled forks in the absence of Rrm3 using stable isotope labeling by amino acids in cell
culture (SILAC)-based quantitative mass spectrometry.

SIGNIFICANCE
This work will allow for a better understanding of nonreplicative helicases
involved in DNA repair and may reveal additional components involved in the DNA
damage response. Elucidating such factors may lead to a greater understanding of how
these proteins are involved in the development of hereditary cancer syndromes, with
implications that may lead to a greater quality of life among affected individuals.
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CHAPTER TWO:
SGS1 TRUNCATIONS INDUCE GENOME REARRANGEMENTS BUT SUPPRESSES
DETRIMENTAL EFFECTS OF BLM OVEREXPRESSION IN SACCHAROMYCES
CEREVISIAE
Note to the reader: This chapter has been previously published with permission from the
publisher as Mirzaei, H, Syed, S, Kennedy, JA, and Schmidt, KH (2011). “Sgs1
Truncations Induce Genome Rearrangments but Suppress Detrimental Effects of BLM
Overexpression in Saccharomyces cerevisiae.” J Mol Biol., 405(4); 877-891. Research
was designed by K. Schmidt. Sgs1 Truncations and experiments were performed by S.
Syed. BLM diploid experiments and chimera protein construction was done by H.
Mirzaei. Point mutations and experiments in zinc-binding domain were done by H.
Mirzaei and J. Kennedy. Corresponding author: Kristina Schmidt, Department of Cell
Biology, Microbiology and Molecular Biology, University of South Florida, 4202 E.
Fowler Avenue, ISA2015, Tampa, FL 33620. Phone: (813) 974-1592. Fax: (813) 9741614.; E-mail: kschmidt@usf.edu

ABSTRACT
RecQ-like DNA helicases are conserved from bacteria to humans. They perform
functions in the maintenance of genome stability, and their mutation is associated with
cancer predisposition and premature aging syndromes in humans. Here, a series of Cterminal deletions and point mutations of Sgs1, the only RecQ-like helicase in yeast,
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show that the HRDC and Rad51 interaction domain are dispensable for Sgs1’s role in
suppressing genome instability, whereas the zinc-binding domain and the helicase
domain are required. BLM expression from the native SGS1 promoter had no adverse
effects on cell growth, but also was unable to complement any sgs1Δ defects. BLM
overexpression, however, significantly increased the rate of accumulating GCRs in a
dosage dependent manner and greatly exacerbated sensitivity to DNA-damaging
agents. Co-expressing sgs1 truncations of up to 900 residues, lacking all known
functional domains of Sgs1, suppressed HU sensitivity of BLM overexpressing cells,
suggesting a functional relationship between Sgs1 and BLM. Indeed, protein disorder
prediction analysis of Sgs1 and BLM was used to produce a functional Sgs1-BLM
chimera by replacing the N-terminus of BLM with the disordered N-terminus of Sgs1.
The functionality of this chimera suggests that it is the disordered N-terminus, a site of
protein binding and post-translational modification, that confers species-specificity to
these two RecQ-like proteins.

INTRODUCTION
RecQ-like DNA helicases, named after the DNA repair protein RecQ of
Escherichia coli, (Hegde, Qin et al. 1996, Morimatsu and Kowalczykowski 2003,
Ivancic-Bace, Salaj-Smic et al. 2005) are evolutionarily highly conserved. These 3′- to
5′-helicases function at the interface between DNA replication and recombination to
maintain genome integrity. Sgs1 is the only known member of this helicase family in
Saccharomyces cerevisiae (Gangloff, McDonald et al. 1994). Sgs1-deficient cells show
increased sensitivity to the DNA-damaging agents hydroxyurea (HU) and methyl
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methanesulfonate

(MMS),

missegregate

chromosomes,

accumulate

gross-

chromosomal rearrangements (GCRs), and have a shortened life span (Sinclair, Mills et
al. 1997, Mullen, Kaliraman et al. 2000, Fricke and Brill 2003, Schmidt, Wu et al. 2006).
In contrast, five RecQ-like helicases (RecQL1, BLM, WRN, RecQL4, and RecQL5) are
known in humans, and mutations in the BLM, WRN, and RECQL4 genes are associated
with the rare, cancer-prone Bloom's syndrome (BS), Werner syndrome, and Rothmund–
Thompson syndrome, respectively (Ellis, Groden et al. 1995, Yu, Oshima et al. 1996,
Kitao, Ohsugi et al. 1998, Kitao, Shimamoto et al. 1999, German, Sanz et al. 2007,
Garcia-Rubio, Chavez et al. 2008). All RecQ-like helicases share a seven-motif helicase
domain with Walker A and DEAH motifs. The RecQ-helicase-conserved (RQC) domain,
located C-terminal to the helicase domain, is thought to be involved in DNA binding and
conferring specificity of binding to DNA structures, such as G4 tetrads (von Kobbe,
Thoma et al. 2003, Guo, Rigolet et al. 2005, Lee, Kusumoto et al. 2005, Huber,
Duquette et al. 2006). The Helicase/RNase D C-terminal (HRDC) domain is the most Cterminal of the conserved domains and resembles domains in other proteins that are
involved in nucleic acid metabolism, such as RNase D and UvrD; however, similar to
the RQC domain, it is not found in all RecQ-like helicases (Morozov, Mushegian et al.
1997, Kitano, Yoshihara et al. 2007). The HRDC domain has been implicated in binding
and resolving DNA structures, such as Holliday junctions, and in mediating protein–
protein interactions (Liu, Macias et al. 1999, Bernstein and Keck 2005, Wu, Chan et al.
2005, Kitano, Yoshihara et al. 2007, Killoran and Keck 2008). Two acidic regions have
also been identified N-terminal of the helicase domain and may be involved in mediating
protein–protein interactions (Kitao, Ohsugi et al. 1998, Miyajima, Seki et al. 2000,
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Bernstein, Shor et al. 2009). Sgs1 is found in a complex with Top3 and Rmi1, and there
is also evidence of physical interactions of the N-terminal half of Sgs1 with Top2, Srs2,
and Rad16 and interactions of the C-terminus with Mlh1 and Rad51 (Watt, Louis et al.
1995, Bennett, Noirot-Gros et al. 2000, Duno, Thomsen et al. 2000, Fricke, Kaliraman et
al. 2001, Chang, Bellaoui et al. 2005, Chiolo, Carotenuto et al. 2005).
Defects in BLM, the human RecQ helicase considered to be most closely related
to Sgs1, cause BS, an autosomal recessive disorder characterized by chromosome
gaps and breaks, elevated sister chromatid exchange, mitotic hyper-recombination, and
aberrant DNA replication events (Chaganti, Schonberg et al. 1974, Hojo, van Diemen et
al. 1995, Bachrati and Hickson 2003). Affected individuals suffer from a high incidence
and wide variety of cancers, infertility, and dwarfism (reviewed in Bachrati et al. 2003).
BLM catalyzes ATP-dependent 3′- to 5′-DNA unwinding, with a preference for DNA
structures that may arise spontaneously during DNA replication or as a result of
homologous recombination (HR) (Mohaghegh, Karow et al. 2001). For example, by
unwinding unusual secondary DNA structures, BLM may aid replication fork
progression, prevent illegitimate recombination during replication, and assist in
restarting stalled forks (Ralf, Hickson et al. 2006, Wu and Hickson 2006, Hanada and
Hickson 2007, Bachrati and Hickson 2008). Evidence supporting a role of BLM in
maintaining genome integrity has been accumulating. For example, BLM-defective cells
exhibit a retarded rate of strand elongation during DNA replication (Hand and German
1975), accumulate abnormal replication intermediates (Lonn, Lonn et al. 1990), and are
hypersensitive to agents that impair DNA replication (Davies, North et al. 2004). BLM
physically interacts with several proteins that play important roles during DNA
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replication and repair, such as replication protein A, flap endonuclease 1, chromatin
assembly factor 1, the mismatch repair protein Mlh1, HR factor Rad51, and
topoisomerase III α (Brosh, Li et al. 2000, Johnson, Lombard et al. 2000, Langland,
Kordich et al. 2001, Wu, Davies et al. 2001, Jiao, Bachrati et al. 2004, Sharma,
Sommers et al. 2004, Wu, Bachrati et al. 2006). BLM peaks in S phase and it localizes
to replication foci, most likely through its physical interaction with a subunit of DNA
polymerase δ (Dutertre, Ababou et al. 2000, Sanz, Proytcheva et al. 2000, Yankiwski,
Marciniak et al. 2000, Bischof, Kim et al. 2001, Selak, Bachrati et al. 2008).
Here, we have determined the role of C-terminal domains and protein interaction
sites of Sgs1 in suppressing GCR accumulation by expressing point mutants and
truncations of Sgs1, lacking as few as 20 residues and as many as 1428 residues.
Human BLM cDNA was expressed under control of the native SGS1 promoter and
overexpressed from a galactose-inducible promoter to investigate BLM's ability to
complement sgs1Δ defects (such as increased genome instability and sensitivity to HU
and MMS), revealing that BLM could suppress sgs1Δ defects neither in haploid nor in
diploid cells. However, using computational protein disorder prediction tools, we have
designed a yeast–human chimera that consists of two nonfunctional segments of BLM
and Sgs1. The ability of this chimera to suppress all sgs1Δ defects that we tested
suggests a functional relationship between BLM and Sgs1, which is also supported by
our finding that short N-terminal fragments of Sgs1, which are devoid of all known
functional domains for helicase activity and DNA binding, suppress severely detrimental
effects of BLM overexpression in yeast.

61

RESULTS
Requirement of the RQC domain of Sgs1, but not the HRDC domain, for
GCR suppression
Sgs1 contains a conserved DEAH helicase domain, a conserved HRDC domain,
two acidic regions (AR1 and AR2), and an RQC domain composed of zinc-binding and
winged-helix domains. Several protein interaction sites have also been located in the
1447-amino-acid-long protein (Fig. 1a). To determine the role of these domains in the
maintenance of genome stability, we generated systematic deletions to the 3′-end of the
chromosomal SGS1 gene, such that truncations of the C-terminus of Sgs1, ranging
from 20 to 1428 amino acids, were expressed as fusions to a myc epitope. Truncations
of up to 80 amino acids were constructed to not affect any known functional domain of
Sgs1, while ΔC100 and ΔC200 deletions partially and completely removed the HRDC
domain and ΔC300 and ΔC400 deletions partially and completely removed the RQC
domain, respectively. The largest deletions (ΔC700, ΔC800, ΔC900, ΔC1000, and
ΔC1100) eliminate the entire helicase domain, including the Walker A motif (residues
803-812), with the ΔC800–ΔC1100 deletions also affecting the part of the N-terminal
half of Sgs1 that contains protein interaction sites (e.g., Rad16, residues 421–792;
Top2, residues 432–724; and Srs2, residues 422–722) and two acidic regions (AR1,
residues 321–447; AR2, residues 502–648), whereas ΔC500 and ΔC600 deletions
partially remove the helicase domain while leaving the Walker A motif intact (Fig. 1a).
All truncation alleles were stably expressed from the chromosomal SGS1 locus under
control of the native SGS1 promoter (Fig. 1b). C-terminal fusion to the myc epitope did
not adversely affect Sgs1 function, as indicated by equal sensitivity to HU and MMS of
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strains expressing tagged and untagged Sgs1 (wild type) (Fig. 2a). The largest deletion,
leaving intact only the 19 N-terminal amino acids of Sgs1 (sgs1ΔC1428), was as
sensitive to HU and MMS as a complete SGS1 deletion (sgs1Δ), thus behaving similar
to a null allele (Fig. 2a). Loss of up to 200 C-terminal amino acids did not increase
sensitivity to HU or MMS, whereas loss of 300 or more amino acids led to sensitivity
similar to that of the sgs1ΔC1428 and sgs1Δ mutants (Fig. 2a). The construction of
additional 20-amino-acid truncations extended the C-terminal region that is dispensable
for HU/MMS resistance to 240 amino acids (Fig. 2b).
It was previously shown that cells lacking the DNA helicase Srs2 (srs2Δ) depend
on functional Sgs1 for their viability (Lee, Johnson et al. 1999). To assess the ability of
sgs1 truncation alleles to support growth of the srs2Δ mutant, we constructed diploid
strains heterozygous for the srs2Δ deletion and heterozygous for the sgs1ΔC200,
sgs1ΔC260, or sgs1ΔC300 allele. The meiotic products of the sporulated diploids were
spread on nonselective, rich media [yeast–peptone–dextrose (YPD)], allowing all spores
to grow (Fig. 2c). Diploids heterozygous for the srs2Δ deletion and for the sgs1ΔC200
truncation yielded spores that grew into colonies of the same size, suggesting that the
200 C-terminal amino acid residues of Sgs1, which harbor the HRDC domain and an
interaction site with the HR factor Rad51, are not required for the viability of the srs2Δ
mutant. In contrast, sporulation of diploids heterozygous for the srs2Δ deletion and
sgs1ΔC260 or sgs1ΔC300 allele yielded mixtures of normal-sized and small colonies.
Genotyping revealed that the small colonies were srs2Δ sgs1ΔC260 or srs2Δ
sgs1ΔC300 mutants, whereas the normal-sized colonies corresponded to wild-type
spores or single mutants. Thus, Sgs1 that lacks 260 or more C-terminal residues and
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therefore does not contain a complete RQC domain cannot support normal growth of
cells lacking Srs2.
When we tested the effect of the C-terminal deletions on the accumulation of
GCRs, we found that 240 C-terminal amino acids were dispensable for maintaining
genome integrity, whereas deleting as little as an additional 20 amino acids
(sgs1ΔC260) caused the GCR rate to increase to that exhibited by the null mutant
without a discernable intermediate phenotype (Table 1). Combining the sgs1ΔC300
truncation allele with a deletion of the DNA-damage checkpoint sensor MEC3 led to a
synergistic GCR rate increase, while, as expected, combining the sgs1ΔC200 allele with
a mec3Δ mutation did not. Thus, these findings show that the HRDC domain and the
previously reported C-terminal interaction with Rad51 are not required for Sgs1's role in
preventing the accumulation of GCRs and supporting normal growth of the srs2Δ
mutant, whereas the integrity of the RQC domain, which has been suggested to span
residues 1075–1207 based on the alignment of three-dimensional structures (Kitano,
Kim et al. 2010), is essential.

BS-associated RQC domain mutations cause loss of Sgs1 function in vivo
Of the 32 exonic base substitutions that are causative of BS, 13 are missense
mutations (Ellis, Groden et al. 1995, Foucault, Vaury et al. 1997, Barakat, Ababou et al.
2000, German, Sanz et al. 2007), with 6 of these mutations affecting conserved
residues that have been shown in vitro to participate in zinc binding and G-tetrad DNA
binding activity (Fig. 3a). Studies, however, have been limited to biochemical and
biophysical analyses of mutant proteins and were hampered by the inability to purify
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some mutant BLM proteins (Janscak, Garcia et al. 2003, Guo, Rigolet et al. 2005,
Huber, Duquette et al. 2006). Since the cysteine residues are highly conserved between
RecQ-like helicases, including Sgs1, we replaced the corresponding cysteine residue in
Sgs1 with the BS-associated mutation (sgs1-C1047F). Unlike BLM with mutations in
any of the three conserved cysteine residues C1036, C1063, or C1066, which degraded
upon purification and could therefore not be characterized (Janscak, Garcia et al. 2003),
the sgs1-C1047F mutant allele was stably expressed in vivo from the native SGS1
locus (Fig. 3b). The sgs1-C1047F mutant showed an increased HU and MMS
sensitivity, which, however, did not reach the level of the sgs1Δ allele, and exhibited
levels of GCR accumulation comparable to the sgs1Δ mutant, demonstrating that the
C1047F mutation severely impairs Sgs1 function (Fig. 3c; Table 1). In addition to
conserved cysteine residues and immediately adjoining arginine (R1037) and aspartic
acid (D1064) residues, ClustalW2 alignments showed F1056 to be the only other fully
conserved amino acid residue in the zinc-binding domain of Sgs1 (Fig. 3a). Although
the corresponding residue in BLM (F1045) is not associated with a BS mutation, the
BLM-F1045A mutation has been shown to cause a severe helicase defect and a singlestranded DNA (ssDNA) binding deficiency in vitro (Janscak, Garcia et al. 2003). When
we introduced the corresponding mutation into Sgs1 (F1056A), however, the mutant
was no more sensitive to HU and MMS than wild-type cells (Fig. 3c) but instead
appeared fully functional with a wild-type GCR rate (Table 1).

65

Expression of human BLM cDNA from the endogenous SGS1 promoter
does not complement sgs1Δ defects
RecQ-like DNA helicases are evolutionarily conserved from bacteria to humans.
Since cells from BS patients share defects seen in sgs1Δ cells, including increased
sensitivity to DNA-damaging agents, increased levels of aberrant genetic exchange,
and reduced life span, it has been suggested that RecQ-like DNA helicases from
different phyla or even kingdoms might complement each other, thus allowing the
development

of

simple

model

organisms

for

the

functional

and

mutational

characterization of disease-associated human RecQ-like helicases, such as BLM and
WRN (Yamagata, Kato et al. 1998). Thus, to assess the ability of BLM to suppress
genome instability in the sgs1Δ mutant, BLM cDNA was inserted in-frame with the start
codon of SGS1 at its chromosomal locus (PSGS1BLM). We reasoned that insertion at the
wild-type SGS1 locus would promote cell-cycle-dependent regulation of BLM
expression and expression levels similar to those previously shown for Sgs1 (Frei and
Gasser 2000). Stable expression of BLM was confirmed by Western blot analysis, using
a yeast strain expressing myc-tagged BLM (Fig. 4a); however, all subsequent
experiments were carried out with untagged BLM. Expression of a single copy of BLM
(PSGS1BLM) neither led to a statistically significant difference in the GCR rate compared
to the sgs1Δ mutant (Table 1 and Table 2) nor alleviated HU sensitivity (Fig. 4b),
demonstrating that BLM can be successfully expressed in yeast under control of the
native SGS1 promoter without detrimental effects on cell growth, but is unable to
complement the tested sgs1Δ defects to any extent.
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Overexpression of BLM leads to increased sensitivity to DNA-damaging
agents and rapid accumulation of GCRs
Since a single copy of BLM (PSGS1BLM) did not complement sgs1Δ defects, we
examined the effect of increasing BLM expression levels on sgs1Δ mutant phenotypes.
For this purpose, the native SGS1 promoter was replaced with a GAL1 promoter and
galactose-dependent expression of BLM was verified by fusing BLM to a myc epitope
tag (Fig. 4a). Overexpression of BLM did not compensate for the lack of Sgs1 when
cells were exposed to HU but instead led to a further increase in sensitivity to HU
compared to the sgs1ΔC1428 cells or cells expressing BLM under the SGS1 promoter
(Fig. 4b). We found that maximum induction of BLM expression led to a 1665-fold
increase in the GCR rate compared to wild type and a 34-fold increase compared to the
sgs1Δ mutant assayed under the same conditions (Table 2). In contrast, overexpression
of Sgs1 from the GAL1 promoter did not lead to GCR accumulation (Table 2). The GCR
rate increase upon BLM overexpression was dependent on induction levels, with the
GCR rate gradually decreasing to that of the sgs1Δ mutant as the galactose
concentration in the media decreased (Table 2). Thus, sgs1Δ defects cannot be
complemented by any level of BLM expression; in fact, increasing BLM expression
levels induce higher sensitivity to DNA-damaging agents and significantly higher
genome instability compared to that of the sgs1Δ mutant.

N-terminus of Sgs1 suppresses detrimental effects of BLM overexpression
Since Sgs1 is important for the suppression of illegitimate recombination
between identical sequences, such as those found in related genes, on homologous
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chromosomes, and on sister chromatids, we tested the HU sensitivity of diploid strains
expressing truncated sgs1 alleles in the presence or in the absence of the SGS1 wildtype allele (Fig. 5). HU sensitivity was fully suppressed for all alleles if a single copy of
wild-type SGS1 was expressed from the other allele (Fig. 5a), demonstrating that the
sgs1 truncation alleles did not have a dominant effect. As in haploid cells, only the
sgs1ΔC200 allele complemented HU sensitivity of the sgs1Δ diploid completely (Fig.
5b); however, cells expressing the sgs1ΔC300 to sgs1ΔC900 alleles were less sensitive
than diploids that expressed larger truncations or the sgs1ΔC1428 null allele (Fig. 5b).
This ability of sgs1Δ300–sgs1ΔC900 truncation alleles to at least partially suppress HU
sensitivity indicates that there may be N-terminal segments in Sgs1 that contribute to
HU resistance.
Diploids expressing BLM from native SGS1 promoters on both alleles were as
sensitive to HU as diploids not expressing Sgs1, whereas diploids overexpressing BLM
from one allele or from both alleles were severely HU sensitive, with the highest
expression level lacking any growth on 100 mM HU (Fig. 5c), reflecting the severe HU
sensitivity of haploid cells expressing the PGALBLM allele (Fig. 4b). Diploids
overexpressing BLM also appeared to grow more slowly than any other diploid tested
here (Fig. 5c). Remarkably, expression of a single copy of SGS1 from its endogenous
promoter (SGS1/PGALBLM) completely eliminated the severe HU sensitivity conferred by
overexpression of BLM. To determine if full-length Sgs1 was required for this
suppression, we crossed the haploid strain overexpressing BLM with haploids
expressing various Sgs1 truncations. We found that a single copy of the sgs1ΔC200
allele was as sufficient as wild-type Sgs1 in suppressing HU sensitivity and slow growth
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of the BLM-overexpressing strain, and as few as 547 N-terminal amino acids remaining
in the sgs1ΔC900 allele were sufficient for significant suppression of HU sensitivity and
slow growth caused by BLM overexpression (Fig. 5c). These findings suggest that none
of the known enzymatic activities or functional and conserved domains are required for
suppressing the HU sensitivity of the BLM-overexpressing diploids but that 547 Nterminal amino acids are sufficient for suppressing the detrimental effects of BLM
overexpression in a diploid. That the sgs1ΔC1000 and sgs1ΔC1100 alleles were clearly
less effective at suppressing HU sensitivity shows that 447 N-terminal amino acids,
which contain the Top3 interaction site, are necessary but not sufficient for
complementation.

Design of a functional Sgs1–BLM chimera
Sgs1 and BLM share about 21% of their amino acid residues in a pairwise
alignment of the full-length proteins (ClustalW2), with most of the identical residues in
the helicase domain. In fact, the N-terminal segment of Sgs1 expressed by the
sgs1ΔC800 allele, which is able to suppress the HU sensitivity of BLM-overexpressing
diploids, shares only 11% with the corresponding N-terminal segment of BLM. Devoid of
conserved domains and known enzymatic activities, the N-terminus of Sgs1 has been
shown to be required for physical interactions with Top3, Top2, Srs2, and Rad16 (Watt,
Louis et al. 1995, Bennett, Noirot-Gros et al. 2000, Duno, Thomsen et al. 2000, Mullen,
Kaliraman et al. 2000, Fricke, Kaliraman et al. 2001, Chiolo, Carotenuto et al. 2005).
Using IUPred, an algorithm for the prediction of intrinsically disordered proteins, we
found that the 650 N-terminal residues contain a similar distribution of ordered and
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intrinsically disordered segments (Fig. 6a and b). In disorder prediction algorithms, such
as IUPred (Dosztanyi, Csizmok et al. 2005, Dosztanyi, Csizmok et al. 2005) a score of
> 0.5 predicts a disordered amino acid residue and a score of < 0.5 predicts an ordered
residue, with 30 consecutive disordered amino acids commonly being used as a lower
limit for detecting disorder in whole proteome searches (Ward, Sodhi et al. 2004,
Dosztanyi, Csizmok et al. 2005, Dosztanyi, Csizmok et al. 2005, Peng, Vucetic et al.
2005). The helicase domains of Sgs1 and of BLM coincide with the predicted ordered
regions in both proteins, starting at around residue 648, and are surrounded by a long
N-terminal and a short C-terminal segment, which contain mostly disordered residues.
In fact, based on the IUPred output scores, 83% of the 648 N-terminal residues of Sgs1
(538/648) are disordered, with 70% of all 648 residues being located in segments of
more than 30 consecutive disordered residues, whereas only 16% of the 800 C-terminal
residues of Sgs1 are predicted to be disordered, with only a single disordered segment
that is longer than 30 residues (residues 1396–1447). Based on the IUPred prediction,
BLM can also be divided into a disordered N-terminus and an ordered C-terminus (Fig.
6a and b). For BLM, 52% of 648 N-terminal residues are predicted to be disordered, but
only 15% of these residues are found in stretches of more than 30 disordered residues.
The difference in the pattern of disorder predicted for the N-terminal segments of Sgs1
and BLM led us to hypothesize that this region may be involved in conferring species
specificity to BLM and Sgs1 function and, thus, prevent BLM from functioning in yeast.
This hypothesis is supported by the fact that the N-terminus of Sgs1 is sufficient for the
complementation of the HU sensitivity induced by overexpression of BLM. To test this
hypothesis, we constructed a yeast–human chimera in which the 647 N-terminal
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residues of BLM were replaced by the 647 N-terminal residues of Sgs1 (sgs1ΔC800blmΔN647) (Fig. 6c). To express this chimera from the native SGS1 promoter, we
replaced nucleotides 1941 to 4344 of the endogenous SGS1 gene with nucleotides
1941 to 4254 of BLM cDNA (Fig. 6e). Remarkably, the chimera was nearly as effective
as wild-type SGS1 in conferring resistance to HU, whereas the N-terminal segment of
Sgs1 by itself was ineffective (Fig. 6d). Moreover, when we combined the chimeric allele
with a mec3Δ mutation, GCRs accumulated at a significantly lower rate than in the
mec3Δ mutant carrying the GCR-deficient sgs1ΔC300 or sgs1ΔC800 allele, albeit not at
the low rate of the mec3Δ mutant carrying the GCR-proficient sgs1ΔC200 allele,
signifying partial functionality of the chimerical protein in the suppression of
chromosomal rearrangements (Table 1). Finally, besides Srs2, the sgs1Δ mutant also
requires the DNA helicase Rrm3 for viability. Synthetic lethality between sgs1Δ and
rrm3Δ mutations is suppressed by disrupting HR factors such as Rad51 and Rad55,
suggesting that the lethality is due to accumulation of aberrant HR intermediates (Ooi,
Shoemaker et al. 2003, Schmidt and Kolodner 2004, Torres, Schnakenberg et al. 2004).
To assess if the Sgs1–BLM chimera was capable of preventing the accumulation of
lethal levels of aberrant recombination intermediates, we constructed a diploid
heterozygous for the rrm3Δ mutation and heterozygous for the sgs1ΔC800-blmΔN647
allele, expressing the Sgs1–BLM chimera. Spreading of spores from this diploid on
YPD, which allows all spores to grow, showed that the rrm3Δ mutant expressing the
chimera grows normally with the diameter of double-mutant colonies measuring
approximately 90% of that of the single mutants (Fig. 6f). These findings indicate that
the Sgs1–BLM chimera is functional and, while not capable of fully suppressing
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chromosomal rearrangements, prevents the accumulation of lethal levels of aberrant
recombination intermediates when Rrm3 helicase is absent.

DISCUSSION
Yeast cells that lack Sgs1 exhibit upregulated and aberrant recombination in
mitosis, increased sensitivity to DNA-damaging agents, accumulation of GCRs,
synthetic lethality with mutations in other DNA metabolic genes, such as the SRS2 and
RRM3 helicase genes, and meiotic defects that lead to poor spore viability (Watt, Louis
et al. 1995, Lee, Johnson et al. 1999, Frei and Gasser 2000, Miyajima, Seki et al. 2000,
Myung, Datta et al. 2001, Cobb, Bjergbaek et al. 2002, Ira, Malkova et al. 2003, Versini,
Comet et al. 2003, Schmidt and Kolodner 2004, Schmidt, Wu et al. 2006). Sgs1
contains several conserved domains (DEAD helicase, RQC, HRDC, AR1, and AR2),
and protein interaction sites (Top2, Top3, Srs2, Rad16, Rad51, and Mlh1) have been
identified by two-hybrid screens (Watt, Louis et al. 1995, Duno, Thomsen et al. 2000,
Saffi, Feldmann et al. 2001, Wu, Davies et al. 2001, Chiolo, Carotenuto et al. 2005).
How the integrity of these conserved motifs and protein–protein interaction sites affects
the role of Sgs1 in suppression of aberrant genome rearrangements has not been
determined. The requirement of some domains and/or protein interaction sites, but not
others, may shed light on the poorly understood mechanism(s) by which Sgs1
contributes to the maintenance of genome integrity in yeast. Here, we find that the
segment made up of 240 C-terminal amino acids, which contains Rad51 and Mlh1
interaction sites and the conserved HRDC domain thought to be involved in DNA
binding and in recognition and processing of double Holliday junctions (Liu, Macias et
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al. 1999, Wu, Chan et al. 2005), is dispensable for Sgs1's role in suppressing GCRs.
The integrity of the RQC domain, however, is essential for GCR suppression. That zinc
binding is crucial for Sgs1 activity, as well as the fact that loss of function of the Cterminal truncation allele was not due to disruption of protein structure/function because
of such a large deletion, was further confirmed by the finding that the point mutation of a
conserved zinc-coordinating cysteine, which has also been observed in BS patients
(Foucault, Vaury et al. 1997), led to the loss of Sgs1's ability to suppress HU sensitivity
and GCR accumulation. This loss of function was not due to degradation of the mutant
protein as had been previously observed for some cysteine mutants of BLM during
attempts at overexpression and purification from E. coli. However, we cannot exclude
the possibility that the loss of function resulted from intracellular mislocalization of the
mutant protein. Previously, modeling of the zinc-binding domain of BLM and instability
of purified mutant proteins had indicated that hydrogen bonds between three conserved
residues, Y1029 (Y1040 in Sgs1), R1037 (R1048 in Sgs1), and D1064 (D1070 in Sgs1),
are required for the folding of the zinc-binding domain and overall protein stability (Guo,
Rigolet et al. 2005). Although F1056 of Sgs1 does not appear to be involved in this zincdomain stabilization and the Sgs1-F1056A mutant protein appears stable in this study,
F1056 is the only other fully conserved residue in the zinc-binding domain of RecQ-like
helicases, suggesting functional significance. However, introduction of the F1056A
mutation had no effect on Sgs1 function in vivo when we assessed HU sensitivity,
consistent with a previous study (Ui, Satoh et al. 2001), or GCR accumulation. That, in a
previous in vitro study (Janscak, Garcia et al. 2003), the corresponding BLM mutation
(F1045A) had severely impaired helicase and ssDNA binding activities could be either
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due to differences in the importance of this residue for enzymatic activity of BLM and
Sgs1 or, more likely, due to the fact that only the helicase-core segment of BLM, lacking
769 residues of N- and C-termini, was purified. The in vitro function of this isolated
domain could be more strongly affected by a mutation than the in vivo function of the
full-length Sgs1 mutant protein assessed here. Although nearly half of all BLM alleles
that are associated with single-amino-acid changes (7 of 17 alleles) in BS patients are
located in the RQC domain (Ellis, Groden et al. 1995, Foucault, Vaury et al. 1997,
Barakat, Ababou et al. 2000, German, Sanz et al. 2007), none affect F1045, consistent
with our finding that mutation of this conserved residue may not be associated with
significant loss of function in vivo.
We find that Sgs1 retains partial functionality even when it lacks the HRDC,
RQC, and DEAH helicase domains, as demonstrated by the greater HU resistance of
diploids that only express 547 N-terminal amino acid residues compared to those alleles
expressing fewer than 447 residues of Sgs1. One possible explanation for this finding is
that protein–protein interactions conferred by the N-terminus could contribute to the
structural stability of multi-protein complexes, such as the Sgs1–Top3–Rmi1 (Chang,
Bellaoui et al. 2005) complex or, even more relevant to HU resistance, DNA-damagespecific complexes with Srs2 and Mre11 (Chiolo, Carotenuto et al. 2005). In these multiprotein complexes, enzymatic activity of Sgs1 may be dispensable. Indeed, sgs1 alleles
with point mutations in the helicase domain have been shown to be capable of
performing some functions of the wild-type allele, including those carried out during
meiosis and checkpoint activation (Miyajima, Seki et al. 2000, Bjergbaek, Cobb et al.
2005).
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In contrast to two previous reports (Yamagata, Kato et al. 1998, Heo,
Tatebayashi et al. 1999), which both used the same yeast strain that constitutively
expressed BLM from a GAPDH promoter and showed partial suppression of some
sgs1Δ defects, including HU sensitivity, we found that neither BLM expression under
control of the natural SGS1 promoter nor varying levels of BLM expression under
control of a galactose-inducible promoter had any positive effect on the sgs1Δ mutant.
That a single copy of BLM, when expressed under control of the native SGS1 promoter,
cannot alleviate sgs1Δ defects initially suggested to us that BLM had no functionality in
yeast. In fact, the strong increase in genome instability, accompanied by severe HU
sensitivity and some growth retardation upon overexpression of BLM, indicated that
BLM expression is detrimental to yeast cells. The absence of any GCR accumulation
upon Sgs1 overexpression suggests that increased accumulation of GCRs in BLMoverexpressing cells is not simply due to increased unwinding. Rather, we propose that
BLM may possess helicase activity in yeast, leading to increased unwinding upon
overexpression, but fails to elicit proper downstream responses, for example, due to
lack of proper N-terminal protein–protein interactions, which ultimately leads to an
overabundance of aberrantly repaired lesions. That endogenous levels of N-terminal
segments of Sgs1 as short as 547 residues suppressed the slow growth phenotype and
the severe HU sensitivity of BLM-overexpressing cells argues in favor of a functional
relationship between Sgs1 and BLM. For example, co-expression of Sgs1 and BLM
could alleviate HU sensitivity in BLM-overexpressing cells by acting as a bridge
between BLM and Top3 (and/or other protein complexes interacting with the Sgs1 Nterminus), thereby linking enzymatic activity to appropriate upstream and downstream
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events. Remarkably, even relatively short N-terminal fragments of Sgs1 are sufficient for
the suppression of the increased HU sensitivity of BLM-overexpressing cells, further
supporting the importance of the Sgs1 N-terminus with its role in mediating interaction
with other DNA metabolic factors. HU resistance comparable to wild-type cells and
significantly reduced GCR accumulation of cells expressing a chimeric fusion of the
Sgs1 N-terminus, which is devoid of enzymatic function and dispensable for helicase
activity and ssDNA binding in vitro, and the BLM C-terminus, which contains
helicase/RQC and HRDC domains, are consistent with helicase activity of BLM in yeast
and a biologically significant, functional interaction between BLM and Sgs1. That fusion
of the Sgs1 and BLM segments provides HU resistance as well as co-expression of
BLM and Sgs1 polypeptides from separate alleles in the same cell may indicate that the
N-terminus of Sgs1 can physically interact with BLM. Our findings also suggest that it is
the inability of the N-terminus of BLM to interact with or be modified by yeast proteins
that leads to the inability of BLM to function in yeast. A previous report that BLM
expression in yeast alleviates several sgs1Δ phenotypes, including partial suppression
of HU sensitivity (Yamagata, Kato et al. 1998, Heo, Tatebayashi et al. 1999), could be
explained by the fact that, in the earlier study, BLM was expressed from a GAPDH
promoter, whereas here it was expressed either from the native SGS1 promoter or from
a galactose-inducible promoter. However, in light of the findings presented here, there
could also be an alternative explanation. Since the GAPDH promoter–BLM construct
appears to have been inserted into the middle of the wild-type SGS1 gene, an Nterminal segment of Sgs1 could have been expressed from the native SGS1 promoter
in addition to BLM being expressed from the GAPDH promoter. As shown here for
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haploids expressing the chimera and for diploids co-expressing the N-termini of Sgs1
and full-length BLM, such co-expression of an N-terminal Sgs1 segment from the native
SGS1 promoter and BLM from the GAPDH promoter could be an explanation for the
reported increase in HU resistance of BLM-expressing cells compared to sgs1Δ cells.
Of the five human RecQ-like DNA helicases, BLM is considered to be most
closely related to Sgs1. Even though we show here that BLM cannot suppress any
defects of the sgs1Δ mutant, the functional chimera does provide evidence for a
functional relationship between the two RecQ-like helicases and provides a model
system for the further characterization of BLM functional domains in yeast. In fact, all
BS-associated missense mutations and numerous polymorphisms are located within the
770-residue C-terminal fragment of BLM that is part of the chimera, so that they are now
accessible to further functional and mutational characterization in yeast. The in vivo
functionality of the Sgs1–BLM chimera also demonstrates the remarkable utility of
protein disorder prediction as a tool for the construction of functional mutants. It will be
interesting to see whether domains of any of the other human RecQ-like helicases, are
capable of forming functional chimeras with the Sgs1 N-terminus.

MATERIALS AND METHODS
Yeast strains and media
All strains are derived from KHSY802, a derivative of S288C. Yeast strains
expressing truncations of Sgs1 helicase were constructed by HR-mediated integration
of PCR products, replacing the desired 3′-segment of SGS1 on chromosome VIII with a
myc epitope coding sequence (from pFA6a-13Myc.His3MX6 (Longtine, McKenzie et al.
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1998), a gift from Mark Longtine, University of Washington) in-frame with the SGS1
coding sequence. The expression of all truncation alleles and the myc-epitope-tagged
wild-type allele of SGS1 was confirmed by Western blot analysis. All gene
replacements, insertions, and truncations were performed via the standard LiAc protocol
(Gietz and Woods 2006), using PCR products with at least 50 nt on each end, which
matched the chromosomal target locus. A PCR fragment containing BLM cDNA (Open
Biosystems) and a HIS3 cassette was amplified by PCR from plasmid pKHS293 using
primers that include 50-nt homology to the chromosomal SGS1 locus to express BLM
from the native SGS1 promoter (PSGS1). This PCR product was fused to the native
chromosomal SGS1 promoter by HR-mediated integration (Gietz and Woods 2006). A
PCR fragment coding for a 13Myc epitope tag was amplified from pFA6a-13MyckanMX6 (Longtine, McKenzie et al. 1998) and integrated in-frame at the 3′-end of
cDNAs or sgs1 alleles for detection of protein expression by Western blot analysis. In
strains KHSY3350 and KHSY3218, galactose-inducible promoters amplified from
plasmids pFA6a-kanMX6-PGAL1 and pFA6a-TRP1-PGAL1 (Longtine, McKenzie et al.
1998), respectively, were used to replace the native SGS1 promoter. To construct
KHSY3355, we amplified the 3′-terminal 2313 bp of BLM cDNA linked to a HIS3
cassette by PCR from plasmid pKHS293 and used them to replace the 3′-terminal
2400 bp of SGS1 in KHSY802. The accuracy of PCR-derived SGS1 or BLM integrations
was confirmed by sequencing. Amino acid changes C1047F and F1056A in Sgs1 were
made by site-directed mutagenesis (QuikChange, Stratagene) of pKHS360 and
integrated at the sgs1∷HIS3 locus in KHSY1338. All yeast strains used in this study
are listed in Table S1. Cells were grown in YPD consisting of 10 g/l yeast extract (Fisher
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Scientific), 20 g/l Bacto-peptone (BD Diagnostic Systems), and 2% glucose (Fisher
Scientific), unless indicated otherwise. For plates, agar (BD Diagnostic Systems) was
added at a concentration of 20 g/l.

Western blot analysis
Cells were grown to an OD600 = 0.5 in YPD, and whole-cell extracts were
prepared from 5 ml of culture (∼ 3.5 × 107 cells) by standard trichloroacetic acid (TCA,
Fisher Scientific) extraction to confirm expression of myc-epitope-tagged BLM and
SGS1 alleles (Foiani, Liberi et al. 1999). Five microliters of TCA extract was separated
on 10% polyacrylamide gels, transferred to a PVDF membrane (Bio-Rad), probed with
anti-c-myc monoclonal antibody (9E10, Covance Research Products), and visualized by
chemiluminescence (ECL Plus, GE Healthcare). To confirm expression of SGS1 and
BLM from the GAL1 promoter, we used the same Western blot procedure, but cells
were grown overnight in yeast–peptone (YP) [(10 g/l yeast extract (Fisher Scientific),
20 g/l Bacto-peptone (BD Diagnostic Systems)] supplemented with 2% sucrose (Fisher
Scientific), diluted to an OD600 = 0.2 in YP supplemented with either 2% sucrose
(uninduced sample) or 2% galactose (induced sample), and harvested for TCA
extraction when cultures reached OD600 = 0.5. Molecular weight marker (Broad Range)
was from Bio-Rad.

Sensitivity to DNA-damaging agents HU and MMS
Cell cultures were grown in YPD to an OD600 = 0.5, and 10-fold serial dilutions
were spotted on YPD supplemented with 0.05% MMS (Sigma Aldrich) or with 50 mM or
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100 mM HU (US Biological), as indicated. For experiments that included strains
expressing BLM or Sgs1 from the GAL1 promoter (Fig. 5), cultures were grown in YP2% sucrose instead of YPD and spotted on YP-1% sucrose + 1% galactose (to induce
gene expression) supplemented with 100 mM HU or without HU as the growth control.

GCR rate measurements
Rates of accumulating GCRs in YPD were determined as previously described
(Schmidt, Pennaneach et al. 2006). For GCR rate measurements of yeast strains
expressing BLM or Sgs1 from the GAL1 promoter, the same procedure was followed,
except that media were supplemented with 2% galactose to induce gene expression.
Briefly, 10 ml of YP-2% galactose was inoculated with a single colony, which had been
grown on YPD agar for 3 days. After 3 days of growth in liquid media at 30 °C with
vigorous shaking, cells were plated on GCR plates (Schmidt, Pennaneach et al. 2006)
supplemented with 2% galactose instead of 2% glucose, and 10− 6 dilutions were plated
on YPD to obtain the viable cell count. Colonies on GCR plates were counted after
5 days of incubation at 30 °C. For GCR rate measurements in the presence of varying
BLM expression levels (Table 2), 0.1% or 0.5% galactose instead of 2% galactose was
added to liquid YP media and to GCR plates, and sucrose was supplemented to reach a
total of 2% sugar in the media. We calculated 95% confidence intervals according to
Nair (Nair 1940).
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Random spore analysis
Diploids heterozygous for the desired mutant alleles were grown overnight at
30 °C in YPD, washed, transferred to 0.1% potassium acetate (Fisher Scientific), and
incubated for 5 days at 30 °C with vigorous shaking. Asci were incubated in the
presence of 500 µg/ml zymolase (MP Biomedicals) in 1 M sorbitol (Fisher Scientific) for
20 min at 30 °C and enriched for haploid spores as previously described (Rockmill,
Lambie et al. 1991). Spores were plated on YPD, incubated at 30 °C, and genotyped by
spotting on synthetic drop-out media (US Biological) to detect the presence of TRP1
and HIS3 marker cassettes linked to the mutant alleles. The presence of mutant alleles
linked to the kanMX6 cassette was detected by the ability of haploids to grow on YPD
supplemented with 200 µg/ml G418 (Axxora LLC, San Diego, CA).
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FIGURES AND TABLES

Figure 2.1. C-terminal truncations of Sgs1 used in this study.
(A) Full-length Sgs1 contains a DEAH-helicase domain, an RQC domain and an HRDC
domain in its C-terminal half; interaction sites with Top3, Top2, Srs2, Rad51 and Rad16
are indicated. C-terminal truncations ranging in size from 200 residues to 1428 residues
were constructed by fusion to a myc-epitope tag. All truncations were introduced to the
endogenous SGS1 locus on chromosome VIII. (B) Expression of wild-type Sgs1 and
truncation alleles from the endogenous SGS1 promoter (PSGS1) was confirmed by
Western blotting, using a myc-antibody. Molecular weights (MW) are indicated on the
left.
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Figure 2.2. Sensitivity of cells expressing Sgs1 truncation alleles to the DNA
damaging agents HU and MMS. Ten-fold dilutions of exponentially growing cultures
(OD600 = 0.5) were spotted on YPD for viable cell count and on YPD containing
100mM HU or 0.05% MMS, followed by incubation at 30° C. (A) Haploid cells
expressing sgs1 alleles lacking 300 or more residues from the C-terminus are as
sensitive to HU and MMS as the null allele. (B). Additional incremental 20-amino-acid
deletions reveal that cells expressing sgs1 alleles lacking up to 240 residues are as
resistant to HU and MMS as wildtype cells whereas those lacking 260 or more residues
are as sensitive as the sgs1Δ mutant. (C) Spores from diploids heterozygous for an
srs2Δ deletion and heterozygous either for the sgs1-ΔC200, sgs1Δ-C260 or sgs1ΔC300 were spread on YPD to allow for growth of spores of all possible genotypes.
Similar sized colonies obtained from the spores of the diploid heterozygous for
sgs1ΔC200 and srs2Δ mutations (left) indicate that the sgs1ΔC200 srs2Δ mutant grows
as well as the single mutants, suggesting that deletion of the C-terminal 200 amino acid
residues does not negatively affect growth of the srs2Δ mutant. In contrast, spores from
diploids heterozygous for the srs2Δ mutation and the sgs1ΔC260 allele (middle) or the
sgs1ΔC300 allele (right), grew into a mixture of normal-sized colonies (corresponding to
single mutants and wildtype) and small-sized colonies (corresponding to srs2Δ
sgs1ΔC260 or srs2Δ sgs1ΔC300 mutants as determined by genotyping), demonstrating
that an intact RQC domain in Sgs1 is required for the viability of the srs2Δ mutant.
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Figure 2.3. Effect of zinc-binding domain mutations on Sgs1 function in vivo. (A)
Zinc-binding domain is conserved from bacterial to human RecQ-like DNA helicases.
Protein sequences were aligned with ClustalW2 (Chenna, Sugawara et al. 2003). The
alignment of RecQL1 was manually adjusted. Amino acid residues identical in all
sequences are highlighted in gray and indicated by '*' below the alignment, conserved
substitutions are indicated by ':' below the alignment, and cysteine residues thought to
be involved in zinc-binding are shown in red. At least six different missense mutations in
the zinc-binding domain are associated with Bloom’s syndrome. (B) C1047F and
F1056A mutations were introduced into Sgs1 and expression was confirmed by western
blot using antibody against the C-terminal myc-epitope. Molecular weights (MW) are
indicated in kDa to the left. (C) Mutation of the highly conserved F1056 does not impair
Sgs1 function whereas the C1047F mutation leads to an increase in sensitivity to HU
and MMS, but not to the level seen in the sgs1Δ mutant.
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Figure 2.4. BLM expression does not suppress sgs1Δ defects and BLM
overexpression is detrimental to yeast cells. (A) Expression of myc-epitope tagged
Sgs1 (lane 1) and BLM (lane 2) from the native chromosomal SGS1 locus or galactoseinducible overexpression of myc-epitope tagged Sgs1 (lane 4) and BLM (lane 6) in
yeast cells grown in YP supplemented with 1% sucrose and 1% galactose (to induce
expression, lanes 4 and 6) or without galactose (lanes 3 and 5). Both BLM and Sgs1
show signs of degradation upon overexpression (lanes 4 and 6) whereas expression
from the native SGS1 promoter is stable (lanes 1 and 2). Molecular weights (MW) are
indicated in kDa on the left. (B) Cells expressing BLM from the SGS1 promoter on
chromosome VIII are as sensitive to HU as cells lacking Sgs1 (Δsgs1). Replacement of
the natural SGS1 promoter with a galactose-inducible GAL1 promoter induces BLM
overexpression and leads to increased HU sensitivity. Ten-fold dilutions of cells were
spotted on media containing 1% sucrose and 1% galactose (to induce BLM
overexpression) with and without 100 mM HU.
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Figure 2.5. HU sensitivity of diploid cells expressing BLM and mutant alleles of
SGS1. (A) Ten-fold dilutions of exponentially growing diploids expressing truncation
alleles of SGS1 in the presence of a wildtype allele were spotted on YPD media with
and without 100 mM HU. (B) Ten-fold dilutions of exponentially growing diploids
expressing truncation alleles of SGS1 in the absence of a wildtype allele were spotted
on YPD media with and without 100 mM HU. (C) Ten-fold dilutions of exponentially
growing diploids overexpressing BLM from a GAL1 promoter inserted at the native
SGS1 locus and expressing truncation alleles of SGS1 under control of the native SGS1
promoter on the other allele were spotted on media containing 1% galactose (to induce
gene expression) and 1% sucrose with or without 100 mM HU.
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Figure 2.6. Construction of a functional chimerical protein composed of the Nterminus of Sgs1 and the C-terminus of BLM. (A – B) Protein disorder prediction of
Sgs1 (red) and BLM (black) using the IUPred algorithm. Values above 0.5 indicate a
disordered residue whereas values below 0.5 indicate ordered residues; amino acid
residue numbers (1–1447) are indicated on the abscissa. Black lines above the graph
show a simplified order and disorder distribution along the length of the protein with
values above 0.5 being assigned a “1” and values below 0.5 being assigned a “0”. The
vertical red line indicates the site in Sgs1, BLM and the chimera where the disordered
N-terminal segment transitions into the ordered helicase domain at residue 647/648.
This site was chosen as the fusion site for the chimera. The approximate location of
Sgs1 domains is indicated above panel A. (C) Disorder prediction for the Sgs1-BLM
chimera in which the N-terminal 647 residues of BLM (black) were replaced with the Nterminal 647 residues of Sgs1 (red). (D) Ten-fold dilutions of exponentially growing
haploids were spotted on YPD with or without 100 mM HU. (E) The C-terminus of the
Sgs1-BLM chimera was fused to a myc-epitope tag and expression was confirmed by
western blotting. Molecular weight marker bands (kD) are indicated on the left (F) A
diploid heterozygous for the rrm3Δ mutation and the sgs1ΔC800-blmΔN647 allele
expressing the chimera was sporulated and random spores were plated on YPD to
allow all spores to grow. An open circle indicates the haploid double mutant, and the
open square and pentagon indicate haploid sgs1ΔC800-blmΔN647 and rrm3Δ single
mutants, respectively.
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Table 2.1. Accumulation of GCRs in cells expressing mutant alleles of SGS1
a

GCR rate (Canr 5FOAr × 10− 10)
1.1
251
7
31
10
159
244
145
106
102
152
189
133
206
64
< 16
11
1003
758
361

95% CIb (Canr 5FOAr × 10− 10)
< 1–6.2
80–310
< 6–23
5–41
< 6–27
85–362
166–387
76–204
60–180
53–252
26–283
49–271
71–225
97–273
35–131
< 10–26
< 7–22
691–1500
645–895
330–419

Relevant Genotype
Wild type
sgs1Δ
sgs1ΔC200
sgs1ΔC220
sgs1ΔC240
sgs1ΔC260
sgs1ΔC280
sgs1ΔC300
sgs1ΔC400
sgs1ΔC500
sgs1ΔC600
sgs1ΔC700
sgs1ΔC800
sgs1ΔC1428
sgs1-C1047F
sgs1-F1056A
mec3Δsgs1ΔC200
mec3Δsgs1ΔC300
mec3Δsgs1ΔC800
mec3Δsgs1ΔC800blmΔN647c
a. All sgs1 truncations (sgs1ΔC) are C-terminally fused to a myc epitope tag.
b. We calculated 95% confidence intervals (CIs) according to Nair (Nair 1940).
c. The sgs1ΔC800-blmΔN647 allele expresses a chimeric protein that consists of the
647 N-terminal residues of Sgs1 and the 770 C-terminal residues of human BLM.
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Table 2.2. Effect of BLM expression on GCR accumulation in the sgs1Δ mutant
Relevant
Galactose concentration
GCR rate (Canr 595% CIb (Canr 5a
r
− 10
genotype
in media (%)
FOA × 10 )
FOAr × 10− 10)
Wild type
0
1.1
< 1–6.2
PSGS1BLM
0
70
56–151
PGALBLM
0
61
30–153
PGALBLM
0.1
335
233–576
PGALBLM
0.5
382
170–777
PGALBLM
2
1832
1090–2910
PGALSGS1
2
< 11
< 9–12
sgs1Δ
2
54
23–104
a. Human BLM cDNA was inserted at the endogenous SGS1 locus and fused to the
native SGS1 promoter (PSGS1) or fused to a galactose-inducible promoter (PGAL). In
PGALSGS1, the native SGS1 promoter region was disrupted by fusing the SGS1 open
reading frame to a galactose-inducible promoter. If strains expressing BLM or SGS1
genes from the galactose-inducible GAL1 promoter were grown in less than 2%
galactose (to lower protein expression levels), media were supplemented with sucrose
to reach a total sugar concentration of 2%.
b. We calculated 95% confidence intervals (CIs)
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TABLE 2.S1. Yeast Strains used in this study
Strain

Genotype

KHSY802

MATa ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1,
ade8, YEL069C::URA3

KHSY1338 MATa ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1,
ade8, YEL069C::URA3, sgs1::HIS3
KHSY1705 MATa ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1,
ade8, YEL069C::ura3::TRP1, sgs1::BLM.HIS3
KHSY2341 MATa ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1,
ade8, YEL069C::URA3, mec3::kanMX6, sgs1ΔC200.MYC.HIS3
KHSY2347 MATa ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1,
ade8, YEL069C::URA3, mec3::kanMX6, sgs1ΔC300.MYC.HIS3
KHSY2599 ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200,
lys2ΔBgl/ lys2ΔBgl, hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8,
YEL069C::URA3/YEL069C::URA3
KHSY2602 ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200,
lys2ΔBgl/ lys2ΔBgl, hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8,
YEL069C::ura3::TRP1/YEL069C::ura3::TRP1,
sgs1::kanMX6/sgs1::kanMX6
KHSY2726 ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200,
lys2ΔBgl/ lys2ΔBgl, hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8,
YEL069C::URA3/YEL069C::URA3, SGS1/sgs1C200.MYC.HIS3
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TABLE 2.S1 (continued)
KHSY2828 ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200,
lys2ΔBgl/ lys2ΔBgl, hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8,
YEL069C::URA3/YEL069C::ura3::TRP1,
sgs1::kanMX6/sgs1C200.MYC.HIS3
KHSY2837 ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200,
lys2ΔBgl/ lys2ΔBgl, hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8,
YEL069C::URA3/YEL069C::ura3::TRP1,
sgs1::kanMX6/sgs1C300.MYC.HIS3
KHSY2880 ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200,
lys2ΔBgl/ lys2ΔBgl, hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8,
YEL069C::URA3/YEL069C::URA3, SGS1/sgs1ΔC300.MYC.HIS3
KHSY2883 ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200,
lys2ΔBgl/ lys2ΔBgl, hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8,
YEL069C::URA3/YEL069C::URA3, SGS1/sgs1ΔC400.MYC.HIS3
KHSY2886 ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200,
lys2ΔBgl/ lys2ΔBgl, hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8,
YEL069C::URA3/YEL069C::URA3, SGS1/sgs1ΔC500.MYC.HIS3
KHSY2889 ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200,
lys2ΔBgl/ lys2ΔBgl, hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8,
YEL069C::URA3/YEL069C::URA3, SGS1/sgs1ΔC600.MYC.HIS3
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TABLE 2.S1 (continued)
KHSY2892 ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200,
lys2ΔBgl/ lys2ΔBgl, hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8,
YEL069C::URA3/YEL069C::URA3, SGS1/sgs1ΔC700.MYC.HIS3
KHSY2895 ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200,
lys2ΔBgl/ lys2ΔBgl, hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8,
YEL069C::URA3/YEL069C::URA3, SGS1/sgs1ΔC800.MYC.HIS3
KHSY2898 ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200,
lys2ΔBgl/ lys2ΔBgl, hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8,
YEL069C::URA3/YEL069C::URA3, SGS1/sgs1ΔC1428.MYC.HIS3
KHSY2928 ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200,
lys2ΔBgl/ lys2ΔBgl, hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8,
YEL069C::URA3/YEL069C::ura3::TRP1,
sgs1::kanMX6/sgs1ΔC400.MYC.HIS3
KHSY2931 ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200,
lys2ΔBgl/ lys2ΔBgl, hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8,
YEL069C::URA3/YEL069C::ura3::TRP1,
sgs1::kanMX6/sgs1ΔC500.MYC.HIS3
KHSY2934 ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200,
lys2ΔBgl/ lys2ΔBgl, hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8,
YEL069C::URA3/YEL069C::ura3::TRP1,
sgs1::kanMX6/sgs1ΔC600.MYC.HIS3
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TABLE 2.S1 (continued)
KHSY2937 ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200,
lys2ΔBgl/ lys2ΔBgl, hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8,
YEL069C::URA3/YEL069C::ura3::TRP1,
sgs1::kanMX6/sgs1ΔC700.MYC.HIS3
KHSY2940 ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200,
lys2ΔBgl/ lys2ΔBgl, hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8,
YEL069C::URA3/YEL069C::ura3::TRP1,
sgs1::kanMX6/sgs1ΔC800.MYC.HIS3
KHSY2943 ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200,
lys2ΔBgl/ lys2ΔBgl, hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8,
YEL069C::URA3/YEL069C::ura3::TRP1,
sgs1::kanMX6/sgs1ΔC1428.MYC.HIS3
KHSY2970 MATa ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1,
ade8, YEL069C::URA3, sgs1.MYC.HIS3
KHSY2972 MATa ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1,
ade8, YEL069C::URA3, sgs1ΔC200.MYC.HIS3
KHSY2973 MATa ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1,
ade8, YEL069C::URA3, sgs1ΔC300.MYC.HIS3
KHSY2974 MATa ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1,
ade8, YEL069C::URA3, sgs1ΔC400.MYC.HIS3
KHSY2975 MATa ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1,
ade8, YEL069C::URA3, sgs1ΔC500.MYC.HIS3
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TABLE 2.S1 (continued)
KHSY2976 MATa ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1,
ade8, YEL069C::URA3, sgs1ΔC600.MYC.HIS3
KHSY2977 MATa ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1,
ade8, YEL069C::URA3, sgs1ΔC700.MYC.HIS3
KHSY2978 MATa ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1,
ade8, YEL069C::URA3, sgs1ΔC800.MYC.HIS3
KHSY2979 MATa ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1,
ade8, YEL069C::URA3, sgs1ΔC1428.MYC.HIS3
KHSY3181 ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200,
lys2ΔBgl/ lys2ΔBgl, hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8,
YEL069C::URA3/YEL069C::URA3, SGS1/sgs1ΔC1100.MYC.HIS3
KHSY3218 MATa ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1,
ade8, YEL069C::URA3, TRP1.PGAL1.SGS1
KHSY3332 MATa ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1,
ade8, YEL069C::URA3, sgs1::BLM.HIS3
KHSY3346 MATa ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1,
ade8, YEL069C::ura3::TRP1, BLM.MYC.kanMX6.HIS3
KHSY3350 MATa ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1,
ade8, YEL069C::URA3, kanMX6.PGAL1.BLM.HIS3
KHSY3353 MATa ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1,
ade8, YEL069C::URA3, kanMX6.PGAL1.BLM.HIS3
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TABLE 2.S1 (continued)
KHSY3355 MATa ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1,
ade8, YEL069C::URA3, sgs1ΔC800-blmΔN647.HIS3
KHSY3363 MATa ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1,
ade8, YEL069C::URA3, sgs1ΔC800-blmΔN647.HIS3, Δmec3::kanMX6
KHSY3372 ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200,
lys2ΔBgl/ lys2ΔBgl, hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8,
YEL069C::URA3/YEL069C::URA3, sgs1::BLM.HIS3/sgs1::BLM.HIS3
KHSY3409 ura3-52/ura3-52, leu2Δ/leu2Δ , trp1Δ63/ trp1Δ63, his3Δ200/his3Δ200,
lys2ΔBgl/ys2ΔBgl,

hom3-10/hom3-10,

ade2Δ1/ade2Δ1,

ade8/ade8,

YEL069C::URA3/YEL069C::URA3,
kanMX6.PGAL1.BLM.HIS3/SGS1.MYC.HIS3
KHSY3410 ura3-52/ura3-52, leu2Δ/leu2Δ , trp1Δ63/ trp1Δ63, his3Δ200/his3Δ200,
lys2ΔBgl/ys2ΔBgl,

hom3-10/hom3-10,

ade2Δ1/ade2Δ1,

ade8/ade8,

YEL069C::URA3/YEL069C::URA3,
kanMX6.PGAL1.BLM.HIS3/sgs1ΔC200.MYC.HIS3
KHSY3412 ura3-52/ura3-52, leu2Δ/leu2Δ , trp1Δ63/ trp1Δ63, his3Δ200/his3Δ200,
lys2ΔBgl/ys2ΔBgl,

hom3-10/hom3-10,

ade2Δ1/ade2Δ1,

YEL069C::URA3/YEL069C::URA3,
kanMX6.PGAL1.BLM.HIS3/sgs1ΔC300.MYC.HIS3
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ade8/ade8,

TABLE 2.S1 (continued)
KHSY3414 ura3-52/ura3-52, leu2Δ/leu2Δ , trp1Δ63/ trp1Δ63, his3Δ200/his3Δ200,
lys2ΔBgl/ys2ΔBgl,

hom3-10/hom3-10,

ade2Δ1/ade2Δ1,

ade8/ade8,

YEL069C::URA3/YEL069C::URA3,
kanMX6.PGAL1.BLM.HIS3/sgs1ΔC400.MYC.HIS3
KHSY3416 ura3-52/ura3-52, leu2Δ/leu2Δ , trp1Δ63/ trp1Δ63, his3Δ200/his3Δ200,
lys2ΔBgl/ys2ΔBgl,

hom3-10/hom3-10,

ade2Δ1/ade2Δ1,

ade8/ade8,

YEL069C::URA3/YEL069C::URA3,
kanMX6.PGAL1.BLM.HIS3/sgs1ΔC500.MYC.HIS3
KHSY3417 ura3-52/ura3-52, leu2Δ/leu2Δ , trp1Δ63/ trp1Δ63, his3Δ200/his3Δ200,
lys2ΔBgl/ys2ΔBgl,

hom3-10/hom3-10,

ade2Δ1/ade2Δ1,

ade8/ade8,

YEL069C::URA3/YEL069C::URA3,
kanMX6.PGAL1.BLM.HIS3/sgs1ΔC600.MYC.HIS3
KHSY3419 ura3-52/ura3-52, leu2Δ/leu2Δ , trp1Δ63/ trp1Δ63, his3Δ200/his3Δ200,
lys2ΔBgl/ys2ΔBgl,

hom3-10/hom3-10,

ade2Δ1/ade2Δ1,

ade8/ade8,

YEL069C::URA3/YEL069C::URA3,
kanMX6.PGAL1.BLM.HIS3/sgs1ΔC700.MYC.HIS3
KHSY3420 ura3-52/ura3-52, leu2Δ/leu2Δ , trp1Δ63/ trp1Δ63, his3Δ200/his3Δ200,
lys2ΔBgl/ys2ΔBgl,

hom3-10/hom3-10,

ade2Δ1/ade2Δ1,

YEL069C::URA3/YEL069C::URA3,
kanMX6.PGAL1.BLM.HIS3/sgs1ΔC800.MYC.HIS3
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ade8/ade8,

TABLE 2.S1 (continued)
KHSY3422 ura3-52/ura3-52, leu2Δ/leu2Δ , trp1Δ63/ trp1Δ63, his3Δ200/his3Δ200,
lys2ΔBgl/ys2ΔBgl,

hom3-10/hom3-10,

ade2Δ1/ade2Δ1,

ade8/ade8,

YEL069C::URA3/YEL069C::URA3,
kanMX6.PGAL1.BLM.HIS3/sgs1ΔC900.MYC.HIS3
KHSY3423 ura3-52/ura3-52, leu2Δ/leu2Δ , trp1Δ63/ trp1Δ63, his3Δ200/his3Δ200,
lys2ΔBgl/ys2ΔBgl,

hom3-10/hom3-10,

ade2Δ1/ade2Δ1,

ade8/ade8,

YEL069C::URA3/YEL069C::URA3,
kanMX6.PGAL1.BLM.HIS3/sgs1ΔC1000.MYC.HIS3
KHSY3424 ura3-52/ura3-52, leu2Δ/leu2Δ , trp1Δ63/ trp1Δ63, his3Δ200/his3Δ200,
lys2ΔBgl/ys2ΔBgl,

hom3-10/hom3-10,

ade2Δ1/ade2Δ1,

ade8/ade8,

YEL069C::URA3/YEL069C::URA3,
kanMX6.PGAL1.BLM.HIS3/sgs1ΔC1100.MYC.HIS3
KHSY3425 ura3-52/ura3-52, leu2Δ/leu2Δ , trp1Δ63/ trp1Δ63, his3Δ200/his3Δ200,
lys2ΔBgl/ys2ΔBgl,

hom3-10/hom3-10,

ade2Δ1/ade2Δ1,

ade8/ade8,

YEL069C::URA3/YEL069C::URA3,
kanMX6.PGAL1.BLM.HIS3/sgs1ΔC1428.MYC.HIS3
KHSY3426 ura3-52/ura3-52, leu2Δ/leu2Δ , trp1Δ63/ trp1Δ63, his3Δ200/his3Δ200,
lys2ΔBgl/ys2ΔBgl,

hom3-10/hom3-10,

ade2Δ1/ade2Δ1,

YEL069C::URA3/YEL069C::URA3,
kanMX6.PGAL1.BLM.HIS3/kanMX6.PGAL1.BLM.HIS3
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ade8/ade8,

TABLE 2.S1 (continued)
KHSY3429 ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200,
lys2ΔBgl/ lys2ΔBgl, hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8,
YEL069C::URA3/YEL069C::ura3::TRP1,
sgs1::kanMX6/sgs1ΔC1100.MYC.HIS3
KHSY3470 MATa ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1,
ade8, YEL069C::URA3, sgs1ΔC220.MYC.HIS3
KHSY3473 MATa ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1,
ade8, YEL069C::URA3, sgs1ΔC240.MYC.HIS3
KHSY3476 MATa ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1,
ade8, YEL069C::URA3, sgs1ΔC260.MYC.HIS3
KHSY3479 MATa ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1,
ade8, YEL069C::URA3, sgs1ΔC280.MYC.HIS3
KHSY3500 MATa ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1,
ade8, YEL069C::URA3, sgs1ΔC900.MYC.HIS3
KHSY3502 MATa ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1,
ade8, YEL069C::URA3, sgs1ΔC1000.MYC.HIS3
KHSY3504 MATa ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1,
ade8, YEL069C::URA3, sgs1ΔC1100.MYC.HIS3
KHSY3510 MATa ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1,
ade8, YEL069C::URA3, TRP1.PGAL1. SGS1.MYC.HIS3
KHSY3512 MATa ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1,
ade8, YEL069C::URA3, sgs1-C1047F.TRP1
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TABLE 2.S1 (continued)
KHSY3516 MATa ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1,
ade8, YEL069C::URA3, sgs1-F1056A.TRP1
KHSY3517 MATa ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1,
ade8, YEL069C::URA3, sgs1-C1047F.MYC.HIS3
KHSY3520 MATa ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1,
ade8, YEL069C::URA3, sgs1-F1056A.MYC.HIS3
KHSY3523 MATa ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1,
ade8, YEL069C::URA3, kanMX6.PGAL1.BLM.MYC.TRP1.HIS3
KHSY3528 ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200,
lys2ΔBgl/ lys2ΔBgl, hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8,
YEL069C::URA3/YEL069C::ura3::TRP1,
sgs1::kanMX6/sgs1ΔC1000.MYC.HIS3
KHSY3534 ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200,
lys2ΔBgl/ lys2ΔBgl, hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8,
YEL069C::URA3/YEL069C::ura3::TRP1,
sgs1::kanMX6/sgs1ΔC900.MYC.HIS3
KHSY3536 ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200,
lys2ΔBgl/ lys2ΔBgl, hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8,
YEL069C::URA3/YEL069C::URA3, SGS1/sgs1ΔC1000.MYC.HIS3
KHSY3539 ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200,
lys2ΔBgl/ lys2ΔBgl, hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8,
YEL069C::URA3/YEL069C::URA3, SGS1/sgs1ΔC900.MYC.HIS3
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TABLE 2.S1 (continued)
KHSY3543 MATa ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1,
ade8. YEL069C::URA3, sgs1ΔC800-blmΔN647.MYC.TRP1
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CHAPTER THREE:
GENETIC CHARACTERIZATION OF RECQL5 IN SACCHAROMYCES CEREVISIAE
AND IDENTIFICATION OF BINDING PARTNERS USING A YEAST TWO-HYBRID
SCREEN
Note to reader: Unpublished data. Experiments were designed by Kristina H. Schmidt
and Salahuddin Syed. Experiments were performed by Salahuddin Syed.

INTRODUCTION
RecQL5 is a RecQ like helicase found in humans, but has no known attributed
genetic disease. It contains 19 exons and encodes three isoforms, RecQL5α, RecQL5β
and RecQL5ɣ [1]. In human tissues RecQL5 isoforms are expressed with high
abundance in the testes [1]. Of the three isoforms RecQL5α and RecQL5ɣ are found in
the cytoplasm whereas RecQL5β is found in the nucleus [2]. RecQL5α and RecQL5ɣ
lack a substantial amount of homology to the other RecQ homologs (Figure 1). Although
all the isoforms of RecQL5 have a conserved helicase domain, only RecQL5β contains
ATPase activity [3, 4]. This activity is insufficient to unwind D-loops, G-quadruplexes,
and Holliday junctions [3, 4]. However, in the presence of ssDNA binding protein and
RPA, RecQL5β can unwind forked duplexes [5]. The inability to efficiently unwind DNA
may be due to the fact that RecQL5β does not have a winged-helix motif, which is
present in RecQL1 and WRN and has been shown to be important for DNA unwinding
[6, 7]. We used RecQL5β in this study because it is the only isoform that has been
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observed to possess enzymatic activity and is abundantly found in humans and mice
[8].
RecQL5 has several protein-protein interactions involved in DNA repair, such as
Rad51, PCNA, Topo3α, Topo3β, the MRN complex, and Pol II [2, 9-14]. RecQL5 is
found at DSBs, but for a shorter time compared to BLM and WRN, suggesting that the
biochemical properties of RecQL5 are important for its activity [15]. In the presence of
HU or UV light, Mre11 recruits RecQL5 to the site of damage and co-localizes with the
MRN complex and has been implicated in regulating the exonuclease activity of MRN
during end resection [12]. RecQL5 has a KIX domain on its C terminus distal to the
RQC domain, which is required for resistance to DNA damaging agents and binding to
DSBs [16]. In addition to having a role at DSBs, RecQL5 has a role during HR as an
anti-recombinase and inhibits the formation of D-loops by removing Rad51 from ssDNA
[17]. It has also been shown that RecQL5 interacts with phosphorylated RPBI, a subunit
of Pol II, which indicates elongation of transcripts, implicating RecQL5 in transcription
[16].
Mouse embryonic fibroblast cell lines deficient for RecQL5 show increased sister
chromatid exchanges (SCEs), elevated number of broken chromosomes, and
quadriradials [9]. Cells deficient for RecQL5 are sensitive to CPT and it has been
suggested that this is due to an inability to restart stalled forks [18]. Although defects in
RecQL5 have not been associated with a known human disease, mice lacking RecQL5
have a higher incidence of cancer, including lymphomas and lung adenocarcinoma [19].
To further characterize the function of RecQL5, human RecQL5 cDNA was expressed
using the SGS1 promoter and overexpressed to assess its ability to complement sgs1∆
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defects. Additionally, we performed a yeast two-hybrid screen using the human testis
library to identify pathways, in DNA repair, which RecQL5 functions in, thus shedding
light on its cellular role.

MATERIALS AND METHODS
Yeast transformation and targeted gene disruption
Modifications to the yeast genome are carried through a lithium acetate mediated
transformation [20]. Cells are grown overnight in liquid YPD media until they reach
saturation and then diluted into 25 ml of YPD media for an initial OD of 0.2. The cells
are grown to an OD of 0.8 and then centrifuged for 2 minutes at 2000 rpm, washed with
dH2O, and centrifuged once more to remove any residual YPD. They are then resuspended in 100mM LiAc and centrifuged for 30 seconds at 14000 rpm. The cells are
re-suspended in 240µl of 100mM LiAc and spread equally amongst 4 eppindorf tubes.
The tubes are centrifuged for 1 minute at 14000 rpm and the following reagents are
added sequentially: 50% PEG, 36µl of 1M LiAc, 75µl of DNA, and 5µl of boiled and
snap-cooled salmon sperm DNA. The pellet is loosely re-suspended using a toothpick
and vortexed for 1 min at high speed. The cells are then incubated at 30ºC for 30 min
followed by heat shocking for 15 min at 42ºC. Cells are then centrifuged at 7000 rpm for
1 min and the pellet re-suspended in 100 µl of dH2O and plated on selective media
corresponding to the type of mutation that is being introduced into the cell. Cells were
grown for 2-3 days at 30ºC and colonies were re-streaked onto new plates and grown
for another 2 days at 30ºC followed by freezing at -80ºC. The transformations were
verified by isolating genomic DNA from positives followed by PCR confirmation.
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Cloning of plasmid DNA using homologous recombination in yeast
DNA of interest is amplified by PCR using primers that share 50-nt homology
upstream and downstream of the plasmid of interest and 20-nt homology to the DNA.
The plasmid of interest is linearized using two different restriction enzymes to reduce religation events. Transformations were performed in strain KHSY2331 (Appendix C),
which is deficient for non-homologous end joining (lig4∆). Lig4, DNA Ligase 4, is
important for resolution of NHEJ by ligating the ends of a double strand break. The
purpose of using this strain is to minimize the possibility that the plasmid of interest will
re-circularize by NHEJ and to force it to use HR to integrate the amplicon into the
plasmid. During the transformation 50-100 ng of linearized plasmid DNA is combined
with 10-75 µl of PCR product and the experiment is carried out using the same method
as that found in the “yeast transformation and targeted gene disruption” section. Cells
are plated on media that selects for the plasmid of interest and plasmid DNA is
extracted using the QIAprep Miniprep Kit (QIAGEN).

Colony PCR
Colony PCR is a method that allows for verification of a large quantity of E. coli
transformants for integration of a plasmid of interest. After the plasmid is transformed
into E. coli, the colonies are re-streaked onto agar LB plates supplemented with the
appropriate antibiotic for selection and incubated overnight at 37ºC. A small quantity of
cells are then inoculated into 100 µl of sterile water and boiled at 100ºC for 10 min in an
Applied Biosystems PCR GeneAmp 9700 Thermocycler. The samples are then
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centrifuged at 14000 rpm for 2 minutes and 2 µl of the top layer is used as a template
for PCR.

Fluctuation assay
GCR rates were determined using a method previously described [21]. In order
to assess overexpression of RecQL5 on accumulating GCRs we modified the assay
such that strains containing a GAL1 promoter were incubated on YPD agar plates for
three days and a single colony was cultured in liquid YP-Galactose (yeast extract 10
g/L, peptone 20 g/L, 2% galactose) instead of YPD. The strains were allowed to reach
saturation and the cultures were spread on synthetic complete agar plates containing 5FOA (1 g/L), canavanine (60 mg/L), and galactose instead of dextrose.

Plasmid construction
RECQL5β cDNA was obtained from Open Biosystems in vector pCMV-SPORT6.
In order to integrate RECQL5 in S. cerevisiae, a selectable marker was integrated
downstream of the cDNA. A HIS3MX6 cassette, in plasmid pRS303, was used [22].
Using PCR, HIS3MX6, was amplified and cloned into vector pCR2.1-TOPO (Invitrogen).
The PCR primers anneal upstream and downstream to the HIS3MX6 cassette and
contain a 5’ XhoI restriction site. The RECQL5 cDNA in pCMV-SPORT6 (pKHS265)
contains an XhoI restriction site at the 3’ end. The plasmids containing RECQL5 and
HIS3MX6 were digested using XhoI and HIS3MX6 was ligated into the pCMV-SPORT6
plasmid using DNA Ligation Kit Ver. 2.1 (Takara) per manufacturer instructions. The
resulting ligated products were introduced into electro-competent E. coli cells and
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selected for on LB agar plates (Tryptone 10 g/L, Yeast extract 5 g/L, and NaCl 5 g/L)
supplemented with 100 µg/ml of Chloramphenicol (CMP). Using colony PCR E. coli
transformants were tested for the presence of HIS3MX6 cassette using primers 1032R
and 1676F that anneal to RECQL5 and HIS3MX6. Plasmid DNA from positive
transformants was isolated using QIAGEN’s QIAprep Spin Miniprep Kit (per
manufacturers directions). The plasmid DNA was further confirmed for integration of
RECQL5 with the HIS3MX6 cassette using restriction digestion with HindIII to determine
the relative orientation of RECQL5 in respect to HIS3MX6. Three isolates were obtained
containing RECQL5 linked to HIS3MX6 (pKHS671, pKHS672, pKHS673).
For yeast two-hybrid, a bait plasmid (pKHS392, Appendix D) containing a GAL4
DNA binding domain (DBD) was linearized by double restriction enzyme digestion using
PvuII and NotI. Using PCR, RECQL5 cDNA was amplified with primers 1672F and
1673R that share 50-nt homology, upstream and downstream of the bait plasmid and
20-nt homology to RECQL5. Transformation was carried out in KHSY2331 in order to
use homologous recombination to integrate the amplicon into the plasmid.
Transformants were selected for on SC-Trp and genomic DNA was isolated from these
positive transformants. Genomic DNA was introduced into electrocompetent E. coli cells
using a MicroPulse device (BioLab). Plasmid DNA was isolated and RECQL5 was
sequenced completely to ensure mutations were not introduced in-frame with the DNA
binding domain and the strain was saved as pKHS525.

114

Yeast strain construction
To integrate RECQL5 at the SGS1 locus, RECQL5.HIS3MX6 (pKHS671) was
used and PCR was performed using primers 1911F and 1912R that anneal upstream of
RECQL5 and downstream of HIS3MX6 cassette. The primers also contain 50nucleotide homology, upstream and downstream of the SGS1 locus. The PCR product
RECQL5.HIS3MX6 was transformed into yeast strain KHSY1633 (sgs1::kanMX6) using
a LiAc-mediated transformation method [23]. KHSY1633 has SGS1 replaced with
kanMX6, which confers resistance to G418-sulfate (Alexis Biochemicals). In order to
isolate RECQL5.HIS3MX6, transformants were picked by plating on agar lacking
histidine (SC-His). To determine if kanMX6 was replaced by RECQL5.HIS3MX6, PCR
was performed using primers 1143F and 1680R, which are specific to RECQL5 and a
sequence upstream of the SGS1 locus. To ensure that this process was not mutagenic
RECQL5 cDNA was amplified by PCR from colonies that had RECQL5.HISMX6
integrated into KHSY1633 and the amplicon was sent out for sequencing using primers
1674F, 1675F, 1676F, 1677F, 1678F, 1679F, and 1680R. Three independent isolates
(KHSY3777, KHSY3778, KHSY3779) were obtained without any mutations and were
used for further characterization.
In order to verify protein expression of RecQL5 a myc-epitope tag was fused to
the 3’ end of RECQL5 in the strain containing RECQL5.HIS3MX6 (KHSY3777). A
13MYC.TRP1 cassete was amplified by PCR from plasmid pFA6a.13MYC.TRP1
(pKHS230, Appendix D) [24]. The myc-epitope was amplified using primers 1911F and
1912R that share 50-nt homology with the 3’ end of RECQL5 and downstream of
HIS3MX6.

The
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containing

RECQL5.HIS3MX6 (KHSY3777) using standard LiAc-mediated transformation [23].
Transformants were selected for integration of 13MYC.TRP1 on synthetic complete
agar minus tryptophan (SC-Trp). Integration of the myc-epitope was verified by PCR
using primers 1678F and 2455R, which anneal to the myc epitope and RECQL5.
Positive transformants were saved as KHSY5172, KHSY5173, and KHSY5174
(Appendix C).
To overexpress RecQL5 a galactose inducible promoter was added upstream of
RECQL5. To achieve this, TRP1.PGAL1 was amplified by PCR using plasmid
pFA6a.TRP1.PGAL1 (pKHS236, Appendix D). Primers 1850F and 1851R were used to
amplify the plasmid and share 50-nt homology upstream of RECQL5 and 5’ of the cDNA
so that the native SGS1 promoter can be replaced. The amplicon was transformed into
a strain containing RECQL5.HIS3MX6 (KHSY3777) using LiAc-mediated transformation
[23] and positive transformants were selected for on SC-Trp agar plates. To determine if
the GAL1 promoter was integrated, PCR was performed using primers 1045F and
1680R, which anneal upstream of the GAL1 promoter and internal to RECQL5 in order
to obtain TRP1.PGAL1.RECQL5.HIS3MX6 and three isolates (KHSY3827, KHSY3828,
KHSY3829) were confirmed and saved. To verify protein expression a myc epitope tag
was added to the 3’ end of RECQL5 in KHSY3827. A 13MYC.kanMX6 cassete was
amplified by PCR from plasmid pFA6a.13MYC.kanMX6 (pKHS229, Appendix D) [24].
The myc-epitope was amplified using primers 1911F and 1912R that share 50-nt
homology with the 3’ end of RECQL5 and downstream of kanMX6. The PCR amplicon
was transformed into the strain containing TRP1.PGAL1.RECQL5.HIS3MX6 (KHSY3827)
using standard LiAc-mediated transformation [23]. Transformants were selected for
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integration of 13MYC.kanMX6 on SC-G418 plates and integration of the myc-epitope
was verified by PCR using primers 1678F and 2455R that anneal to the myc epitope
and RECQL5. Positive transformants were saved as KHSY5175, KHSY5176, and
KHSY5177 (Appendix C).
To generate a Sgs1-RecQL5 chimeric protein the entire RECQL5 cDNA was
used. RECQL5.HIS3MX6 (KHSY3777) was amplified by PCR and the amplicon was
transformed into KHSY802 at the SGS1 locus (wildtype, Appendix C). The primers for
this PCR were designed so that 50-nt would anneal to SGS1 in order to retain its N
terminal 1-647 residues and its native promoter. Positive transformants were selected
for on SC-His for the presence of RECQL5.HIS3MX6. These isolates were tested by
PCR for further confirmation that a chimeric protein was generated using primers 1257F
and 1680R that anneal to the 5’ end of SGS1 and internal to RECQL5. Primer
combinations were used to ensure that the SGS1 N terminal sequence and RECQL5
would be amplified and the entire ORF was sent out for sequencing to ensure that
mutations were not incorporated using the following primers: 1256F, 1257F, 1258F,
1259F, 1260F, 1261F, 1262F, 1674F, 1675F, 1676F, 1677F, 1678F, 1679F, 1680R.
Positive candidates were saved as KHSY5178, KHSY5179, and KHSY5180 (Appendix
C). To verify protein expression of the Sgs1-RecQL5 chimeric protein a myc epitope
was added to the C terminus of Sgs1-RecQL5 using plasmid pFA6a.13MYC.TRP1
(pKHS230, Appendix D) [24]. Positive transformants were saved as KHSY5181,
KHSY5182, and KHSY5183 (Appendix C).
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Analyzing protein expression by western blot
An overnight culture of cells was diluted to an OD600 = 0.2 in YPD and allowed to
grow to an OD600 = 0.5. Protein was extracted using the trichloroacetic acid method
using ~3.5 x 107 cells to confirm expression of the myc epitope tagged strains. The TCA
extract was analyzed on a 10% polyacrylamide gel, transferred to PVDF membrane
(Bio-Rad), and then analyzed with anti-c-myc monoclonal antibody (9E10, Covance
Research Products). Myc tagged proteins were visualized by chemoluminescence (ECL
Plus, GE Healthcare). To induce RECQL5 cDNA under the control of a GAL1 promoter
media was supplemented with 2% galactose or 1% sucrose/1% galactose instead of 2%
dextrose.

Yeast two-hybrid screen
This screen utilized the Clontech Matchmaker Gold Yeast Two-Hybrid System
and the Clontech Mate and Plate Human Testis cDNA library. For our yeast two-hybrid
screen, we used yeast strain AH109 (KHSY3130, Appendix C), which we obtained from
the Clontech Matchmaker Gold Yeast Two-Hybrid System. This strain possess four
different reporter genes, which allow for varying degrees of stringency (Figure 3.7).
pKHS525 containing RECQL5 was transformed into AH109 (Appendix C) using
standard LiAc-mediated transformation. Protein from yeast strain AH109 containing
RecQL5 was isolated by TCA extraction and verified by Western blot analysis. The
membrane was incubated with anti-DBD monoclonal antibody (Santa Cruz) and three
isolates were found to express RecQL5 (KHSY5184, KHSY5185, KHSY5186).
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The bait strain (KHSY5184) was inoculated and cultured overnight in 100 ml of
SC-Trp liquid media until it reached an optical density of 0.6. The culture was
centrifuged and divided into eight aliquots and 600 ng of plasmid DNA (Clontech Mate
and Plate Human Testis cDNA Library) was transformed using standard LiAc-mediated
transformation and plated on SC-Leu-Trp and SC-Leu-Trp-His+3AT. SC-Leu-Trp plates
were incubated for 2 days at 30ºC and SC-Leu-Trp-His+3AT plates were incubated for 14
days at 30ºC. To exclude false positives, colonies that appeared on SC-Leu-Trp-His+3AT
were re-streaked on new SC-Leu-Trp-His+3AT plates and incubated for two days. These
colonies were re-suspended in 40% glycerol and saved at -80ºC for further analysis.
Western blot was performed on positive candidates using anti-AD monoclonal antibody
(Santa Cruz). It is important to note that the molecular weight of the activation domain is
30 kDa and for this reason candidates that are larger than 30 kDa were excluded.
For manual verification of interactions between RecQL5 and candidates identified
through yeast two-hybrid, colonies that were saved for further analysis were spotted
onto SC-Leu-Trp, SC-Leu-Trp-His, and SC-Leu-Trp-His+3AT. Using candidates that grow
on all three plates, plasmids from these positives were rescued. The rescued AD
plasmids were introduced into the bait strain (KHSY5184) containing RecQL5 using
standard LiAc transformation. Positives were spotted onto SC-Leu-Trp, SC-Leu-Trp-His,
and SC-Leu-Trp-His+3AT to determine if interaction is reproducible.

119

RESULTS
Expression of human RecQL5 cDNA in S. cerevisiae does not complement
sgs1∆ defects
Cells lacking Sgs1 are not resistant to DNA-damaging agents hydroxyurea (HU)
and methyl methanesulfonate (MMS) and have increased gross-chromosomal
rearrangements (GCRs) [25, 26]. RecQ-like helicases are conserved across species
and share many of the functional domains so it is possible that RecQ-like helicases from
different species may be able to complement each others functions. In order to assess
RecQL5’s ability to suppress sgs1∆ defects we placed RECQL5 cDNA in-frame with the
start codon of SGS1 in order to regulate RecQL5 expression similar to that of Sgs1.
Protein expression of RecQL5 was determined through Western blot analysis from
yeast strain KHSY5172 (Figure 3.3). RecQL5 was unable to suppress the sensitivity on
HU and MMS seen in an sgs1∆ cell and was unable to suppress the accumulation of
GCRs (Figure 3.4 and Table 3.2).
Next, we explored the possibility that a single copy of RECQL5 was insufficient to
suppress sgs1∆ defects, and overexpressed RecQL5 in a sgs1∆ strain (KHSY5175). In
order to do this, the SGS1 promoter was replaced with a GAL1 promoter and
overexpression of RecQL5 was verified by probing for a myc epitope tag on the C
terminus of RecQL5 (Figure 3.3). Overexpression of RecQL5 was unable to suppress
the sensitivity on HU and MMS, nor was it able to suppress the accumulation of GCRs
(Figure 3.4 and Table 3.2).
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Sgs1-RecQL5 chimera is unable to suppress defects observed in the
absence of Sgs1
The N terminus of Sgs1 does not possess any catalytic activity but interacts with
Top3, Top2, Srs2, and Rad16 [27-33]. RECQL5 is unable to complement sgs1∆ defects
and this may be because it lacks a conserved N terminal region found in other RecQlike helicases. We have previously shown that an N-terminal fragment of Sgs1
expressed by the sgs1∆C800 allele can suppress HU sensitivity seen in a BLM
overexpressing cell suggesting Sgs1 and BLM have a functional relationship [34]. The
Sgs1-BLM chimeric protein was able to suppress defects seen in a sgs1∆ cell [34]. To
test if RecQL5 can suppress defects of a sgs1∆ cell with addition of the N terminal
region of Sgs1 (Sgs1 1-647), we fused this region to RecQL5 to produce a Sgs1RecQL5 chimera. Protein expression of Sgs1-RecQL5 was confirmed through Western
blot (Figure 3.3), probing for a myc epitope. The Sgs1-RecQL5 chimera was unable to
suppress sensitivity to HU and MMS, nor was it able to suppress the accumulation of
GCRs seen in an sgs1∆ strain (Figure 3.4 and Table 3.2).

Yeast two-hybrid screen using human testis cDNA library to determine
novel RecQL5 interacting partners
There are ten known RecQL5 interacting partners to date: Fen1, TopoIIa,
TopoIIIα/β, PCNA, WRN, Rad51, Mre11, Nbs1, Rad50, RnaPII, SWI/SNF, and PARP-1
[2, 7, 10-12, 15, 17, 35-41]. These interacting partners have all been discovered through
either pull down assays or proteomic analysis. To date a comprehensive screen was not
performed to identify RecQL5 interacting proteins. So we set out to perform a yeast two-
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hybrid screen using the human testis cDNA library since RecQL5 is abundantly
expressed in the testis [1]. Using the Clontech Matchmaker Gold Yeast Two-Hybrid
system we were screened approximately 1.5 million transformants. Transformants that
grew on SC-His, SC-Leu, and SC-Trp indicate a interaction with RecQL5 and these
isolates were frozen for further analysis. The potential positive transformants were
spotted once more on selective media for further stringency and validation. From this
additional test we obtained 61 positive transformants that may be potential RecQL5
interacting partners. These transformants were then set up for TCA protein extraction
and Western blot was performed using an antibody against the activating domain. We
decided to exclude any protein bands less than 30kDa because that is indicative of the
activating domain (Figure 3.9). Through this exclusion we pursued 36 candidates that
have a high likelihood of interaction with RecQL5. Lastly, we performed a manual test
and spotted the transformants on selective media to confirm interaction and determined
isolates 1 and 10 to express interacting proteins of RecQL5 (Figure 3.10). This test was
to ensure that there is a positive interaction between the bait and prey and not a result
of auto-activation by the prey plasmid. For this purpose, the prey plasmid, expressing
RecQL5 interacting protein, was isolated and transformed into strain KHSY3989
(reporter strain with empty bait plasmid) and a strain expressing RecQL5 (KHSY5184),
and then spotted on the following selective media: SC-Leu-Trp, SC-Leu-Trp-His, SCLeu-Trp-His+3AT. Growth on SC-Leu-Trp suggests presence of both bait and prey
plasmids. Growth on SC-Leu-Trp-His plates has lower stringency for selection of
protein-protein interaction and growth on SC-Leu-Trp-His+3AT has the highest stringency
because of the presence of 3AT (3-Amino-1,2,3-triazole), which is a competitive
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inhibitor of the HIS3 gene and is utilized to isolate strong protein-protein interactions. Of
the 36 transformants that were tested only two were able to activate the reporter genes
(Figure 3.10). To determine the identity of these isolates, the cDNA insert in the prey
plasmid was isolated from yeast and primer F1975, that binds upstream of the cDNA
insert was used to sequence the prey plasmid. The sequences were analyzed using
NCBI BLAST and isolate 1 and 10 (Figure 3.10) were found to be UBE2I and HLP2
respectively.

DISCUSSION
BLM and WRN, human RecQ-like helicases, have been studied in depth in a
yeast system, but RecQL5 had not been investigated in a similar fashion, so this study
sets out to functionally characterize RecQL5 in order to better understand its cellular
function. We hypothesized that RecQL5, being a RecQ-like helicase, could suppress
defects seen in an sgs1∆ cell. We found that cells expressing RecQL5 under control of
the native SGS1 promoter were as sensitive as an sgs1∆ cell on both HU and MMS,
were unable to suppress this sensitivity when overexpressed, and could not suppress
the accumulation of GCRs. The inability of RecQL5 to suppress the defects of an sgs1∆
cell may be due to the fact that RecQL5 lacks a long N terminal region found in Sgs1,
which is important for protein-protein interaction with Top2, Top3, Srs2, and Rad16 [26,
27, 33, 42-44]. The absence of this N terminus may prevent Top3 from localizing to
sites of damage, resulting in toxic intermediates that cannot be resolved without the
combined function of the RecQ helicase and topoisomerase. It has been shown that an
Sgs1-BLM chimera can suppress defects seen in an sgs1∆ cell because it regains the
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important N terminal functions of Sgs1 so we fused the long N terminal region of Sgs1
to RecQL5 to determine if retaining these functions could suppress defects similar to a
Sgs1-BLM chimera [34]. We exposed cells expressing the chimeric protein to DNA
damaging agents HU and MMS and also assessed its ability to suppress accumulation
of GCRs and found that the Sgs1-RecQL5 chimeric protein was unable to suppress
these defects suggesting a separation of function between this helicase and BLM. The
inability to complement may be because the fusion protein lacks the HRDC domain.
Removing the HRDC domain in BLM has been shown to reduce its ability to unwind
double Holliday junctions, and both BLM and WRN are unable to recognize damage
induced by MMS and mitomycin C in the absence of the HRDC domain [45, 46].
Considering RecQL5 lacks an HRDC domain, it is possible that it is unable to respond
to DNA damage because it cannot recognize these structures. Additionally, looking at
protein disorder, RecQL5 is distinct from BLM because its C terminus is disordered [34].
Disordered regions have been associated with protein-protein interactions so it is
possible that the C terminus of RecQL5 mediates interactions with proteins involved in
DNA repair, but inability to recognize DNA substrates may be inhibitory to its function.
A useful approach to understand the cellular mechanisms in which RecQL5
functions is to identify proteins it interacts with. Through yeast two-hybrid screen of a
human testis cDNA library we identified strong interaction with Hlp2 and Ube2I (Figure
3.10). Human Hlp2 is an ATP-dependent RNA helicase that is part of the DEAD box
family of helicases [47, 48]. The homolog in S. cerevisiae, Ded1, is an essential gene,
which has ATP-dependent RNA helicase activity and plays a role in translation initiation
[49]. Ded1 has been shown to displace protein complexes from RNA and is capable of
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RNA duplex unwinding [49]. Proteomics studies have shown that RecQL5 can associate
with Pol II through its KIX domain, providing a role for RecQL5 in transcription [16].
Further evidence has indicated that in the absence of RecQL5, DSBs accumulate
during replication as a result of the transcription machinery converging with the
replication fork [15]. The interaction between RecQL5 and Hlp2 may suggest a role for
RecQL5 apart from DNA metabolism.
Ube2I is a SUMO-conjugating enzyme that is important in regulating DNA repair,
the stress response, and cell cycle progression [50-54]. In S. cerevisiae UBE2I is
essential and is required for cell viability and defects in this gene result in abnormal
chromosome segregation [55]. Ube2I has also been shown to interact with transcription
factor AP-2 [56]. AP-2 belongs to a transcription factor family that is involved in
regulating genes that have a role in differentiation including ERBB2, a proto-oncogene,
and has functions during embryonic development [57, 58]. Ube2I has been shown to
associate with this transcription factor and down-regulate its activity by protein-protein
interaction and post-translational modification [56]. Since Ube2I has such diverse roles
in the cell, RecQL5 may target Ube2I to damage in the cell so that it can regulate
proteins involved in repair [59].
It will be important to confirm the interaction with endogenous proteins in human
cells by co-immunoprecipitation. It is possible that Hlp2 and Ube2I interact with the
unstructured C terminal half of RecQL5. By creating systematic deletions to the C
terminus of RecQL5, we can narrow the site of interaction and may be able to identify if
the KIX domain and SRI domain have a role in this interaction. Better understanding the
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role of novel interacting proteins, such as Ube2I and Hlp2 with RecQL5 will give us
better insight into the molecular mechanism by which RecQL5 functions.
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FIGURES AND TABLES
Table 3.1. Primers used in this study
Primer ID
1031F
1032R
1045F
1143F
1144R
1256F
1257F
1258F
1259F
1260F
1261F
1262F
1263F
1264F
1265F
1266F
1267R
1268R

Name
HIS3-5'Chk
HIS3-3'Chk
SGS1Confirm
SGS1-5'Chk
SGS1-3'Chk
SGS1 SEQ1
SGS1 SEQ2
SGS1 SEQ3
SGS1 SEQ4
SGS1 SEQ5
SGS1 SEQ6
SGS1 SEQ7
SGS1 SEQ8
SGS1 SEQ9
SGS1 SEQ10
SGS1 SEQ11
SGS1 SEQ12R
SGS1 SEQ13R

1672F

POBD2 RECQL5 F

1673R

POBD2 RECQL5 R

1674F
1675F
1676F
1677F
1678F
1679F
1680R
1697R

RECQL5 SEQ F 1
RECQL5 SEQ F 2
RECQL5 SEQ F 3
RECQL5 SEQ F 4
RECQL5 SEQ F 5
RECQL5 SEQ F 6
RECQL5 SEQ R 1
RECQL5 R

1850F

R5 F

1851R

R5 R

1911F

R5 HIS3 F

1912R

R5 HIS3 R

1913R

R5 HIS3 KI R

Sequence
TCGAGTGCTCTATCGCTAGGGGACC
AGTGCGTTCAAGGCTCTTGCGGTTG
GGTTGATATACCAGCCAGCA
CTGGGTGATCATTGGTGATA
GCACACCACAATATGTCGTG
ATGGTGACGAAGCCGTCACA
GTATAGGCAAACAGCTCGAA
ACTGTGACCCTCCTGTAATA
GTTCCCTCAAATGGCCAAAA
GAGGAAGACGATTTTGATGA
GAAGTCTTTAAACTGCCTGG
CTGCAAGTGAACAAGTCAGA
GCAGACAATGATCCAGAAGG
GCTGACTGGAAAAATGGAGA
GATCAAGCGAGGATCATGAA
CCGAGGTCACTACAGAGGAA
TAACCATTTGTGCTCCCTTC
CTTGAAGGCGGATCACCTCT
AAGATACCCCACCAAACCCAAAAAAAGAGATCGAATTCC
AGCTGACCACCATGAGCAGCCACCATACCAC
CTACGATTCATAGATCTCTGCAGGTCGACGGATCCCCGG
GAATTGCCATGTCATCTCTGGGGGCCACACA
ATGAGCAGCCACCATACCAC
AGCCACCCCACAGGTCCAAG
TCTATTACTCCAGGAATGAC
CCAGATGAGAACTGTCCCCT
GAGCCGGCCCTGTGGCCTCC
AGAACCCAGAGAGCCAGCCT
AATGAGCTTCATCCACCACC
TCATCTCTGGGGGCCACACA
ATTATTGTTGTATATATTTAAAAAATCATACACGTACAC
ACAAGGCGGTAATGAGCAGCCACCATACCAC
TTGGCGAATGGTGTCGTAGTTATAAGTAACACTATTTAT
TTTTCTACTCTTCATCTCTGGGGGCCACACA
TTCCCAGTCACGACGTTGTAAAACGACGGCCAGTGCCAA
GCTTGCATGCCATGAGCAGCCACCATACCAC
CCAAGCTCTTAAAACGATAACTTCGTATAATGTATGCTA
TACGAAGTTATTCATCTCTGGGGGCCACACA
TTGGCGAATGGTGTCGTAGTTATAAGTAACACTATTTAT
TTTTCTACTCTATTCGAGCTCGGTACCCGGG
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Table 3.1 (continued)
1975F
2454F
2455R

pact2ADF
MycChkF
MycChkR

ACCACTACAATGGATGATGT
CAGAAACTGATCTCTGAAGA
TCTTCAGAGATCAGTTTCTG
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Table 3.2. Rate of accumulating Gross Chromosomal Rearrangements (GCRs)
Strain
Wildtype
Δsgs1
RECQL5
Pgal.RECQL5
sgs1ΔC800.RECQL5

GCR Rate
r
− 10
(Can 5-FOA × 10 )
1.1
251
187
96
110
r

129

95% CI
r
− 10
(Can 5-FOA × 10 )
<1-6.2
80-310
40-200
71-264
47-250
r

Figure 3.1. RecQ-like helicases
Domain structures of RecQ-like helicases from Saccharomyces cerevisiae and Homo
sapiens. RecQL5β lacks the N terminal region present in Sgs1, WRN, BLM, and
RecQL4, but still contains a conserved helicase domain and partial RQC domain. In
addition to these domains RecQL5β possess a KIX domain and a SRI domain not
present in any of the other RecQ-like helicases. For this study RecQL5β was used
instead of RecQL5α and RecQL5ɣ because of its localization to the nucleus and
implicated roles in DNA repair.
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Figure 3.2. Construction of a chimeric protein containing the N terminal region of
Sgs1 and full length RecQL5β
Protein disorder was determined using IUPred algorithm. Data points above 0.5 indicate
a disordered residue and data points below 0.5 indicate ordered residues. N terminal
region of Sgs1, residues 1-647 were fused to RecQL5.

131

MW
(kDa)

Figure 3.3. Expression of RecQL5 at the endogenous SGS1 locus
RECQL5 was integrated into a strain deficient for SGS1 and a myc epitope tag was
added to the C terminus. Protein was extracted using standard TCA extraction and run
on a 10% SDS-PAGE gel and transferred to a PVDF membrane before visualization
with ECL Plus (GE Healthcare). RecQL5 was probed by using anti-myc (COVANCE)
antibody. In order to overexpress RecQL5, a GAL1 promoter was added to the N
terminus of RecQL5 while maintaining the myc epitope tag at the C terminus and
expression was verified using anti-myc antibody (COVANCE). The N terminus of SGS1
was fused to RecQL5 and expression verified using anti-myc antibody (COVANCE).
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Figure 3.4. RecQL5 does not suppress the defects seen in a sgs1∆ strain
Exponentially growing haploid cells were spotted on YPD media in the presence and
absence of DNA damaging agent hydroxyurea. Expressing RecQL5 from the native
SGS1 promoter, overexpressing, or generating a chimeric Sgs1-RecQL5 protein were
as sensitive as the sgs1∆ strain.
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Figure 3.5. Expression of RecQL5 from bait plasmid containing a DNA binding
domain
Cells were grown to an OD600 = 0.5 in SC-Trp media and protein was extracted using
standard TCA extraction. Sample was loaded on a 10% SDS-PAGE gel and transferred
to a PVDF membrane (Bio-Rad) then probed with anti-DBD monoclonal antibody (Santa
Cruz). Protein was visualized using ECL Plus (GR Healthcare). RecQL5β is
approximately 109kDa and all three independent isolates produced similar expression
and were therefore used for the yeast two-hybrid.
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Figure 3.6. Schematic of yeast two-hybrid using a testis cDNA library to find
RecQL5 interacting proteins
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Figure 3.7. Strain AH109 (Clontech) with the four reporter constructs
Strain AH109 used in the Clontech Matchmaker Gold Yeast Two-Hybrid System
containing the four reporter constructs. HIS3 and ADE2 contain GAL1 and GAL2
promoter elements and an upstream activating sequence. LacZ and MEL1 contain a
MEL1 UAS promoter element, which is a GAL4 response gene. The reporter genes in
this strain allow for a high level of stringency to determine RecQL5 interacting proteins
when using the human testis cDNA library.
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Figure 3.8. Positive candidates identified in the yeast two-hybrid system using
human testis cDNA library against RecQL5
Colonies that show a noticeable growth on SC-Leu-Trp-His+3AT were saved for protein
extraction and further analysis.
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Figure 3.9. Western blot analysis of candidates identified in yeast two-hybrid
using a human testis cDNA library for RecQL5 interacting proteins
Positive transformants from the yeast two-hybrid screen were grown to an OD600 = 0.5
in SC-Leu-Trp media and protein was extracted using standard TCA extraction to
confirm the expression of the activating domain and cDNA ORF from the testis library.
TCA extractions were run on 10% SDS-PAGE gels and transferred to a PVDF
membrane (Bio-Rad) and probed with anti-AD monoclonal antibody (Santa Cruz).
Protein was visualized using ECL Plus (GE Healthcare). The activating domain within
the plasmid containing the cDNA is approximately 30kDa. For this study candidates that
are greater than 30kDa are circled and were utilized for further analysis.
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Figure 3.10. Manual verification of RecQL5 interacting proteins
Positive candidates from yeast two-hybrid were evaluated for expression using an
activating antibody and candidates larger than 30kDa were used for further evaluation
are shown above. Genomic DNA from candidates larger than 30kDa was isolated and
transformed into E. coli in order to isolate the plasmid containing the cDNA. The isolated
plasmid was transformed into a strain containing the bait plasmid with RECQL5
(KHSY5184) and a strain with an empty bait vector (KHSY3989) in order to ensure that
the interaction observed was not a byproduct of the prey plasmid self-activating. The
candidates were spotted on SC-Leu-Trp, to select for presence of both plasmids and on
SC-Leu-Trp-His+3AT, to select for activation of the HIS3 reporter gene with 3AT allowing
for an extra level of stringency. The images on the left are of candidates grown on SCLeu-Trp and the images on the right are of candidates grown on SC-Leu-Trp-His+3AT.
From 36 candidates tested only two reproduced as positives, Ube2I and Hlp2.
139

REFERENCES
1.

Kitao, S., et al., Cloning of two new human helicase genes of the RecQ family:
biological significance of multiple species in higher eukaryotes. Genomics, 1998.
54(3): p. 443-52.

2.

Shimamoto, A., et al., Human RecQ5beta, a large isomer of RecQ5 DNA
helicase, localizes in the nucleoplasm and interacts with topoisomerases 3alpha
and 3beta. Nucleic Acids Res, 2000. 28(7): p. 1647-55.

3.

Ren, H., et al., The zinc-binding motif of human RECQ5beta suppresses the
intrinsic strand-annealing activity of its DExH helicase domain and is essential for
the helicase activity of the enzyme. Biochem J, 2008. 412(3): p. 425-33.

4.

Croteau, D.L., et al., Human RecQ helicases in DNA repair, recombination, and
replication. Annu Rev Biochem, 2014. 83: p. 519-52.

5.

Garcia, P.L., et al., Human RECQ5beta, a protein with DNA helicase and strandannealing activities in a single polypeptide. EMBO J, 2004. 23(14): p. 2882-91.

6.

Pike, A.C., et al., Structure of the human RECQ1 helicase reveals a putative
strand-separation pin. Proc Natl Acad Sci U S A, 2009. 106(4): p. 1039-44.

7.

Tadokoro, T., et al., Human RECQL5 participates in the removal of endogenous
DNA damage. Mol Biol Cell, 2012. 23(21): p. 4273-85.

8.

Ohhata, T., et al., Cloning, genomic structure and chromosomal localization of
the gene encoding mouse DNA helicase RECQL5beta. Gene, 2001. 280(1-2): p.
59-66.

9.

Hu, Y., et al., RECQL5/Recql5 helicase regulates homologous recombination
and suppresses tumor formation via disruption of Rad51 presynaptic filaments.
Genes Dev, 2007. 21(23): p. 3073-84.

10.

Kanagaraj, R., et al., RECQ5 helicase associates with the C-terminal repeat
domain of RNA polymerase II during productive elongation phase of
transcription. Nucleic Acids Res, 2010. 38(22): p. 8131-40.

11.

Kanagaraj, R., et al., Human RECQ5beta helicase promotes strand exchange on
synthetic DNA structures resembling a stalled replication fork. Nucleic Acids Res,
2006. 34(18): p. 5217-31.

12.

Zheng, L., et al., MRE11 complex links RECQ5 helicase to sites of DNA damage.
Nucleic Acids Res, 2009. 37(8): p. 2645-57.

13.

Aygun, O. and J.Q. Svejstrup, RECQL5 helicase: connections to DNA
recombination and RNA polymerase II transcription. DNA Repair (Amst), 2010.
9(3): p. 345-53.
140

14.

Izumikawa, K., et al., Association of human DNA helicase RecQ5beta with RNA
polymerase II and its possible role in transcription. Biochem J, 2008. 413(3): p.
505-16.

15.

Popuri, V., et al., Recruitment and retention dynamics of RECQL5 at DNA double
strand break sites. DNA Repair (Amst), 2012. 11(7): p. 624-35.

16.

Kassube, S.A., et al., Structural mimicry in transcription regulation of human RNA
polymerase II by the DNA helicase RECQL5. Nat Struct Mol Biol, 2013. 20(7): p.
892-9.

17.

Schwendener, S., et al., Physical interaction of RECQ5 helicase with RAD51
facilitates its anti-recombinase activity. J Biol Chem, 2010. 285(21): p. 15739-45.

18.

Hu, Y., et al., Recql5 plays an important role in DNA replication and cell survival
after camptothecin treatment. Mol Biol Cell, 2009. 20(1): p. 114-23.

19.

Hu, Y., et al., Recql5 and Blm RecQ DNA helicases have nonredundant roles in
suppressing crossovers. Mol Cell Biol, 2005. 25(9): p. 3431-42.

20.

Gietz, R.D. and R.A. Woods, Yeast transformation by the LiAc/SS Carrier
DNA/PEG method. Methods Mol Biol, 2006. 313: p. 107-20.

21.

Schmidt, K.H., et al., Analysis of gross-chromosomal rearrangements in
Saccharomyces cerevisiae. Methods Enzymol, 2006. 409: p. 462-76.

22.

Sikorski, R.S. and P. Hieter, A system of shuttle vectors and yeast host strains
designed for efficient manipulation of DNA in Saccharomyces cerevisiae.
Genetics, 1989. 122(1): p. 19-27.

23.

Schiestl, R.H., S. Prakash, and L. Prakash, The SRS2 suppressor of rad6
mutations of Saccharomyces cerevisiae acts by channeling DNA lesions into the
RAD52 DNA repair pathway. Genetics, 1990. 124(4): p. 817-31.

24.

Longtine, M.S., et al., Additional modules for versatile and economical PCRbased gene deletion and modification in Saccharomyces cerevisiae. Yeast, 1998.
14(10): p. 953-61.

25.

Schmidt, K.H. and R.D. Kolodner, Suppression of spontaneous genome
rearrangements in yeast DNA helicase mutants. Proc Natl Acad Sci U S A, 2006.
103(48): p. 18196-201.

26.

Mullen, J.R., V. Kaliraman, and S.J. Brill, Bipartite structure of the SGS1 DNA
helicase in Saccharomyces cerevisiae. Genetics, 2000. 154(3): p. 1101-14.

27.

Bennett, R.J., M.F. Noirot-Gros, and J.C. Wang, Interaction between yeast sgs1
helicase and DNA topoisomerase III. J Biol Chem, 2000. 275(35): p. 26898-905.

141

28.

Argueso, J.L., et al., Systematic mutagenesis of the Saccharomyces cerevisiae
MLH1 gene reveals distinct roles for Mlh1p in meiotic crossing over and in
vegetative and meiotic mismatch repair. Mol Cell Biol, 2003. 23(3): p. 873-86.

29.

Saffi, J., et al., Interaction of the yeast Pso5/Rad16 and Sgs1 proteins: influences
on DNA repair and aging. Mutat Res, 2001. 486(3): p. 195-206.

30.

Wu, L., et al., Potential role for the BLM helicase in recombinational repair via a
conserved interaction with RAD51. J Biol Chem, 2001. 276(22): p. 19375-81.

31.

Wang, T.F. and W.M. Kung, Supercomplex formation between Mlh1-Mlh3 and
Sgs1-Top3 heterocomplexes in meiotic yeast cells. Biochem Biophys Res
Commun, 2002. 296(4): p. 949-53.

32.

Dherin, C., et al., Characterization of a highly conserved binding site of Mlh1
required for exonuclease I-dependent mismatch repair. Mol Cell Biol, 2009.
29(3): p. 907-18.

33.

Chiolo, I., et al., Srs2 and Sgs1 DNA helicases associate with Mre11 in different
subcomplexes following checkpoint activation and CDK1-mediated Srs2
phosphorylation. Mol Cell Biol, 2005. 25(13): p. 5738-51.

34.

Mirzaei, H., et al., Sgs1 truncations induce genome rearrangements but suppress
detrimental effects of BLM overexpression in Saccharomyces cerevisiae. J Mol
Biol, 2011. 405(4): p. 877-91.

35.

Speina, E., et al., Human RECQL5beta stimulates flap endonuclease 1. Nucleic
Acids Res, 2010. 38(9): p. 2904-16.

36.

Ramamoorthy, M., et al., RECQL5 cooperates with Topoisomerase II alpha in
DNA decatenation and cell cycle progression. Nucleic Acids Res, 2012. 40(4): p.
1621-35.

37.

Popuri, V., et al., The Human RecQ helicases, BLM and RECQ1, display distinct
DNA substrate specificities. J Biol Chem, 2008. 283(26): p. 17766-76.

38.

Popuri, V., et al., RECQL5 plays co-operative and complementary roles with
WRN syndrome helicase. Nucleic Acids Res, 2013. 41(2): p. 881-99.

39.

Aygun, O., J. Svejstrup, and Y. Liu, A RECQ5-RNA polymerase II association
identified by targeted proteomic analysis of human chromatin. Proc Natl Acad Sci
U S A, 2008. 105(25): p. 8580-4.

40.

Islam, M.N., et al., RecQL5 promotes genome stabilization through two parallel
mechanisms--interacting with RNA polymerase II and acting as a helicase. Mol
Cell Biol, 2010. 30(10): p. 2460-72.

142

41.

Zhou, G., et al., Purification of a novel RECQL5-SWI/SNF-RNAPII super
complex. Int J Biochem Mol Biol, 2010. 1(1): p. 101-111.

42.

Watt, P.M., et al., Sgs1: a eukaryotic homolog of E. coli RecQ that interacts with
topoisomerase II in vivo and is required for faithful chromosome segregation.
Cell, 1995. 81(2): p. 253-60.

43.

Duno, M., et al., Genetic analysis of the Saccharomyces cerevisiae Sgs1
helicase defines an essential function for the Sgs1-Top3 complex in the absence
of SRS2 or TOP1. Mol Gen Genet, 2000. 264(1-2): p. 89-97.

44.

Fricke, W.M., V. Kaliraman, and S.J. Brill, Mapping the DNA topoisomerase III
binding domain of the Sgs1 DNA helicase. J Biol Chem, 2001. 276(12): p. 884855.

45.

Wu, L., et al., The HRDC domain of BLM is required for the dissolution of double
Holliday junctions. Embo J, 2005. 24(14): p. 2679-87.

46.

Samanta, S. and P. Karmakar, Recruitment of HRDC domain of WRN and BLM
to the sites of DNA damage induced by mitomycin C and methyl
methanesulfonate. Cell Biol Int, 2012. 36(10): p. 873-81.

47.

Cordin, O., et al., The DEAD-box protein family of RNA helicases. Gene, 2006.
367: p. 17-37.

48.

Rocak, S. and P. Linder, DEAD-box proteins: the driving forces behind RNA
metabolism. Nat Rev Mol Cell Biol, 2004. 5(3): p. 232-41.

49.

Banroques, J., et al., Motif III in superfamily 2 "helicases" helps convert the
binding energy of ATP into a high-affinity RNA binding site in the yeast DEADbox protein Ded1. J Mol Biol, 2010. 396(4): p. 949-66.

50.

Scheffner, M., J.M. Huibregtse, and P.M. Howley, Identification of a human
ubiquitin-conjugating enzyme that mediates the E6-AP-dependent ubiquitination
of p53. Proc Natl Acad Sci U S A, 1994. 91(19): p. 8797-801.

51.

Goebl, M.G., et al., The yeast cell cycle gene CDC34 encodes a ubiquitinconjugating enzyme. Science, 1988. 241(4871): p. 1331-5.

52.

Jentsch, S., J.P. McGrath, and A. Varshavsky, The yeast DNA repair gene RAD6
encodes a ubiquitin-conjugating enzyme. Nature, 1987. 329(6135): p. 131-4.

53.

Jungmann, J., et al., Resistance to cadmium mediated by ubiquitin-dependent
proteolysis. Nature, 1993. 361(6410): p. 369-71.

54.

Seufert, W. and S. Jentsch, Ubiquitin-conjugating enzymes UBC4 and UBC5
mediate selective degradation of short-lived and abnormal proteins. EMBO J,
1990. 9(2): p. 543-50.
143

55.

Dieckhoff, P., et al., Smt3/SUMO and Ubc9 are required for efficient APC/Cmediated proteolysis in budding yeast. Mol Microbiol, 2004. 51(5): p. 1375-87.

56.

Eloranta, J.J. and H.C. Hurst, Transcription factor AP-2 interacts with the SUMOconjugating enzyme UBC9 and is sumolated in vivo. J Biol Chem, 2002. 277(34):
p. 30798-804.

57.

Schorle, H., et al., Transcription factor AP-2 essential for cranial closure and
craniofacial development. Nature, 1996. 381(6579): p. 235-8.

58.

Zhang, J., et al., Neural tube, skeletal and body wall defects in mice lacking
transcription factor AP-2. Nature, 1996. 381(6579): p. 238-41.

59.

Tahmasebi, S., et al., The SUMO conjugating enzyme Ubc9 is required for
inducing and maintaining stem cell pluripotency. Stem Cells, 2014. 32(4): p.
1012-20.

144

CHAPTER FOUR:
NOVEL ROLE OF RRM3 IN CONTROLLING DNA SYNTHESIS IS SEPARABLE
FROM ITS HELICASE-DEPENDENT ROLE IN AVOIDANCE OF REPLICATION
FORK PAUSING
Note to reader: Unpublished data. Experiments were designed by Kristina H. Schmidt
and Salahuddin Syed. Experiments were performed by Salahuddin Syed.

ABSTRACT
In response to replication stress cells activate the DNA Damage checkpoint,
induce DNA repair pathways, increasing nucleotide levels, and inhibit late origin firing.
Here, we report that Rrm3 controls DNA synthesis during replication stress and normal
S phase. This novel Rrm3 function is independent of its established role as an
ATPase/helicase in facilitating replication fork progression through polymerase blocking
obstacles; instead the new functional domain maps to residues 186-212 that are also
critical for binding Orc5 of the origin recognition complex. Deletion of this domain is
lethal to cells lacking the replication checkpoint mediator Mrc1 and leads to mutations
upon exposure to the replication stressor hydroxyurea, but not upon induction of
alkylating DNA damage. Using quantitative mass spectrometry and genetic analysis, we
find that the chromatin remodeler Rdh54 and Rad5-depenent error-free DNA damage
bypass act as independent mechanisms on DNA lesions that arise when Rrm3 catalytic
activity is disrupted whereas these mechanisms are dispensable for DNA damage
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tolerance when the replication function is disrupted, indicating that the DNA lesions
generated by the loss of each Rrm3 function are distinct. Although both lesion types
activate the DNA-damage checkpoint, we find that the resultant increase in nucleotide
levels is not sufficient for continues DNA synthesis under replication stress. Together,
our findings suggest a role of Rrm3, via its Orc5-binding domain, in restricting DNA
synthesis that is genetically and physical separable from its established catalytic role in
facilitating fork progression through replication blocks.

INTRODUCTION
The replication machinery constantly at risk of encountering obstacles such as
protein-DNA complexes, DNA secondary structures, transcribing RNA polymerases,
and DNA damage, which can block fork progression. If these structures cannot
immediately be resolved the paused fork may eventually collapse as replisome
components become irretrievably inactivated.
The 5’ to 3’ DNA helicase Rrm3 is a member of the Pif1 family, which is
conserved from yeast to humans (Azvolinsky, Dunaway et al. 2006). Saccharomyces
cerevisiae RRM3 was first discovered as a suppressor of recombination between
tandem arrays and ribosomal DNA (rDNA) repeats (Keil and McWilliams 1993). Without
Rrm3, extrachromosomal rDNA circles accumulate, suggesting a role in maintaining
rDNA stability, and cells accumulate recombination intermediates at stalled replication
forks, suggesting that Rrm3 facilitates DNA unwinding and the removal of protein blocks
from DNA to help fork convergence during replication termination (Ivessa, Zhou et al.
2000, Ivessa, Zhou et al. 2002, Ivessa, Lenzmeier et al. 2003, Fachinetti, Bermejo et al.
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2010). Additionally, replication fork pausing has been observed in the absence of Rrm3
at centromeres, telomeres, tRNA genes, the mating type loci, inactive origins of
replication, and RNA polymerase II-transcribed genes (Keil and McWilliams 1993,
Ivessa, Zhou et al. 2002, Ivessa, Lenzmeier et al. 2003).
The mechanism by which Rrm3 aids fork progression is poorly understood, but it
is thought that Rrm3 facilitates replication through protein blocks and may also be able
to remove RNA transcripts (Ivessa, Lenzmeier et al. 2003, Stamenova, Maxwell et al.
2009). Within each rRNA coding region are two intergenic spacers that contain
termination (Ter) sites that are bound by the replication terminator protein Fob1 to
promote fork arrest in order to prevent unscheduled transcription (Kobayashi, Nomura
et al. 2001, Kobayashi 2003, Mohanty and Bastia 2004). Ter function also requires the
intra-S phase checkpoint proteins Tof1 and Csm3, which form a complex with the
replisome and antagonize Rrm3 function (Mohanty, Bairwa et al. 2006, Mohanty, Bairwa
et al. 2009). It is thought that Rrm3 removes Fob1 and other non-histone proteins from
DNA before the replication fork encounters them. This ability of Rrm3 to promote
replication fork progression is dependent on its catalytic activity (Ivessa, Zhou et al.
2000). Further supporting a role of Rrm3 in fork progression are synthetic fitness
defects or lethality between rrm3Δ and mutations that disrupt genes involved in
maintaining the integrity of stalled forks, including rad53Δ, mec1Δ, srs2Δ, sgs1Δ, mrc1Δ,
and rtt101Δ (Ivessa, Lenzmeier et al. 2003, Schmidt and Kolodner 2004, Torres,
Schnakenberg et al. 2004, Luke, Versini et al. 2006).
Rrm3 possesses an N-terminal PCNA-interacting motif, associates with the
replication fork in vivo and is hyperphosphorylated by Rad53 under replication stress
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(Schmidt, Derry et al. 2002, Azvolinsky, Dunaway et al. 2006, Rossi, Ajazi et al. 2015).
The replication damage that arises in the absence of Rrm3 causes constitutive,
Mec3/Mec1/Rad9-dependent activation of the checkpoint kinase Rad53 (Ivessa,
Lenzmeier et al. 2003, Schmidt and Kolodner 2006, Rossi, Ajazi et al. 2015). As a
result, Dun1 kinase is activated, leading to degradation of the ribonucleotide reductase
(RNR) inhibitor Sml1 and an increase in the dNTP pool (Zhao and Rothstein 2002, Poli,
Tsaponina et al. 2012). This increased dNTP pool has been associated with enhanced
DNA synthesis in hydroxyurea (HU) in chromosome instability mutants (Poli, Tsaponina
et al. 2012).
Here we show that cells lacking Rrm3 fail to inhibit DNA replication in the
presence of HU-induced replication stress and that this failure is not caused by the
increased dNTP pool resulting from constitutive DNA-damage checkpoint activation.
This novel function of Rrm3 is independent of its ATPase/helicase activity and, thus,
distinct from Rrm3’s established catalytic role in facilitating fork progression through
replication blocks. Instead, we have identified dependency on a novel functional domain
in the Rrm3 N-terminus that we find is critical for binding the Orc5 subunit of the origin
recognition complex (ORC), suggesting that Rrm3 may control DNA synthesis by
controlling origin activity. Quantitative mass spectrometry and genetic analyses further
implicate Rad5-dependent error-free DNA damage bypass and Rdh54 translocase as
novel repair mechanisms for DNA lesions that result from inactivating the catalytic
activity of Rrm3, whereas the same DNA repair factors are dispensable when the Orc5binding domain is disrupted, leading us to conclude that the types of DNA lesions that
result from the inactivation of the two independent Rrm3 functions are distinct.
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RESULTS
SILAC-based proteomics to identify the cellular response to replication fork
pausing
In the absence of Rrm3 cells accumulate replication pause sites at the rDNA
locus, in tRNA genes and at centromeric regions, as well as many other sites
throughout the genome (Ivessa, Zhou et al. 2002, Ivessa, Lenzmeier et al. 2003, Torres,
Schnakenberg et al. 2004). To identify DNA metabolic pathways that deal with stalled
forks, we sought to identify proteins whose association with chromatin changed in the
absence of Rrm3 using stable isotope labeling by amino acids in cell culture (SILAC)based quantitative mass spectrometry (Ong, Blagoev et al. 2002, Ong and Mann 2006).
We extracted the chromatin fraction from nuclei purified from a mixture of wildtype and
rrm3Δ cells grown in the presence of heavy- or light-labeled arginine and lysine,
respectively (Figures 1A and 1B). Across chromatin fractions from three biological
replicates we identified 490 peptides from 137 different proteins, with the abundance of
11 proteins changing significantly in at least two out of the three replicates (Figure 1C).
The largest change in chromatin association was a 5.1-fold increase (p<0.001) of Rad5,
which belongs to the SWI/SNF family of ATPases and defines an error-free pathway for
bypassing replication-blocking DNA lesions (Torres-Ramos, Prakash et al. 2002,
Gangavarapu, Haracska et al. 2006, Blastyak, Pinter et al. 2007, Ortiz-Bazan, GalloFernandez et al. 2014). The increase in Rad5 was followed by smaller, but significant,
increases for Top2 (1.9-fold, p<0.01), a type II topoisomerase that is important for the
decatenation of replication intermediates, and Rdh54 (1.8-fold, p<0.01), a chromatin
remodeler with a role in homologous recombination that is still largely unclear. Like
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Rad5, Rdh54 is a member of the SWI/SNF family of ATPases; it possesses translocase
activity on double-stranded (ds) DNA and has been shown to be capable of modifying
DNA topology, especially in chromatinized DNA (Petukhova, Sung et al. 2000, Chi,
Kwon et al. 2006, Shah, Zheng et al. 2010). We observed significant decreases in
chromatin association for the Rsc1 subunit of the chromatin-structure-remodeling (RSC)
complex (2-fold, p<0.01), the Mcm4 subunit of the minichromosome maintenance
(MCM) replicative DNA helicase (1.9-fold, p<0.01), and the catalytic subunit Hda1 of the
histone deacetylase (HDAC) complex (1.7-fold, p<0.01).
Upon treatment with HU, which induces replication stress by reducing the
nucleotide pool, Rdh54 abundance in the chromatin fraction of the rrm3Δ mutant
increased the most (2.6-fold, p<0.01) whereas the histone deacetylase Set3 and the
Rsc9 subunit of the RSC chromatin remodelling complex saw the largest decreases
(2.7-fold, p<0.05) (Figures 1D and 1E). The complete list of proteins that underwent
significant changes in the HU-treated or untreated rrm3Δ mutant, including the FANCMrelated Mph1 helicase, the recombination factor Mgm101, and the cohesion
components Smc1, Smc3 and Scc3, is provided in Supplemental Table S1.

Rad5 and Rdh54 independently act on DNA lesions that arise in the
absence of Rrm3
Rrm3 helicase is required to prevent excessive replication fork pausing at
protein-bound sites, possibly by acting as a protein displacement helicase (Ivessa, Zhou
et al. 2002). The role of Rdh54 as a chromatin remodeler (Kwon, Seong et al. 2008,
San Filippo, Sung et al. 2008) and the fork reversal activity of Rad5 suggest that they
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are recruited to chromatin to recover forks that are blocked due to the lack of Rrm3 or to
substitute for Rrm3 in preventing fork pausing. We therefore examined the effect of
deleting RAD5 and RDH54 in the rrm3Δ mutant on genome stability and sensitivity to
DNA damage and replication stress. We found synergistic increases in DNA damage
sensitivity in the rrm3Δ rad5Δ and rrm3Δ rdh54Δ mutants (Figure 2A). The negative
genetic interaction between rrm3Δ and rad5Δ was particularly strong; both single
mutants were no more sensitive to HU than wildtype, but the double mutant failed to
form colonies on 100 mM HU and grew very poorly even on 20 mM HU. In contrast to
HU, the rad5Δ mutant was extremely sensitive to methyl methanesulfonate (MMS), and
deleting RRM3 led to a further, synergistic increase in MMS sensitivity. Inactivation of
the ATPase activity of Rrm3 (rrm3-K260A/D) caused the same DNA-damage sensitivity
in the rad5Δ mutant as an RRM3 deletion (Figure 2B). We also identified a negative
genetic interaction between rrm3Δ and rdh54Δ, which was especially strong on MMS.
The increase in DNA-damage sensitivity of rdh54Δ cells upon deletion of RRM3
extended to diploid cells (Figure 2G), suggesting that the lesions generated in the
absence of Rrm3 are substrates for recombination between homologous chromosomes
that is controlled by Rdh54. Even though the rrm3Δ rad5Δ mutant was hypersensitive to
MMS and HU, deletion of RDH54 caused further synergistic increases in sensitivity to
both DNA damaging agents, suggesting that Rad5 and Rdh54 define important
pathways for dealing with DNA lesions that arise in the absence of Rrm3, and that they
perform (at least some) independent roles.
In addition to structure-specific helicase activity, Rad5 also possesses a RING
motif associated with ubiquitin ligase activity that plays a role in polyubiquitination of
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PCNA (Johnson, Henderson et al. 1992, Johnson, Prakash et al. 1994, Ulrich and
Jentsch 2000, Hoege, Pfander et al. 2002). Disrupting the ubiquitin-ligase activity (rad5Ub) or ubiquitin ligase and ATPase activity (rad5-Ub-ATPase), had the same effect on
the MMS and HU sensitivity of wildtype cells (Figure 2B), consistent with a previous
report (Gangavarapu, Haracska et al. 2006). In the rrm3Δ mutant, however, disrupting
both activities caused significantly greater DNA damage sensitivity than disrupting either
activity (rrm3Δ rad5-Ub, rrm3Δ rad5-ATPase), indicating that the ATPase/helicase and
ubiquitin ligase activities of Rad5 contribute independently to repair of DNA lesions that
arise in the absence of Rrm3.
Although Rad5 and Rdh54 chromatin association increased most in the absence
of Rrrm3 (Figure 1E), gross-chromosomal rearrangements (GCRs) did not accumulate
at higher rates in the rrm3Δ rad5Δ or rrm3Δ rdh54Δ mutants compared to the single
mutants, even after exposure to HU and MMS (Table 1). However, disruption of both,
Rad5 and Rdh54, in the rrm3Δ mutant caused significantly higher chromosome
instability than disruption of a single pathway, especially upon exposure to HU or MMS,
underlining the independent contributions of Rdh54 and Rad5-mediated repair
mechanisms to genome stability and DNA damage tolerance in the absence of Rrm3.
Whereas rdh54Δ and rad5Δ cells moved through an undisturbed cell cycle with
similar kinetics as wildtype cells, rrm3Δ cells were delayed in progressing through S
phase (Figure 2C), consistent with previous observations (Ivessa, Zhou et al. 2002,
Schmidt and Kolodner 2004). We find that this accumulation of rrm3Δ cells in S phase
was enhanced when RDH54 or RAD5 were deleted. To examine progression of rrm3Δ
rad5Δ and rrm3Δ rdh54Δ cells through S phase under replication stress, we released α152

factor arrested cells from G1 in the presence of hydroxyurea and trapped them in G2/M
with nocodazole. After 140 minutes, virtually all wildtype cells had reached 2C DNA
content, whereas rrm3Δ and rdh54Δ entered S phase similarly to wildtype cells, but then
slowed down significantly (Figure 2D, 100 minute time point). When we combined rrm3Δ
and rdh54Δ mutations, this slowdown was so severe that most cells still had near 1C
DNA content 100 minutes after release from G1 arrest. Similarly, rad5Δ rrm3Δ cells
were delayed in reaching 2C DNA content in HU (Figure 2E). However, all mutants
were able to recover from a 2-hour arrest in 100 mM HU and resume the cell cycle
normally (Supplemental Figure S1). When we examined the ability of cells arrested in
G2/M with nocodazole to complete mitosis and reach G1 phase we found that a
significant number of wildtype cells had reached G1 after 20 minutes, whereas virtually
all rrm3Δ, rad5Δ and rrm3Δ rad5Δ cells remained arrested in mitosis (Figure 2F).
Together, these findings indicate that Rad5 and Rdh54 facilitate the progression of
rrm3Δ cells through S phase, both in the presence and in the absence of HU, and that in
the absence of Rrm3, cells accumulate DNA damage that impairs mitosis.
In addition to Rad5 and Rdh54, which exhibited the most significant increases in
chromatin association in the absence of Rrm3 (Figure 1E), we tested DNA damage
sensitivity of cells that lacked Rrm3 in combination with other nonessential factors
revealed in the proteome screen (Figures 1C and 1D), including Mgm101, Hda1, Set3,
and Mph1. Whereas deletions of MGM101, HDA1 or SET3 had no effect on DNA
damage sensitivity of wildtype or rrm3Δ cells (Supplemental Figure S2), deletion of
MPH1 caused synergistic increases in HU and MMS sensitivity of the rrm3Δ mutant
(Supplemental Figure S3), consistent with our previous finding (Schmidt, Viebranz et al.
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2010). In the absence of Mph1, rrm3Δ cells progressed very slowly through an
undisturbed cell cycle and accumulated in G2/M when they were released from a 2-hour
incubation in 100 mM HU (Supplemental Figures 3B and 3C). When cells were released
from HU arrest into media with 40 mM HU and α-factor, virtually all wildtype cells and
the single mutants had been trapped in G1 after 60 minutes (with a slight S-phase delay
in the mph1Δ mutant), whereas the majority of rrm3Δ mph1Δ cells accumulated in S
phase, never forming a majority peak at 1C DNA content in the 120-minute time course
(Supplemental Figure S3D). These findings implicate Mhp1 as another crucial factor for
overcoming spontaneous and DNA-damage-induced replication-blocking lesions.
Together these findings suggest error-free DNA lesion bypass, implicated by Rad5 and
Mph1, and homologous recombination, implicated by Rdh54, as two mechanisms that
can act independently on blocked replication forks.

A novel function of Rrm3 in controlling DNA replication maps to the Nterminal tail and is independent of Rrm3 catalytic activity
All functions of the Rrm3 helicase known to date are dependent on its
ATPase/helicase activity. During our analysis of cell cycle progression, however, we
observed that cells with a deletion of RRM3 continue to replicate DNA in the presence
of HU, similar to a rad53Δ checkpoint mutant, whereas the helicase-defective rrm3K260A and rrm3-K260D mutants maintained near 1C DNA content after 2 hours in HU,
similar to wildtype (Figures 3B and 3C). This observation suggested the presence of a
previously unknown, ATPase/helicase-independent function of Rrm3 in DNA replication.
Since this replication defect was independent of the ATPase/helicase activity located in
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the ordered C-terminal domain of Rrm3 (residues 250-723), we explored a possible
involvement of the 230-residue, disordered N-terminal tail (Figure 3A, Supplemental
Figure S4A). The only motifs previously identified in this tail are a putative PCNAinteracting peptide (PIP) box between residues 35-42 (Schmidt, Derry et al. 2002) and a
cluster of phosphorylated residues between S85 and S92 (Rossi, Ajazi et al. 2015).
Deletion or mutation of the PIP-box (rrm3-ΔN54, rrm3-FFAA) had no effect on DNA
replication in HU, whereas deletion of the entire N-terminal tail (rrm3-ΔN230) caused the
same replication defect as deleting RRM3 (rrm3Δ) (Figure 3D). By constructing a series
of N-terminal truncations (Figure 3A and 3D) we determined that deletion of up to 186
residues, which include the PIP-box and the phosphorylation site, was able to maintain
the wildtype replication phenotype in HU (Figures 3D and 3E), whereas deletion of 212
residues caused the same replication defect as rrm3-ΔN230, thus narrowing down the
critical functional site for control of DNA replication to the 26 residues between residues
186-212. The importance of this region for controlling DNA replication was limited to
HU, and not observed when cells were exposed to the alkylating agent methane
methylsulfonate (Supplementary Figure S4B).
Deletion of RRM3 or inactivation of its ATPase/helicase activity was recently
reported to partially suppresses the HU hypersensitivity of the rad53Δ mutant (Rossi,
Ajazi et al. 2015). We obtained the same findings, but also observed that the rrm3ΔN212 allele does not act as a suppressor (Figure 3J), indicating that this rrm3-∆N212
codes for a functional ATPase/helicase. This is also supported by the finding that a
introduction of the K260A mutation in rrm3-ΔN212 allele suppressed HU hypersensitivity
of the rad53Δ mutant to the same extent as the rrm3-K260A allele (Figure 3J). Still, the
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Rad53 checkpoint kinase was constitutively activated in the rrm3-ΔN212 mutant just like
in the ATPase/helicase-defective rrm3-K260A/D mutants, and Rad53 activation in both
mutants was dependent on the mediator of the DNA damage checkpoint Rad9 (Figures
3G and 3I).
Through degradation of the ribonucleotide reductase (RNR) inhibitor Sml1, the
nucleotide pool increases upon Rad53 activation, and this correlates with enhanced fork
progression (Poli, Tsaponina et al. 2012). However, we found that the rrm3 mutants that
continued DNA replication in HU (rrm3Δ, rrm3ΔN212) and the rrm3 mutant that
maintained 1C DNA content (rrm3-K260D) had a constitutively increased nucleotide
pool (Figure 3F), indicating that the continued DNA replication in HU seen in the rrm3-

ΔN212 mutant could not be explained by a larger nucleotide reservoir prior to its
depletion by HU addition. In fact, we estimate that in the rrm3Δ and rrm3Δ-N212
mutants the peak of cells with 1C DNA content had progressed nearly 40% toward 2C
DNA content after 2 hours in HU (Figure 3H), and continued to progress (Supplemental
Figure S4C), whereas wildtype cells, the helicase-dead rrm3 mutants, and rrm3Δ-N186
mutant had progressed less than 10%.
Together, these findings indicate a novel function of Rrm3 in the control of DNA
replication and prevention of S phase damage, which maps to residues 186-212 of the
N-terminal tail and does not require Rrm3’s established activity as an ATPase/DNA
helicase.
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Residues of Rrm3 required for control of DNA replication are critical for
Orc5 binding
Long disordered tails, such as the N-terminal 230 residues of Rrm3, which
extend from its structured catalytic core, typically serve as sites for protein binding and
posttranslational modification (Gsponer and Babu 2009). The phenotype of the rrm3-

ΔN212 allele in the rad53Δ mutant indicates that it encodes a proficient
ATPase/helicase, raising the possibility that the replication defect of this allele is caused
by loss of a protein-binding site. Because deletion of the putative PIP-box (Schmidt,
Derry et al. 2002) and the recently identified phosphorylation site (Rossi, Ajazi et al.
2015) did not impair the ability of Rrm3 to control DNA replication, we explored the
possibility that Orc5, an ATP-binding subunit of the origin recognition complex (ORC),
binds to the N-terminal tail of Rrm3. An interaction between the two full-length proteins
had previously been identified in a yeast-two-hybrid screen (Matsuda, Makise et al.
2007). When we combined ORC5 with the various rrm3 truncation alleles in a yeast
two-hybrid assay, we found that deletion of 186 residues did not diminish Orc5 binding
to Rrm3, in the presence or absence of MMS or HU, whereas deletion of 212 or 230
residues eliminated binding (Figure 4A). These findings show that the same site of
Rrm3 that controls DNA replication is required for a physical interaction with Orc5 and
raise the possibility that Rrm3 may control DNA replication by affecting origin activity.

157

Differential requirements of Rrm3 function in controlling DNA replication
and ATPase/helicase activity in cells lacking Rad5, Rdh54, Mph1 or
replication checkpoint factors Mrc1 and Tof1
To investigate the link between Rrm3 functions and DNA replication, we first
examined the replication checkpoint. Replication mutants exhibit strong genetic
interactions with Mrc1/Claspin, which acts as a mediator of the replication stress
checkpoint – a Rad9-independent pathway of the intra-S-phase checkpoint (Alcasabas,
Osborn et al. 2001, Katou, Kanoh et al. 2003, Osborn and Elledge 2003, Suter, Tong et
al. 2004, Xu, Boone et al. 2004). Mrc1 is also a component of normal replication forks,
which is loaded at origins of replication and stays associated with the replisome
(Alcasabas, Osborn et al. 2001, Osborn and Elledge 2003, Szyjka, Viggiani et al. 2005,
Tourriere, Versini et al. 2005). Mrc1, like Rrm3, is required for efficient replication
(Naylor, Li et al. 2009). The function of Mrc1 in DNA replication is essential for the
viability of cells lacking Rrm3 (Szyjka, Viggiani et al. 2005) whereas Mrc1
phosphorylation on SQ and TQ sites linked to its checkpoint function is dispensable
(Schmidt and Kolodner 2006). However, the role of this functional interaction between
Rrm3 and Mrc1 in DNA replication has remained unclear. We therefore tested if the
ability of Rrm3 to control DNA replication was required for the viability of the mrc1Δ
mutant. For this purpose, we transformed diploids heterozygous for the mrc1Δ and
rrm3Δ mutations with plasmids expressing N-terminal truncations of Rrm3 and analyzed
the viability of meiotic products. Figure 4B shows that the rrm3-ΔN186 allele supported
viability of the rrm3Δ mrc1Δ mutant as effectively as the wildtype RRM3 allele, whereas
the helicase-dead alleles and the rrm3-ΔN212 allele were as ineffective as the null allele
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(empty vector). Thus the helicase activity of Rrm3 is not sufficient for viability of the
mrc1Δ mutant; Rrm3’s new N-terminal domain for controlling DNA replication is also
required.
In addition to Mrc1, Tof1 promotes normal progression of the replication fork;
however, in contrast to Mrc1, its requirement for fork progression appears more limited,
assisting primarily replication through non-histone protein complexes with DNA
(Hodgson, Calzada et al. 2007). TOF1 deletion was not lethal in the rrm3Δ mutant and
neither single mutant was hypersensitive to HU or MMS. The combined loss of Rrm3
and Tof1, however, caused a synergistic increase in DNA-damage sensitivity (Figure
4C). Identical to the functional requirements in the absence of Mrc1 both, the
ATPase/helicase activity of Rrm3 and the Orc5 binding domain, were required for
growth in the presence of DNA damage and replication stress in the absence of Tof1.
In contrast to mrc1Δ and tof1Δ mutants, we found that only the ATPase/helicase
activity of Rrm3 was required for the suppression of HU and MMS hypersensitivity of the
rad5Δ, rdh54Δ, and mph1Δ mutants (Figures 4D – 4F, Figure 2B). The N-terminal tail,
including its function in controlling DNA replication, was dispensable, with the rrm3-

ΔN212 allele exhibiting wildtype phenotypes in rad5Δ, rdh54Δ, and mph1Δ mutants
(Figures 4D – 4F).
Together, these findings suggest two separable functions of Rrm3 in DNA
replication.

First,

an

ATPase/helicase-dependent

function

that

promotes

fork

progression through protein-DNA complexes, which if disrupted (rrm3-K260A/D) causes
aberrant replication intermediates that can be rescued by Rad5, Rdh54 or Mph1
mechanisms. Second, an N-terminal function that controls DNA replication, possibly
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mediated by Rrm3’s physical interaction with ORC, which if disrupted (rrm3-ΔN212)
requires the replication checkpoint factors Mrc1 and Tof1 for viability and DNA damage
survival. These differential requirements of factors involved in DNA repair and DNA
damage tolerance pathways in the rrm3-ΔN212 and rrm3-K260A/D mutants also
suggests that the types of DNA lesions that accumulate upon inactivation of the two
Rrm3 functions are different, but both lead to dependence on Mrc1 for survival and both
are sufficient for constitutive activation of the DNA-damage checkpoint.

Requirement of the Orc5-binding domain of Rrm3 for suppression of HUinduced

mutations,

but

not

MMS-induced

mutations

and

gross-

chromosomal rearrangements
If Rrm3 is important for the response to replication stress, cells lacking the
catalytic activity of Rrm3 or its Orc5-binding domain may be prone to accumulating
mutations at higher rates than wildtype cells. To test this, we measured forward
mutation rates at the CAN1 locus and the accumulation of GCRs on chromosome V in
the presence and absence of HU or MMS (Table 2). Two-fold (ung1Δ) to 50-fold
(rad27Δ) increases in CAN1 forward mutation rates compared to wildtype have
previously been reported for numerous DNA metabolism mutants (Huang, Rio et al.
2003). Deletion of RRM3 or disruption of its ATPase activity caused a significant
increase in spontaneous CAN1 mutations. Of the truncation alleles, which encode
catalytically active rrm3 mutants, rrm3Δ-N186 was indistinguishable from wildtype
whereas rrm3Δ-N212 caused a small, but significant, increase in the CAN1 mutation
rate in untreated cells and upon exposure to HU (Table 2). In contrast, expression of the
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rrm3Δ-N212 allele had no effect on the CAN1 mutation rate if cells were treated with
MMS, consistent with our observation that the rrm3-ΔN212 mutant exhibits a defect in
controlling replication in HU, but not MMS. GCRs accumulated at increased rates in the
rrm3Δ and rrm3-K260A/D mutants in the absence and presence of DNA damaging
agents, but accumulated at wildtype levels in cells expressing N-terminal truncations
under all conditions. These mutator phenotypes, albeit mild, reveal that Rrm3’s
ATPase/helicase activity is required for the suppression of all tested mutation types
induced by either HU or MMS, or in their absence, whereas the N-terminal site that
controls DNA replication and binds Orc5 plays a role specifically in the suppression of
spontaneous and HU-induced mutations, but not for the suppression of MMS-induced
mutations, or GCRs under any conditions.

DISCUSSION
By quantifying changes in chromatin composition we have identified Rad5 and
Rdh54 as novel factors that respond to increased replication fork stalling induced by the
absence of Rrm3, and affirmed the importance of Mph1. These factors suggest that
error-free post-replicative repair (PRR), implicated by Rad5 and Mph1, and HR,
implicated by Rdh54, act on DNA polymerase blocking sites in the genome that arise in
the absence of Rrm3. The N-terminal unstructured tail is entirely dispensable for this
ATPase/helicase-dependent role of Rrm3 in facilitating fork progression. Instead, we
have discovered that the N-terminal tail encodes a new function of Rrm3 – to control
DNA replication. This function of Rrm3 is distinct from its established role as an
ATPase/helicase, is not regulated by the previously identified phosphorylation cluster
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(Rossi, Ajazi et al. 2015) or the PIP-box (Schmidt, Derry et al. 2002) and, in contrast to
the ATPase/helicase activity, does not contribute to the HU hypersensitivity of the
rad53Δ mutant.
Based on changes in DNA content as measure by flow cytometry, we observed
that wildtype cells maintained near 1C DNA content for 180 minutes after release from
G1 phase into HU, whereas rad53∆, rrm3∆ and rrm3-∆N212 did so for only 60 minutes
(Figure 3C, Supplemental Figure S4C). The extent of continuing DNA replication in the
presence of HU, however, was not as pronounced in the rrm3 mutants as in the intra-S
checkpoint-deficient rad53∆ mutant. Although the Rad9-dependent DNA-damage
checkpoint is chronically activated in the rrm3-∆N212 mutant and, as a consequence,
nucleotide levels are increased compared to wildtype cells and the rrm3-∆N186 mutant,
the increased nucleotide levels are not the cause for the ability of the rrm3-∆N212
mutant to continue DNA replication upon HU exposure because the rrm3-K260A/D
mutants showed the same nucleotide level increase and DNA-damage checkpoint
activation, but maintained a peak at 1C DNA content in HU.
Therefore, considering Rrm3’s known function as an accessory ATPase/helicase
that facilitates progression of the replication fork through obstacles, and its new function
in controlling DNA synthesis reported here, we propose a model (Figure 5) where Rrm3
performs two genetically and physically separable functions to deal with challenges
during genome duplication: the N-terminal tail of Rrm3 plays a structural role in
preventing untimely replication in the presence of replication stress (HU) and in normal
S phase, whereas the C-terminal ATPase/helicase domain plays a catalytic role in
preventing fork pausing. The site between residues 186 to 212, which is in a segment of
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the N-terminal tail not previously assigned a function, is not only critical for restricting
DNA replication, but also for binding Orc5, raising the possibility that Rrm3 may exert
control over DNA replication by affecting origin activity; such a link would be consistent
with a previously identified role of ORC in suppressing late-origin firing under replication
stress (Shirahige, Hori et al. 1998). For example, Rrm3 could be recruited to prereplication complexes as they are assembled at origins during G1 by binding to the
ATP-binding ORC subunit Orc5, which does not appear to play a role in the completion
of S phase, or the remainder of the cell cycle (Bell and Dutta 2002, Labib 2010). There,
Rrm3 could act as an inhibitor of ORC ATPase activity, which is required for loading of
minichromosome maintenance (MCM) proteins and initiation of DNA replication
(Bowers, Randell et al. 2004, Randell, Bowers et al. 2006).
Instead of a global role in controlling origin activity, however, the wildtype level of
HU sensitivity of rrm3Δ cells and the importance of Rrm3 for replicating through certain
nonhistone-protein-bound regions suggest that Rrm3 may play a role at origins in
specific loci, such as those in highly transcribed regions and regions with converging
transcription, which are often late-firing (Soriano, Morafraile et al. 2014), rRNA and
tRNA coding loci, or highly transcribed metabolic genes, where ORC has been found to
be bound to the open reading frames, possibly to coordinate the timing of replication
with transcription (Shor, Warren et al. 2009). The absence of Rrm3 from these regions
could cause more wide-spread (untimely) origin firing early in S-phase and, thus, an
overabundance of replication intermediates and, eventually, DNA lesions, causing
constitutive activation of the DNA-damage checkpoint (Figure 5B). It has been proposed
that the temporal separation of origins into early and late firing might be required to
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prevent excessive accumulation of replication intermediates, such as ssDNA, that could
activate the intra-S checkpoint (Shimada, Pasero et al. 2002). In rrm3Δ and rrm3-ΔN212
mutants, a subset of regions whose replication may be controlled by Rrm3 to fire late
could convert to firing early, so that in HU, when firing of late origins is inhibited in cells
with a proficient intra-S checkpoint (Santocanale and Diffley 1998, Shirahige, Hori et al.
1998), rrm3Δ and rrm3-ΔN212 mutants exhibit a DNA replication profile that is similar to
that of the rad53Δ mutant.
Inactivation of the ATPase/helicase activity does not affect Rrm3’s novel role in
controlling DNA replication. Instead, it impairs Rrm3’s established function in facilitating
fork progression through replication blocks, leading to the accumulation of DNA lesions
that activate the DNA-damage checkpoint and increase formation of chromosome
rearrangements and point mutations (Figure 5C). By identifying changes in chromatin
composition combined with genetic assays we have identified Rad5 and Rdh54 as
novel factors that contribute to the maintenance of genome stability in the absence of
Rrm3’s ATPase/helicase activity. Rad5 defines an error-free pathway for the bypass of
DNA polymerase blocking lesions (Nelson, Lawrence et al. 1996, Johnson, Prakash et
al. 1999, Torres-Ramos, Prakash et al. 2002, Prakash, Johnson et al. 2005,
Gangavarapu, Haracska et al. 2006, Ortiz-Bazan, Gallo-Fernandez et al. 2014). As a
structure-specific DNA helicase, Rad5 is capable of regressing replication forks in vitro
(Blastyak, Pinter et al. 2007). Such a regressed fork is thought to provide an alternative
template for DNA synthesis, generating enough nascent DNA to eventually bypass the
replication block. The increased association of Rad5 with chromatin in rrm3Δ cells and
the severe synergistic interaction between rad5Δ and rrm3Δ deletions in HU-treated
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cells suggest that some type of nascent strand annealing by Rad5 is involved in
replication fork progression in rrm3Δ cells. Notably, we found that the ATPase activity of
Rad5 and the RING motif involved in polyubiquitination of PCNA (Johnson, Henderson
et al. 1992, Johnson, Prakash et al. 1994, Hoege, Pfander et al. 2002, Haracska,
Torres-Ramos et al. 2004) make independent contributions to DNA damage tolerance in
the absence of Rrm3. Evidence for a role of the ATPase activity of Rad5 in remodeling
blocked replication forks has been obtained in vitro (Blastyak, Pinter et al. 2007)
whereas a role of Rad5-dependent polyubiquitination of PCNA in activating HRdependent template switching has more recently been suggested (Minca and Kowalski
2010). Evidence that these two Rad5 activities can function independently, albeit
inefficiently, as we determined here in the rrm3Δ mutant, was also observed for bypass
of MMS-induced lesions by sister-chromatid recombination (Minca and Kowalski 2010).
Besides fork regression, Rad5 has also been implicated in DNA damage bypass
by HR-dependent template switching between sister-chromatids (Minca and Kowalski
2010) and the major HR factors Rad51, Rad52 and Rad54 as well as Sgs1 have been
implicated in error-free DNA lesion bypass (Branzei, Sollier et al. 2006). It was therefore
surprising that Rdh54, a chromatin remodeler that plays a major role in meiotic, but not
mitotic, HR (Klein 1997, Shinohara, Shita-Yamaguchi et al. 1997, Holzen, Shah et al.
2006), is recruited to chromatin when Rrm3 is absent - both in the presence and
absence of HU. Rdh54 was only required in the absence of the ATPase/helicase activity
of Rrm3, but not in the absence of the Orc5-binding domain, implicating Rdh54 in repair
of DNA lesions that arise when Rrm3 cannot facilitate fork progression through
replication blocks. Even though Rdh54 does not affect gene conversion repair of a DSB,
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a role specifically in repair that involves template switches was recently reported
(Tsaponina and Haber 2014), and could be related to its increased chromatin
association and the DNA-damage hypersensitivity of the rrm3Δ rdh54Δ and rrm3-K260A
rdh54Δ mutants.
Although it is unknown how Rdh54 acts in template switching, its activities in vitro
seem compatible with those that may be required to rescue a paused fork. Like Rad5
and the human Rad5 ortholog, HTLF, Rdh54 is a dsDNA translocase of the SWI/SNF
family (Petukhova, Sung et al. 2000, Chi, Kwon et al. 2006, Blastyak, Hajdu et al. 2010).
In vitro, it can dislodge the HR factor Rad51 from dsDNA and introduces negative
supercoiling into dsDNA that can cause strand separation (Petukhova, Sung et al. 2000,
Chi, Kwon et al. 2006, Shah, Zheng et al. 2010). These Rdh54 activities could help to
regulate repair at fork pause sites within Rad5-mediated pathways, such as fork
regression/reversal or template switching, and in HR-mediated template switching
events outside of Rad5 mechanisms. Whereas Rdh54 can remove proteins from dsDNA
and remodel chromatinized DNA, an ability to remove bound proteins from DNA has not
yet been shown for Rad5, and RecQ-like helicases are only capable of acting on forked
DNA structures that are protein-free (Kwon, Seong et al. 2008, San Filippo, Sung et al.
2008). The synergistic interactions between rad5Δ and rdh54Δ in the absence of RRM3
clearly identify a role of Rdh54 outside of a Rad5 mechanism. In addition to facilitating
template switching HR when error-free PRR is inactivated, Rdh54 could act in the
avoidance of replication fork pausing in a manner similar to Rrm3 by removing certain
proteins from dsDNA, such as shown for Rad51, which appears to have a tendency to
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associate with nonrecombinogenic dsDNA (Chi, Kwon et al. 2006, Holzen, Shah et al.
2006, Shah, Zheng et al. 2010).
That the ATPase activity of Rrm3 is required in the absence of Rad5, Rdh54 and
Mph1, whereas the role of Rrm3 in controlling DNA replication is dispensable strongly
suggests that the types of DNA damage checkpoint activating DNA lesions in the rrm3K260A and rrm3-ΔN212 mutants are different, and that Rad5, Rdh54 and Mph1 act on
DNA lesions that form when replication forks are unable to move through replication
blocks, but not on DNA lesions that form during uncontrolled DNA replication. In
contrast, Mrc1 and Tof1 were required for viability and DNA damage tolerance when
either of the two Rrm3 activities was disrupted. Mrc1, the mediator of the replication
stress checkpoint, mediates Rad53 phosphorylation specifically in response to
replication fork pausing, leading to intra-S checkpoint activation and inhibition of lateorigin firing (Osborn and Elledge 2003, Crabbe, Thomas et al. 2010). That synthetic
lethality between rrm3Δ and mrc1∆ is limited to those mrc1 alleles that cause DNA
damage accumulation during S phase (Naylor, Li et al. 2009), whereas the checkpoint
function of Mrc1 is dispensable (Schmidt and Kolodner 2006, Naylor, Li et al. 2009)
suggests that the additive accumulation of S phase damage and slowing of S phase
progression due to lack of both, Mrc1 and Rrm3, is lethal and suggests that uncontrolled
replication in the rrm3-ΔN212 mutant also leads to S phase damage, consistent with our
observation of Rad9-dependent activation of Rad53 (Figure 5B).
Finally, the new N-terminal Rrm3 function in controlling DNA replication is
separated from Rrm3’s established C-terminal function as an ATPase/helicase in
facilitating fork progression by the differential requirement of Rad5, Rdh54 and Mph1 for
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DNA lesion repair and by the different spontaneous and DNA-damage induced mutation
spectra. This suggests that the N-terminal tail is neither involved in the recruitment of
Rrm3 to active replication forks nor in facilitating fork progression through protein-bound
sites, and that a separate replisome binding site is likely to be located in the
ATPase/helicase domain. The accumulation of GCRs and point mutations in the
ATPase/helicase mutant, spontaneously or induced by HU or MMS, could be indicative
of DNA break formation as a result of replication fork stalling. In contract, the Orc5binding domain mutant did no accumulate GCRs under any conditions, suggesting
wildtype levels of DNA breaks, including in HU and MMS, but increasingly formed point
mutations. That these point mutations formed specifically in response to HU, but not
MMS, suggests that they arise during the unscheduled DNA synthesis that occurs in
this mutant in HU.
In summary, this study has revealed a 26-resiude region in Rrm3 that is critical
for a novel, ATPase-independent function of Rrm3 in preventing untimely DNA
replication and for binding Orc5, which might be mechanistically linked. Genome-wide
quantification of DNA synthesis in cells expressing the new rrm3 alleles will help to
reveal any regions with increased origin activity and undergoing untimely DNA
replication, and provide insight into the mechanism underlying continued DNA synthesis
under replication stress and lethality with mrc1∆. That Rrm3 does not appear to have a
homolog in multicellular eukaryotes, although the Pif1 family to which is belongs is
conserved, might be an indication that Rrm3’s role in DNA replication is highly
specialized to control replication and facilitate fork progression in genomic regions that
are distinctively organized in yeast, such as its rDNA array, and to deal with the high
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gene density imposed on its small genome that requires tight coordination between
replication initiation and ongoing transcription.

MATERIALS AND METHODS
Stable isotope labeling by amino acids in cell culture (SILAC) and isolation
of chromatin fraction
For double isotope labeling of lysine and arginine, yeast strain KHSY5144 (lys2∆
arg4∆), was grown at 30ºC with vigorous shaking for at least ten generations in “heavy”
medium (6.9 g/l yeast nitrogen base without amino acids (Formedium), 1.85 g/l amino
acid dropout mixture without arginine and lysine (Kaiser formulation, Formedium), 2%
glucose, 15 mg/l [13C6] L-arginine and 30 mg/l [13C6] or [13C6, 15N2] L-lysine). KHSY5143
(lys2∆ arg4∆ rrm3Δ) was grown in “light” medium, containing 15 mg/l L-arginine and 30
mg/l L-lysine at 30ºC with vigorous shaking.
Chromatin was isolated using a method adapted from (Kubota, Stead et al.
2012). Approximately 4 x 109 cells were re-suspended in 10 ml of 100 mM PIPES/KOH,
pH 9.4, 10 mM dithio-treitol (DTT), 0.1% sodium azide, then incubated for 10 min at
room temperature, followed by incubation in 10 ml of 50 mM KH2PO4/K2HPO4, pH 7.4,
0.6 M Sorbitol, 10 mM DTT, containing 200 mg/ml Zymolyase-100T at 37ºC for 30 min.
Spheroplasts were washed with 5 ml of cold wash buffer (20 mM KH2PO4/K2HPO4, pH
6.5, 0.6 M Sorbitol, 1 mM MgCl2, 1 mM DTT, 20 mM beta-glycerophosphate, 1 mM
phenyl-methylsulfonyl fluoride (PMSF), protease inhibitor tablets (EDTA free, Roche)
and re-suspended in 5 ml of cold wash buffer. The suspension was overlaid onto 5 ml of
7.5% Ficoll-Sorbitol cushion buffer (7.5% Ficoll, 20 mM KH2PO4/K2HPO4, pH 6.5, 0.6 M
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sorbitol, 1 mM MgCl2, 1 mM DTT, 20 mM beta-glycerophosphate, 1 mM PMSF,
protease inhibitor tablets) and spheroplasts were centrifuged through the cushion buffer
at 5000 rpm for 5 min to remove proteases derived from Zymolyase. Pelleted
spheroplasts were re-suspended in 200 ml of cold wash buffer and dropped into 18%
Ficoll, 20 mM KH2PO4/K2HPO4, pH 6.5, 1 mM MgCl2, 1 mM DTT, 20 mM betaglycerophosphate, 1 mM PMSF, protease inhibitor tablets, 0.01% Nonidet P-40, with
stirring. Unbroken cells were removed by two spins (5000 x g for 5 min at 4ºC). Nuclei
were pelleted by centrifugation at 16,100 x g for 20 min and the cytoplasmic fraction
removed. After washing in cold wash buffer, nuclei were re-suspended in 200 ml of EB
buffer (50 mM HEPES/KOH, pH 7.5, 100 mM KCl, 2.5 mM MgCl2, 0.1 mM ZnSO4, 2 mM
NaF, 0.5 mM spermidine, 1 mM DTT, 20 mM beta-glycerophosphate, 1 mM PMSF,
protease inhibitor tablets) and lysed by addition of Triton X-100 to 0.25%, followed by
incubation on ice for 10 min. Lysate was overlaid on 500 ml of EB buffer, 30% sucrose,
0.25% Triton X-100, and centrifuged at 12,000 rpm for 10 min at 4ºC. The top layer was
removed and the chromatin pellet was washed in 1 ml of EB buffer, 0.25% Triton X-100
and centrifuged at 10,000 rpm for 2 min at 4ºC.

Sample preparation and LC-MS/MS
The chromatin pellet was re-suspended in 40 µl of 1.5x Tris-Glycine SDS Sample
Buffer and incubated for 2 min at 85ºC. DTT was added to a final concentration of 5 mM
and incubated for 25 min at 56ºC. Iodoacetamide was added to 14 mM final
concentration and incubated for 30 min at room temperature in the dark. DTT was
added to a final concentration of 5 mM and incubated for 15 minutes at room
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temperature in the dark. The protein mixture was diluted 1:5 in 25 mM Tris-HCl, pH 8.2,
CaCl2 was added to a 1mM final concentration and trypsin was added to a
concentration of 4-5 ng/µl, followed by incubation at 37ºC overnight. Trifluoroacetic acid
was added to 0.4% final concentration and centrifuged at 2,500 x g for 10 min at room
temperature. Peptides in the supernatant were desalted using reverse-phase tC18
SepPak solid-phase extraction cartridges (Waters). The sample was eluted with 5 ml of
50% acetonitrile (ACN) and lyophilized. The lyophilized product was re-suspended in
0.1% formic acid prior to tandem mass spectrometric analysis on an LTQ Orbitrap XL
(Thermo). Scans on the Orbitrap were obtained at a mass resolving power of 60000 at
m/z 400 and top 10 abundant ions were selected for fragmentation in the LTQ ion trap.
Further processing of the RAW files was done in MaxQuant version 1.5.3.30 (Cox and
Mann 2008) against the Saccharomyces genome database (SGD). A database of
known contaminants in MaxQuant was used as well as constant modification of cysteine
by carbamidomethylation and variable modification of methionine oxidation. The first
search tolerance was set at 20 ppm, then 8 ppm tolerance for the main search.
Fragment ion mass tolerance was set to 0.5 Da and the minimum peptide length was 6
amino acids. Unique and razor peptides were used for identification and the false
discovery rate was set to 1% for peptides and proteins (Hochberg and Benjamini 1990,
Cox and Mann 2008). Statistical analysis of the data was carried out using Perseus
software using an approach by Benjamini and Hochberg (Benjamini, Drai et al. 2001).
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Yeast strains and plasmids
SILAC labeling and chromatin fractionation was performed using yeast strains
from the same genetic background as KHSY5036 (MAT ɑ, ura3-52, trp1∆63, his3∆200).
To determine resistance to DNA damaging agents and mutation assays, yeast strains
from the same genetic background as KHSY802 were used (MAT ɑ, ura3-52, trp1∆63,
his3∆200, leu2∆1, lys2Bgl, hom3-10, ade2∆1, ade8, hxt13::URA3). Genes were deleted
through homologous recombination and integration of a selectable marker (Gietz and
Woods 2006). To generate more than one gene deletion or point mutation, random
spore isolation was performed using diploid yeast strains heterozygous for the
mutations. Point mutations were introduced into plasmids by site-directed mutagenesis
and confirmed by sequencing. RRM3 N-terminal truncations were created in plasmid
pKHS137 and plasmid pJG4-5* using HR-mediated integration in KHSY2331 (lig4Δ)
and verified by sequencing. Yeast strains and plasmids from this study are listed in
Tables S2 and S3, respectively.

Fluctuation assays
GCR rates were determined as previously described (Schmidt, Pennaneach et
al. 2006). To observe the effect of exposure of DNA damaging agents on GCR rates,
cells were grown to OD600 = 0.5, placed into media containing the drug and cultured for
2 hours at 30ºC. Cells were then inoculated in YPD and grown for 24 hours before being
plated. Forward mutation rates were determined as described previously (Nair 1940,
Lea and Coulson 1949, Reenan and Kolodner 1992). To obtain forward mutation rates
and GCR rates after exposure to MMS and HU, cells were grown to OD600 = 0.5,
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released into medium containing the drug and incubated for 2 hours at 30ºC. Cells were
then placed into YPD and grown for 24 hours before being subjected to fluctuation
analysis.

DNA damage sensitivity assay
Cells were grown on either YPD or selective media to maintain plasmids (SC-Leu)
to an OD600 = 0.5, serially diluted, and spotted on YPD or SC-Leu containing methyl
methanesulfonate (Sigma Aldrich) or hydroxyurea (US Biological) at the indicated
concentrations. Cell growth was recorded after 2 to 3 days of incubation at 30ºC.

DNA content analysis
Cells were prepared for DNA content analysis as previously described (Nash,
Tokiwa et al. 1988). Cells were washed and re-suspended in 70% ethanol for an hour at
room temperature. The ethanol was removed and cells were re-suspended in 50 mM
sodium citrate (pH 7), sonicated, washed in 50 mM sodium citrate (pH 7), and RNAse A
was added to a final concentration of 250µg/ml. The cells were incubated overnight at
37ºC, washed in 50 mM sodium citrate and Sytox green (Molecular Probes) was added
to reach a 1µM final concentration. These cells were incubated in the dark for an hour
and then subjected to FACS analysis using a BLD LSR II analyzer. Cell distribution was
analyzed using FlowJo v8.3.3.
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Protein expression by western blot
Cells were cultured in YPD to a final OD600 = 0.5 in YPD at 30ºC, arrested in G1
with α-factor (15 µg/ml), and then released into pre-warmed YPD. Cells were harvested
after 30 min, immediately put on ice and diluted to obtain equal cell number. Whole cell
extracts were generated with 20% TCA as previously described (Kennedy, Daughdrill et
al. 2013) and run on 10% SDS-PAGE for Western blot analysis. Phosphospecific Rad53
antibody, EL7, was a gift from A. Pellicioli (FIRC Institute of Molecular Oncology
Foundation, Milan, Italy). Antibody sc-6680 (SCBT) was used for Mcm2, ab34680
(Abcam) for Adh1, ab46765 (Abcam) for histone H3, and RFA antibody AS07214
(Agrisera) for Rfa1.

Determination of dNTP levels
Cells grown to stationary phase were transferred to acidic media (pH 3.5) and
grown to logarithmic phase. Cells were synchronized in G1 phase over two hours with
the addition of 2 µg/ml alpha-factor (Genscript) every hour. Cells were washed twice
with sterile water. 2.5×108 yeast cells were pelleted,

resuspended in 1 ml 60%

methanol, and disrupted by 5 consecutive freeze and thaw cycles using liquid nitrogen
and warm water, followed by incubation at -20ºC for 90 minutes, and boiling at 100ºC
for 3 minutes. The lysate was centrifuged at 19000×g for 15 minutes and the
supernatant frozen in liquid nitrogen. Methanol was evaporated in a SpeedVac (Thermo
Scientific) and the residue was rehydrated in 100 µl Ultra-pure H2O (Invitrogen, GIBCO).
Determination of cellular dNTP concentration was performed as earlier described
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(Desler, Munch-Petersen et al. 2007). Each extraction was performed at least in
triplicate.

Yeast two-hybrid assay
For yeast-two hybrid yeast strain EGY48 with a reporter plasmid was transformed with
the bait vector (pEG202) and a prey vector (pJG4-5*). Cells were plated on synthetic
complete media lacking histidine and tryptophan (SC-Trp-His). Positive transformants
were selected and re-suspended in liquid SC-Trp-His media supplemented with 2%
galactose and 1% raffinose, and cultured overnight at 30ºC. Cells were diluted to an
OD600 =0.2, cultured to a final OD600 =0.8, and serially dilutions were spotted on SC-TrpHis-Leu supplemented with either 2% glucose or 2% galactose in the presence or
absence of hydroxyurea (HU) or methyl methanesulfonate (MMS). Pictures of cell
growth were taken after 72 hours.

Analysis of meiotic products
Diploids heterozygous for the desired mutant alleles (rrm3::TRP1, mrc1::HIS3)
transformed with plasmid-borne alleles of RRM3 (linked to LEU2) were sporulated by
nitrogen starvation in 0.1% potassium acetate for 5 days at 30ºC with vigorous shaking.
Asci were incubated in the presence of 500 µg/ml of zymolase in 1M sorbitol for 20 min
at 30ºC, enriched for meiotic products as previously described (Rockmill, Lambie et al.
1991) and plated on nonselective media (YPD). After incubation for 2 days at 30ºC,
colonies were spotted on SC-Leu media and 100 leu+ colonies genotyped further by
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spotting on SC-Leu-Trp, SC-Leu-His, and SC-Leu-Trp-His to identify rrm3Δ, mrc1Δ and
rrm3Δ mrc1Δ mutants, respectively, all harboring various plasmid borne RRM3 alleles.

176

FIGURES AND TABLES

Figure 4.1. SILAC-based quantification of changes in chromatin association in
cells lacking Rrm3. (A) Equal numbers of light-labeled (wildtype) and heavy-labeled
(rrm3Δ) cells were mixed, nuclei isolated, and the chromatin fraction extracted and
analyzed by tandem mass spectrometry using a hybrid linear ion trap-Orbitrap
instrument. (B) Subcellular fractionation was verified by following the distribution of
proteins in cytoplasmic (Cyto), nucleoplasm (NP), and chromatin (Ch) fractions during
the enrichment procedure by Western blotting. Chromatin fractions were analyzed from
three biological replicates in (C) the absence of hydroxyurea and (D) in the presence of
hydroxyurea. (E) Merger of peptide quantification in the absence and presence of
hydroxyurea.
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Figure 4.2. Rad5 and Rdh54 contribute independently to DNA lesion bypass/repair
in cells lacking Rrm3. (A) Synergistic increases in DNA-damage sensitivity of rrm3Δ
mutant lacking RAD5 and/or RDH54 were identified by spotting serial dilutions of
exponentially growing cultures of the indicated mutants on MMS and HU. (B) Ubiquitin
ligase and ATPase activities of Rad5 contribute independently to DNA damage
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tolerance in the absence of Rrm3. The ATPase/helicase activity of Rrm3 is required for
growth of the rad5Δ mutant under chronic exposure to HU or MMS. (C) Accumulation of
rrm3Δ cells in S phase increases upon deletion of RAD5 or RDH54. Cells were
synchronized in G1 phase with α-factor, released in YPD to resume the cell cycle, and
DNA content analyzed by fluorescence-activated cell sorting every 20 minutes for 3
hours. (D-E) Deletion of RAD5 or RDH54 slows progression of rrm3Δ cells through S
phase in the presence of HU. Cells were synchronized in G1 with α-factor, released into
media containing 100 mM HU (rdh54Δ) or 40 mM HU (rad5Δ) and nocodazole (to trap
cells in G2/M). DNA content was analyzed by fluorescence activated cell sorting every
20 minutes for 3 hours. (F) rrm3Δ and rad5Δ mutations slow progression through
mitosis to G1 phase. Cells were trapped in mitosis with nocodazole and released into
media with α-factor. (G) Deletion of RRM3 increases DNA damage sensitivity of the
diploid rdh54Δ mutant. Serial dilutions of exponentially growing cultures of diploids
heterozygous or homozygous for rrm3Δ or rdh54Δ mutations were spotted on HU and
MMS.
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Figure 4.3. A 26-residue region in the N-terminal tail of Rrm3 is required for the
control of DNA replication under replication stress independently of
ATPase/helicase activity. (A) Rrm3 consist of a ~230-residue disordered N-terminal
tail and a ~400 residue ordered C-terminal ATPase/helicase domain. A putative PCNAinteraction motif (PIP) between residues 35-42 (Schmidt, Derry et al. 2002) and a
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cluster of phosphorylated residues (P) between residues 85-95 (Rossi, Ajazi et al. 2015)
are indicated by gray boxes in the disordered tail. N-terminal tail truncations (rrm3∆N54,
rrm3∆N142, rrm3∆N186, rrm3∆N212, rrm3∆N230) and point mutations designed to
inactivate the PIP box (rrm3-FFAA) and the Walker A motif of the helicase domain
(rrm3-K260A, rrm3-K260D) were constructed. Point mutations are indicated by a red
box. (B) DNA content analysis by fluorescence-activated cell sorting (FACS) of rrm3
mutants shows continued DNA replication in rrm3Δ, rrm3-ΔN212 and rrm3-ΔN230
mutants during a 2-hour incubation in 200 mM hydroxyurea, but maintenance of a peak
at 1C DNA content for wildtype cells and the other rrm3 mutants. (C) Similar to
checkpoint-deficient rad53Δ sml1Δ cells, rrm3Δ cells continue DNA replication in the
presence of HU, but not MMS (Figure S2B). Cells were synchronized in G1 phase with
α-factor and released into media containing 100 mM HU. DNA content was analyzed by
FACS every 20 minutes for 2 hours after G1 release. (D) Cells expressing an Nterminal truncations of 212 residues continue DNA replication in the presence of 200
mM HU whereas those expressing a 186-residue truncation or the ATPase/helicasedead mutant arrest with 1C DNA content like wildtype cells. Cells were synchronized in
G1 with α-factor and released into 200 mM HU for 2 hours. Aliquots were removed prior
to release from G1 and then every 20 minutes for 2 hours and DNA content analyzed by
FACS. (E) Nucleotide pool, represented here by dTTP, is increased in rrm3Δ cells and
in cells expressing the rrm3-ΔN212 truncation or the ATPase/helicase-dead rrm3K260A mutant, but not in cells expressing the shorter rrm3-ΔN186 truncation. (F) Rad53
is constitutively activated in catalytically inactive rrm3Δ, rrm3-K260A and rrm3-K260D
mutants, and in the rrm3-ΔN212 truncation mutant. Cells were arrested in G1 with αfactor and Rad53 phosphorylation analyzed 30 min after release from arrest with a
phospho-specific Rad53 antibody. Rad53 activation in rrm3 mutants correlates with an
increased dNTP pool, but not with continued DNA synthesis in the presence of
hydroxyurea. (G) DNA content in wildtype cells and rrm3 mutants in the presence of
hydroxyurea was analyzed by FACS analysis and progression toward genome
duplication (2n) estimated by setting the 1C peak of untreated wildtype cells to 0% and
the 2C peak to 100%. (H) Rad53 phosphorylation in rrm3 mutants, irrespective of
continued DNA replication in HU or catalytic activity, is Rad9-dependent. (I) Rrm3
truncated by 212 N-terminal residues is an active ATPase/helicase. Deletion of RRM3
or inactivation of its ATPase/helicase activity suppresses HU hypersensitivity of the
rad53Δ sml1Δ mutant whereas the rrm3-ΔN212 allele does not, exhibiting wildtype
ATPase/helicase activity.
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Figure 4.4. The N-terminal Rrm3 region that controls DNA replication is an Orc5binding site that is required for cell viability and DNA lesion avoidance in the
absence of Mrc1/Tof1 but not in the absence of Rad5, Rdh54 or Mph1. (A)
Residues 186-212 of Rrm3 are critical for physical interaction with origin recognition
complex (ORC) subunit Orc5. Orc5 binding to wildtype Rrm3 and rrm3 mutants was
assessed by yeast-two-hybrid analysis on media lacking leucine to identify cells
expressing the LEU2 reporter gene upon bait-prey binding. Rrm3 truncated by 186
residues binds Orc5, in the presence or absence of HU or MMS, whereas deletion of an
additional 26 residues (rrm3-ΔN212) eliminates binding of Orc5. (B) Orc5-Rrm3 binding
site is required for mrc1∆ viability. Diploids heterozygous for mrc1∆ and rrm3∆
mutations were transformed with plasmids expressing N-terminal truncations of Rrm3
and 100 meiotic products that grew on SC-Leu media, indicating the presence of the
plasmid-borne RRM3 alleles, were genotyped. Absence of meiotic products that grew
on SC-Leu-Trp-His indicates synthetic lethality between the rrm3 allele and mrc1Δ. (C)
Deletion of the Orc5-Rrm3 binding site increases DNA-damage senstivity of the tof1∆
mutant. (D-F) Requirement of the ATPase/helicase activity of Rrm3, but not the Orc5binding site, for suppression of HU and MMS hypersensitivity of rad5∆, rdh54Δ, and
mph1∆ mutants.
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Figure 4.5. Rrm3 performs two genetically and physically separable functions
during DNA replication. (A) Rrm3 controls DNA synthesis via residues 186-212 (green
rectangle) in its disordered N-terminal tail (blue double line). The involvement of this
region in Orc5 binding suggests that Rrm3 may control DNA synthesis by controlling
origin activity to prevent untimely replication events during replication stress and during
normal S phase, as indicated by constitutive checkpoint activation. Rrm3 assists in
replication through nonhistone-protein-bound sites throughout the genome, including
the rRNA coding region, and may also be needed in other highly transcribed regions
and those with convergent transcription. Such regions often contain late-firing origins.
Independently of its N-terminal tail, Rrm3 associates with the replisome and utilizes its
ATPase/helicase activity (blue oval labeled H) to facilitate fork progression through
replication blocks. (B) Deleting the Orc5-binding domain disrupts Rrm3’s function in
controlling DNA synthesis, leading to untimely DNA synthesis and accumulation of point
mutations in normal S-phase and in HU. Excessive accumulation of replication
intermediates and ensuing DNA lesions are the most probable cause of intra-S
checkpoint activation in these cells. Despite loss of the N-terminal function, the
ATPase/helicase-dependent function of Rrm3 in fork progression through blockages is
intact, suggesting that Rrm3 can be recruited to replisomes independently of the Nterminal tail. (C) Disrupting the ATPase/helicase activity of Rrm3 maintains control over
DNA synthesis timing, but forks are unable to progress through replication blocks,
leading to DNA lesions that require Rad5, Rdh54, and Mph1 for bypass or repair and
activate the intra-S checkpoint. In contrast to loss of the Orc5-binding site, GCRs form
in addition to point mutations, indicating the formation of different types of DNA lesions
in the ATPase/helicase mutant, most likely DNA breaks.
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Figure 4.S1. Rad5 and Rdh54 are not required for S phase progression of rrm3Δ
cells after release from 2 hour exposure to 100 mM HU.

184

Figure 4.S2. Deletion of the nonessential HDA1, SET3, or MGM101 genes does not
affect the DNA damage sensitivity of the rrm3Δ mutant. Chromatin association of
Hda1 and Set3 significantly decreased in the absence of Rrm3 whereas Mgm101
increased. Deletion of MGM101 resulted in the ‘petite’ phenotype. Serial dilutions of
exponentially growing cultures of the indicated mutants were spotted on rich media
containing 0.01% MMS or 100 mM HU, or no drug (YPD), followed by incubation for 2-3
days at 30ºC.
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Figure 4.S3. Requirement of Mph1 for DNA repair and DNA replication in the
absence of Rrm3. (A) Deletion of RRM3 causes a synergistic increase in DNA damage
sensitivity of cells lacking the DNA helicase Mph1. Absence of Mph1 causes delayed S
phase progression of rrm3Δ cells in the absence of DNA damaging agents (B), after
release from HU into an undisturbed S phase (C), and, most severely, during chronic
exposure to HU (D).
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Figure 4.S4. The Rrm3 N-terminal tail controls DNA replication. (A) The N-terminal
tail of Rrm3 is predicted to be unstructured. A disorder score of >0.5 indicates a
disordered residue whereas a score <0.5 indicates a residue in a ordered region
(Dosztanyi et al., 2005). (B) In contrast to HU, rrm3-ΔN212 and rrm3Δ mutants arrest
with 1C DNA content when exposed to MMS. (C) 4 hour time course of rrm3Δ mutant
released from G1 arrest into 100 mM HU.
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Table 4.1. Effect of Deletions of RRM3, RAD5, RDH54 on Accumulation of GrossChromosomal Rearrangements in the Presence or Absence of Genotoxic Agents
Genotype

GCR rate
(Canr 5-FOAr)
(x 10-10)

wildtype
rrm3∆
∆rad5
∆rrm3 ∆rad5
∆rdh54
∆rrm3 ∆rdh54
∆rad5 ∆rdh54
∆rrm3 ∆rad5 ∆rdh54

1.1 (<1-6.1)
14 (11-27)
237 (220-271)
260 (224-263)
17 (11-27)
25 (14-54)
263 (244-272)
322 (278-419)

GCR rate
(Canr 5-FOAr)
(x 10-10)
+HU
GCR Rate
20 (9.6-35)
139 (106-171)
1477 (1300-1590)
1600 (1390-1680)
191 (144-212)
202 (194-224)
1578 (1320-1710)
2446 (2140-2670)
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GCR rate
(Canr 5-FOAr)
(x 10-10)
+MMS
65 (55-75)
97 (90-114)
928 (837-1020)
1040 (834-1220)
108 (87-135)
120 (99-266)
991 (907-1160)
1664 (1350-1810)

Table 4.2. Accumulation of Forward Mutations at CAN1 and Gross-chromosomal
Rearrangements in Untreated rrm3 Mutants and after Treatment with Genotoxic
Agents
Genotype

Can
(x10-7)

Wildtype

1.6 (1.41.9)
5.1 (4.35.8)
1.9 (1.72.3)
2.8 (2.63.0)
4.3 (4.05.0)
4.4 (4.34.8)

rrm3∆
rrm3-∆N186
rrm3-∆N212
rrm3-K260A
rrm3-K260D

Can
(x10-7)
+HU

Can
(x10-6)
+MMS

GCR rate
(Canr 5-FOAr)
(x 10-10)

Mutation rate
2.3 (2.01.9 (1.72.8)
2.3)
8.1 (7.43.2 (2.88.8)
3.4)
2.5 (2.22.3 (1.92.9)
2.4)
4.1 (4.02.1 (2.04.5)
2.4)
8.0 (7.93.0 (2.78.4)
3.1)
8.2 (7.62.9 (2.79.2)
3.3)
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1.1 (<1-6.1)
14 (11-27)
4.4 (<1-8.8)
4.5 (<1-13)
14 (10-23)
18 (10-25)

GCR rate
(Canr 5FOAr)
(x 10-10)
+HU
GCR Rate
20 (9.635)
139 (106171)
43 (1847)
33 (1739)
158 (105201)
132 (110170)

GCR rate
(Canr 5FOAr)
(x 10-10)
+MMS
65 (55-75)
97 (90114)
56 (39-71)
78 (63-92)
93 (81117)
97 (88113)

TABLE 4.S1. Proteins that undergo significant changes in cells lacking Rrm3 in
the presence and absence of HU
Protein
ID
Rad5

Fold
Change
-HU
5.1

Top2
Rdh54

1.9
1.8

Smc1

1.5

Sif2
1.5
Mgm101 1.4
Smc3

1.3

Irr1

1.3

Hda1

-1.7

Mcm4

-1.9

Rsc1

-2.0

Description
RING domain-containing ubiquitin ligase involved in error
free DDT
Type II topoisomerase that catalyzes decatenation of DNA
DNA-dependent ATPase activity, can supercoil and unwind
DNA and promote D-loop formation and branch migration to
promote HR
Subunit of the cohesin complex that associates with SMC3
and is required for sister chromatid cohesion
Subunit of Set3C histone deacetylase complex
Role in mitochondrial DNA recombinational repair and
interstrand cross-link repair
Subunit of the cohesin complex that assicates with SMC1
and is required for sister chromatid cohesion
Subunit of the cohesin complex, thought to close the
cohesion ring
Putative catalytic subunit of a class II histone deacetylase
complex
Essential helicase component of heterohexameric MCM2-7
complexes
Component of the RSC chromatin remodeling complex

Protein
ID

Fold
Description
Change
+HU
Rdh54
2.6
DNA-dependent ATPase activity, can supercoil and unwind
DNA and promote D-loop formation and branch migration to
promote HR
Spt7
1.7
SAGA core component which may regulate Spt20 and Ada1,
components of the SAGA complex.
Ybp2
1.6
Central kinetochore associated protein
Cdc28
1.6
Associates with six B-type cyclins to direct mitotic spindle
assembly in S-phase and spindle function during mitosis
Rpt4
1.6
ATPase of the 19S regulatory particle of the 26S
proteasome. One of six ATPases of the regulatory particle,
involved in degradation of ubiquitinated substrates
Mgm101 1.5
Role in mitochondrial DNA recombinational repair and
interstrand cross-link repair
Mph1
1.4
3'-5' DNA helicase involved in error-free bypass of DNA
lesions
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Table 4.S1 (continued)
Top2
Rsc9

1.4
-1.9

Set3

-2.7

Vps72

-2.7

Type II topoisomerase that catalyzes decatenation of DNA
Component of the RSC chromatin remodeling complex
which targets genes regulated by stress
Component of the 7-subunit HDAC complex with a role in
transcription
Part of the SWR1 complex, exchanges histone variant H2AZ
(Htz1p) for chromatin-bound histone H2A
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Table 4.S2. Yeast Strains used in this study
Strain

Genotype

EGY48[1]

MATα ura3-52, trp1Δ63, his3Δ200, LexAop (x6)-LEU2

KHSY304

MATα ura3-52, trp1Δ63, his3Δ200, rrm3::TRP1

KHSY745

ura3-52/ura3-52, trp1Δ63/ trp1Δ63, his3Δ200/his3Δ200,
RRM3/rrm3::TRP1, MRC1/mrc1::HIS3

KHSY802

MATa ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10,
ade2Δ1, ade8, YEL069C::URA3

KHSY1063

MATa ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10,
ade2Δ1, ade8, YEL069C::URA3, rrm3::TRP1
ura3-52/ura3-52, leu2∆1/leu2∆1, trp1∆63/trp1∆63,
his3∆200/his3∆200, lys2∆Bgl/lys2∆Bgl, hom3-10/hom3-10,
ade2∆1/ade2∆1, ade8/ade8. YEL069C::URA3/YEL069C::URA3,
RAD53/rad53::his3, SML1/sml1::G418, RRM3/rrm3::TRP1
ura3-52, lys2-801 amber, ade2-101 ochre, trp1-∆63, his3-∆200,
leu2-∆1, rad9::G418, rrm3::URA3
ura3-52/ura3-52, leu2∆1/leu2∆1, trp1∆63/trp1∆63,
his3∆200/his3∆200, lys2∆Bgl/lys2∆Bgl, hom3-10/hom3-10,
ade2∆1/ade2∆1, ade8/ade8. YEL069C::URA3/YEL069C::URA3

KHSY1065

KHSY1133
KHSY1157
KHSY1557

MATa ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10,
ade2Δ1, ade8, YEL069C::URA3, mph1::HIS3

KHSY1713

MATa ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10,
ade2Δ1, ade8, YEL069C::URA3, rrm3::TRP1, mph1::HIS3

KHSY2331

MATa ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10,
ade2Δ1, ade8, YEL069C::URA3, lig4::loxP-G418-loxP

KHSY4570

MATa ura3-52, trp1Δ63, his3Δ200

KHSY4743

ura3-52/ura3-52, trp1Δ63/ trp1Δ63, his3Δ200/his3Δ200,
RRM3/rrm3::TRP1

KHSY5143

MATα ura3-52, trp1Δ63, his3Δ200, arg4::G418, lys2::HIS3

KHSY5144

MATα ura3-52, trp1Δ63, his3Δ200, arg4::G418, lys2::HIS3,
rrm3::TRP1

KHSY5145

MATa ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10,
ade2Δ1, ade8, YEL069C::URA3, rad5::HIS3

KHSY5146

MATa ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10,
ade2Δ1, ade8, YEL069C::URA3, rrm3::TRP1, rad5::HIS3

KHSY5147

MATa ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10,
ade2Δ1, ade8, YEL069C::URA3, rdh54::HIS3
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Table 4.S2 (continued)
KHSY5148

MATa ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10,
ade2Δ1, ade8, YEL069C::URA3, rrm3::TRP1, rdh54::HIS3

KHSY5149

MATa ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10,
ade2Δ1, ade8, YEL069C::URA3, rad5::HIS3 rdh54::G418

KHSY5150

MATa ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10,
ade2Δ1, ade8, YEL069C::URA3, rrm3::TRP1, rdh54::HIS3,
rad5::TRP1

KHSY5151

MATa ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10,
ade2Δ1, ade8, YEL069C::URA3, set3::HIS3

KHSY5152

MATa ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10,
ade2Δ1, ade8, YEL069C::URA3, rrm3::TRP1, set3::HIS3

KHSY5153

MATa ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10,
ade2Δ1, ade8, YEL069C::URA3, tof1::HIS3

KHSY5154

MATa ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10,
ade2Δ1, ade8, YEL069C::URA3, rrm3::TRP1, tof1::HIS3

KHSY5155

MATa ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10,
ade2Δ1, ade8, YEL069C::URA3, ies4::HIS3

KHSY5156

MATa ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10,
ade2Δ1, ade8, YEL069C::URA3, rrm3::TRP1, ies4::HIS3

KHSY5157

MATa ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10,
ade2Δ1, ade8, YEL069C::URA3, had1::HIS3

KHSY5158

MATa ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10,
ade2Δ1, ade8, YEL069C::URA3, rrm3::TRP1, had1::HIS3

KHSY5159

MATa ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10,
ade2Δ1, ade8, YEL069C::URA3, mgm101::HIS3

KHSY5160

MATa ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10,
ade2Δ1, ade8, YEL069C::URA3, rrm3::TRP1, mgm101::HIS3

KHSY5161

MATa ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10,
ade2Δ1, ade8, YEL069C::URA3, sml1::G418

KHSY5162

MATa ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10,
ade2Δ1, ade8, YEL069C::URA3, sml1::G418, rrm3::TRP1

KHSY5163

MATa ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10,
ade2Δ1, ade8, YEL069C::URA3, sml1::G418, rrm3::TRP1,
rad53::HIS3
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Table 4.S2 (continued)
KHSY5164

ura3-52/ura3-52, leu2∆1/leu2∆1, trp1∆63/trp1∆63,
his3∆200/his3∆200, lys2∆Bgl/lys2∆Bgl, hom3-10/hom3-10,
ade2∆1/ade2∆1, ade8/ade8. YEL069C::URA3/YEL069C::URA3,
rdh54::HIS3/rdh54::HIS3

KHSY5165

ura3-52/ura3-52, leu2∆1/leu2∆1, trp1∆63/trp1∆63,
his3∆200/his3∆200, lys2∆Bgl/lys2∆Bgl, hom3-10/hom3-10,
ade2∆1/ade2∆1, ade8/ade8. YEL069C::URA3/YEL069C::URA3,
rrm3::TRP1/rrm3::TRP1, rdh54::HIS3/rdh54::HIS3

KHSY5166

ura3-52/ura3-52, leu2∆1/leu2∆1, trp1∆63/trp1∆63,
his3∆200/his3∆200, lys2∆Bgl/lys2∆Bgl, hom3-10/hom3-10,
ade2∆1/ade2∆1, ade8/ade8. YEL069C::URA3/YEL069C::URA3,
rrm3::TRP1/rrm3::TRP1

KHSY5167

ura3-52/ura3-52, leu2∆1/leu2∆1, trp1∆63/trp1∆63,
his3∆200/his3∆200, lys2∆Bgl/lys2∆Bgl, hom3-10/hom3-10,
ade2∆1/ade2∆1, ade8/ade8. YEL069C::URA3/YEL069C::URA3,
RRM3/rrm3::TRP1, RDH54/rdh54::HIS3

KHSY5168

ura3-52/ura3-52, leu2∆1/leu2∆1, trp1∆63/trp1∆63,
his3∆200/his3∆200, lys2∆Bgl/lys2∆Bgl, hom3-10/hom3-10,
ade2∆1/ade2∆1, ade8/ade8. YEL069C::URA3/YEL069C::URA3,
RRM3/rrm3::TRP1

KHSY5169

ura3-52/ura3-52, leu2∆1/leu2∆1, trp1∆63/trp1∆63,
his3∆200/his3∆200, lys2∆Bgl/lys2∆Bgl, hom3-10/hom3-10,
ade2∆1/ade2∆1, ade8/ade8. YEL069C::URA3/YEL069C::URA3,
RDH54/rdh54::HIS3

KHSY5170

ura3-52/ura3-52, leu2∆1/leu2∆1, trp1∆63/trp1∆63,
his3∆200/his3∆200, lys2∆Bgl/lys2∆Bgl, hom3-10/hom3-10,
ade2∆1/ade2∆1, ade8/ade8. YEL069C::URA3/YEL069C::URA3,
RRM3/rrm3::TRP1, rdh54::HIS3/rdh54::HIS3

KHSY5171

ura3-52/ura3-52, leu2∆1/leu2∆1, trp1∆63/trp1∆63,
his3∆200/his3∆200, lys2∆Bgl/lys2∆Bgl, hom3-10/hom3-10,
ade2∆1/ade2∆1, ade8/ade8. YEL069C::URA3/YEL069C::URA3,
rrm3::TRP1/rrm3::TRP1, RDH54/rdh54::HIS3

1. Gyuris, J., et al., Cdi1, a human G1 and S phase protein phosphatase that

associates with Cdk2. Cell, 1993. 75(4): p. 791-803.
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TABLE 4.S3. Plasmids used in this study
Plasmid

Description

Reference

pRS315

CEN/ARS, LEU2

(Sikorski and Hieter 1989)

pEG202

LexA bait plasmid, HIS3, 2µm

(Estojak, Brent et al. 1995)

pR5-19

CEN/ARS, LEU2, rad5-C914A/C917A

(Pages, Bresson et al.
2008)

pR5-28

CEN/ARS,LEU2, RAD5

(Pages, Bresson et al.
2008)

pR5-30

CEN/ARS,LEU2, rad5-D681A/E682A

(Pages, Bresson et al.
2008)

pJG4-5*

GALI promoter-GAL4AD, TRP1, 2µm

(Schmidt, Derry et al. 2002)

pKHS124

pJG-4-5*-RRM3

(Schmidt, Derry et al. 2002)

pKHS126

pEG202-RRM3

(Schmidt, Derry et al. 2002)

pKHS133

pEG202-rrm3-∆N54

(Schmidt, Derry et al. 2002)

pKHS135

pEG202-rrm3∆N230

(Schmidt, Derry et al. 2002)

pKHS136

pRS315-rrm3-∆N54

this study

pKHS137

pRS315-rrm3-∆N230

this study

pKHS170

pRS315-RRM3

this study

pKHS174

pRS315-rrm3-F41A/F42A

this study

pKHS183

pEG202-rrm3-F41A/F42A

(Schmidt, Derry et al. 2002)

pKHS644

pR5-30-rad5D681A/E682A/C914A/C917A

this study

pKHS645

pRS315-rrm3-N∆142

this study

pKHS646

pRS315-rrm3-∆N186

this study

pKHS647

pRS315-rrm3-∆212

this study

pKHS648

pRS315-rrm3-K260A

this study

pKHS649

pRS315-rrm3-K260D

this study

pKHS650

pRS315-rrm3-D102P

this study

pKHS651

pRS315-rrm3-S605A

this study

pKHS652

pRS315-rrm3-S605D

this study

pKHS653

peg202-rrm3-∆N186

this study

pKHS654

peg202-rrm3-∆N212

this study

pKHS655

peg202-rrm3-∆N230

(Schmidt, Derry et al. 2002)
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Table 4.S3 (continued)
pKHS656

pJG4-5*-ORC5

this study
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CHAPTER FIVE:
IMPLICATIONS AND FUTURE DIRECTIONS

IMPLICATIONS
DNA helicases are conserved amongst species and are enzymes that function to
unwind DNA in several processes, including replication, DNA repair, and transcription.
Defective helicases can lead to human genetic disorders with high incidence of genomic
instability and predisposition to cancer. For example, mutations to XPB and XPD, can
result in xeroderma pigmentosum, Cockayne syndrome, or trichothiodystrophy [1-3].
Mutations to these genes result in defects during nucleotide excision repair and
transcription [3]. Mutations to the RecQ family members in humans, BLM, WRN, and
RECQL4 can result in Bloom syndrome, Werner syndrome, and Rothmund-Thomson
syndrome [4-9] and these patients are characterized by having increased genomic
instability and mutation rates [10-12]. If the integrity of the genome is not maintained
from one generation to another, chromosomal defects may arise, which can result in
cancer

predisposition,

developmental

defects,

and

premature

aging.

Better

understanding the role of these helicases in DNA repair may allow us to better develop
therapeutic approaches to help individuals affected by these syndromes and allow for a
better quality of life.
Here we investigated the role of RecQ-like helicases Sgs1, BLM and RecQL5
using yeast as a model system. We also looked at a non-RecQ-like helicase, Rrm3,
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which is involved in maintaining genome stability by promoting fork progression.

FUTURE DIRECTIONS
Humanized yeast model for BLM characterization
In chapter two of this dissertation we were able to create a yeast model to study
BLM function [13]. This humanized yeast model was used to study the functional impact
of 27 variants in the C terminal region of BLM and with this approach we found nine new
functionally defective BLM variants [13, 14]. Unlike the known Bloom syndrome, causing
mutations that have been characterized biochemically, these new variants are
uncharacterized and may be informative in better understanding BLM function [8]. Of
the newly identified variants, three only partially impair BLM function, leading to a new
class of BLM alleles that may have an impact on the risk for disease [14]. These new
variants in BLM (R791C, P868L, G1120R) were evaluated in patient derived BLM
deficient cells (GMO8505) to determine if they complement cellular defects [15]. These
variants were tested for their ability to suppress sister chromatid exchanges, resistance
to DNA damage, and ability to induce the DNA damage response [15]. Through these
assays it was found that these variants produced defects similar to a Bloom syndrome
cell, but these defects were less pronounced [15]. The implication for this study and
discovery of these new variants is that individuals who possess these variants may
have an increased risk for cancer or Bloom syndrome associated disorders. The next
step is to biochemically characterize these variants and determine if they have defects
in catalytic activity. For this, we will look at DNA binding, unwinding, and annealing
activities of these variants.
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RQC domain of Sgs1 is critical in maintaining genome stability, whereas
the

HRDC domain is dispensable

In chapter two of this dissertation we created systematic truncations to the C
terminus of Sgs1 and found that impinging on the RQC domain was deleterious to the
cell whereas removing the HRDC domain had no effect [13]. To further narrow down the
requirement of the C terminus of Sgs1 we further truncated the region between Sgs1
1147-1247 and found that deleting C terminal 260 amino acids resulted in sensitivity to
DNA damaging agents HU and MMS and there was an accumulation of gross
chromosomal rearrangements [13]. We looked at the possibility that the inability of the
sgs1∆C260 mutant to resist DNA damaging agents was due to loss of protein-protein
interaction. It has been shown previously that Rad51 interacts with the C terminus of
Sgs1 but the precise location of this interaction has not been determined [16]. Using pull
down experiments we have validated Sgs1-Rad51 interaction and isolated the
interaction to regions 1187-1207 of Sgs1. We narrowed down the binding site to the
flexible linker region between the winged helix and HRDC domains and have found
important residues for binding. Generating a Sgs1F1197D mutant located within this
region resulted in loss of interaction with Rad51. In contrast to the sgs1∆C260
truncation, Sgs1F1197D was resistant to DNA damaging agents suggesting that loss of
interaction with Rad51 is not important for conferring resistance but may be important
for other functions of Sgs1, and that impinging on the RQC domain is deleterious to the
cell. This interaction is being genetically characterized to see if this loss of interaction is
important in combination with other DNA metabolic factors.
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Novel RecQL5 interaction with Ube2I and Hlp2
In this dissertation we looked at the human RecQ like helicase, RecQL5β, which
has not been associated with a syndrome but defects in this helicase lead to increased
levels of sister chromatid exchanges, broken chromosomes, and quadriradials [17, 18].
To better understand the molecular mechanism of this helicase we used yeast as a
model system to investigate its ability to complement Sgs1 functions. We found that it is
unable to perform functions of Sgs1 suggesting its role in the cell is different than its
Sgs1 counterpart, BLM. We performed a yeast two-hybrid assay using the human testis
cDNA library to gain better insight into functions of RecQL5 by determining proteins it
interacts with. From this screen we found that Hlp2 and Ube2I showed strong
interaction with RecQL5. Human Hlp2 is an ATP-dependent RNA helicase that belongs
to the DEAD box family of helicases [19, 20]. Ube2I is a SUMO-conjugating enzyme
that has several roles in regulating DNA repair [21]. To further investigate these
interactions we will use two approaches.
Interaction will be tested first by performing co-immunoprecipitation of
endogenous proteins or tagged protein. If interaction is verified then we will map the
interaction domain of each protein by placing a stop codon using site-directed
mutagenesis and evaluate this loss of interaction in cells. If the co-immunoprecipitation
approach fails to work we will determine protein-protein interactions by mass
spectrometry. For mass spectrometry, we will create a stable cell line expressing Flagtagged RecQL5 and immunoprecipitate tagged RecQL5 and isolate polypeptides for
analysis by mass spectrometry. This approach will help confirm interaction of our
proteins and may elucidate new candidates for further study. We will then perform a
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reciprocal IP using antibodies against Hlp2 and Ube2I to determine if we can identify
RecQL5. We will look for interaction with Rad51, PCNA, and the MRN complex as
positive controls.
In addition to the helicase domain and RQC domain, RecQL5 also possess a KIX
domain and SRI domain [22, 23]. The KIX domain is located between amino acids 540620 and the SRI domain is between 909-991 amino acids [23]. The KIX domain has
been found in many Pol II transcriptional regulators and the SRI domain is found in the
histone methyltransferase SetD2, which also has a role in transcription [22]. It is
possible that RecQL5 interaction with Hlp2 may help regulate transcription and prevent
head-on collisions between the replication and transcription machinery, resulting in
fewer stalled forks [24].
To test if the interaction with Hlp2 is regulating transcription we can recreate
mammalian RNAPII transcription using purified general transcription factors (GTFs),
RNAPII, and template DNA with a adenovirus major late promoter. To determine if
RecQL5 is inhibitory to transcription, we can add increasing concentration of RecQL5
and observe the production of the transcript. After determining the site of Hlp2
interaction we can create a point mutation abolishing this interaction and perform the
same experiment to determine if interaction with Hlp2 is regulating transcription and
should see more run-off transcripts if this interaction is important. Additionally, we can
determine if this regulation is helicase dependent by generating point mutations
inactivating the helicase activity of RecQL5 (D157A) and loss of protein-protein
interaction. It will be interesting to see if RecQL5 has dual roles, one in maintaining
genome stability by preventing head-on collisions between the replication and
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transcription machineries and another in preventing chromosomal instability by using its
helicase activity to reduce unwanted homologous recombination events through its
ability to resolve D loops [25].
Unlike Hlp2, Ube2I is a SUMO-conjugating enzyme that can regulate DNA repair,
the stress response, and cell cycle progression [21]. Since Ube2I has a more diverse
role in cell compared to Hlp2, it is possible that RecQL5 may target Ube2I to sites of
DNA damage so that it can regulate downstream proteins for repair. Determining the
interaction site of this protein on RecQL5 will help determine if it interacts with any
RecQL5 conserved domains. We can then create targeted point mutations to assess if
loss of interaction with Ube2I contributes to some of the cellular defects in cells deficient
for RecQL5. We can perform similar assays looking at the role of RecQL5-Ube2I
interaction during transcription by assessing formation of run-off transcripts. It is more
reasonable to assume that interaction with Ube2I is important for maintaining genome
stability by regulating repair during replication, possibly by preventing sister chromatid
exchanges. It has been shown previously in DT40 cells that deleting RecQL5-/- / BLM-/resulted in higher SCE level than BLM-/- cells [26]. Introducing RecQL5 into RecQL5-/- /
BLM-/- resulted in a level similar to BLM-/- cells [26]. Considering RecQL5 can suppress
SCEs in this double mutant, we can look at the importance of interaction with Hlp2 and
Ube2I in preventing SCEs. In addition to increased SCEs in the absence of RecQL5-/-,
these cells also have increased sensitivity to camptothecin, a topoisomerase I inhibitor
that blocks replication [26]. RecQL5-/- / BLM-/- cells have a synergistic increase in
sensitivity to CPT, so we can look at RecQL5 interactions to see if they are important in
suppressing this sensitivity. Through these experiments it will be possible to determine
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the importance of these protein-protein interactions and better determine the molecular
mechanism of RecQL5 in DNA repair.

New role for Rrm3 in controlling replication
In addition to RecQ like helicases we also looked at a non-RecQ like helicase,
Rrm3, which is involved in promoting fork progression through protein-DNA complexes.
Using quantitative mass spectrometry we were able to find two significant mechanisms
that act on DNA lesions created in the absence of Rrm3 catalytic activity. Rdh54, is a
chromatin remodeler, and Rad5 is involved in error-free DNA damage bypass, and both
were significantly increased in our screen [27, 28]. In addition to this, we found a novel
function for Rrm3 in controlling replication through residues 186-212 that interact with
Orc5. In the absence of this region we observe that cells replicate much faster, and this
is independent of activation of Rad53, suggesting Rrm3 is physically controlling the
activity of origins where Orc5 is located.
To test if Rrm3 is controlling origin activity, we can perform an experiment where
we probe for origins in specific loci where Rrm3 is thought to function such as highly
transcribed regions, rRNA and tRNA coding loci, and highly transcribed metabolic
genes [29, 30]. Using 2D gel electrophoresis we can probe for origins in cells lacking
Rrm3 under replication stress to see if they have fired. Alternatively, we can use a
genomics approach and perform NextGen sequencing to look at origins. This approach
will reveal more detail because we can look at all origins and determine precisely where
Rrm3 may play a role. To determine mechanistically how it controls replication we will
look at the interaction sites between Rrm3 and Orc5. Orc5 is the ATP-binding subunit of
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the origin recognition complex (ORC) and is an essential gene. We hypothesize that
Rrm3 has a role in controlling origin activity by inhibiting Orc5 activity, possibly by
preventing it from binding ATP and initiating replication. To validate this, we can use two
approaches. First we can generate truncations to Orc5 keeping in mind not to disturb
the ATP-binding subunit and locate the interaction site for Rrm3. Alternatively, we can
perform an experiment where we pull down Rrm3 in yeast and analyze the sample
using mass spectrometry and analyze the results to see which peptides from Orc5
interact with Rrm3.
Through these approaches we can gain a better understanding of how the
genome deals with stalled replication forks and replication stress. Determining where
Rrm3 plays a role will help us better understand whether it has a global role in the cell
or a more specific role in controlling replication.
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APPENDIX A:
DEFECTS IN DNA LESION BYPASS LEAD TO SPONTANEOUS CHROMOSOMAL
REARRANGEMENTS AND INCREASED CELL DEATH
Note to the reader: This chapter has been previously published with permission from the
publisher as Schmidt, KH, Viebranz, EB, Harris, LB, Mirzaei, H, Syed, S, Medicus, R
(2010). “Defects in DNA Lesion Bypass Lead to Spontaneous Chromosomal
Rearrangements and Increased Cell Death.” Eukaryotic Cell. 2010;9(2):315-324.
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Florida, 4202 E. Fowler Avenue, ISA2015, Tampa, FL 33620. Phone: (813) 974-1592.
Fax: (813) 974- 1614.; E-mail: kschmidt@usf.edu

ABSTRACT
Rev3 polymerase and Mph1 DNA helicase participate in error-prone and errorfree pathways, respectively, for the bypassing of template lesions during DNA
replication. Here we have investigated the role of these pathways and their genetic
interaction with recombination factors, other nonreplicative DNA helicases, and DNA
damage checkpoint components in the maintenance of genome stability, viability, and
sensitivity to the DNA-damaging agent methyl methanesulfonate (MMS). We find that
cells lacking Rev3 and Mph1 exhibit a synergistic, Srs2-dependent increase in the rate
of accumulating spontaneous, gross chromosomal rearrangements, suggesting that the
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suppression of point mutations by deletion of REV3 may lead to chromosomal
rearrangements. While mph1Δ is epistatic to homologous recombination (HR) genes,
both Rad51 and Rad52, but not Rad59, are required for normal growth of the rev3Δ
mutant and are essential for survival of rev3Δ cells during exposure to MMS, indicating
that Mph1 acts in a Rad51-dependent, Rad59-independent subpathway of HR-mediated
lesion bypass. Deletion of MPH1 helicase leads to synergistic DNA damage sensitivity
increases in cells with chl1Δ or rrm3Δ helicase mutations, whereas mph1Δ is hypostatic
to sgs1Δ. Previously reported slow growth of mph1Δ srs2Δ cells is accompanied by
G2/M arrest and fully suppressed by disruption of the Mec3-dependent DNA damage
checkpoint. We propose a model for replication fork rescue mediated by translesion
DNA synthesis and homologous recombination that integrates the role of Mph1 in
unwinding D loops and its genetic interaction with Rev3 and Srs2-regulated pathways in
the suppression of spontaneous genome rearrangements and in mutation avoidance.

INTRODUCTION
Nonreplicative DNA helicases play an important role in the maintenance of
genome stability from bacteria to humans, most likely by affecting the formation and/or
resolution of recombination intermediates and by facilitating replication fork progression
through chromosomal regions with a propensity to adopt unusual DNA structures or
those bound by proteins. In Saccharomyces cerevisiae, this group of DNA helicases
includes the 3′-to-5′ helicases Sgs1 and Srs2 and the 5′-to-3′ DNA helicase Rrm3. In the
absence of any two of these three helicases, unresolved recombination intermediates
accumulate and lead to extremely slow growth that is fully suppressed by deletion of
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genes encoding early homologous recombination (HR) factors (Lee, Johnson et al.
1999, Gangloff, Soustelle et al. 2000, Klein 2001, Fabre, Chan et al. 2002, Schmidt and
Kolodner 2004, Torres, Schnakenberg et al. 2004). In the absence of Sgs1, cells exhibit
increased rates of mitotic recombination, frequent chromosome missegregation,
accumulation of extrachromosomal ribosomal DNA (rDNA) circles, and increased rates
of gross chromosomal rearrangements (GCRs) involving nonhomologous chromosomes
(Gangloff, McDonald et al. 1994, Watt, Louis et al. 1995, Sinclair, Mills et al. 1997,
Yamagata, Kato et al. 1998, Mullen, Kaliraman et al. 2000, Myung, Datta et al. 2001,
Schmidt and Kolodner 2006, Schmidt, Wu et al. 2006). Based on the increased
crossover frequency during HO endonuclease-induced double-strand breaks (DSBs) in
cells lacking Sgs1, it has also been proposed that Sgs1 may function in decatenation of
Holliday junctions (HJs) to yield noncrossovers (Ira, Malkova et al. 2003, Lo, Paffett et
al. 2006). Like Sgs1, Srs2 acts to favor noncrossover outcomes during DSB repair but
appears to act earlier than Sgs1 in regulating recombination outcomes through its ability
to dislodge Rad51 from recombinogenic 3′ overhangs, thereby promoting a
noncrossover synthesis-dependent single-strand annealing (SDSA) pathway (Ira,
Malkova et al. 2003, Robert, Dervins et al. 2006, Prakash, Satory et al. 2009). In
contrast, Rrm3 has not been implicated in DNA repair but is thought to be important for
avoidance of recombination substrate formation by removal of DNA protein complexes
in certain chromosomal locations, such as chromosome ends and replication fork
barriers at the rDNA locus, thus facilitating replication fork progression (Ivessa, Zhou et
al. 2002, Ivessa, Lenzmeier et al. 2003).
In addition to Sgs1, Rrm3, and Srs2, the yeast genome encodes two other
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nonreplicative DNA helicases with proposed functions in DNA repair, Mph1 and Chl1.
Mph1 possesses 3′-to-5′ helicase activity, and its ATPase activity requires a relatively
long fragment of single-stranded DNA (ssDNA) (≥40 nucleotides [nt]) for full activity in
vitro (Prakash, Krejci et al. 2005). Mph1 is also necessary for resistance to the DNA
damaging agents methyl methanesulfonate (MMS) and 4-nitroquinoline-1-oxide (4NQO) and suppresses spontaneous mutations toward canavanine resistance (Entian,
Schuster et al. 1999, Schurer, Rudolph et al. 2004). The modest mutator phenotype of
the mph1Δ mutant is enhanced by additional mutations in base excision repair (apn1Δ
and apn2Δ) and is suppressed by mutations in translesion DNA synthesis (TLS) (rev3Δ)
(Scheller, Schurer et al. 2000, Schurer, Rudolph et al. 2004). These findings, in
combination with the observation of an epistatic relationship between mph1Δ and
homologous recombination mutations, have led to the proposal that Mph1 may act in
Rad52-dependent, error-free bypassing of DNA lesions (Schurer, Rudolph et al. 2004).
Like the 3′-to-5′ DNA helicases Sgs1 and Srs2, Mph1 was recently shown to affect
crossover frequency during repair of an HO endonuclease-induced DNA DSB, favoring
noncrossovers as the outcome (Prakash, Satory et al. 2009). The authors showed that
Mph1 can unwind intermediates of homologous recombination in vitro, specifically D
loops that are thought to form early during homologous recombination when a
homoduplex is invaded by a Rad51 filament. While Srs2 has been shown to be able to
disassemble Rad51 filaments in vitro, it does not appear to possess Mph1's ability to
dissociate D loops once they have formed (Krejci, Van Komen et al. 2003, Veaute,
Jeusset et al. 2003).
Although Chl1 has been shown to be required for the establishment of sister
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chromatid cohesion, a possible role in DNA repair by homologous recombination has
also been proposed (Shiratori, Shibata et al. 1999, Holloway 2000, Petronczki, Chwalla
et al. 2004, Ogiwara, Ui et al. 2007). While Chl1 possesses a conserved helicase
domain, helicase activity has so far been shown only for its putative human homolog,
hCHLR1 (Hirota and Lahti 2000).
To further elucidate the functional interaction between nonreplicative DNA
helicases and DNA repair pathways, we generated a series of mutants with
combinations of mph1Δ, chl1Δ, rrm3Δ, srs2Δ, and sgs1Δ mutations and mutations in
translesion

DNA

synthesis

(TLS),

base

excision

repair

(BER),

homologous

recombination (HR), and DNA damage checkpoints. In addition to synthetic fitness
defects due to aberrant HR and checkpoint activation, we identified epistatic and
synergistic relationships with regard to fitness, the accumulation of gross chromosomal
rearrangements (GCRs), and sensitivity to DNA damage. We propose that Mph1
functions in a Rad51-dependent, Rad59-independent pathway of HR for DNA lesion
bypass and interacts genetically with REV3 in the suppression of gross chromosomal
rearrangements.

RESULTS
Translesion DNA synthesis suppresses GCR accumulation in mph1∆ cells
Deletion of MPH1 has been shown to cause an increase in spontaneous base
substitutions at CAN1, which can be suppressed by disrupting error-prone translesion
DNA synthesis (Schurer, Rudolph et al. 2004). To determine how spontaneous DNA
lesions are processed if they cannot be bypassed by Mph1 or TLS, we deleted MPH1
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and REV3 in a yeast strain that has been modified to allow the detection of gross
chromosomal rearrangements, such as translocations, large deletions, and de novo
telomere additions (Kolodner, Putnam et al. 2002, Schmidt, Pennaneach et al. 2006).
We found that the rev3Δ mph1Δ mutant showed a statistically significant increase in the
GCR rate over that of the single mutants, as indicated by the nonoverlapping 95%
confidence intervals (α < 0.05) for the median GCR rates (Table 2). This may indicate
that the avoidance of point mutations by deletion of the error-prone DNA polymerase
Rev3 occurs at the expense of increased formation of chromosomal rearrangements,
suggesting that as long as Rev3 is present, spontaneous DNA lesions in the mph1Δ
mutant are preferentially taken care of by TLS, whereas an alternative repair pathway
preferentially utilized in the rev3Δ mph1Δ mutant is prone to GCR formation. To test the
possibility that Srs2, a DNA helicase that has been shown to regulate homologous
recombination by disrupting recombinogenic Rad51-filaments (Krejci, Van Komen et al.
2003, Veaute, Jeusset et al. 2003), may channel DNA lesions into this alternative DNA
repair pathway, we determined the effect of an srs2Δ mutation on GCR formation in the
rev3Δ mph1Δ mutant and found that GCR formation was eliminated (Table 2). That the
viability of the rev3Δ mph1Δ mutant was significantly reduced upon introduction of the
srs2Δ mutation (Fig. 1A) is consistent with previous reports of reduced fitness for the
mph1Δ srs2Δ mutant (Tong, Evangelista et al. 2001, Tong, Lesage et al. 2004,
Prakash, Satory et al. 2009) and suggests that spontaneous DNA lesions in the rev3Δ
mph1Δ mutant may become substrates for homologous recombination pathways that
need to be regulated by Srs2 to prevent cell death. In contrast to the mph1Δ mutant, the
rev3Δ mutant does not require Srs2 for normal growth (Fig. 1A).
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To test whether slow growth of the mph1Δ srs2Δ and rev3Δ mph1Δ srs2Δ
mutants was due to increased G2/M arrest or to slowed progression through S phase
resulting from impaired DNA lesion bypass, cell cycle profiles were obtained (Fig. 2A)
and the fraction of cells in each cell cycle phase from three independent cultures was
quantified (Fig. 2B). We found that the mph1Δ srs2Δ and rev3Δ mph1Δ srs2Δ mutants
showed increased arrest in G2/M compared to the corresponding single and double
mutants, but the mutations lacked any discernible affect on S phase. That the fraction of
cells in S phase was largely unaffected indicates that impairment of DNA lesion bypass
does not hinder the timely completion of genome replication but may instead cause the
formation of DNA structures that later in the cell cycle impair progress through mitosis.
Deletion of RAD51, which had previously been shown to improve colony growth
of the mph1Δ srs2Δ mutant and other DNA helicase double mutants (Lee, Johnson et
al. 1999, Gangloff, Soustelle et al. 2000, Klein 2001, Fabre, Chan et al. 2002, Schmidt
and Kolodner 2004, Torres, Schnakenberg et al. 2004, Prakash, Satory et al. 2009),
abolished the G2/M arrest of mph1Δ srs2Δ cells and allowed them to progress through
the cell cycle as did the srs2Δ single mutant (Fig. 3A). In addition to disrupting
homologous recombination, we found that disruption of the DNA damage checkpoint
clamp by MEC3 deletion also improved growth of the mph1Δ srs2Δ mutant (Fig. 1A)
and had the same effect on viability and cell cycle progression as the deletion of RAD51
(Fig. 3). In contrast, introduction of a rev3Δ mutation into the mph1Δ srs2Δ mutant did
not affect growth (Fig. 1A) but led to a small increase in the fraction of G2/M-arrested
cells (Fig. 2). Similarly, sensitivity of the mph1Δ srs2Δ mutant to MMS was aggravated
further by a rev3Δ mutation but was alleviated by a rad51Δ mutation (Fig. 4). In the
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presence of MMS, rev3Δ mph1Δ srs2Δ cells emerged only after incubation for >72 h.
This strong synergistic increase in MMS sensitivity of the triple mutant compared to that
of any of the double mutants suggests that all three genes mediate independent
pathways for survival in the presence of DNA damage. Taken together, these findings
suggest that deleting the error-prone DNA polymerase Rev3 in mph1Δ cells while
effectively avoiding points mutations causes the appearance of a different mutation
type, i.e., gross chromosomal rearrangements, which activates the DNA damage
checkpoint in G2/M and causes cell death if Srs2 is not present to regulate HRdependent DNA lesion bypass.

Suppression of genome rearrangements by srs2∆ depends on functional
DNA damage checkpoint
Genome instability in cells lacking Sgs1 helicase is suppressed by the DNA
damage checkpoint, as demonstrated by synergistic GCR rate increases upon
introduction of the mec3Δ, rad24Δ, mec1Δ, rad53Δ or rad9Δ mutation into the sgs1Δ
mutant (Schmidt, Wu et al. 2006). As demonstrated by overlapping 95% confidence
intervals, no statistically significant changes in the GCR rate of the mph1Δ mutant were
observed upon introduction of checkpoint mutations (mec3Δ and mec1Δ) (Table 2),
suggesting that the DNA damage checkpoint is not required for the suppression of
GCRs in the mph1Δ mutant. However, when we introduced the mec3Δ mutation into the
mph1Δ srs2Δ mutant, which itself exhibited wild-type levels of GCRs, the GCR rate
increased to that of the mph1Δ mec3Δ mutant (Table 2), thus suggesting that, in
contrast to the case with the rev3Δ mph1Δ and mph1Δ mutants, GCR formation in
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checkpoint-deficient mutants is not dependent on Srs2. Similarly, the GCR rate of the
mec3Δ mutant did not change upon introduction of an srs2Δ mutation. This ability of the
srs2Δ mutation to suppress GCR formation in checkpoint-proficient cells but not in
checkpoint-deficient cells suggests that the Mec3 checkpoint detects the aberrant HR
intermediates that form in the absence of Srs2, leading to G2/M arrest and avoidance of
GCRs, whereas in the absence of the checkpoint, these aberrant HR intermediates go
on to form GCRs.

Lack of Rev3 and Mph1 causes synergistic GCR rate increase in new GCR
strain susceptible to duplication-mediated rearrangements
Putnam et al. (Putnam, Hayes et al. 2009) recently showed that the rate of GCR
accumulation depends significantly on chromosomal features in the breakpoint region.
For example, while GCRs in the standard GCR strain background (RDKY3615) are due
largely to single-copy-sequence-mediated rearrangements, GCRs in a newly designed
strain (RDKY6678) are duplication mediated due to the presence of imperfect homology
between the HXT13-DSF1 sequence in the breakpoint region on chromosome V and
sequences on chromosomes IV, X, and XIV (Putnam, Hayes et al. 2009). This new
GCR strain accumulates chromosomal rearrangements at an increased rate compared
to that for the standard GCR strain, with wild-type cells having a 56-fold-higher GCR
rate than the standard strain (Putnam, Hayes et al. 2009). To assess the effect of DNA
lesion bypass defects on GCR formation in this new strain, rev3Δ, mph1Δ, srs2Δ, and
mec3Δ mutations were introduced into RDKY6678 (Table 3). Consistent with our
observations with the standard GCR strain background (Table 2), the rev3Δ mph1Δ
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double mutant exhibited a synergistic GCR rate increase compared to results for the
mph1Δ and rev3Δ single mutants. Interestingly, the significantly greater synergistic
effect of combining the rev3Δ and mph1Δ mutations in the new GCR strain background
(Table 3; 167-fold increase over rates for the RDKY6678 wild type) compared to results
with the standard GCR strain background (Table 2, 16-fold increase over rates for the
RDKY3615 wild type) indicates that alternative pathways utilized for DNA lesion bypass
in the rev3Δ mph1Δ mutant may be more prone to duplication-mediated than to singlecopy-sequence mediated genome rearrangements. As in the standard GCR strain
(Table 2), deletion of SRS2 in the new GCR strain led to a significant decrease in the
GCR rate of the rev3Δ mph1Δ mutant to the level of the srs2Δ mutant, suggesting that
viable GCR formation depends on the antirecombinase Srs2 despite the different
breakpoint regions in the two GCR strain backgrounds and the different GCR types that
are likely to arise from them. The fact that deletion of SRS2 did not cause a GCR rate
increase in the mph1Δ mec3Δ mutant in the standard GCR background (Table 2) but
led to a significant GCR rate increase in the new GCR background (Table 3) is likely
due to the greater requirement of Srs2 for GCR suppression in the new GCR strain
background (Table 3, srs2Δ: 26-fold increase over wild-type level) than in the standard
GCR strain (Table 2, srs2Δ: 0.6-fold increase over wild-type level).

Genetic interactions between MPH1 and other DNA helicases
Negative genetic interactions between any two of the DNA helicases Sgs1, Srs2,
and Rrm3 have previously been shown to be caused by the accumulation of aberrant
intermediates of homologous recombination (Gangloff, Soustelle et al. 2000, Ooi,
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Shoemaker et al. 2003, Schmidt and Kolodner 2004, Torres, Schnakenberg et al. 2004).
Since such a negative, HR-dependent genetic interaction has now also been
established between mph1Δ and srs2Δ, we tested mph1Δ mutants with deletions of
other confirmed or putative DNA helicase genes (sgs1Δ, rrm3Δ, and chl1Δ) for growth
defects, GCR accumulation, and sensitivity to MMS. We observed that unlike the case
with the mph1Δ srs2Δ mutant, the meiotic products of diploids heterozygous for the
mph1Δ mutation and either the sgs1Δ, rrm3Δ, or chl1Δ mutation grew normally. In
addition to a synergistic increase in sensitivity to MMS for the mph1Δ srs2Δ mutant
(Banerjee, Smith et al. 2008), we also identified synergistic increases in sensitivity for
the mph1Δ rrm3 and mph1Δ chl1Δ mutants but not for the mph1Δ sgs1Δ mutant, which
appeared as sensitive as the sgs1Δ single mutant (Fig. 5). This indicates that Mph1,
Chl1, Rrm3, and Srs2 contribute independently to survival during exposure to MMS,
while Mph1 appears to be hypostatic to Sgs1. Since Schurer et al. (Schurer, Rudolph et
al. 2004) reported a synergistic increase in mitotic homologous recombination at three
markers for the mph1Δ sgs1Δ mutant and therefore suggested that Mph1 may play an
antirecombinogenic role in the sgs1Δ mutant, we tested whether Mph1 also interacted
with Sgs1 or other DNA helicases in the suppression of GCRs. However, we found that
the mph1Δ sgs1Δ mutant accumulates GCRs at the same rate as the sgs1Δ mutant,
indicating no genetic interaction between MPH1 and SGS1 in the suppression of
chromosomal rearrangements (Table 2). Deletion of MPH1 also failed to induce
significant changes in the accumulation of GCRs in srs2Δ, chl1Δ, and rrm3Δ mutants,
as indicated by the overlap between 95% confidence intervals (Table 2).

225

Rad52/Rad51, but not Rad59, are essential for DNA damage tolerance and
normal growth in the absence of translesion DNA synthesis
Although the rev3Δ mph1Δ mutant exhibits a synergistic increase in the GCR
rate and in sensitivity to MMS, it grows unimpaired in the absence of MMS, with a
doubling time indistinguishable from that of the single mutants (Fig. 1B). However,
sporulation of diploids heterozygous for the rev3Δ and rad52Δ mutations revealed
slower growth for the rev3Δ rad52Δ mutant that was unaffected by deletion of MPH1
(Fig. 1B). That the rev3Δ rad52Δ mutant does grow, albeit slowly, could mean that
spontaneous DNA lesions needing to be bypassed during DNA replication are rare
and/or that alternative, yet minor, pathways for lesion bypass exist in addition to HR and
TLS. To distinguish between these possibilities, the ability of the HR-deficient rev3Δ
mutant to grow in the presence of MMS was assessed (Fig. 4). While the rev3Δ mutant
was no more sensitive than wild-type cells, consistent with previous findings (Schurer,
Rudolph et al. 2004), the rev3Δ rad52Δ mutant was significantly more sensitive than the
rad52Δ mutant. In fact, not a single colony emerged in repeated experiments, even after
a >72-h incubation time on 0.001% MMS, for strains lacking both REV3 and RAD52,
lending support to the proposal that besides HR and TLS, no other pathways exist in
yeast for the bypassing of induced DNA lesions. To determine whether Rad51- or
Rad59-dependent branches of homologous recombination are essential for rev3Δ
survival, the viability of spores obtained from diploids heterozygous for rev3Δ and either
the rad51Δ or rad59Δ mutation was assessed, revealing normal growth for the rev3Δ
rad59Δ mutant while the rev3Δ rad51Δ mutant grew slowly (Fig. 1B). Moreover, the
rev3Δ rad59Δ mutant was no more sensitive than the single mutants, whereas the

226

rev3Δ rad51Δ mutant could not form any colonies in the presence of MMS (Fig. 4),
similar to the case with the rev3Δ rad52Δ mutant. Thus, although rev3Δ exhibits
synergistic increases in sensitivity to MMS when combined with mph1Δ, mph1Δ srs2Δ,
rad52Δ, or rad51Δ, the normal growth of the rev3Δ mph1Δ mutant as opposed to the
impaired growth of the rev3Δ rad51Δ and rev3Δ rad52Δ mutants suggests that in
addition to Mph1-dependent HR, other, Mph1-independent, Rad51-dependent HR
pathways exist for DNA lesion bypass.

DISCUSSION
We have investigated genetic interactions between genes involved in DNA lesion
bypass (MPH1 and REV3), homologous recombination (RAD52, RAD51, RAD59, and
SRS2), and the DNA damage checkpoint (MEC3 and MEC1) with regard to fitness,
MMS sensitivity, and suppression of genome instability. We find that suppression of
point mutations that arise in an mph1Δ mutant as a result of the error-prone Rev3
polymerase replicating across a template lesion results in the appearance of GCRs.
This finding may suggest that mutations are not actually avoided but are simply shifted
toward a different mutation type. Synergistic GCR rate increases in two strain
backgrounds, each designed to accumulate different GCR spectra (Putnam, Hayes et
al. 2009), demonstrate that REV3 and MPH1 interact genetically to suppress various
types of spontaneous GCRs but are especially effective at suppressing GCRs in the
newly designed GCR strain background. For this new GCR strain, Putnam et al.
(Putnam, Hayes et al. 2009) determined that GCRs accumulate largely as a result of
nonallelic homologous recombination (NAHR) between DNA sequences in the
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breakpoint region on chromosome V and similar regions on chromosomes IV, X, and
XIV. Hence, the greater synergistic GCR rate increase identified here in this new GCR
background compared to that for the standard GCR strain suggests greater roles for
MPH1 and REV3 in the suppression of such NAHR-mediated GCRs than in the
suppression of single-copy-sequence-mediated rearrangements. The requirement of
Srs2, which regulates the outcomes of HR by antagonizing strand invasion, for the
formation of viable chromosomal rearrangements further supports a prominent role of
HR in the formation of GCRs when Mph1 and Rev3 are absent for DNA lesion bypass.
We further show that the negative genetic interaction between the mph1Δ and srs2Δ
mutations, coupled with accumulation of cells in G2/M and further exacerbation of the
G2/M arrest by disruption of REV3, is suppressed by disrupting the DNA damage
checkpoint. Synergism in MMS sensitivity was observed for mph1Δ mutants lacking
CHL1, RRM3, SRS2, or REV3, whereas epistasis was observed for mph1Δ mutants
lacking RAD52, RAD51, or SGS1. Combined with our observation that the rev3Δ mutant
required RAD51 and RAD52 but not RAD59 or MPH1 for normal growth, this suggests
that Rev3 (TLS) and RAD51 (HR) are the two pathways for bypass of spontaneous
DNA lesions, with Mph1 defining only one Rad51 subpathway. While the rad51Δ
mutation appeared to suppress MMS sensitivity of the mph1Δ srs2Δ mutant to the level
exhibited by a rad51Δ single mutant, the rev3Δ mutation led to a further synergistic
increase, suggesting that Mph1, Srs2, and Rev3 contribute to bypass and/or repair of
induced DNA lesions independently.
Our observation of suppression of the G2/M arrest of the mph1Δ srs2Δ mutant by
mec3Δ, in addition to the recently reported suppression by rad51Δ (Prakash, Satory et
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al. 2009), suggests that cells lacking Mph1 and Srs2 are overwhelmed with HR
intermediates that do not impair S phase but activate the DNA damage checkpoint prior
to mitosis. That Srs2 is essential for normal growth in the absence of Mph1 could mean
that DNA lesions, normally bypassed by the Mph1 pathway, will enter another HR
pathway that is potentially lethal if it is not regulated by Srs2. According to recent
findings by Prakash et al. (Prakash, Satory et al. 2009), Srs2, Mph1, and Sgs1
independently promote noncrossover pathways during mitotic DSB repair. They suggest
that Srs2 diverts DNA lesions away from crossover events that can result from double
Holliday junction (dHJ) resolution into the noncrossover SDSA pathway by preventing
second-strand invasion. Accumulation of dHJs due to the absence of Srs2 could
overwhelm resolution pathways, especially when alternative pathways for DNA lesion
bypass, such as TLS, are absent. In addition to its ability to inhibit crossover formation
during repair of an HO-induced DSB, Mph1 has also been reported to unwind D loops in
vitro (Prakash, Satory et al. 2009). It has therefore been proposed that Mph1 promotes
SDSA and may reverse strand invasion events before they can form dHJs. Thus, the
overall burden of lesions that are committed to HR pathways and could potentially go on
to form dHJs would be expected to increase in the absence of Mph1 and even further
when Rev3 is also absent.
Recent findings suggest how FANCM, a human homolog of Mph1, could perform
a role in error-free bypass of DNA lesions. FANCM is part of the eight-component
Fanconi anemia core complex, which is involved in the repair of intrastrand cross-links
and is associated with Fanconi anemia (Joenje and Patel 2001, Niedzwiedz, Mosedale
et al. 2004, Kennedy and D'Andrea 2005, Mathew 2006, Wang 2007). FANCM can
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branch migrate three- and four-way junctions and, like Mph1, unwind D loops (Gari,
Decaillet et al. 2008, Gari, Decaillet et al. 2008). Combining these two activities, it has
been proposed that FANCM may stall and remodel replication forks to promote repair of
an approaching DNA lesion, thus preventing the fork from encountering the lesion and
collapsing (Gari, Decaillet et al. 2008). Without FANCM, forks would collapse, leading to
broken chromatids and increased gross chromosomal rearrangements, both hallmarks
of Fanconi cells (Thompson, Hinz et al. 2005).
The recruitment of Srs2 to the replisome when PCNA becomes sumoylated in
the presence of DNA damage (Pfander, Moldovan et al. 2005) and the ability of the
human Mph1 homolog FANCM to remodel replication forks in vitro lead us to propose a
model in which Mph1 and Srs2 perform their roles in recombination directly at the fork to
restart replication after encountering a DNA lesion (Fig. 6). Based on the slow growth of
Rad52/Rad51-deficient rev3Δ cells and the inability of the rev3Δ rad52Δ and rev3Δ
rad51Δ mutants to form any colonies in the presence of MMS, we propose that in wildtype cells, DNA lesions may be bypassed by either Rev3-mediated TLS or Rad51dependent HR, with Mph1 being involved in only one subpathway of Rad51-dependent
HR. Rev3-mediated TLS is prone to errors but not GCR formation, while properly
regulated HR pathways, including the Mph1 pathway, are error free. Mph1 may act at a
stalled replication fork by unwinding the leading strand from its template, a scenario
which has been suggested to resemble unwinding of a D loop (Gari, Decaillet et al.
2008). Mediated by HR proteins, the leading strand may then anneal with the lagging
strand, forming a chicken foot (Fig. 6, structure A), or invade the sister chromatid,
forming a D loop (Fig. 6, structure B), followed by DNA synthesis at the 3′ end. Based
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on the ability of Mph1 to reverse D loops in vitro, it also seems possible that Mph1 acts
to resolve these HR intermediates. For example, Mph1 could unwind the D loop formed
by HR proteins after limited DNA synthesis or dissolve the chicken-foot structure by
reverse branch migration. Reannealing of the daughter strands with their templates
would then result in error-free bypass of the DNA lesion in the template strand and
resumption of replication. While FANCM has been shown to migrate three- and fourway junctions in vitro (Gari, Decaillet et al. 2008, Gari, Decaillet et al. 2008), as
proposed in this model, this remains to be determined for Mph1. The recent report of a
physical interaction between Mph1 and RPA (Banerjee, Smith et al. 2008) could
suggest that Mph1 is recruited to stalled replication forks via RPA-bound regions of
ssDNA that are generated when the replication machinery stalls at a lesion in the
template. While Mph1 can unwind 40 bp by itself, it requires RPA to unwind duplexes
that are 100 bp and fails on those that are 500 bp (Prakash, Krejci et al. 2005). This
rather modest helicase activity could ensure that Mph1 does not expose unnecessarily
large regions of ssDNA at stalled forks while at the same time being sufficiently strong
to unwind the leading strand from its template needed for D-loop/chicken-foot formation
and/or to reverse HR-mediated invasion of the sister chromatid. Moreover, the ATPase
activity of Mph1 requires a relatively long stretch of ssDNA (≥40 nt) for full activation in
vitro (Prakash, Krejci et al. 2005), which could help to ensure that Mph1 is active only
on replication forks that have stalled because they are likely to contain longer regions of
ssDNA than unperturbed forks. In our model, Srs2 is recruited to damaged replication
forks to suppress dHJ formation, thereby promoting Mph1-mediated fork rescue. Such a
role for Srs2 at the replication fork is consistent with recent findings (Liberi, Chiolo et al.
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2000, Pfander, Moldovan et al. 2005). Hence, in the absence of Srs2, an increasing
number of forks would enter dHJ pathways for rescue, overwhelming dHJ resolution
pathways and leading to aberrant and/or unresolved intermediates and eventually G2/M
arrest. This accumulation of srs2Δ cells in G2/M accelerates as more DNA lesions
become substrates for dHJ pathways upon elimination of Mph1 and Rev3. Unresolved
or aberrant DNA structures may not be the only cause for Mec3-dependent cell cycle
arrest of mph1Δ srs2Δ cells. According to findings by Prakash et al. (Prakash, Satory et
al. 2009), HR intermediates during DSB repair are increasingly resolved as crossovers
when Srs2 and Mph1 are absent, possibly due to increased HR and impairment of
single-strand annealing pathways, such as SDSA. Thus, not only is increased dHJ
formation likely to overwhelm dHJ resolution pathways, it is also likely to increase the
number of crossovers, which could be dangerous for haploid mitotic cells and contribute
to diminished cell proliferation. Although formation and unwinding of D-loop-like
structures could be envisaged at replication forks and the recently proposed role of
Mph1 in SDSA repair of DSBs could be likened to reversing chicken-foot/D-loop
structures at stalled forks, it remains to be tested whether Mph1 can branch migrate
three- or four-way junctions to reverse these HR intermediates and does indeed
function at the replication fork.

MATERIALS AND METHODS
Yeast strains and media
All strains used in this study are derived from Saccharomyces cerevisiae strain
S288C and are listed in Table 1. For GCR rate measurements, desired gene deletions
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were introduced into KHSY802 (MATa ura3-52 trp1Δ63 his3Δ200 leu2Δ1 lys2Bgl hom310 ade2Δ1 ade8 hxt13::URA3), RDKY5027 (MATα ura3-52 trp1Δ63 his3Δ200 leu2Δ1
lys2Bgl hom3-10 ade2Δ1 ade8 hxt13::URA3), or RDKY6678 (MATa ura3-52 leu2Δ1
trp1Δ63 his3Δ200 lys2ΔBgl hom3-10 ade2Δ1 ade8 can1::hisG yel072w::CAN1/URA3
iYEL072::hph) by HR-mediated integration of PCR products by the lithium acetate
method (Gietz and Woods 2006). All haploid strains, including single mutants, for GCR
rate measurements, growth analysis, and fluorescence-activated cell sorting (FACS)
were obtained by sporulating diploids heterozygous for the desired mutation(s). Spores
were genotyped on selective media or by PCR. For tetrad dissection, desired mutations
were introduced by HR-mediated integration of PCR fragments in the strain background
RDKY2666 (MATa ura3-52 trp1Δ63 his3Δ200) or RDKY2664 (MATα ura3-52 trp1Δ63
his3Δ200). Media for propagating strains have been previously described (Chen,
Umezu et al. 1998).

GCR analysis
GCR rates were determined exactly as previously described (Schmidt,
Pennaneach et al. 2006). Initially, GCR rates were derived from 10-ml cultures of two or
three independent strain isolates. For mutants with low GCR rates, up to 75 cultures,
ranging from 10 to 50 ml in volume, were analyzed per mutant. To determine the
statistical significance of differences between median GCR rates, 95% confidence
intervals (α < 0.05) for all median GCR rates were calculated according to the method of
Nair (Nair 1940). GCR rates were measured in the standard GCR strain background
RDKY3615 and a modified GCR strain background, RDKY6678 (both strains were
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kindly provided by Richard Kolodner, University of California—San Diego). In
RDKY3615, the CAN1 gene is in its wild-type location on chromosome V and a URA3
cassette was used to replace the HXT13 gene on chromosome V (Schmidt,
Pennaneach et al. 2006, Putnam, Hayes et al. 2009). In RDKY6678, the CAN1 gene is
deleted (can1::hisG) and a URA3/CAN1 cassette is inserted into YEL072W, located
telomeric of HXT13 on chromosome V (Putnam, Hayes et al. 2009).

Tetrad analysis
Diploids were sporulated in 1% potassium acetate for 5 days at 30°C, washed,
digested with zymolase (500 µg/ml in 1 M sorbitol), and dissected on yeast extractpeptone-dextrose (YPD) agar plates using a micromanipulator mounted on an Axioskop
40 microscope (Zeiss). The YPD plates were incubated for 2 days at 30°C and
photographed.

Doubling time measurement
Overnight cultures of independent isolates were diluted in 5 ml of YPD to an
optical density at 600 nm (OD600) of 0.1 to 0.2, and the OD600 was measured in 60min or 120-min intervals for 6 to 8 h. Doubling times are reported in minutes and are
presented as the average doubling time of two or three independent strains for each
genotype, with error bars showing the standard deviations.
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DNA content analysis
Cells were grown overnight at 30°C in YPD medium. Cultures were diluted in
YPD to an OD600 of 0.2, and incubation was continued until cultures reached an
OD600 of 0.6 to 0.8. Cells were then fixed in 70% ethanol for 1 h at room temperature
and sonicated in 50 mM sodium citrate (pH 7). The cells were washed once in 50 mM
sodium citrate (pH 7), and RNase A was added to a final concentration of 250 µg/ml.
After overnight incubation at 37°C, the cells were washed twice in 50 mM sodium
citrate. To stain the DNA, Sytox green (Molecular Probes) was added to a final
concentration of 1 µM and the cells were incubated in the dark at room temperature for
1 h immediately prior to fluorescence-activated cell sorting (FACS) on a BD LSR II
analyzer. The distribution of cells throughout the cell cycle phases was quantified with
the FlowJo v8.3.3 software program. The mean obtained from measurements of at least
three cultures and standard deviation are reported for every strain.

MMS sensitivity
Overnight cultures were diluted in YPD to an OD600 of 0.2 and grown at 30°C to
an OD600 of 0.6. A series of 10-fold dilutions was prepared for every yeast culture, and
5 µl was spotted on YPD and on YPD containing the appropriate levels of MMS. Colony
growth was recorded after 24 h, 48 h, and 72 h of incubation at 30°C. The 48-h time
point is shown.
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FIGURES AND TABLES

Figure A.1. Genetic interactions between rev3Δ, mph1Δ, srs2Δ, and HR mutations
were assessed by testing the fitness of mutants. (A) Tetrads from diploids
heterozygous for rev3Δ, mph1Δ, and srs2Δ; mph1Δ, srs2Δ, and rad51Δ; or mph1Δ,
srs2Δ, and mec3Δ were dissected on rich medium and genotyped by spotting on
selective medium or by PCR to determine the presence of gene deletions. In contrast to
the mph1Δ mutant, the rev3Δ mutant does not require SRS2 for normal growth.
Deletion of MEC3 or disruption of HR rescues the slow growth of the mph1Δ srs2Δ
mutant. (B) Doubling times of mutant strains and appropriate controls in rich medium
(YPD) are shown with standard deviations. Cells lacking Rev3 require Rad51 and
Rad52 but not Rad59 for normal growth, and these growth defects are unaffected by
Mph1.
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Figure A.2. Effect of rev3Δ and srs2Δ mutations on cell cycle progression of cells
lacking Mph1. Asynchronous cultures were grown to mid-log phase, fixed, and stained
with Sytox green to measure DNA content by FACS. (A) Cell cycle profiles reveal that
mph1Δ srs2Δ cells accumulate in G2/M phase, which is enhanced further by a rev3Δ
mutation. (B) Quantification of cell fractions in G1, S, and G2/M phases, determined by
FACS analysis of three cell cultures for each strain, using FlowJo v8.3.3. Error bars
indicate the standard deviations.
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Figure A.3. The G2/M arrest of mph1Δ srs2Δ cells is suppressed by disrupting
homologous recombination or the DNA damage checkpoint. Cell cycle profiles (A)
and quantification (B) of the fractions of cells in G1, S, and G2/M phases show that the
rad51Δ and mec3Δ mutations are equally effective at decreasing cell accumulation in
G2/M, showing an increase in the fraction of cells in G1. Neither mutation affects the
fraction of cells in S phase. The DNA content of Sytox green-stained cells from at least
three mid-log-phase cultures of every strain was analyzed by FACS.
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Figure A.4. Effect of mutations affecting translesion DNA synthesis and
homologous recombination on sensitivity to MMS. Tenfold dilutions of exponentially
growing cultures were spotted on YPD (viable cell count) or YPD containing 0.001% or
0.005% MMS. Colony growth after 48 h (and 72 h for selected mutants) of incubation at
30°C is shown.
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Figure A.5. Effect of an mph1Δ mutation on MMS sensitivity of mutants lacking
various other confirmed (Sgs1, Rrm3, and Srs2) or putative (Chl1) DNA helicases.
Tenfold dilutions of exponentially growing cultures were spotted on YPD or YPD
containing 0.01% or 0.005% MMS. Colony growth after 48 h of incubation at 30°C is
shown.
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Figure A.6. Model for the role of Mph1 in the maintenance of genome stability.
DNA lesions arise spontaneously during DNA replication and are bypassed by an errorfree, Mph1-mediated, noncrossover pathway of homologous recombination (HR). Mph1
may unwind the leading strand from its template, suggested to resemble a D loop (Gari,
Decaillet et al. 2008), followed by Rad51/52-mediated chicken-foot formation (A) and
then resolution by reverse branch migration. A D-loop structure could also form when
the leading strand switches template (B), and Mph1 could dissolve this D loop by
reverse branch migration. In the absence of Mph1, lesions are bypassed by error-prone,
Rev3-mediated TLS or they are channeled by Srs2 into alternative bypass pathways
that can result in GCRs. If TLS is disrupted in the mph1Δ mutant, point mutations from
TLS are avoided, but GCRs arise as a consequence of aberrant repair, most likely
nonallelic HR. In the absence of both Mph1 and Srs2, cells accumulate at G2/M and
lose viability due to Rad51-mediated accumulation of dHJs and Mec3-mediated
checkpoint activation. In the absence of the checkpoint, cells continue through the cell
cycle in the presence of DNA lesions. The dotted line emerging from Srs2 indicates that
Srs2 tightly regulates the levels of dHJ formation at paused replication forks by inhibiting
Rad51-mediated strand invasion.
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TABLE A.1. Saccharomyces cerevisiae strains used in this study
Strain

Genotype

RDKY3615a MATa ura3-52 trp1Δ63 his3Δ200 leu2Δ1 lys2ΔBgl hom3-10 ade2Δ1 ade8
hxt13::URA3
RDKY2666a MATa ura3-52 trp1Δ63 his3Δ200
RDKY2664a MATα ura3-52 trp1Δ63 his3Δ200
RDKY6678a MATa ura3-52 leu2Δ1 trp1Δ63 his3Δ200 lys2ΔBgl hom3-10 ade2Δ1 ade8
can1::hisG yel072w::CAN1/URA3 iYEL072::hph
RDKY6795a MATa ura3-52 leu2Δ1 trp1Δ63 his3Δ200 lys2ΔBgl hom3-10 ade2Δ1 ade8
can1::hisG yel072w::CAN1/URA3 iYEL072::hph mph1::HIS3
KHSY883

MATa ura3-52 trp1Δ63 his3Δ200 leu2Δ1 lys2ΔBgl hom3-10 ade2Δ1 ade8
hxt13::URA3 rad51::HIS3

KHSY1258

MATa ura3-52 trp1Δ63 his3Δ200 leu2Δ1 lys2ΔBgl hom3-10 ade2Δ1 ade8
hxt13::URA3 rad52::HIS3

KHSY1399

MATa ura3-52 trp1Δ63 his3Δ200 leu2Δ1 lys2ΔBgl hom3-10 ade2Δ1 ade8
hxt13::URA3 rrm3::kanMX6

KHSY1557

MATa ura3-52 trp1Δ63 his3Δ200 leu2Δ1 lys2ΔBgl hom3-10 ade2Δ1 ade8
hxt13::URA3 mph1::HIS3

KHSY1561

MATa ura3-52 trp1Δ63 his3Δ200 leu2Δ1 lys2ΔBgl hom3-10 ade2Δ1 ade8
hxt13::URA3 chl1::HIS3

KHSY1598

MATa ura3-52 trp1Δ63 his3Δ200 leu2Δ1 lys2ΔBgl hom3-10 ade2Δ1 ade8
hxt13::URA3 rad52::HIS3 mph1::HIS3
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TABLE A1.1 (continued)
KHSY1600

MATa ura3-52 trp1Δ63 his3Δ200 leu2Δ1 lys2ΔBgl hom3-10 ade2Δ1 ade8
hxt13::URA3 sgs1::TRP1 mph1::HIS3

KHSY1630

MATa ura3-52 trp1Δ63 his3Δ200 leu2Δ1 lys2ΔBgl hom3-10 ade2Δ1 ade8
hxt13::URA3 sgs1::TRP1

KHSY1702

MATa ura3-52 trp1Δ63 his3Δ200 leu2Δ1 lys2ΔBgl hom3-10 ade2Δ1 ade8
hxt13::URA3 srs2::kanMX6 mph1::HIS3

KHSY1713

MATa ura3-52 trp1Δ63 his3Δ200 leu2Δ1 lys2ΔBgl hom3-10 ade2Δ1 ade8
hxt13::URA3 rrm3::TRP1 mph1::HIS3

KHSY1725

MATa ura3-52 trp1Δ63 his3Δ200 leu2Δ1 lys2ΔBgl hom3-10 ade2Δ1 ade8
hxt13::URA3 chl1::HIS3 mph1::HIS3

KHSY1872

MATa/α

ura3-52/ura3-52

trp1Δ63/trp1Δ63

his3Δ200/his3Δ200

MPH1/mph1::HIS3 SRS2/srs2::TRP1
KHSY1878

MATa ura3-52 trp1Δ63 his3Δ200 leu2Δ1 lys2ΔBgl hom3-10 ade2Δ1 ade8
hxt13::URA3 mec3::kanMX6 mph1::HIS3

KHSY1889

MATa/α

ura3-52/ura3-52

trp1Δ63/trp1Δ63

his3Δ200/his3Δ200

MPH1/mph1::HIS3 MRE11/mre11::URA3
KHSY1894

MATa ura3-52 trp1Δ63 his3Δ200 leu2Δ1 lys2ΔBgl hom3-10 ade2Δ1 ade8
hxt13::URA3 mph1::HIS3 mec1::HIS3 sml1::TRP1

KHSY1932

MATa/α

ura3-52/ura3-52

trp1Δ63/trp1Δ63

his3Δ200/his3Δ200

MPH1/mph1::URA3 SRS2/srs2::HIS3 MEC3/mec3::TRP1
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TABLE A1.1 (continued)
KHSY1935

MATa/α

ura3-52/ura3-52

trp1Δ63/trp1Δ63

his3Δ200/his3Δ200

MPH1/mph1::HIS3 SRS2/srs2::TRP1 RAD51/rad51::kanMX6
KHSY1954

MATa ura3-52 trp1Δ63 his3Δ200 leu2Δ1 lys2ΔBgl hom3-10 ade2Δ1 ade8
hxt13::URA3 rev3::TRP1

KHSY1957

MATa ura3-52 trp1Δ63 his3Δ200 leu2Δ1 lys2ΔBgl hom3-10 ade2Δ1 ade8
hxt13::URA3 apn1::TRP1

KHSY1970

MATa ura3-52 trp1Δ63 his3Δ200 leu2Δ1 lys2ΔBgl hom3-10 ade2Δ1 ade8
hxt13::URA3 apn1::TRP1 mph1::HIS3

KHSY1976

MATa ura3-52 trp1Δ63 his3Δ200 leu2Δ1 lys2ΔBgl hom3-10 ade2Δ1 ade8
hxt13::URA3 rev3::TRP1 mph1::HIS3

KHSY2020

MATa ura3-52 trp1Δ63 his3Δ200 leu2Δ1 lys2ΔBgl hom3-10 ade2Δ1 ade8
hxt13::URA3 rad51::HIS3 srs2::kanMX6 mph1::HIS3

KHSY2038

MATa ura3-52 trp1Δ63 his3Δ200 leu2Δ1 lys2ΔBgl hom3-10 ade2Δ1 ade8
hxt13::URA3 mec3::HIS3 srs2::kanMX6 mph1::TRP1

KHSY2226

MATa ura3-52 trp1Δ63 his3Δ200 leu2Δ1 lys2ΔBgl hom3-10 ade2Δ1 ade8
hxt13::URA3 rev3::TRP1 srs2::kanMX6 mph1::HIS3

KHSY2416

MATa ura3-52 trp1Δ63 his3Δ200 leu2Δ1 lys2ΔBgl hom3-10 ade2Δ1 ade8
hxt13::URA3 rev3::TRP1 rad52::HIS3 mph1::HIS3

KHSY2420

MATa ura3-52 trp1Δ63 his3Δ200 leu2Δ1 lys2ΔBgl hom3-10 ade2Δ1 ade8
hxt13::URA3 rev3::TRP1 rad52::HIS3
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TABLE A1.1 (continued)
KHSY2492

MATa ura3-52 trp1Δ63 his3Δ200 leu2Δ1 lys2ΔBgl hom3-10 ade2Δ1 ade8
hxt13::URA3 mph1::HIS3 rad51::HIS3

KHSY3042

MATa ura3-52 leu2Δ1 trp1Δ63 his3Δ200 lys2ΔBgl hom3-10 ade2Δ1 ade8
can1::hisG yel072w::CAN1/URA3 iYEL072::hph mec3::TRP1 mph1::HIS3

KHSY3056

MATa ura3-52 leu2Δ1 trp1Δ63 his3Δ200 lys2ΔBgl hom3-10 ade2Δ1 ade8
can1::hisG yel072w::CAN1/URA3 iYEL072::hph rev3::TRP1 mph1::HIS3

KHSY3065

MATa ura3-52 leu2Δ1 trp1Δ63 his3Δ200 lys2ΔBgl hom3-10 ade2Δ1 ade8
can1::hisG yel072w::CAN1/URA3 iYEL072::hph mec3::TRP1

KHSY3067

MATa ura3-52 leu2Δ1 trp1Δ63 his3Δ200 lys2ΔBgl hom3-10 ade2Δ1 ade8
can1::hisG yel072w::CAN1/URA3 iYEL072::hph srs2::HIS3

KHSY3101

MATa ura3-52 leu2Δ1 trp1Δ63 his3Δ200 lys2ΔBgl hom3-10 ade2Δ1 ade8
can1::hisG yel072w::CAN1/URA3 iYEL072::hph srs2::HIS3 mph1::HIS3

KHSY3123

MATa ura3-52 leu2Δ1 trp1Δ63 his3Δ200 lys2ΔBgl hom3-10 ade2Δ1 ade8
can1::hisG yel072w::CAN1/URA3 iYEL072::hph srs2::HIS3 mph1::HIS3
rev3::TRP1

KHSY3126

MATa ura3-52 leu2Δ1 trp1Δ63 his3Δ200 lys2ΔBgl hom3-10 ade2Δ1 ade8
can1::hisG yel072w::CAN1/URA3 iYEL072::hph srs2::HIS3 mph1::HIS3
mec3::TRP1

a

Obtained from Richard Kolodner (University of California—San Diego).
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TABLE A.2. Effect of defects in DNA lesion bypass, homologous recombination,
DNA helicases, and the DNA damage checkpoint on accumulation of gross
chromosomal rearrangements in the standard GCR strain background RDKY3615
Relevant

Strain

GCR rate (Canr 5- 95% CIb (Canr 5- Fold increase over
FOAr) (× 10−10)a

genotype

FOAr) (× 10−10)

wild-type level

Wild type

RDKY3615

3.5c

mph1

KHSY1557

20

5–34

6

rev3

KHSY1954

10

5–21

3

rev3

KHSY1976

56

44–71

16

KHSY2226

<14

<11–18

<4

srs2

RDKY5557

2d

<2–11

0.6

mph1

KHSY1702

1.2

<2–6

0.3

KHSY1878

55

24–73

16

KHSY2038

56

30–68

16

KHSY895

471

209–859

135

1

mph1
rev3
mph1
srs2

srs2
mph1
mec3
mph1
mec3
srs2
mec1
sml1
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Table A.2 (continued)
mec1

KHSY1894

290

154–467

83

apn1

KHSY1957

19

14–41

5

apn1

KHSY1970

15

<15–51

4

rad52

KHSY1258

435

317–520

124

rad52

KHSY1598

275

131–467

79

sgs1

KHSY1630

220

144–276

64

sgs1

KHSY1600

239

162–528

68

chl1

KHSY1561

14

<14–94

4

chl1

KHSY1725

40

<10–202

11

rrm3

KHSY1399

14d

5–28

4

rrm3

KHSY1713

21

<17–48

6

sml1
mph1

mph1

mph1

mph1

mph1

mph1
a

5-FOA, 5-fluoroorotic acid.
Ninety-five percent confidence intervals (CIs) were calculated according to the
method of Nair (Nair 1940), with nonoverlapping confidence intervals indicating
statistically significant differences (α < 0.05) between median GCR rates.
c
GCR rate from reference (Chen, Umezu et al. 1998).
d
GCR rate from reference (Schmidt and Kolodner 2006).
b
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APPENDIX B:
STRUCTURAL MOTIFS CRITICAL FOR IN VIVO FUNCTION AND STABILITY OF
THE RECQ-MEDIATED GENOME INSTABILITY PROTEIN RMI1
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ABSTRACT
Rmi1 is a member of the Sgs1/Top3/Rmi1 (STR) complex of Saccharomyces
cerevisiae and has been implicated in binding and catalytic enhancement of Top3 in the
dissolution of double Holliday junctions. Deletion of RMI1 results in a severe growth
defect resembling that of top3Δ. Despite the importance of Rmi1 for cell viability, little is
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known about its functional domains, particularly in Rmi1 of S. cerevisiae, which does not
have a resolved crystal structure and the primary sequence is poorly conserved. Here,
we rationally designed point mutations based on bioinformatics analysis of
order/disorder and helical propensity to define three functionally important motifs in
yeast Rmi1 outside of the proposed OB-fold core. Replacing residues F63, Y218 and
E220 with proline, designed to break predicted N-terminal and C-terminal α-helices, or
with lysine, designed to eliminate hydrophobic residues at positions 63 and 218, while
maintaining α-helical structure, caused hypersensitivity to hydroxyurea. Further, Y218P
and E220P mutations, but not F63P and F63K mutations, led to reduced Rmi1 levels
compared to wild type Rmi1, suggesting a role of the C-terminal α-helix in Rmi1
stabilization, most likely by protecting the integrity of the OB-fold core. Our
bioinformatics analysis also suggests the presence of a disordered linker between the
N-terminal α-helix and the OB fold core; a P88A mutation, designed to increase helicity
in this linker, also impaired Rmi1 function in vivo. In conclusion, we propose a model
that maps all functionally important structural features for yeast Rmi1 based on
biological findings in yeast and structure-prediction-based alignment with the recently
established crystal structure of the N-terminus of human Rmi1.

INTRODUCTION
The RecQ-like DNA helicase family is evolutionarily conserved and necessary for
genomic stability from bacteria to humans. In yeast the RecQ-like Sgs1 helicase forms a
complex with the topoisomerase Top3 and the recQ-mediated genome instability 1
protein Rmi1 (STR) and facilitates both early and late steps of DNA double-strand break
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(DSB) repair (Chang, Bellaoui et al. 2005, Mullen, Nallaseth et al. 2005, Chu and
Hickson 2009). Early in the repair of a two-ended DSB, STR contributes to DSB end
resection to facilitate the formation of a single-strand 3’ overhang on which the
homologous recombination (HR) factor Rad51 filament assembles (Bennett, Keck et al.
1999, Mimitou and Symington 2008, Zhu, Chung et al. 2008, Daley, Chiba et al. 2014).
This Rad51 filament is then able to initiate a genome-wide search for sequence
homology, eventually leading to the formation of double Holliday Junctions (dHJs) that
need to be resolved prior to cell division. Resolution can be achieved by the HJ-specific
endonuclease Yen1, randomly leading to crossover and noncrossover products, or
dHJs can be dissolved by STR in a process involving dHJ migration and decatenation of
the single strands, yielding exclusively noncrossover products (Mitchel, Lehner et al.
2013). STR has also been implicated in the unwinding of strand invasion after extension
of the invading 3’end by DNA synthesis to promote DSB repair by synthesis-dependent
strand annealing, as well as reversal of strand invasion prior to 3’end extension
(Fasching, Cejka et al. 2015). Through these functions, STR promotes noncrossover
outcomes of HR and regulates HR levels. Hence, yeast cells that lack the helicase
activity of the STR complex (sgs1Δ) are prone to hyper-recombination, accumulate
gross chromosomal rearrangements, and are hypersensitive to DNA-damaging agents,
with cells lacking Top3 or Rmi1 additionally exhibiting a severe growth defect not seen
in cells lacking Sgs1 (Gangloff, McDonald et al. 1994, Myung, Datta et al. 2001, Chang,
Bellaoui et al. 2005, Mullen, Nallaseth et al. 2005). Similarly, in mice inactivation of
RMI1 or Topo IIIα leads to embryonic lethality earlier (no blastocysts) than inactivation
of BLM (day 13.5), the human RecQ-like helicase most closely related Sgs1 (Chen, You
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et al. 2011).
Despite the growth defect of the rmi1Δ mutant, the contribution of Rmi1 to the
function of the STR complex and the regions of Rmi1 that are critical for these functional
contributions are still poorly understood. Rmi1, was first discovered in S. cerevisiae in a
screen for components of the Sgs1/Top3 pathway (Mullen, Nallaseth et al. 2005). Yeast
cells lacking Rmi1 are hypersensitive to hydroxyurea (HU) and several other genotoxic
agents, have an increased rate of spontaneous DNA damage as indicated by an
increase in Rad52 foci, an increase in chromosomal rearrangements, and deficiency in
activation of the DNA-damage checkpoint kinase Rad53 (Chang, Bellaoui et al. 2005,
Mullen, Nallaseth et al. 2005). Diploids lacking Rmi1 are defective in meiosis, and
deletion of genes with roles in the checkpoint response to replication stress, such as
Mrc1, Tof1, Csm3, cause synthetic lethality, implying a diverse role for Rmi1 in several
chromatin processes (Chang, Bellaoui et al. 2005, Mullen, Nallaseth et al. 2005).
Despite the severity of rmi1Δ phenotypes, Rmi1 has no known catalytic function. It has
been shown to stimulate the final decatenation step of dHJ dissolution by Sgs1/Top3,
while inhibiting the relaxation activity of the topoisomerase on negatively supercoiled
DNA, possibly by affecting the conformation of the topoisomerase gate (Chen and Brill
2007, Cejka, Plank et al. 2010, Yang, O'Donnell et al. 2012). This function is conserved
in the BLM/Topo IIIα/Rmi1/Rmi2 (BTR) complex, the human variant of STR, and studies
in human cell lines also imply a role for Rmi1 in Topo IIIα stability (Wu, Bachrati et al.
2006, Yang, O'Donnell et al. 2012, Guiraldelli, Eyster et al. 2013).
The N-terminal 219 residues of the 625-residue long human Rmi1 have been
crystallized, providing some clues to its role in catalytic enhancement and stability of the
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BTR complex (Wang, Yang et al. 2010, Bocquet, Bizard et al. 2014). The N-terminus of
human Rmi1 is most closely related to S. cerevisiae Rmi1, is capable of binding BLM
and Topo IIIα, and contains an oligonucleotide-binding (OB) fold that is similar in
structure to that of the replication protein A subunit RPA70, though it is suggested that it
is incapable of binding DNA like RPA (Raynard, Bussen et al. 2006, Wang, Yang et al.
2010). Human Rmi1 contains a disordered loop needed for dHJ dissolution
enhancement of Topo IIIα (Bocquet, Bizard et al. 2014). Co-crystallization of the Rmi1
N-terminal lobe peptide with Topo IIIα reveals that the OB-fold of Rmi1 lies opposite of
the ssDNA-binding domain of Topo IIIα, and a mostly disordered loop that protrudes
from the OB fold of Rmi1 physically interacts with the topoisomerase by inserting itself
into the central topoisomerase gate (Ira, Malkova et al. 2003). It has been hypothesized
that this loop may be what facilitates the catalytic enhancement of Topo IIIα by
regulating opening and closing of the gate (Wang, Yang et al. 2010, Bocquet, Bizard et
al. 2014).
Because of the severe growth retardation, low viability and rapid accumulation of
suppressor mutations, the identification and functional analysis of deleterious rmi1
mutations through genetic screens has proved difficult; one rmi1 mutant, the
temperature-sensitive E69K, was identified through this conventional approach (Ashton,
Mankouri et al. 2011). In an effort to better understand the molecular basis of Rmi1
function, we have combined structure prediction tools with an in vivo mutational analysis
of RMI1 function in yeast. This approach has identified structural motifs that are
essential for Rmi1 function and stability and we propose hypotheses for how these
motifs contribute to Rmi1’s role in maintaining the functional integrity of the STR
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complex. As an alternative to primary sequence alignments, which have been only
minimally informative because of the poor sequence conservation among Rmi1
homologues, we present a structure-based alignment between yeast and human Rmi1
that maps the location of conserved motifs and suggests differences in the size and
structure of the DUF1767 domain.

MATERIALS AND METHODS
Bioinformatics analysis
The 241 residues of S. cerevisiae Rmi1 and the N-terminal 240 residues of the
625-residue human Rmi1 were analyzed with algorithms for helical propensity (Munoz
and Serrano 1995, Munoz and Serrano 1997), structural disorder using a combination
of three predictors in VL-XT (Li, Romero et al. 1999, Romero, Obradovic et al. 2001),
and amino acid sequence alignments based on phylogenetic analysis in PhylomeDB v4
(Huerta-Cepas, Capella-Gutierrez et al. 2014).

Plasmids
The open reading frame of RMI1 plus 500 bp up- and downstream was amplified
by PCR from the endogenous RMI1 locus of KHSY1338 (ura3-52, leu2Δ1, trp1Δ63,
his3Δ200, lys2-Bgl, hom3-10, ade2Δ1, ade8, sgs1::HIS3, YEL069C::URA3,). The
fragment was inserted into XbaI-digested pRS415 by gap-repair cloning using the nonhomologous-endjoining deficient yeast strain KHSY2331 (ura3-52, leu2Δ1, trp1Δ63,
his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8, YEL069C::URA3, lig4::loxP-G418-loxP)
and standard lithium-acetate transformation (Gietz and Woods 2006). The integrity of
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RMI1 and the promoter region in the resulting plasmid pKHS621 was verified by
sequencing. Point mutations were introduced into the RMI1 ORF in pKHS621 by
QuikChange site-directed mutagenesis (Agilent Technologies). To construct pKHS621
derivatives that express myc-epitope-tagged Rmi1 and rmi1 mutant proteins, pKHS621
was linearized with BoxI and the HIS3-linked myc-epitope-coding sequence from
pFA6a-13MYC-HIS3MX6 (Longtine, McKenzie et al. 1998) was inserted by gap-repair
cloning. Point mutations were introduced into the resulting plasmid (pKHS630, S1 Table
Plasmids used in this study) using the QuikChange protocol (Agilent Technologies).

Hydroxyurea hypersensitivity assay
Derivatives of pKHS621 were transformed into KHSY4695 (MATα, ura3Δ0,
leu2Δ0, his3Δ1, lys2Δ0, rmi1::HIS3, TOP3.V5.VSV.KANMX6), grown to OD600 = 0.5 in
synthetic complete media lacking leucine (SC-Leu), and spotted in 10-fold dilutions on
yeast extract/peptone/dextrose (YPD) and on YPD supplemented with 150 mM
hydroxyurea. Growth was documented after 3 to 5 days of incubation at 30°C.

Viability assay
Yeast strain KHSY4695 (rmi1Δ) was transformed with plasmids pKHS621,
pKHS624, and pKHS626. Independent cultures were set up from 9 to 12 transformants
for each plasmid and grown to approximately 2 x 107 cells/ml. Actual cell counts were
determined using a hemocytometer and cultures were diluted to plate ~ 400 cells.
Plates were incubated for 3 days at 30°C and colonies counted. Viability was calculated
by dividing the number of colony forming units by the number of cells plated based on
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the hemocytometer count.

Protein extraction and western blotting
A BY4741 derivative (MATa, ura3Δ0, leu2Δ0, his3Δ1, lys2Δ0, RAD51-V56xHIS.KANMX6) from the Yeast Cross and Capture Collection (GE Dharmacon) was
transformed with pKHS630 or its derivatives (S1 Table Plasmids used in this study)
expressing myc-tagged Rmi1 or rmi1 mutants and grown in synthetic complete media
lacking histidine overnight. Cultures were then diluted to OD600 = 0.2 and grown to
OD600 = 0.4. Cultures were synchronized in G1 phase with 2 µg/ml of α-factor for one
hour, followed by addition of 1 µg/ml of α-factor for a second hour. Cells were released
for 30 min and cells equivalent to 2 ODs were harvested and washed twice in distilled
water. Whole cell extract was prepared with 20% trichloroacetic acid as previously
described (Kennedy, Daughdrill et al. 2013), separated by SDS-PAGE, and myc-tagged
Rmi1 and rmi1 mutants detected by Western blotting on PVDF and hybridization with cmyc (9E10) monoclonal antibody (Covance).

RESULTS
Computational analysis of yeast Rmi1 structure
Determining functionally important residues in S. cerevisiae Rmi1 has been
challenging as it lacks catalytic activity and a crystal structure has not been resolved.
The primary sequence is only minimally conserved (~35% identical residues between
yeast genera, 18% between S. cerevisiae and human Rmi1) and lengths range from
241 residues in S. cerevisiae to 625 residues in humans. The crystal structure of the N-
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terminal 219 residues of human Rmi1 was recently resolved (Wang, Yang et al. 2010).
It revealed an N-terminal three-helix bundle of unknown function (DUF1767) followed by
an OB-fold with a largely unstructured loop inserted between strands β1 and β2 by
which Rmi1 binds to Topo IIIα. In the absence of catalytic activity/domains and very
limited sequence identity, we reasoned that structure prediction tools (Munoz and
Serrano 1997, Lacroix, Viguera et al. 1998, Peng, Vucetic et al. 2005) could reveal
functionally important motifs in yeast Rmi1. Analyzing the distribution of ordered and
disordered residues, we noticed disordered N- and C-termini as well as two internal
regions of increased disorder (Fig 1A). Further, we identified two regions of increased
helical propensity, spanning residues 58–74 and residues 212–228 near the N- and Cterminal disordered regions, as well as two regions of lesser helical propensity between
residues 125–132 and 137–145 (Fig 1B). Alignment of these two predictors would be
consistent with the putative OB-fold core mapping to the central, ordered region, and
the topoisomerase-binding loop to the disordered insertion with two segments of weak
helical propensity. The DUF1767 domain, predicted to be present in Rmi1 of all species,
is typically located N-terminally of the OB-fold core, and appears to be connected to it in
yeast Rmi1 by a disordered linker (Fig 1A).

Mutational analysis of predicted structural elements of yeast Rmi1
We had previously determined that disruption of an α-helix was most effective
when a residue with high helical propensity near the peak or in the N-terminal half of the
helix was replaced with the helix breaker proline (Kennedy, Daughdrill et al. 2013).
Therefore, to determine the importance of the four regions of increased helicity for Rmi1
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function, we constructed F63P, A128P, A139P and E220P mutations. The proline
substitutions led to marked decreases in predicted helical propensity in these regions
(Fig 1C–1F). We also noticed that the proline at position 88 seemed to disrupt what
might otherwise be a region with high helical propensity, and hypothesized that this
native break was helping to maintain a degree of flexibility in what would otherwise be a
persistent, structured region. We considered that replacing P88 with a residue with high
helical propensity that was otherwise benign, such as alanine, would restore helicity to
this region. Indeed, the P88A mutation is predicted to lead to an extraordinary increase
in helical propensity not seen in any region of the wildtype forms of yeast or human
Rmi1 (Fig 1G). We exploited the HU hypersensitivity of yeast cells lacking Rmi1
(Chang, Bellaoui et al. 2005) to assess the functional impact of these proline
substitutions in vivo. We found that rmi1Δ cells expressing rmi1-A128P and rmi1-A139P
exhibited the same HU sensitivity as the rmi1Δ mutant complemented with wildtype
RMI1, whereas the rmi1-P88A allele was only able to partially suppress the HU
hypersensitivity of rmi1Δ (Fig 1H). This mild, 5- to 10-fold, increase in HU sensitivity of
the rmi1-P88A mutant compared to wildtype or the rmi1-A128P mutant was not due to
decreased viability of the rmi1-P88A mutant as the viability of all three strains was
similar (33–36%).
The rmi1-F63P allele caused the same degree of HU hypersensitivity as a
deletion of RMI1, indicating that it was a null allele (Fig 1H). We also considered the
possibility that the phenotype of the F63P mutation could be due to the loss of a strong
hydrophobic interaction via the aromatic residue. Thus, we chose to replace F63 with a
hydrophilic residue with high helical propensity, such as lysine, that would be predicted
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to maintain the structural integrity of the motif, but change its chemical properties. We
found that the F63K mutation caused the same hypersensitivity to HU as the F63P
mutation (Fig 1H), implicating that this residue maps to an α-helical structure that must
conserve both its shape and hydrophobic character in order to maintain wildtype
function of Rmi1. Similar to F63, proline substitution of E220 in the predicted C-terminal
helix abolished Rmi1 function in vivo (Fig 1F and 1H).
The function of the putative helices defined by F63 and E220 may arise from
stabilizing the putative OB-fold core of Rmi1 as seen in other proteins containing this
fold type (Theobald, Mitton-Fry et al. 2003) or by otherwise contributing to Rmi1
stability. To test this possibility, we inserted a myc-epitope-coding sequence at the 3’
end of RMI1 in pRS415 and introduced the deleterious F63P, F63K and E220P
mutations, as well as the benign A128P mutation as a control. Equal numbers of cells
were harvested from synchronized cultures for protein extraction and Western blotting,
which revealed that mutations in the C-terminal helix, but neither in the N-terminal helix
nor the helical elements in the insertion loop led to reduced Rmi1 levels (Fig 2).

Structure predictions and in vivo mutagenesis suggest differences in the
N-termini of yeast and human Rmi1
Structural prediction analysis indicated a single α-helical region in the N-terminus
of yeast Rmi1, centered on F63 (Fig 3A). When we extended this analysis to the Nterminus of human Rmi1, we identified three segments of increased helical propensity
(Fig 3B), which form a three-helix bundle in the crystal structure (Wang, Yang et al.
2010, Bocquet, Bizard et al. 2014). The lack of helical propensity in the first 57 residues
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of yeast Rmi1 suggests that this region may not adopt helical structures in the apo form
as human Rmi1 does. To identify conserved residues and regions of conserved
chemical character that could be indicative of a functional role, we analyzed primary
sequence alignments of Rmi1. We found that S.c. Rmi1 is ~85% identical to Rmi1 of
other Saccharomyces species, but identity markedly decreased to ~30% when
compared to yeast species outside of the genus (e.g., K. lactis, C. glabrata), and to
~18% when compared to the N-terminal 241 residues of human Rmi1. Because of the
low level of sequence identity between human and yeast Rmi1 we decided to analyze
the alignment of the N-termini of twelve closely related Rmi1 sequences from fully
sequenced Saccharomyces and non-Saccharomyces yeast species in PhylomeDB v4
(Huerta-Cepas, Capella-Gutierrez et al. 2014). We noticed two discrete regions (Fig 3C,
residues S2-I15 and R27-L41 of S.c. Rmi1) that contain hydrophobic residues in the
i,i+4 pattern typical of an α-helix and are separated from each other by residues with the
lowest helical propensity, proline and glycine. To test the possibility that these two
regions could become helical upon binding to another protein, possibly Sgs1, or could
be analogous to α1 and α2 in human Rmi1, we replaced L7 and Y35 with proline (Fig
3C). Expression of either mutant, however, was sufficient to fully restore wildtype growth
to the rmi1Δ mutant on HU (Fig 3D), suggesting either that, unlike in human Rmi1, this
region in yeast Rmi1 does not adopt α-helical structures or that any helical structure or
binding-induced folding in this region is not required for Rmi1’s role in tolerating HUinduced DNA-damage. Based on comparisons of helical propensity and primary
sequences of yeast Rmi1 and the N-terminus of human Rmi1 (Fig 3A–3C), we propose
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structural equivalence between the sole predicted α-helix in yeast and α3 in human
Rmi1, with a potential equivalent of F63 at residue F53 in human Rmi1.

A conserved alpha helix in the C-terminus contributes to yeast Rmi1
stability
When we extended the analysis of sequence alignments to the C-terminus of
Rmi1 it revealed that the chemical characteristics of the predicted α-helical region
centered on residue E220 were conserved, with a short stretch of hydrophobic residues
surrounded by charged residues (Fig 4C). Whereas neither E220 nor the acidic or
hydrophilic character of the residue was conserved outside of the Saccharomyces
genus, the hydrophobic residues were, including a tyrosine at position 218. We
hypothesized that this residue was not only part of the functional α-helical structure we
had inferred from the E220P mutant, but was also a key residue for binding in an
otherwise fairly charged α-helix. Indeed, we found that either breaking the helix (rmi1Y218P) or increasing its hydrophilicity (rmi1-Y218K) abolished Rmi1 function (Fig 4D).
Although yeast and human Rmi1 are only 18% identical, we found that they share
regions of similar helical propensity, including the region that surrounds Y218 in yeast
and Y201 in an amphipathic α-helix in human Rmi1 (Fig 4A–4C). Similar to the
disruption of the C-terminal helix by the E220P mutation, the Y218P mutation led to
reduced Rmi1 levels (Fig 2).
Taken together, the bioinformatics analysis and corresponding mutagenesis of
Rmi1 in vivo indicates the presence of two functionally critical N-terminal and C-terminal
α-helices, with the latter contributing to Rmi1 stability. It further indicates a disordered
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linker, defined by the P88A mutation, that appears to connect the N-terminal α-helix to
the putative OB-fold core. The function of a disordered loop in the OB fold whose
equivalent in human Rmi1 binds Topo IIIα, was not disrupted by mutagenesis of two
predicted, albeit very weak, helical motifs.

DISCUSSION
In this study, we have combined three bioinformatics tools—order/disorder
prediction, helical propensity and phylomes (Munoz and Serrano 1994, Munoz and
Serrano 1997, Lacroix, Viguera et al. 1998, Li, Romero et al. 1999, Peng, Vucetic et al.
2005, Huerta-Cepas, Capella-Gutierrez et al. 2014)–with in vivo mutagenesis to
elucidate structure/function relationships in yeast Rmi1. We focused on the regions that
surround a putative OB-fold core previously identified in human Rmi1 that is involved in
binding BLM and Topo IIIα (Munoz and Serrano 1997, Ira, Malkova et al. 2003). The
regions surrounding the central OB-fold core are predicted to contain two short regions
of increased helical propensity (residues 58–74, 212–228) and a highly disordered
linker (residues 82–97) connecting the N-terminal helix to the OB-fold core. We
determined that the structural and chemical integrity of the N-terminal α-helix defined by
F63P/K, and the C-terminal α-helix defined by E220P and Y218P/K, are critical for Rmi1
function in vivo, and that the disorder of the linker, defined by P88A, contributes to
normal Rmi1 function.
Performing the same structural prediction analysis for human Rmi1 suggests that
the two N- and C-terminal α-helices and the spacing between them, where the core of
an OB-fold has been confirmed in human Rmi1, are conserved (Fig 5). In human Rmi1,

266

a loop that maps to residues 98–134 emerges from the OB-fold between strands β1 and
β2 and inserts itself into the Topo IIIα gate; its deletion eliminates complex formation of
Rmi1 with BLM and Topo IIIα (Wang, Yang et al. 2010). Based on a sequence
alignment Bocquet and colleagues (Bocquet, Bizard et al. 2014) suggested that the
equivalent loop for Top3 binding in yeast Rmi1 maps to residues 87–146 and showed
that replacement of this region with a scrambled version of equal chemistry still
mediated binding to Sgs1 and Top3, but failed to stimulate Top3 catalytic activity and
dHJ dissolution. The structural alignment in our study, however, which we explored
because of the poor sequence conservation of only 18% between yeast and human
Rmi1, suggests that residues 87–116 of yeast Rmi1 contain the β1 strand of the OB-fold
and the disordered linker that connects β1 to the N-terminal helical region (Fig 5). The
insertion loop in yeast Rmi1, therefore, may be significantly shorter, mapping to
residues 116–145. As in human Rmi1, this insertion loop contains two segments of
increased helical propensity (Figs 1B and 6E), but proline mutagenesis of these
segments (A128P, A139P) suggests that the adoption of helical structure is not required
for Rmi1’s function. Since both regions adopt short helices, if any, and the prolines
replaced alanines that are likely to be in the first turn, it is also possible that proline
substitution is not structurally disruptive in this disordered loop.
The N-terminal region flanking the OB-fold in the crystal structure of human Rmi1
forms a three-helix bundle that has been designated a DUF1767 domain (Ira, Malkova
et al. 2003). The three α-helices are also indicated in our structural analysis, whereas
the corresponding region in yeast Rmi1 contains only one predicted α-helix (residues
58–74). Our structural alignment (Fig 5) suggests that it corresponds to α3 of human
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Rmi1 (Fig 6C); this is also supported by our manual alignment of the N-terminus of
human Rmi1 with the N-terminal sequences of the yeast Rmi1 phylome (Fig 3C). How
this α-helix contributes to yeast Rmi1 function is unclear. Genetic analysis of Rmi1 from
Arabidopsis thaliana showed that the OB-fold core and the N-terminal helical region
DUF1767 can function independently of each other (Bonnet, Knoll et al. 2013). In
human Rmi1, the three-helix bundle in the corresponding DUF1767 region makes
contacts with the top region of the OB-fold core and was shown to be indispensable for
its folding and solubility (Ira, Malkova et al. 2003). The F63P mutation, which we
designed to disrupt the N-terminal α-helix in yeast Rmi1, caused a null phenotype;
however, it had no noticeable effect on Rmi1 levels in the cell. This is in contrast to the
C-terminal α-helix whose amphipathic properties and importance for Rmi1 stability
strongly suggest that it protects the OB-fold core. Instead, the N-terminal α-helix—and
the region N-terminal of the OB-fold in general—could also mediate association with
another protein, possibly Sgs1, whose binding site on Top3/Rmi1 is unknown. This type
of small binding motif paired with disorder has been seen in other proteins, including
yeast Adr1, which contains two small zinc finger motifs in a disordered domain (Hyre
and Klevit 1998); interestingly, the disordered components of this domain undergo
extensive folding when contact is made between the zinc fingers and DNA. The
structural alignment between yeast and human Rmi1 put forth in this study also
suggests that the N-terminus of yeast Rmi1 is extended by approximately 18 residues.
Since residues 1–16 are arranged in the typical i,i+4 pattern of an α-helix (residues F3,
L7, I11, I15) and the yeast phylome indicates two regions of similarity in the N-terminal
57 residues, we tested if binding-induced helix formation could also be a function of the
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extended unstructured N-terminus of yeast Rmi1, but found that introducing proline
residues where prospective helices might form (L7, Y35), did not impair Rmi1 function.
This limited analysis, however, cannot exclude the possibility that shorter helices fully
capable of supporting Rmi1 function in vivo can still be induced with the L7P and Y35P
mutations present.
In contrast to the N-terminal α-helix, our findings suggest that the C-terminal αhelix defined by the Y218P/K and E220P mutations plays a major role in stabilizing
Rmi1 as seen in other proteins containing an OB-fold (Theobald, Mitton-Fry et al. 2003).
Our structural prediction suggests that the C-terminal α-helix extends from residues 212
to 228 and is equivalent to the α-helix between residues 194–211 in human Rmi1, with
Y201 corresponding to Y218 in yeast Rmi1 (Figs 4A–4C and 5). In contrast to mutations
that disrupt the N-terminal helix, the Y218P and E220P mutations cause substantially
reduced Rmi1 levels, which is the most likely cause of their null phenotype. Indeed, in
the crystal structure of human Rmi1 the hydrophobic face of the corresponding
amphipathic α-helix packs against the bottom of the OB-fold core, which is likely to
stabilize it by shielding it from the solvent (Fig 6D) (Bocquet, Bizard et al. 2014). Binding
of human Rmi1 to Rmi2 involves extensive interactions between the α-helices Cterminal of the second OB-fold of Rmi1 and the OB-fold of Rmi2 (Ira, Malkova et al.
2003, Hoadley, Xu et al. 2010); however, a similar function in mediating interaction with
another protein has not been identified for the α-helix C-terminal of the N-terminal OBfolds of human or yeast Rmi1.
Finally, our bioinformatics analysis suggests a disordered loop in yeast Rmi1
linking the OB-fold core to an N-terminal α-helix. The structural disorder in this linker
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appears to depend largely on a single proline, whereas multiple prolines are present in
human Rmi1, suggesting a more flexible linkage of the three-helix bundle to the OB-fold
core (Fig 6F). A mutation predicted to increase helicity of this flexible linker partially
impaired Rmi1 function. This mutant grows normally, but exhibits increased DNAdamage sensitivity, most likely by reducing the overall conformational elasticity of Rmi1.
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FIGURES

Figure B.1. Structure-prediction-guided mutagenesis of S.c. Rmi1.
A, prediction of order/disorder in Rmi1 by the VLXT algorithm (Li, Romero et al. 1999,
Romero, Obradovic et al. 2001). A score of 1 denotes an ideal prediction of disorder
and a score of 0 an ideal prediction of order with the order/disorder threshold at a score
of 0.5. A domain of unknown function (DUF1767), and an OB-fold with an insertion loop
are conserved in all Rmi1 species (Xu, Guo et al. 2008). The position of DUF1767, the
OB-fold, the insertion loop and a predicted flexible linker between DUF1767 and the
OB-fold shown above the disorder plot are based on the VLXT order/disorder prediction.
α-helices (cylinders) and β-strands (arrows) in this region of human Rmi1 are indicated
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below the domain map. B, prediction of four regions of increased helical in Rmi1 with
residues F63, A128,A139, E220 having some of the highest helical propensity in the
DUF1767 domain, the insertion loop, and the C-terminus, respectively. We predict that
P88 is responsible for the sudden loss in helical propensity in the linker that connects Nterminal domain and the OB-fold. C–G, substitution of F63, A128, A139 and E220 with
proline, which has the lowest helical propensity of all amino acids, is predicted to disrupt
the increased helical propensity in these regions, whereas substitution of P88 with
alanine, which has excellent helical propensity, is predicted to lead to a strong increase
in continuous helical propensity of the linker. H, plasmid pRS415 expressing RMI1 and
rmi1 mutants under control of the endogenous RMI1 promoter were transformed into
Δrmi1 mutant KHSY4695 and tested for the ability to suppress the hypersensitivity of
the rmi1Δ strain to hydroxyurea.
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Figure B.2. Effect on expression levels of mutations designed to disrupt
structural motifs of yeast Rmi1.
Mutants of Rmi1 with point mutations that disrupt the function of the putative N-terminal
α-helix (F63P, F63K) are expressed at similar levels as wildtype Rmi1 and the benign
rmi1-A128P mutant, whereas mutations that disrupt the function of the putative Cterminal α-helix (Y218P, E220P) are expressed at reduced levels. Whole cells extracts
from equal numbers of cells from synchronized cultures expressing myc-epitope-tagged
Rmi1 or rmi1 mutants were analyzed by Western blotting. Expression levels of two
independently constructed plasmids expressing rmi1-Y218P are shown.
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Figure B.3. Structural prediction and in vivo functional analysis suggest
differences between the N-termini of yeast and human Rmi1.
A and B, one segment of increased helical propensity (residues 58–74) is predicted for
the N-terminus of yeast Rmi1, whereas three such segments (residues 5–18, 23–32,
44–55) are predicted for human Rmi1, corresponding to the three-helix bundle
confirmed in the Rmi1 crystal structure [4CGY (Bocquet, Bizard et al. 2014)]. The
estimated equivalent to yeast F63, F53 in α3 of human Rmi1, is indicated. C, alignment
of Rmi1 N-termini from twelve yeast species in PhylomeDB (Huerta-Cepas, CapellaGutierrez et al. 2014) suggests two segments of conserved residue chemistry between
residues 2–15 and residues 27–41 (indicated below the alignment by light red
rectangles), in addition to the highly conserved segment predicted to have high helical
propensity (indicated by a red rectangle). The N-terminus of human Rmi1 was aligned
to S.c. Rmi1 by ClustalW and manually adjusted. The three segments of increased
helical propensity predicted in the DUF1767 region of human Rmi1 are shown as light
blue rectangles (residues 5–18, 23–32, 44–55) and dark blue rectangles (residues 3–
19, 23–38, 44–58) indicate the confirmed location of α-helices that make up the threehelix bundle in the DUF1767 domain in the crystal structure of the N-terminus of Rmi1
with Topo IIIα (4CGY) (Bocquet, Bizard et al. 2014). D, substitution of L7 and Y35 with
proline, aimed at preventing the two segments from adopting α-helical structure induced
by intra- or intermolecular binding events, does not impair Rmi1 function in vivo.
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Figure B.4. Mutational analysis of the C-terminal region of increased helical
propensity.
A and B, Yeast Rmi1 and human Rmi1-N, the N-terminal 240-residue region of human
Rmi1 that is most similar to yeast Rmi1, have comparable predicted structure in the far
C-terminus. Y218 is in the same predicted helix as E220 and has a potential equivalent
in Y201 in human Rmi1. C, PhylomeDB alignment of Rmi1 C-termini from different
yeast species reveals a highly conserved tyrosine at position 218. The corresponding
region of human Rmi1 (residues 178–231) was manually aligned to the yeast Rmi1
phylome. The position of the predicted α-helix in yeast Rmi1 is indicated by a red
rectangle below the alignment. The corresponding α-helix defined by Y201 in the crystal
structure of human Rmi1 (PDB: 4CGY) is indicated by a blue rectangle. D, like rmi1E220P, rmi1-Y218P and rmi1-Y218K mutants fail to complement the hydroxyurea
hypersensitivity of an Δrmi1 mutant.
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Figure B.5. Proposed structure-prediction-based alignment of yeast and human
Rmi1.
Residues to which confirmed domains in the human Rmi1 crystal structure (4CGY) map
are indicated above the alignment in black. Proposed location of conserved domains
and motifs in yeast Rmi1 are indicated in red. Conserved residues whose mutation to
proline abolished Rmi1 function in vivo are indicated in the alignment with the proposed
corresponding residue in human Rmi1 (F63/F53; Y281/Y201). Compared to human
Rmi1, the N-terminus (DUF1767) of yeast Rmi1 appears to be extended by
approximately 18 residues. The predicted size and location of the topoisomerasebinding loop (residues 116–145) differs from that previously proposed (residues 87–
145) for yeast Rmi1 (Bocquet, Bizard et al. 2014).
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Figure B.6. Conserved domains, and putative differences between yeast Rmi1 and
the N-terminus of human Rmi1.
A, functional importance of seven structural motifs predicted in yeast Rmi1 was tested
by analyzing point mutations in vivo. Mutation of putative motifs highlighted in light
yellow did not impair Rmi1 function in vivo, including L7P and Y35P mutations in the
putative DUF1767 domain, and A128P and A139P in the topoisomerase-binding loop.
Mutations in motifs highlighted in dark yellow impaired Rmi1 function in vivo; F63P and
F63K mutations in an N-terminal α-helix (H), Y218P, Y218K, and E220P mutations in a
C-terminal α-helix (H) caused null phenotypes, and the P88A mutation in the flexible
linker (fL) between the DUF1767 domain and the OB-fold caused intermediate
functional impairment. B, he crystal structure of the N-terminus of human Rmi1 bound to
Topo IIIα (4CGY (Bocquet, Bizard et al. 2014)) was rendered in PyMol. The DUF1767
domain, the OB-fold core and the insertion loop extending between strands β1 and β2
are shown in grey, blue, and red, respectively. A part of the disordered insertion loop
missing from the crystal structure is indicated by a red dashed line. Topo IIIα is shown in
green. C, the domain structure of Rmi1 is shown as in (B) with α3, corresponding to the
functionally important, putative α-helix in yeast Rmi1, highlighted in yellow. Residue F53
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of human Rmi1 and the corresponding F63P null mutation in yeast Rmi1 (in brackets)
are indicated. D, the C-terminal α-helix interacting with the bottom of the OB-fold core is
shown in yellow. Y201 and the corresponding Y218P null mutation in yeast Rmi1 (in
parentheses) are indicated. Disruption of this α-helix leads to lower Rmi1 expression
levels and total loss of Rmi1 function (Fig 3E). E, human Rmi1 contains two helical
segments in the insertion loop, shown in yellow. A128P and A139P mutations were
designed to disrupt helical propensity in the corresponding insertion loop in yeast Rmi1,
but did not interrupt Rmi1 function. F, a flexible linker connects the DUF1767 domain to
the OB-fold in human Rmi1, indicated in yellow. A single proline at position 88 is
predicted to disrupt the strong helical propensity of this linker in yeast Rmi1 whereas
this linker is more proline-rich in human Rmi1. The location of P70 in human Rmi1,
corresponding to P88 in yeast Rmi1, is indicated.
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SUPPORTING INFORMATION
Table B.S1. Plasmids used in this study
Plasmid

Description

pKHS621

pRS415-RMI1

pKHS622

pRS415-rmi1-F63P

pKHS635

pRS415-rmi1-F63K

pKHS623

pRS415-rmi1-E220P

pKHS624

pRS415-rmi1-A128P

pKHS625

pRS415-rmi1-A139P

pKHS626

pRS415-rmi1-P88A

pKHS627

pRS415-rmi1-Y218P

pKHS634

pRS415-rmi1-Y218K

pKHS628

pRS415-rmi1-L7P

pKHS629

pRS415-rmi1-Y35P

pKHS630

pRS415-RMI1-myc.HIS3MX6

pKHS631

pRS415-rmi1-F63P-myc.HIS3MX6

pKHS632

pRS415-rmi1-A128P-myc.HIS3MX6

pKHS633

pRS415-rmi1-Y218P-myc.HIS3MX6

pKHS642

pRS415-rmi1-F63K-myc.HIS3MX6

pKHS643

pRS415-rmi1-E220P-myc.HIS3MX6
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APPENDIX C:
YEAST STRAINS
Strains
(KHSY)
304
421
802
1062
1063
1064
1338
1866
1867
1868
1869
1870
1871
1875
1876
1877
1999
2000

Genotype
his3Δ200, trp1Δ63,ura3-52, rrm3::TRP1
ura3-52, trp1Δ63, his3Δ200, leu2Δ1
ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8.
YEL069C::URA3
ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8.
YEL069C::URA3, rrm3::TRP1
ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8.
YEL069C::URA3, rrm3::TRP1
ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8.
YEL069C::URA3, rrm3::TRP1
ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8.
YEL069C::URA3, sgs1::HIS3
ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8.
YEL069C::URA3, sgs1::sgs1-hd.TRP1
ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8.
YEL069C::URA3, sgs1::sgs1-hd.TRP1
ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8.
YEL069C::URA3, sgs1::sgs1-hd.TRP1
ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8.
YEL069C::URA3, sgs1::sgs1.ΔC795.TRP1
ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8.
YEL069C::URA3, sgs1::sgs1ΔC795.TRP1
ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8.
YEL069C::URA3, sgs1::sgs1ΔC795.TRP1
ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8.
YEL069C::URA3, sgs1::sgs1ΔC200.TRP1
ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8.
YEL069C::URA3, sgs1::sgs1ΔC200.TRP1
ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8.
YEL069C::URA3, sgs1::sgs1ΔC200.TRP1
ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8.
YEL069C::URA3, sgs1::sgs1-hd.myc.HIS
ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8.
YEL069C::URA3, sgs1::sgs1-hd.myc.HIS
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Yeast Strains (continued)
2001 ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8.
YEL069C::URA3, sgs1::sgs1-hd.myc.HIS
2017 ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8.
YEL069C::URA3, sgs1::HIS3
2018 ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8.
YEL069C::URA3, sgs1::HIS3
2019 ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8.
YEL069C::URA3, sgs1::HIS3
2341 ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8.
YEL069C::URA3, mec3::G418, sgs1C200.myc.HIS3
2342 ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8.
YEL069C::URA3, mec3::G418, sgs1C200.myc.HIS3
2343 ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8.
YEL069C::URA3, mec3::G418, sgs1C200.myc.HIS3
2344 ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8.
YEL069C::URA3, mec3::G418, sgs1C200.myc.HIS3
2345 ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8.
YEL069C::URA3, sgs1C200.myc.HIS3
2346 ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8.
YEL069C::URA3, sgs1C200.myc.HIS3
2347 ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8.
YEL069C::URA3, mec3::G418, sgs1C300.myc.HIS3
2348 ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8.
YEL069C::URA3, mec3::G418, sgs1C300.myc.HIS3
2349 ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8.
YEL069C::URA3, mec3::G418, sgs1C300.myc.HIS3
2350 ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8.
YEL069C::URA3, mec3::G418, sgs1C300.myc.HIS3
2351 ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8.
YEL069C::URA3, sgs1C300.myc.HIS3
2352 ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8.
YEL069C::URA3, sgs1C300.myc.HIS3
2353 ura3-52/ura3-52, leu2Δ1/leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200,
lys2ΔBgl/lys2ΔBgl, hom3-10/hom3-10, ade2Δ1/ade2Δ1, ade8/ade8.
YEL069C::URA3/YEL069C::URA3, SGS1/sgs1C400.myc.HIS3,
MEC3/mec3::G418
2354 ura3-52/ura3-52, leu2Δ1/leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200,
lys2ΔBgl/lys2ΔBgl, hom3-10/hom3-10, ade2Δ1/ade2Δ1, ade8/ade8.
YEL069C::URA3/YEL069C::URA3, SGS1/sgs1C400.myc.HIS3,
MEC3/mec3::G418
2355 ura3-52/ura3-52, leu2Δ1/leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200,
lys2ΔBgl/lys2ΔBgl, hom3-10/hom3-10, ade2Δ1/ade2Δ1, ade8/ade8.
YEL069C::URA3/YEL069C::URA3, SGS1/sgs1C400.myc.HIS3,
MEC3/mec3::G418
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2356 ura3-52/ura3-52, leu2Δ1/leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200,
lys2ΔBgl/lys2ΔBgl, hom3-10/hom3-10, ade2Δ1/ade2Δ1, ade8/ade8.
YEL069C::URA3/YEL069C::URA3, SGS1/sgs1C500.myc.HIS3,
MEC3/mec3::G418
2357 ura3-52/ura3-52, leu2Δ1/leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200,
lys2ΔBgl/lys2ΔBgl, hom3-10/hom3-10, ade2Δ1/ade2Δ1, ade8/ade8.
YEL069C::URA3/YEL069C::URA3, SGS1/sgs1C500.myc.HIS3,
MEC3/mec3::G418
2358 ura3-52/ura3-52, leu2Δ1/leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200,
lys2ΔBgl/lys2ΔBgl, hom3-10/hom3-10, ade2Δ1/ade2Δ1, ade8/ade8.
YEL069C::URA3/YEL069C::URA3, SGS1/sgs1C500.myc.HIS3,
MEC3/mec3::G418
2383 (ura3Δ0, leu2Δ0, his3Δ1, met15Δ0), SGS1.V5.6xHIS
2385 (ura3Δ0, leu2Δ0, his3Δ1, lys2Δ0), RAD51.V5.VSV
2473 (ura3Δ0/ura3Δ0, leu2Δ0/leu2Δ0, his3Δ1/his3Δ1, met15Δ0/met15,
lys2Δ0/lys2), SGS1/SGS1.V5.6xHIS, RAD51/RAD51.V5.3xVSV
2474 (ura3Δ0/ura3Δ0, leu2Δ0/leu2Δ0, his3Δ1/his3Δ1, met15Δ0/met15,
lys2Δ0/lys2), SGS1/SGS1.V5.6xHIS, RAD51/RAD51.V5.3xVSV
2475 (ura3Δ0/ura3Δ0, leu2Δ0/leu2Δ0, his3Δ1/his3Δ1, met15Δ0/met15,
lys2Δ0/lys2), SGS1/SGS1.V5.6xHIS, RAD51/RAD51.V5.3xVSV
2494 (ura3Δ0, leu2Δ0, his3Δ1, met15Δ0), RAD51.V5.6xHIS
2495 (ura3Δ0, leu2Δ0, his3Δ1, met15Δ0), TOP3.V5.6xHIS
2496 (ura3Δ0, leu2Δ0, his3Δ1, met15Δ0), MLH1.V5.6xHIS
2497 (ura3Δ0, leu2Δ0, his3Δ1, lys2Δ0), TOP3.V5.3xVSV.G418
2498 (ura3Δ0, leu2Δ0, his3Δ1, lys2Δ0), SGS1.V5.3xVSV
2499 (ura3Δ0, leu2Δ0, his3Δ1, lys2Δ0), MLH1.V5.3xVSV
2529 (ura3Δ0/ura3Δ0, leu2Δ0/leu2Δ0, his3Δ1/his3Δ1, met15Δ0/met15,
lys2Δ0/lys2), Rad51/Rad51.V5.6xHIS, Sgs1/Sgs1.V5.3xVSV
2530 (ura3Δ0/ura3Δ0, leu2Δ0/leu2Δ0, his3Δ1/his3Δ1, met15Δ0/met15,
lys2Δ0/lys2), Rad51/Rad51.V5.6xHIS, Sgs1/Sgs1.V5.3xVSV
2531 (ura3Δ0/ura3Δ0, leu2Δ0/leu2Δ0, his3Δ1/his3Δ1, met15Δ0/met15,
lys2Δ0/lys2), Rad51/Rad51.V5.6xHIS, Sgs1/Sgs1.V5.3xVSV
2532 (ura3Δ0/ura3Δ0, leu2Δ0/leu2Δ0, his3Δ1/his3Δ1, met15Δ0/met15,
lys2Δ0/lys2), Sgs1/Sgs1.V5.6xHIS, Top3/Top3.V5.3xVSV
2533 (ura3Δ0/ura3Δ0, leu2Δ0/leu2Δ0, his3Δ1/his3Δ1, met15Δ0/met15,
lys2Δ0/lys2), Sgs1/Sgs1.V5.6xHIS, Top3/Top3.V5.3xVSV
2534 (ura3Δ0/ura3Δ0, leu2Δ0/leu2Δ0, his3Δ1/his3Δ1, met15Δ0/met15,
lys2Δ0/lys2), Sgs1/Sgs1.V5.6xHIS, Top3/Top3.V5.3xVSV
2535 (ura3Δ0/ura3Δ0, leu2Δ0/leu2Δ0, his3Δ1/his3Δ1, met15Δ0/met15,
lys2Δ0/lys2), Sgs1/Sgs1.V5.6xHIS, Mlh1/Mlh1.V5.3xVSV
2536 (ura3Δ0/ura3Δ0, leu2Δ0/leu2Δ0, his3Δ1/his3Δ1, met15Δ0/met15,
lys2Δ0/lys2), Sgs1/Sgs1.V5.6xHIS, Mlh1/Mlh1.V5.3xVSV
2537 (ura3Δ0/ura3Δ0, leu2Δ0/leu2Δ0, his3Δ1/his3Δ1, met15Δ0/met15,
lys2Δ0/lys2), Sgs1/Sgs1.V5.6xHIS, Mlh1/Mlh1.V5.3xVSV
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2538 (ura3Δ0/ura3Δ0, leu2Δ0/leu2Δ0, his3Δ1/his3Δ1, met15Δ0/met15,
lys2Δ0/lys2), Top3/Top3.V5.6xHIS, Sgs1/Sgs1.V5.3xVSV
2539 (ura3Δ0/ura3Δ0, leu2Δ0/leu2Δ0, his3Δ1/his3Δ1, met15Δ0/met15,
lys2Δ0/lys2), Top3/Top3.V5.6xHIS, Sgs1/Sgs1.V5.3xVSV
2540 (ura3Δ0/ura3Δ0, leu2Δ0/leu2Δ0, his3Δ1/his3Δ1, met15Δ0/met15,
lys2Δ0/lys2), Top3/Top3.V5.6xHIS, Sgs1/Sgs1.V5.3xVSV
2541 (ura3Δ0/ura3Δ0, leu2Δ0/leu2Δ0, his3Δ1/his3Δ1, met15Δ0/met15,
lys2Δ0/lys2), Mlh1/Mlh1.V5.6xHIS, Sgs1/Sgs1.V5.3xVSV
2542 (ura3Δ0/ura3Δ0, leu2Δ0/leu2Δ0, his3Δ1/his3Δ1, met15Δ0/met15,
lys2Δ0/lys2), Mlh1/Mlh1.V5.6xHIS, Sgs1/Sgs1.V5.3xVSV
2543 (ura3Δ0/ura3Δ0, leu2Δ0/leu2Δ0, his3Δ1/his3Δ1, met15Δ0/met15,
lys2Δ0/lys2), Mlh1/Mlh1.V5.6xHIS, Sgs1/Sgs1.V5.3xVSV
2651 can1Δ::STE2pr-Sp_his5 lyp1Δ; his3Δ1 leu2Δ0 ura3Δ0 met15Δ0
2681 ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8.
YEL069C::URA3, SGS1.myc.HIS3
2682 ura3-52/ura3Δ0, leu2Δ1/leu2Δ0, trp1Δ63/trp1, his3Δ200/his3Δ1,
lys2ΔBgl/lys2Δ0, hom3-10/hom3, ade2Δ1/ade2, ade8/ade8.
YEL069C::URA3/YEL069C, sgs1C200.myc.his3/sgs1, top3.v5.6xHIS/top3
2683 ura3-52/ura3Δ0, leu2Δ1/leu2Δ0, trp1Δ63/trp1, his3Δ200/his3Δ1,
lys2ΔBgl/lys2Δ0, hom3-10/hom3, ade2Δ1/ade2, ade8/ade8.
YEL069C::URA3/YEL069C, sgs1C200.myc.his3/sgs1, top3.v5.6xHIS/top3
2684 ura3-52/ura3Δ0, leu2Δ1/leu2Δ0, trp1Δ63/trp1, his3Δ200/his3Δ1,
lys2ΔBgl/lys2Δ0, hom3-10/hom3, ade2Δ1/ade2, ade8/ade8.
YEL069C::URA3/YEL069C, sgs1C200.myc.his3/sgs1, mlh1.v5.6xHIS/mlh1
2685 ura3-52/ura3Δ0, leu2Δ1/leu2Δ0, trp1Δ63/trp1, his3Δ200/his3Δ1,
lys2ΔBgl/lys2Δ0, hom3-10/hom3, ade2Δ1/ade2, ade8/ade8.
YEL069C::URA3/YEL069C, sgs1C200.myc.his3/sgs1, mlh1.v5.6xHIS/mlh1
2686 ura3-52/ura3Δ0, leu2Δ1/leu2Δ0, trp1Δ63/trp1, his3Δ200/his3Δ1,
lys2ΔBgl/lys2Δ0, hom3-10/hom3, ade2Δ1/ade2, ade8/ade8.
YEL069C::URA3/YEL069C, sgs1C200.myc.his3/sgs1, rad51.v5.6xHIS/rad51
2687 ura3-52/ura3Δ0, leu2Δ1/leu2Δ0, trp1Δ63/trp1, his3Δ200/his3Δ1,
lys2ΔBgl/lys2Δ0, hom3-10/hom3, ade2Δ1/ade2, ade8/ade8.
YEL069C::URA3/YEL069C, sgs1C200.myc.his3/sgs1, rad51.v5.6xHIS/rad51
2946 ura3Δ0, leu2Δ0, his3Δ1, met15Δ0, RAD16.V5.6xHIS
2947 ura3Δ0, leu2Δ0, his3Δ1, met15Δ0, SRS2.V5.6xHIS
2948 ura3-52/ura3Δ0, leu2Δ1/leu2Δ0, trp1Δ63/trp1, his3Δ200/his3Δ1,
lys2ΔBgl/lys2Δ0, hom3-10/hom3, ade2Δ1/ade2, ade8/ade8.
YEL069C::URA3/YEL069C, sgs1C300.myc.his3/sgs1, mlh1.v5.6xHIS/mlh1
2949 ura3-52/ura3Δ0, leu2Δ1/leu2Δ0, trp1Δ63/trp1, his3Δ200/his3Δ1,
lys2ΔBgl/lys2Δ0, hom3-10/hom3, ade2Δ1/ade2, ade8/ade8.
YEL069C::URA3/YEL069C, sgs1C300.myc.his3/sgs1, mlh1.v5.6xHIS/mlh1
2950 ura3-52/ura3Δ0, leu2Δ1/leu2Δ0, trp1Δ63/trp1, his3Δ200/his3Δ1,
lys2ΔBgl/lys2Δ0, hom3-10/hom3, ade2Δ1/ade2, ade8/ade8.
YEL069C::URA3/YEL069C, sgs1C300.myc.his3/sgs1, top3.v5.6xHIS/top3
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2952 ura3-52/ura3Δ0, leu2Δ1/leu2Δ0, trp1Δ63/trp1, his3Δ200/his3Δ1,
lys2ΔBgl/lys2Δ0, hom3-10/hom3, ade2Δ1/ade2, ade8/ade8.
YEL069C::URA3/YEL069C, sgs1C300.myc.his3/sgs1, top3.v5.6xHIS/top3
2953 ura3-52/ura3Δ0, leu2Δ1/leu2Δ0, trp1Δ63/trp1, his3Δ200/his3Δ1,
lys2ΔBgl/lys2Δ0, hom3-10/hom3, ade2Δ1/ade2, ade8/ade8.
YEL069C::URA3/YEL069C, sgs1C300.myc.his3/sgs1, rad51.v5.6xHIS/rad51
2954 ura3-52/ura3Δ0, leu2Δ1/leu2Δ0, trp1Δ63/trp1, his3Δ200/his3Δ1,
lys2ΔBgl/lys2Δ0, hom3-10/hom3, ade2Δ1/ade2, ade8/ade8.
YEL069C::URA3/YEL069C, sgs1C300.myc.his3/sgs1, rad51.v5.6xHIS/rad51
2955 ura3-52/ura3-52, leu2Δ1/leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200,
lys2ΔBgl/lys2ΔBgl, hom3-10/hom3-10, ade2Δ1/ade2Δ1, ade8/ade8.
YEL069C::URA3/YEL069C::URA3, SGS1/sgs1C200.myc.HIS3
2956 ura3-52/ura3-52, leu2Δ1/leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200,
lys2ΔBgl/lys2ΔBgl, hom3-10/hom3-10, ade2Δ1/ade2Δ1, ade8/ade8.
YEL069C::URA3/YEL069C::URA3, SGS1/sgs1C200.myc.HIS3
2957 ura3-52/ura3-52, leu2Δ1/leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200,
lys2ΔBgl/lys2ΔBgl, hom3-10/hom3-10, ade2Δ1/ade2Δ1, ade8/ade8.
YEL069C::URA3/YEL069C::URA3, SGS1/sgs1C300.myc.HIS3
2958 ura3-52/ura3-52, leu2Δ1/leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200,
lys2ΔBgl/lys2ΔBgl, hom3-10/hom3-10, ade2Δ1/ade2Δ1, ade8/ade8.
YEL069C::URA3/YEL069C::URA3, SGS1/sgs1C300.myc.HIS3
2959 ura3-52/ura3-52, leu2Δ1/leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200,
lys2ΔBgl/lys2ΔBgl, hom3-10/hom3-10, ade2Δ1/ade2Δ1, ade8/ade8.
YEL069C::URA3/YEL069C::URA3, SGS1/sgs1.myc.HIS3,
MEC3/mec3::G418
2960 ura3-52/ura3-52, leu2Δ1/leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200,
lys2ΔBgl/lys2ΔBgl, hom3-10/hom3-10, ade2Δ1/ade2Δ1, ade8/ade8.
YEL069C::URA3/YEL069C::URA3, SGS1/sgs1.myc.HIS3,
MEC3/mec3::G418
2970 ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8.
YEL069C::URA3, sgs1.myc.His3
2971 ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8.
YEL069C::URA3, sgs1.myc.His3
2972 ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8.
YEL069C::URA3, sgs1C200.myc.HIS3
2973 ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8.
YEL069C::URA3, sgs1C300.myc.HIS3
2974 ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8.
YEL069C::URA3, sgs1C400.myc.HIS3
2975 ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8.
YEL069C::URA3, sgs1C500.myc.HIS3
2976 ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8.
YEL069C::URA3, sgs1C600.myc.HIS3
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2977 ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8.
YEL069C::URA3, sgs1C700.myc.HIS3
2978 ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8.
YEL069C::URA3, sgs1C800.myc.HIS3
2979 ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8.
YEL069C::URA3, sgs1C1428.myc.HIS3
2980 ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8.
YEL069C::URA3, SGS1.myc.HIS3
2981 ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8.
YEL069C::URA3, SGS1.myc.HIS3
2982 ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8.
YEL069C::URA3, SGS1.myc.HIS3
2983 ura3-52/ura3-52, leu2Δ1/leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200,
lys2ΔBgl/lys2ΔBgl, hom3-10/hom3-10, ade2Δ1/ade2Δ1, ade8/ade8.
YEL069C::URA3/YEL069C::URA3, SGS1/sgs1.myc.HIS3
2984 ura3-52/ura3-52, leu2Δ1/leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200,
lys2ΔBgl/lys2ΔBgl, hom3-10/hom3-10, ade2Δ1/ade2Δ1, ade8/ade8.
YEL069C::URA3/YEL069C::URA3, SGS1/sgs1.myc.HIS3
2985 ura3-52/ura3-52, leu2Δ1/leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200,
lys2ΔBgl/lys2ΔBgl, hom3-10/hom3-10, ade2Δ1/ade2Δ1, ade8/ade8.
YEL069C::URA3/YEL069C::URA3, SGS1/sgs1.myc.HIS3
2986 ura3-52/ura3-52, leu2Δ1/leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200,
lys2ΔBgl/lys2ΔBgl, hom3-10/hom3-10, ade2Δ1/ade2Δ1, ade8/ade8.
YEL069C::URA3/YEL069C::URA3, SGS1/sgs1.myc.HIS3
2987 ura3-52/ura3Δ0, leu2Δ1/leu2Δ0, trp1Δ63/trp1, his3Δ200/his3Δ1,
lys2ΔBgl/lys2Δ0, hom3-10/hom3, ade2Δ1/ade2, ade8/ade8.
YEL069C::URA3/YEL069C, sgs1.myc.his3/sgs1, rad51.v5.6xHIS/rad51
2988 ura3-52/ura3Δ0, leu2Δ1/leu2Δ0, trp1Δ63/trp1, his3Δ200/his3Δ1,
lys2ΔBgl/lys2Δ0, hom3-10/hom3, ade2Δ1/ade2, ade8/ade8.
YEL069C::URA3/YEL069C, sgs1.myc.his3/sgs1, rad51.v5.6xHIS/rad51
2989 ura3-52/ura3Δ0, leu2Δ1/leu2Δ0, trp1Δ63/trp1, his3Δ200/his3Δ1,
lys2ΔBgl/lys2Δ0, hom3-10/hom3, ade2Δ1/ade2, ade8/ade8.
YEL069C::URA3/YEL069C, sgs1.myc.his3/sgs1, mlh1.v5.6xHIS/mlh1
2990 ura3-52/ura3Δ0, leu2Δ1/leu2Δ0, trp1Δ63/trp1, his3Δ200/his3Δ1,
lys2ΔBgl/lys2Δ0, hom3-10/hom3, ade2Δ1/ade2, ade8/ade8.
YEL069C::URA3/YEL069C, sgs1.myc.his3/sgs1, mlh1.v5.6xHIS/mlh1
2991 ura3-52/ura3Δ0, leu2Δ1/leu2Δ0, trp1Δ63/trp1, his3Δ200/his3Δ1,
lys2ΔBgl/lys2Δ0, hom3-10/hom3, ade2Δ1/ade2, ade8/ade8.
YEL069C::URA3/YEL069C, sgs1.myc.his3/sgs1, top3.v5.6xHIS/top3
2992 ura3-52/ura3Δ0, leu2Δ1/leu2Δ0, trp1Δ63/trp1, his3Δ200/his3Δ1,
lys2ΔBgl/lys2Δ0, hom3-10/hom3, ade2Δ1/ade2, ade8/ade8.
YEL069C::URA3/YEL069C, sgs1.myc.his3/sgs1, top3.v5.6xHIS/top3
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2993 ura3-52/ura3Δ0, leu2Δ1/leu2Δ0, trp1Δ63/trp1, his3Δ200/his3Δ1,
lys2ΔBgl/lys2Δ0, hom3-10/hom3, ade2Δ1/ade2, ade8/ade8.
YEL069C::URA3/YEL069C, sgs1.myc.his3/sgs1, srs2.v5.6xHIS/srs2
2994 ura3-52/ura3Δ0, leu2Δ1/leu2Δ0, trp1Δ63/trp1, his3Δ200/his3Δ1,
lys2ΔBgl/lys2Δ0, hom3-10/hom3, ade2Δ1/ade2, ade8/ade8.
YEL069C::URA3/YEL069C, sgs1.myc.his3/sgs1, srs2.v5.6xHIS/srs2
2995 ura3-52/ura3Δ0, leu2Δ1/leu2Δ0, trp1Δ63/trp1, his3Δ200/his3Δ1,
lys2ΔBgl/lys2Δ0, hom3-10/hom3, ade2Δ1/ade2, ade8/ade8.
YEL069C::URA3/YEL069C, sgs1.myc.his3/sgs1, rad16.v5.6xHIS/rad16
2996 ura3-52/ura3Δ0, leu2Δ1/leu2Δ0, trp1Δ63/trp1, his3Δ200/his3Δ1,
lys2ΔBgl/lys2Δ0, hom3-10/hom3, ade2Δ1/ade2, ade8/ade8.
YEL069C::URA3/YEL069C, sgs1.myc.his3/sgs1, rad16.v5.6xHIS/rad16
2997 ura3-52/ura3Δ0, leu2Δ1/leu2Δ0, trp1Δ63/trp1, his3Δ200/his3Δ1,
lys2ΔBgl/lys2Δ0, hom3-10/hom3, ade2Δ1/ade2, ade8/ade8.
YEL069C::URA3/YEL069C, sgs1C200.myc.his3/sgs1, srs2.v5.6xHIS/srs2
2998 ura3-52/ura3Δ0, leu2Δ1/leu2Δ0, trp1Δ63/trp1, his3Δ200/his3Δ1,
lys2ΔBgl/lys2Δ0, hom3-10/hom3, ade2Δ1/ade2, ade8/ade8.
YEL069C::URA3/YEL069C, sgs1C200.myc.his3/sgs1, srs2.v5.6xHIS/srs2
2999 ura3-52/ura3Δ0, leu2Δ1/leu2Δ0, trp1Δ63/trp1, his3Δ200/his3Δ1,
lys2ΔBgl/lys2Δ0, hom3-10/hom3, ade2Δ1/ade2, ade8/ade8.
YEL069C::URA3/YEL069C, sgs1C200.myc.his3/sgs1, rad16.v5.6xHIS/rad16
3000 ura3-52/ura3Δ0, leu2Δ1/leu2Δ0, trp1Δ63/trp1, his3Δ200/his3Δ1,
lys2ΔBgl/lys2Δ0, hom3-10/hom3, ade2Δ1/ade2, ade8/ade8.
YEL069C::URA3/YEL069C, sgs1C200.myc.his3/sgs1, rad16.v5.6xHIS/rad16
3001 ura3-52/ura3Δ0, leu2Δ1/leu2Δ0, trp1Δ63/trp1, his3Δ200/his3Δ1,
lys2ΔBgl/lys2Δ0, hom3-10/hom3, ade2Δ1/ade2, ade8/ade8.
YEL069C::URA3/YEL069C, sgs1C300.myc.his3/sgs1, srs2.v5.6xHIS/srs2
3002 ura3-52/ura3Δ0, leu2Δ1/leu2Δ0, trp1Δ63/trp1, his3Δ200/his3Δ1,
lys2ΔBgl/lys2Δ0, hom3-10/hom3, ade2Δ1/ade2, ade8/ade8.
YEL069C::URA3/YEL069C, sgs1C300.myc.his3/sgs1, srs2.v5.6xHIS/srs2
3003 ura3-52/ura3Δ0, leu2Δ1/leu2Δ0, trp1Δ63/trp1, his3Δ200/his3Δ1,
lys2ΔBgl/lys2Δ0, hom3-10/hom3, ade2Δ1/ade2, ade8/ade8.
YEL069C::URA3/YEL069C, sgs1C300.myc.his3/sgs1, rad16.v5.6xHIS/rad16
3004 ura3-52/ura3Δ0, leu2Δ1/leu2Δ0, trp1Δ63/trp1, his3Δ200/his3Δ1,
lys2ΔBgl/lys2Δ0, hom3-10/hom3, ade2Δ1/ade2, ade8/ade8.
YEL069C::URA3/YEL069C, sgs1C300.myc.his3/sgs1, rad16.v5.6xHIS/rad16
3130 MATa, trp1-901, leu2-3, 112, ura3-52, his3-200, gal4Δ, gal80Δ,
lys2::Gal1uas-Gal1tata-HIS3, GAL2uas-GAL2tata-ADE2, URA3::MEL1uasMEL1tata-lacZ
3467 ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8.
YEL069C::URA3, sgs1C200.myc.HIS3
3468 ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8.
YEL069C::URA3, sgs1C200.myc.HIS3
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3469 ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8.
YEL069C::URA3, sgs1C200.myc.HIS3
3470 ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8.
YEL069C::URA3, sgs1C220.myc.HIS3
3471 ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8.
YEL069C::URA3, sgs1C220.myc.HIS3
3472 ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8.
YEL069C::URA3, sgs1C220.myc.HIS3
3473 ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8.
YEL069C::URA3, sgs1C240.myc.HIS3
3474 ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8.
YEL069C::URA3, sgs1C240.myc.HIS3
3475 ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8.
YEL069C::URA3, sgs1C240.myc.HIS3
3476 ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8.
YEL069C::URA3, sgs1C260.myc.HIS3
3477 ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8.
YEL069C::URA3, sgs1C260.myc.HIS3
3478 ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8.
YEL069C::URA3, sgs1C260.myc.HIS3
3479 ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8.
YEL069C::URA3, sgs1C280.myc.HIS3
3480 ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8.
YEL069C::URA3, sgs1C280.myc.HIS3
3481 ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8.
YEL069C::URA3, sgs1C280.myc.HIS3
3482 ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8.
YEL069C::URA3, sgs1C300.myc.HIS3
3483 ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8.
YEL069C::URA3, sgs1C300.myc.HIS3
3484 ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8.
YEL069C::URA3, sgs1C300.myc.HIS3
3485 ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8.
YEL069C::URA3, sgs1C400.myc.HIS3
3486 ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8.
YEL069C::URA3, sgs1C400.myc.HIS3
3487 ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8.
YEL069C::URA3, sgs1C400.myc.HIS3
3488 ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8.
YEL069C::URA3, sgs1C500.myc.HIS3
3489 ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8.
YEL069C::URA3, sgs1C500.myc.HIS3
3490 ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8.
YEL069C::URA3, sgs1C500.myc.HIS3
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3491 ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8.
YEL069C::URA3, sgs1C600.myc.HIS3
3492 ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8.
YEL069C::URA3, sgs1C600.myc.HIS3
3493 ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8.
YEL069C::URA3, sgs1C600.myc.HIS3
3494 ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8.
YEL069C::URA3, sgs1C700.myc.HIS3
3495 ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8.
YEL069C::URA3, sgs1C700.myc.HIS3
3496 ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8.
YEL069C::URA3, sgs1C700.myc.HIS3
3497 ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8.
YEL069C::URA3, sgs1C800.myc.HIS3
3498 ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8.
YEL069C::URA3, sgs1C800.myc.HIS3
3499 ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8.
YEL069C::URA3, sgs1C800.myc.HIS3
3500 ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8.
YEL069C::URA3, sgs1C900.myc.HIS3
3501 ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8.
YEL069C::URA3, sgs1C900.myc.HIS3
3502 ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8.
YEL069C::URA3, sgs1C1000.myc.HIS3
3503 ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8.
YEL069C::URA3, sgs1C1000.myc.HIS3
3504 ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8.
YEL069C::URA3, sgs1C1100.myc.HIS3
3505 ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8.
YEL069C::URA3, sgs1C1100.myc.HIS3
3506 ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8.
YEL069C::URA3, sgs1C1100.myc.HIS3
3507 ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8.
YEL069C::URA3, sgs1C1428.myc.HIS3
3508 ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8.
YEL069C::URA3, sgs1C1428.myc.HIS3
3509 ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8.
YEL069C::URA3, sgs1C1428.myc.HIS3
3510 ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8.
YEL069C::URA3, Pgal.TRP1.SGS1.myc.HIS3
3511 ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8.
YEL069C::URA3, Pgal.TRP1.SGS1.myc.HIS3
3512 ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8.
YEL069C::URA3, Pgal.TRP1.SGS1.myc.HIS3
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3513 ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8.
YEL069C::URA3, sgs1C1047F.TRP1
3514 ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8.
YEL069C::URA3, sgs1C1047F.TRP1
3515 ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8.
YEL069C::URA3, sgs1C1047F.TRP1
3516 ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8.
YEL069C::URA3, sgs1F1056A.TRP1
3517 ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8.
YEL069C::URA3, sgs1C1047F.myc.HIS3
3518 ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8.
YEL069C::URA3, sgs1C1047F.myc.HIS3
3519 ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8.
YEL069C::URA3, sgs1C1047F.myc.HIS3
3520 ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8.
YEL069C::URA3, sgs1F1056A.myc.HIS3
3521 ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8.
YEL069C::URA3, sgs1F1056A.myc.HIS3
3522 ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8.
YEL069C::URA3, sgs1F1056A.myc.HIS3
3543 ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8.
YEL069C::URA3, sgs1ΔC800-blmΔN647.MYC.TRP1
3544 ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8.
YEL069C::URA3, sgs1ΔC800-blmΔN647.MYC.TRP1
3545 ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8.
YEL069C::URA3, Pgal.G418.BLM.MYC.TRP1
3546 ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8.
YEL069C::URA3, Pgal.G418.BLM.MYC.TRP1
3547 ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8.
YEL069C::URA3, Pgal.G418.BLM.MYC.TRP1
3558 MATa trp1-901 leu2-3,112 ura3-52 his3-200 gal4Δ gal80Δ LYS2::GAL1-HIS3
GAL2-ADE2 met2::GAL7-lacZ
3559 trp1-901 leu2-3,112 ura3-52 his3-200 gal4∆ gal80∆ LYS2::GAL1-HIS3 GAL2ADE2 met2::GAL7-lacZ
3560 MATalpha trp1-901 leu2-3,112 ura3-52 his3-200 gal4∆ gal80∆ LYS2::GAL1HIS3 GAL2-ADE2 met2::GAL7-lacZ, pBDC
3777 MATa ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1,
ade8. YEL069C::URA3, sgs1::RECQL5.HIS3
3778 MATa ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1,
ade8. YEL069C::URA3, sgs1::RECQL5.HIS3
3779 MATa ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1,
ade8. YEL069C::URA3, sgs1::RECQL5.HIS3
3827 MATa ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1,
ade8. YEL069C::URA3, sgs1::TRP1.PGAL1.RECQL5.HIS3
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3828 MATa ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1,
ade8. YEL069C::URA3, sgs1::TRP1.PGAL1.RECQL5.HIS3
3829 MATa ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1,
ade8. YEL069C::URA3, sgs1::TRP1.PGAL1.RECQL5.HIS3
3925 Y258 pep4-3, his4-580, ura3-53, leu2-3, 112
3926 Y258 is MATa pep4-3, his4-580, ura3-53, leu2-3, 112
3927 Y258 is MATa pep4-3, his4-580, ura3-53, leu2-3, 112 Mgs1
3928 Y258 is MATa pep4-3, his4-580, ura3-53, leu2-3, 112 Exo1
3929 Y258 is MATa pep4-3, his4-580, ura3-53, leu2-3, 112 Sgs1
3930 Empty pOAD vector in 3558
3983 trp1-901 leu2-3,112 ura3-52 his3-200 gal4∆ gal80∆ LYS2::GAL1-HIS3 GAL2ADE2 met2::GAL7-lacZ pOAD (empty) vector is in this strain
3984 trp1-901 leu2-3,112 ura3-52 his3-200 gal4∆ gal80∆ LYS2::GAL1-HIS3 GAL2ADE2 met2::GAL7-lacZ Mec3 in pOAD
3985 trp1-901 leu2-3,112 ura3-52 his3-200 gal4∆ gal80∆ LYS2::GAL1-HIS3 GAL2ADE2 met2::GAL7-lacZ
3986 trp1-901 leu2-3,112 ura3-52 his3-200 gal4∆ gal80∆ LYS2::GAL1-HIS3
GAL2-ADE2 met2::GAL7-lacZ
pOBD vector in this strain
3987 trp1-901 leu2-3,112 ura3-52 his3-200 gal4∆ gal80∆ LYS2::GAL1-HIS3
GAL2-ADE2 met2::GAL7-lacZ
Rad17 in pOBD
3988 trp1-901 leu2-3,112 ura3-52 his3-200 gal4∆ gal80∆ LYS2::GAL1-HIS3 GAL2ADE2 met2::GAL7-lacZ
4062 his3, trp1, ura3-52, lex(leu2)3a
4107 MATa, trp1-901, leu2-3, 112, ura3-52, his3-200, gal4Δ, gal80Δ,
lys2::Gal1uas-Gal1tata-HIS3, GAL2uas-GAL2tata-ADE2, URA3::MEL1uasMEL1tata-lacZ SGS1 647-1447 in pBDC
4108 MATa, trp1-901, leu2-3, 112, ura3-52, his3-200, gal4Δ, gal80Δ,
lys2::Gal1uas-Gal1tata-HIS3, GAL2uas-GAL2tata-ADE2, URA3::MEL1uasMEL1tata-lacZ SGS1 647-1447 in pBDC
4109 MATa, trp1-901, leu2-3, 112, ura3-52, his3-200, gal4Δ, gal80Δ,
lys2::Gal1uas-Gal1tata-HIS3, GAL2uas-GAL2tata-ADE2, URA3::MEL1uasMEL1tata-lacZ SGS1 1-347 in pBDC
4110 MATa, trp1-901, leu2-3, 112, ura3-52, his3-200, gal4Δ, gal80Δ,
lys2::Gal1uas-Gal1tata-HIS3, GAL2uas-GAL2tata-ADE2, URA3::MEL1uasMEL1tata-lacZ SGS1 1-347 in pBDC
4111 MATa, trp1-901, leu2-3, 112, ura3-52, his3-200, gal4Δ, gal80Δ,
lys2::Gal1uas-Gal1tata-HIS3, GAL2uas-GAL2tata-ADE2, URA3::MEL1uasMEL1tata-lacZ SGS1 1-265 in pBDC
4112 MATa, trp1-901, leu2-3, 112, ura3-52, his3-200, gal4Δ, gal80Δ,
lys2::Gal1uas-Gal1tata-HIS3, GAL2uas-GAL2tata-ADE2, URA3::MEL1uasMEL1tata-lacZ SGS1 1-265 in pBDC
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4113 MATa, trp1-901, leu2-3, 112, ura3-52, his3-200, gal4Δ, gal80Δ,
lys2::Gal1uas-Gal1tata-HIS3, GAL2uas-GAL2tata-ADE2, URA3::MEL1uasMEL1tata-lacZ SGS1 1-265 in pBDC
4114 MATa, trp1-901, leu2-3, 112, ura3-52, his3-200, gal4Δ, gal80Δ,
lys2::Gal1uas-Gal1tata-HIS3, GAL2uas-GAL2tata-ADE2, URA3::MEL1uasMEL1tata-lacZ SGS1 1-265 in pBDC
4115 MATa, trp1-901, leu2-3, 112, ura3-52, his3-200, gal4Δ, gal80Δ,
lys2::Gal1uas-Gal1tata-HIS3, GAL2uas-GAL2tata-ADE2, URA3::MEL1uasMEL1tata-lacZ SGS1 1-187 in pBDC
4116 MATa, trp1-901, leu2-3, 112, ura3-52, his3-200, gal4Δ, gal80Δ,
lys2::Gal1uas-Gal1tata-HIS3, GAL2uas-GAL2tata-ADE2, URA3::MEL1uasMEL1tata-lacZ SGS1 1-187 in pBDC
4117 MATa, trp1-901, leu2-3, 112, ura3-52, his3-200, gal4Δ, gal80Δ,
lys2::Gal1uas-Gal1tata-HIS3, GAL2uas-GAL2tata-ADE2, URA3::MEL1uasMEL1tata-lacZ SGS1 1-187 in pBDC
4118 MATa, trp1-901, leu2-3, 112, ura3-52, his3-200, gal4Δ, gal80Δ,
lys2::Gal1uas-Gal1tata-HIS3, GAL2uas-GAL2tata-ADE2, URA3::MEL1uasMEL1tata-lacZ SGS1 1-187 in pBDC
4119 MATa, trp1-901, leu2-3, 112, ura3-52, his3-200, gal4Δ, gal80Δ,
lys2::Gal1uas-Gal1tata-HIS3, GAL2uas-GAL2tata-ADE2, URA3::MEL1uasMEL1tata-lacZ SGS1 1-100 in pBDC
4120 MATa, trp1-901, leu2-3, 112, ura3-52, his3-200, gal4Δ, gal80Δ,
lys2::Gal1uas-Gal1tata-HIS3, GAL2uas-GAL2tata-ADE2, URA3::MEL1uasMEL1tata-lacZ SGS1 1-100 in pBDC
4121 MATa, trp1-901, leu2-3, 112, ura3-52, his3-200, gal4Δ, gal80Δ,
lys2::Gal1uas-Gal1tata-HIS3, GAL2uas-GAL2tata-ADE2, URA3::MEL1uasMEL1tata-lacZ SGS1 1-100 in pBDC
4122 MATa, trp1-901, leu2-3, 112, ura3-52, his3-200, gal4Δ, gal80Δ,
lys2::Gal1uas-Gal1tata-HIS3, GAL2uas-GAL2tata-ADE2, URA3::MEL1uasMEL1tata-lacZ SGS1 1-100 in pBDC
4123 MATa, trp1-901, leu2-3, 112, ura3-52, his3-200, gal4Δ, gal80Δ,
lys2::Gal1uas-Gal1tata-HIS3, GAL2uas-GAL2tata-ADE2, URA3::MEL1uasMEL1tata-lacZ SGS1 1-100 in pBDC
4124 MATa, trp1-901, leu2-3, 112, ura3-52, his3-200, gal4Δ, gal80Δ,
lys2::Gal1uas-Gal1tata-HIS3, GAL2uas-GAL2tata-ADE2, URA3::MEL1uasMEL1tata-lacZ SGS1 1-100 in pBDC
4125 MATa, trp1-901, leu2-3, 112, ura3-52, his3-200, gal4Δ, gal80Δ,
lys2::Gal1uas-Gal1tata-HIS3, GAL2uas-GAL2tata-ADE2, URA3::MEL1uasMEL1tata-lacZ SGS1 1-100 in pBDC
4126 MATa, trp1-901, leu2-3, 112, ura3-52, his3-200, gal4Δ, gal80Δ,
lys2::Gal1uas-Gal1tata-HIS3, GAL2uas-GAL2tata-ADE2, URA3::MEL1uasMEL1tata-lacZ SGS1 1-100 in pBDC
4156 trp1-901 leu2-3,112 ura3-52 his3-200 gal4∆ gal80∆ LYS2::GAL1-HIS3 GAL2ADE2 met2::GAL7-lacZ SGS1 647-1447 in pBDC
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4157 trp1-901 leu2-3,112 ura3-52 his3-200 gal4∆ gal80∆ LYS2::GAL1-HIS3 GAL2ADE2 met2::GAL7-lacZ SGS1 647-1447 in pBDC
4158 trp1-901 leu2-3,112 ura3-52 his3-200 gal4∆ gal80∆ LYS2::GAL1-HIS3 GAL2ADE2 met2::GAL7-lacZ SGS1 1-265 in pBDC
4159 trp1-901 leu2-3,112 ura3-52 his3-200 gal4∆ gal80∆ LYS2::GAL1-HIS3 GAL2ADE2 met2::GAL7-lacZ SGS1 1-265 in pBDC
4160 trp1-901 leu2-3,112 ura3-52 his3-200 gal4∆ gal80∆ LYS2::GAL1-HIS3 GAL2ADE2 met2::GAL7-lacZ SGS1 1-265 in pBDC
4161 trp1-901 leu2-3,112 ura3-52 his3-200 gal4∆ gal80∆ LYS2::GAL1-HIS3 GAL2ADE2 met2::GAL7-lacZ SGS1 1-265 in pBDC
4162 trp1-901 leu2-3,112 ura3-52 his3-200 gal4∆ gal80∆ LYS2::GAL1-HIS3 GAL2ADE2 met2::GAL7-lacZ SGS1 1-187 in pBDC
4163 trp1-901 leu2-3,112 ura3-52 his3-200 gal4∆ gal80∆ LYS2::GAL1-HIS3 GAL2ADE2 met2::GAL7-lacZ SGS1 1-187 in pBDC
4164 trp1-901 leu2-3,112 ura3-52 his3-200 gal4∆ gal80∆ LYS2::GAL1-HIS3 GAL2ADE2 met2::GAL7-lacZ SGS1 1-187 in pBDC
4165 trp1-901 leu2-3,112 ura3-52 his3-200 gal4∆ gal80∆ LYS2::GAL1-HIS3 GAL2ADE2 met2::GAL7-lacZ SGS1 1-187 in pBDC
4166 trp1-901 leu2-3,112 ura3-52 his3-200 gal4∆ gal80∆ LYS2::GAL1-HIS3 GAL2ADE2 met2::GAL7-lacZ SGS1 1-100 in pBDC
4167 trp1-901 leu2-3,112 ura3-52 his3-200 gal4∆ gal80∆ LYS2::GAL1-HIS3 GAL2ADE2 met2::GAL7-lacZ SGS1 1-100 in pBDC
4168 trp1-901 leu2-3,112 ura3-52 his3-200 gal4∆ gal80∆ LYS2::GAL1-HIS3 GAL2ADE2 met2::GAL7-lacZ SGS1 1-100 in pBDC
4169 trp1-901 leu2-3,112 ura3-52 his3-200 gal4∆ gal80∆ LYS2::GAL1-HIS3 GAL2ADE2 met2::GAL7-lacZ SGS1 1-100 in pBDC
4170 trp1-901 leu2-3,112 ura3-52 his3-200 gal4∆ gal80∆ LYS2::GAL1-HIS3 GAL2ADE2 met2::GAL7-lacZ SGS1 1-100 in pBDC
4171 trp1-901 leu2-3,112 ura3-52 his3-200 gal4∆ gal80∆ LYS2::GAL1-HIS3 GAL2ADE2 met2::GAL7-lacZ SGS1 1-100 in pBDC
4172 trp1-901 leu2-3,112 ura3-52 his3-200 gal4∆ gal80∆ LYS2::GAL1-HIS3 GAL2ADE2 met2::GAL7-lacZ SGS1 1-100 in pBDC
4173 trp1-901 leu2-3,112 ura3-52 his3-200 gal4∆ gal80∆ LYS2::GAL1-HIS3 GAL2ADE2 met2::GAL7-lacZ SGS1 1-100 in pBDC
4174 trp1-901 leu2-3,112 ura3-52 his3-200 gal4∆ gal80∆ LYS2::GAL1-HIS3 GAL2ADE2 met2::GAL7-lacZ SGS1 1-187 in pBDC
4175 trp1-901 leu2-3,112 ura3-52 his3-200 gal4∆ gal80∆ LYS2::GAL1-HIS3 GAL2ADE2 met2::GAL7-lacZ SGS1 1-187 in pBDC
4176 trp1-901 leu2-3,112 ura3-52 his3-200 gal4∆ gal80∆ LYS2::GAL1-HIS3 GAL2ADE2 met2::GAL7-lacZ SGS1 1-100 in pBDC
4177 trp1-901 leu2-3,112 ura3-52 his3-200 gal4∆ gal80∆ LYS2::GAL1-HIS3 GAL2ADE2 met2::GAL7-lacZ SGS1 1-100 in pBDC
4178 trp1-901 leu2-3,112 ura3-52 his3-200 gal4∆ gal80∆ LYS2::GAL1-HIS3 GAL2ADE2 met2::GAL7-lacZ SGS1 1-100 in pBDC
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4179 MATa, trp1-901, leu2-3, 112, ura3-52, his3-200, gal4Δ, gal80Δ,
lys2::Gal1uas-Gal1tata-HIS3, GAL2uas-GAL2tata-ADE2, URA3::MEL1uasMEL1tata-lacZ SGS1 647-1447 in pBDC
4180 MATa, trp1-901, leu2-3, 112, ura3-52, his3-200, gal4Δ, gal80Δ,
lys2::Gal1uas-Gal1tata-HIS3, GAL2uas-GAL2tata-ADE2, URA3::MEL1uasMEL1tata-lacZ SGS1 1-347 in pBDC
4181 MATa, trp1-901, leu2-3, 112, ura3-52, his3-200, gal4Δ, gal80Δ,
lys2::Gal1uas-Gal1tata-HIS3, GAL2uas-GAL2tata-ADE2, URA3::MEL1uasMEL1tata-lacZ SGS1 1-265 in pBDC
4182 MATa, trp1-901, leu2-3, 112, ura3-52, his3-200, gal4Δ, gal80Δ,
lys2::Gal1uas-Gal1tata-HIS3, GAL2uas-GAL2tata-ADE2, URA3::MEL1uasMEL1tata-lacZ SGS1 1-187 in pBDC
4183 MATa, trp1-901, leu2-3, 112, ura3-52, his3-200, gal4Δ, gal80Δ,
lys2::Gal1uas-Gal1tata-HIS3, GAL2uas-GAL2tata-ADE2, URA3::MEL1uasMEL1tata-lacZ SGS1 1-187 in pBDC
4184 MATa, trp1-901, leu2-3, 112, ura3-52, his3-200, gal4Δ, gal80Δ,
lys2::Gal1uas-Gal1tata-HIS3, GAL2uas-GAL2tata-ADE2, URA3::MEL1uasMEL1tata-lacZ SGS1 1-100 in pBDC
4185 MATa, trp1-901, leu2-3, 112, ura3-52, his3-200, gal4Δ, gal80Δ,
lys2::Gal1uas-Gal1tata-HIS3, GAL2uas-GAL2tata-ADE2, URA3::MEL1uasMEL1tata-lacZ SGS1 1-100 in pBDC
4186 MATa, trp1-901, leu2-3, 112, ura3-52, his3-200, gal4Δ, gal80Δ,
lys2::Gal1uas-Gal1tata-HIS3, GAL2uas-GAL2tata-ADE2, URA3::MEL1uasMEL1tata-lacZ SGS1 1-100 in pBDC
4187 MATa, trp1-901, leu2-3, 112, ura3-52, his3-200, gal4Δ, gal80Δ,
lys2::Gal1uas-Gal1tata-HIS3, GAL2uas-GAL2tata-ADE2, URA3::MEL1uasMEL1tata-lacZ SGS1 1-100 in pBDC
4188 MATa, trp1-901, leu2-3, 112, ura3-52, his3-200, gal4Δ, gal80Δ,
lys2::Gal1uas-Gal1tata-HIS3, GAL2uas-GAL2tata-ADE2, URA3::MEL1uasMEL1tata-lacZ SGS1 647-1447 in pBDC and empty pOAD
4189 MATa, trp1-901, leu2-3, 112, ura3-52, his3-200, gal4Δ, gal80Δ,
lys2::Gal1uas-Gal1tata-HIS3, GAL2uas-GAL2tata-ADE2, URA3::MEL1uasMEL1tata-lacZ SGS1 647-1447 in pBDC and empty pOAD
4190 MATa, trp1-901, leu2-3, 112, ura3-52, his3-200, gal4Δ, gal80Δ,
lys2::Gal1uas-Gal1tata-HIS3, GAL2uas-GAL2tata-ADE2, URA3::MEL1uasMEL1tata-lacZ SGS1 1-347 in pBDC and empty pOAD
4191 MATa, trp1-901, leu2-3, 112, ura3-52, his3-200, gal4Δ, gal80Δ,
lys2::Gal1uas-Gal1tata-HIS3, GAL2uas-GAL2tata-ADE2, URA3::MEL1uasMEL1tata-lacZ SGS1 1-347 in pBDC and empty pOAD
4192 MATa, trp1-901, leu2-3, 112, ura3-52, his3-200, gal4Δ, gal80Δ,
lys2::Gal1uas-Gal1tata-HIS3, GAL2uas-GAL2tata-ADE2, URA3::MEL1uasMEL1tata-lacZ SGS1 1-265 in pBDC and empty pOAD
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4193 MATa, trp1-901, leu2-3, 112, ura3-52, his3-200, gal4Δ, gal80Δ,
lys2::Gal1uas-Gal1tata-HIS3, GAL2uas-GAL2tata-ADE2, URA3::MEL1uasMEL1tata-lacZ SGS1 1-265 in pBDC and empty pOAD
4194 MATa, trp1-901, leu2-3, 112, ura3-52, his3-200, gal4Δ, gal80Δ,
lys2::Gal1uas-Gal1tata-HIS3, GAL2uas-GAL2tata-ADE2, URA3::MEL1uasMEL1tata-lacZ SGS1 1-265 in pBDC and empty pOAD
4195 MATa, trp1-901, leu2-3, 112, ura3-52, his3-200, gal4Δ, gal80Δ,
lys2::Gal1uas-Gal1tata-HIS3, GAL2uas-GAL2tata-ADE2, URA3::MEL1uasMEL1tata-lacZ SGS1 1-265 in pBDC and empty pOAD
4196 MATa, trp1-901, leu2-3, 112, ura3-52, his3-200, gal4Δ, gal80Δ,
lys2::Gal1uas-Gal1tata-HIS3, GAL2uas-GAL2tata-ADE2, URA3::MEL1uasMEL1tata-lacZ SGS1 1-187 in pBDC and empty pOAD
4197 MATa, trp1-901, leu2-3, 112, ura3-52, his3-200, gal4Δ, gal80Δ,
lys2::Gal1uas-Gal1tata-HIS3, GAL2uas-GAL2tata-ADE2, URA3::MEL1uasMEL1tata-lacZ SGS1 1-187 in pBDC and empty pOAD
4198 MATa, trp1-901, leu2-3, 112, ura3-52, his3-200, gal4Δ, gal80Δ,
lys2::Gal1uas-Gal1tata-HIS3, GAL2uas-GAL2tata-ADE2, URA3::MEL1uasMEL1tata-lacZ SGS1 1-187 in pBDC and empty pOAD
4199 MATa, trp1-901, leu2-3, 112, ura3-52, his3-200, gal4Δ, gal80Δ,
lys2::Gal1uas-Gal1tata-HIS3, GAL2uas-GAL2tata-ADE2, URA3::MEL1uasMEL1tata-lacZ SGS1 1-187 in pBDC and empty pOAD
4200 MATa, trp1-901, leu2-3, 112, ura3-52, his3-200, gal4Δ, gal80Δ,
lys2::Gal1uas-Gal1tata-HIS3, GAL2uas-GAL2tata-ADE2, URA3::MEL1uasMEL1tata-lacZ SGS1 1-100 in pBDC and empty pOAD
4201 MATa, trp1-901, leu2-3, 112, ura3-52, his3-200, gal4Δ, gal80Δ,
lys2::Gal1uas-Gal1tata-HIS3, GAL2uas-GAL2tata-ADE2, URA3::MEL1uasMEL1tata-lacZ SGS1 1-100 in pBDC and empty pOAD
4202 MATa, trp1-901, leu2-3, 112, ura3-52, his3-200, gal4Δ, gal80Δ,
lys2::Gal1uas-Gal1tata-HIS3, GAL2uas-GAL2tata-ADE2, URA3::MEL1uasMEL1tata-lacZ SGS1 1-100 in pBDC and empty pOAD
4203 MATa, trp1-901, leu2-3, 112, ura3-52, his3-200, gal4Δ, gal80Δ,
lys2::Gal1uas-Gal1tata-HIS3, GAL2uas-GAL2tata-ADE2, URA3::MEL1uasMEL1tata-lacZ SGS1 1-100 in pBDC and empty pOAD
4204 MATa, trp1-901, leu2-3, 112, ura3-52, his3-200, gal4Δ, gal80Δ,
lys2::Gal1uas-Gal1tata-HIS3, GAL2uas-GAL2tata-ADE2, URA3::MEL1uasMEL1tata-lacZ SGS1 1-100 in pBDC and empty pOAD
4205 MATa, trp1-901, leu2-3, 112, ura3-52, his3-200, gal4Δ, gal80Δ,
lys2::Gal1uas-Gal1tata-HIS3, GAL2uas-GAL2tata-ADE2, URA3::MEL1uasMEL1tata-lacZ SGS1 1-100 in pBDC and empty pOAD
4206 MATa, trp1-901, leu2-3, 112, ura3-52, his3-200, gal4Δ, gal80Δ,
lys2::Gal1uas-Gal1tata-HIS3, GAL2uas-GAL2tata-ADE2, URA3::MEL1uasMEL1tata-lacZ SGS1 1-100 in pBDC and empty pOAD
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4207 MATa, trp1-901, leu2-3, 112, ura3-52, his3-200, gal4Δ, gal80Δ,
lys2::Gal1uas-Gal1tata-HIS3, GAL2uas-GAL2tata-ADE2, URA3::MEL1uasMEL1tata-lacZ SGS1 1-100 in pBDC and empty pOAD
4208 MATa, trp1-901, leu2-3, 112, ura3-52, his3-200, gal4Δ, gal80Δ,
lys2::Gal1uas-Gal1tata-HIS3, GAL2uas-GAL2tata-ADE2, URA3::MEL1uasMEL1tata-lacZ empty pBDC and empty pOAD vectors
4209 MATa, trp1-901, leu2-3, 112, ura3-52, his3-200, gal4Δ, gal80Δ,
lys2::Gal1uas-Gal1tata-HIS3, GAL2uas-GAL2tata-ADE2, URA3::MEL1uasMEL1tata-lacZ empty pBDC and empty pOAD vectors
4210 MATa, trp1-901, leu2-3, 112, ura3-52, his3-200, gal4Δ, gal80Δ,
lys2::Gal1uas-Gal1tata-HIS3, GAL2uas-GAL2tata-ADE2, URA3::MEL1uasMEL1tata-lacZ empty pBDC and empty pOAD vectors
4211 MATa, trp1-901, leu2-3, 112, ura3-52, his3-200, gal4Δ, gal80Δ,
lys2::Gal1uas-Gal1tata-HIS3, GAL2uas-GAL2tata-ADE2, URA3::MEL1uasMEL1tata-lacZ empty pBDC and empty pOAD vectors
4743 his3Δ200/his3Δ200, trp1Δ63/trp1Δ63,ura3-52/ura3-52, rrm3::TRP1/RRM3
4744 his3Δ200/his3Δ200, trp1Δ63/trp1Δ63,ura3-52/ura3-52, rrm3::TRP1/RRM3
4745 his3Δ200/his3Δ200, trp1Δ63/trp1Δ63,ura3-52/ura3-52, sgs1::HIS3/SGS1
4746 his3Δ200/his3Δ200, trp1Δ63/trp1Δ63,ura3-52/ura3-52, sgs1::HIS3/SGS1
4747 his3Δ200/his3Δ200, trp1Δ63/trp1Δ63,ura3-52/ura3-52, sgs1::HIS3/SGS1
4748 his3Δ200/his3Δ200, trp1Δ63/trp1Δ63,ura3-52/ura3-52, sgs1::HIS3/SGS1
4749 his3Δ200/his3Δ200, trp1Δ63/trp1Δ63,ura3-52/ura3-52, srs2::HIS3/SRS2
4750 his3Δ200/his3Δ200, trp1Δ63/trp1Δ63,ura3-52/ura3-52, srs2::HIS3/SRS2
4751 his3Δ200/his3Δ200, trp1Δ63/trp1Δ63,ura3-52/ura3-52, srs2::HIS3/SRS2
4752 his3Δ200/his3Δ200, trp1Δ63/trp1Δ63,ura3-52/ura3-52, srs2::HIS3/SRS2
4753 ura3-52, trp1Δ63, hisΔ200
4754 ura3-52, trp1Δ63, hisΔ200
4755 ura3-52, trp1Δ63, hisΔ200
4756 ura3-52, trp1Δ63, hisΔ200
4757 ura3-52, trp1Δ63, hisΔ200
4758 ura3-52, trp1Δ63, hisΔ200, rrm3::TRP1
4759 ura3-52, trp1Δ63, hisΔ200, rrm3::TRP1
4760 his3∆200, trp1∆63, ∆ura3-52, ∆rrm3::TRP1, ∆lys2::HIS3, ∆arg4::G418
4761 his3∆200, trp1∆63, ∆ura3-52, ∆rrm3::TRP1, ∆lys2::HIS3, ∆arg4::G418
4762 his3∆200, trp1∆63, ∆ura3-52, ∆rrm3::TRP1, ∆lys2::HIS3, ∆arg4::G418
4763 his3∆200, trp1∆63, ∆ura3-52, ∆rrm3::TRP1, ∆lys2::HIS3, ∆arg4::G418
4764 his3∆200/his3∆200, trp1∆63/trp1∆63, ∆ura3-52/∆ura3-52,
RRM3/∆rrm3::TRP1, LYS2/∆lys2::HIS3, ARG4/∆arg4::G418
4765 his3∆200/his3∆200, trp1∆63/trp1∆63, ∆ura3-52/∆ura3-52,
RRM3/∆rrm3::TRP1, LYS2/∆lys2::HIS3, ARG4/∆arg4::G418
4766 his3∆200/his3∆200, trp1∆63/trp1∆63, ∆ura3-52/∆ura3-52,
RRM3/∆rrm3::TRP1, LYS2/∆lys2::HIS3, ARG4/∆arg4::G418
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4767 his3∆200/his3∆200, trp1∆63/trp1∆63, ∆ura3-52/∆ura3-52,
RRM3/∆rrm3::TRP1, LYS2/∆lys2::HIS3, ARG4/∆arg4::G418
4768 his3∆200/his3∆200, trp1∆63/trp1∆63, ∆ura3-52/∆ura3-52,
RRM3/∆rrm3::TRP1, LYS2/∆lys2::HIS3, ARG4/∆arg4::G418
4769 his3∆200/his3∆200, trp1∆63/trp1∆63, ∆ura3-52/∆ura3-52,
RRM3/∆rrm3::TRP1, LYS2/∆lys2::HIS3, ARG4/∆arg4::G418
4770 his3∆200/his3∆200, trp1∆63/trp1∆63, ∆ura3-52/∆ura3-52,
RRM3/∆rrm3::TRP1, LYS2/∆lys2::HIS3, ARG4/∆arg4::G418
4771 his3∆200/his3∆200, trp1∆63/trp1∆63, ∆ura3-52/∆ura3-52,
RRM3/∆rrm3::TRP1, LYS2/∆lys2::HIS3, ARG4/∆arg4::G418
4772 his3∆200, trp1∆63, ∆ura3-52, ∆tof1::His3
4773 his3∆200, trp1∆63, ∆ura3-52, ∆tof1::His3
4774 his3∆200, trp1∆63, ∆ura3-52, ∆tof1::His3
4775 his3∆200, trp1∆63, ∆ura3-52, ∆tof1::His3
4776 his3∆200, trp1∆63, ∆ura3-52, ∆rrm3::TRP1, ∆tof1::His3
4777 his3∆200, trp1∆63, ∆ura3-52, ∆rrm3::TRP1, ∆tof1::His3
4778 his3∆200, trp1∆63, ∆ura3-52, ∆rrm3::TRP1, ∆tof1::His3
4779 his3∆200, trp1∆63, ∆ura3-52, ∆ume1::His3
4780 his3∆200, trp1∆63, ∆ura3-52, ∆ume1::His3
4781 his3∆200, trp1∆63, ∆ura3-52, ∆ume1::His3
4782 his3∆200, trp1∆63, ∆ura3-52, ∆ume1::His3
4783 his3∆200, trp1∆63, ∆ura3-52, ∆rrm3::TRP1, ∆ume1::His3
4784 his3∆200, trp1∆63, ∆ura3-52, ∆rrm3::TRP1, ∆ume1::His3
4785 his3∆200, trp1∆63, ∆ura3-52, ∆rrm3::TRP1, ∆ume1::His3
4786 his3∆200, trp1∆63, ∆ura3-52, ∆rrm3::TRP1, ∆ume1::His3
4787 his3∆200, trp1∆63, ∆ura3-52, ∆dpb4::His3
4788 his3∆200, trp1∆63, ∆ura3-52, ∆dpb4::His3
4789 his3∆200, trp1∆63, ∆ura3-52, ∆rrm3::TRP1, ∆dpb4::His3
4790 his3∆200, trp1∆63, ∆ura3-52, ∆rrm3::TRP1, ∆dpb4::His3
4791 his3∆200, trp1∆63, ∆ura3-52, ∆rrm3::TRP1, ∆dpb4::His3
4792 his3∆200, trp1∆63, ∆ura3-52, ∆rrm3::TRP1, ∆dpb4::His3
5036 ura3-52, trp1Δ63, hisΔ200
5143 MATα ura3-52, trp1Δ63, his3Δ200, arg4::G418, lys2::HIS3
5144 MATα ura3-52, trp1Δ63, his3Δ200, arg4::G418, lys2::HIS3, rrm3::TRP1
5145 MATa ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1,
ade8, YEL069C::URA3, rad5::HIS3
5146 MATa ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1,
ade8, YEL069C::URA3, rrm3::TRP1, rad5::HIS3
5147 MATa ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1,
ade8, YEL069C::URA3, rdh54::HIS3
5148 MATa ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1,
ade8, YEL069C::URA3, rrm3::TRP1, rdh54::HIS3
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5149 MATa ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1,
ade8, YEL069C::URA3, rad5::HIS3 rdh54::G418
5150 MATa ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1,
ade8, YEL069C::URA3, rrm3::TRP1, rdh54::HIS3, rad5::TRP1
5151 MATa ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1,
ade8, YEL069C::URA3, set3::HIS3
5152 MATa ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1,
ade8, YEL069C::URA3, rrm3::TRP1, set3::HIS3
5153 MATa ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1,
ade8, YEL069C::URA3, tof1::HIS3
5154 MATa ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1,
ade8, YEL069C::URA3, rrm3::TRP1, tof1::HIS3
5155 MATa ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1,
ade8, YEL069C::URA3, ies4::HIS3
5156 MATa ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1,
ade8, YEL069C::URA3, rrm3::TRP1, ies4::HIS3
5157 MATa ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1,
ade8, YEL069C::URA3, had1::HIS3
5158 MATa ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1,
ade8, YEL069C::URA3, rrm3::TRP1, had1::HIS3
5159 MATa ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1,
ade8, YEL069C::URA3, mgm101::HIS3
5160 MATa ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1,
ade8, YEL069C::URA3, rrm3::TRP1, mgm101::HIS3
5161 MATa ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1,
ade8, YEL069C::URA3, sml1::G418
5162 MATa ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1,
ade8, YEL069C::URA3, sml1::G418, rrm3::TRP1
5163 MATa ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1,
ade8, YEL069C::URA3, sml1::G418, rrm3::TRP1, rad53::HIS3
5164 ura3-52/ura3-52, leu2∆1/leu2∆1, trp1∆63/trp1∆63, his3∆200/his3∆200,
lys2∆Bgl/lys2∆Bgl, hom3-10/hom3-10, ade2∆1/ade2∆1, ade8/ade8.
YEL069C::URA3/YEL069C::URA3, rdh54::HIS3/rdh54::HIS3
5165 ura3-52/ura3-52, leu2∆1/leu2∆1, trp1∆63/trp1∆63, his3∆200/his3∆200,
lys2∆Bgl/lys2∆Bgl, hom3-10/hom3-10, ade2∆1/ade2∆1, ade8/ade8.
YEL069C::URA3/YEL069C::URA3, rrm3::TRP1/rrm3::TRP1,
rdh54::HIS3/rdh54::HIS3
5166 ura3-52/ura3-52, leu2∆1/leu2∆1, trp1∆63/trp1∆63, his3∆200/his3∆200,
lys2∆Bgl/lys2∆Bgl, hom3-10/hom3-10, ade2∆1/ade2∆1, ade8/ade8.
YEL069C::URA3/YEL069C::URA3, rrm3::TRP1/rrm3::TRP1
5167 ura3-52/ura3-52, leu2∆1/leu2∆1, trp1∆63/trp1∆63, his3∆200/his3∆200,
lys2∆Bgl/lys2∆Bgl, hom3-10/hom3-10, ade2∆1/ade2∆1, ade8/ade8.
YEL069C::URA3/YEL069C::URA3, RRM3/rrm3::TRP1, RDH54/rdh54::HIS3
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5168 ura3-52/ura3-52, leu2∆1/leu2∆1, trp1∆63/trp1∆63, his3∆200/his3∆200,
lys2∆Bgl/lys2∆Bgl, hom3-10/hom3-10, ade2∆1/ade2∆1, ade8/ade8.
YEL069C::URA3/YEL069C::URA3, RRM3/rrm3::TRP1
5169 ura3-52/ura3-52, leu2∆1/leu2∆1, trp1∆63/trp1∆63, his3∆200/his3∆200,
lys2∆Bgl/lys2∆Bgl, hom3-10/hom3-10, ade2∆1/ade2∆1, ade8/ade8.
YEL069C::URA3/YEL069C::URA3, RDH54/rdh54::HIS3
5170 ura3-52/ura3-52, leu2∆1/leu2∆1, trp1∆63/trp1∆63, his3∆200/his3∆200,
lys2∆Bgl/lys2∆Bgl, hom3-10/hom3-10, ade2∆1/ade2∆1, ade8/ade8.
YEL069C::URA3/YEL069C::URA3, RRM3/rrm3::TRP1,
rdh54::HIS3/rdh54::HIS3
5171 ura3-52/ura3-52, leu2∆1/leu2∆1, trp1∆63/trp1∆63, his3∆200/his3∆200,
lys2∆Bgl/lys2∆Bgl, hom3-10/hom3-10, ade2∆1/ade2∆1, ade8/ade8.
YEL069C::URA3/YEL069C::URA3, rrm3::TRP1/rrm3::TRP1,
RDH54/rdh54::HIS3
5172 MATa ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1,
ade8. YEL069C::URA3, sgs1::RECQL5.13MYC.TRP1
5173 MATa ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1,
ade8. YEL069C::URA3, sgs1::RECQL5.13MYC.TRP1
5174 MATa ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1,
ade8. YEL069C::URA3, sgs1::RECQL5.13MYC.TRP1
5175 MATa ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1,
ade8. YEL069C::URA3, sgs1::TRP1.PGAL1.RECQL5.13MYC.kanMX6
5176 MATa ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1,
ade8. YEL069C::URA3, sgs1::TRP1.PGAL1.RECQL5.13MYC.kanMX6
5177 MATa ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1,
ade8. YEL069C::URA3, sgs1::TRP1.PGAL1.RECQL5.13MYC.kanMX6
5178 MATa ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1,
ade8. YEL069C::URA3, sgs1∆C800-RECQL5.HIS3
5179 MATa ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1,
ade8. YEL069C::URA3, sgs1∆C800-RECQL5.HIS3
5180 MATa ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1,
ade8. YEL069C::URA3, sgs1∆C800-RECQL5.HIS3
5181 MATa ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1,
ade8. YEL069C::URA3, sgs1∆C800-RECQL5.13MYC.TRP1
5182 MATa ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1,
ade8. YEL069C::URA3, sgs1∆C800-RECQL5.13MYC.TRP1
5183 MATa ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1,
ade8. YEL069C::URA3, sgs1∆C800-RECQL5.13MYC.TRP1
5184 MATa, trp1-901, leu2-3, 112, ura3-52, his3-200, gal4Δ, gal80Δ,
lys2::Gal1uas-Gal1tata-HIS3, GAL2uas-GAL2tata-ADE2, URA3::MEL1uasMEL1tata-lacZ RECQL5 in pBDC
5185 MATa, trp1-901, leu2-3, 112, ura3-52, his3-200, gal4Δ, gal80Δ,
lys2::Gal1uas-Gal1tata-HIS3, GAL2uas-GAL2tata-ADE2, URA3::MEL1uasMEL1tata-lacZ RECQL5 in pBDC
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5186 MATa, trp1-901, leu2-3, 112, ura3-52, his3-200, gal4Δ, gal80Δ,
lys2::Gal1uas-Gal1tata-HIS3, GAL2uas-GAL2tata-ADE2, URA3::MEL1uasMEL1tata-lacZ RECQL5 in pBDC
5187 MATa, trp1-901, leu2-3, 112, ura3-52, his3-200, gal4Δ, gal80Δ,
lys2::Gal1uas-Gal1tata-HIS3, GAL2uas-GAL2tata-ADE2, URA3::MEL1uasMEL1tata-lacZ RECQL5 in pBDC and empty pOAD
5188 MATa, trp1-901, leu2-3, 112, ura3-52, his3-200, gal4Δ, gal80Δ,
lys2::Gal1uas-Gal1tata-HIS3, GAL2uas-GAL2tata-ADE2, URA3::MEL1uasMEL1tata-lacZ RECQL5 in pBDC and empty pOAD
5189 MATa, trp1-901, leu2-3, 112, ura3-52, his3-200, gal4Δ, gal80Δ,
lys2::Gal1uas-Gal1tata-HIS3, GAL2uas-GAL2tata-ADE2, URA3::MEL1uasMEL1tata-lacZ RECQL5 in pBDC and empty pOAD
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Strain
(pKHS)
pRS303
pRS304
pRS306
pRS415
124
125
126
127
133
135
136
137
220
221
222
226
227
228
229
230
231
232
233
234
235
236
237
257
265
273
274

Description

Source

HIS3
TRP1
URA3
CEN/ARS, LEU2
pKHS619-RRM3
pKHS619-POL30
pKHS620-RRM3
pKHS620-POL30
pKHS620-rrm3∆N54
pKHS620-rrm3∆N230
pRS315-rrm3∆N54
pRS315-rrm3∆N230
pFA6a-kanMX6
pFA6a-TRP1
pFA6a-His3MX6
pFA6a-3HA-kanMX6
pFA6a-3HA-TRP1
pFA6a-3HA-His3MX6
pFA6a-13Myc-kanMX6
pFA6a-13Myc-TRP1
pFA6a-13Myc-His3MX6
pFA6a-GST-kanMX6
pFA6a-GST-TRP1
pFA6a-GST-His3MX6
pFA6a-kanMX6-PGAL1
pFA6a-TRP1-PGAL1
pFA6a-His3MX6-PGAL1
pFA-kanMX
pCMV-SPORT6-RECQL5
sgs1∆C795
sgs1-hd

(Sikorski and Hieter 1989)
(Sikorski and Hieter 1989)
(Sikorski and Hieter 1989)
(Sikorski and Hieter 1989)
(Schmidt, Derry et al. 2002)
(Schmidt, Derry et al. 2002)
(Schmidt, Derry et al. 2002)
(Schmidt, Derry et al. 2002)
This study
This study
This study
This study
(Longtine, McKenzie et al. 1998)
(Longtine, McKenzie et al. 1998)
(Longtine, McKenzie et al. 1998)
(Longtine, McKenzie et al. 1998)
(Longtine, McKenzie et al. 1998)
(Longtine, McKenzie et al. 1998)
(Longtine, McKenzie et al. 1998)
(Longtine, McKenzie et al. 1998)
(Longtine, McKenzie et al. 1998)
(Longtine, McKenzie et al. 1998)
(Longtine, McKenzie et al. 1998)
(Longtine, McKenzie et al. 1998)
(Longtine, McKenzie et al. 1998)
(Longtine, McKenzie et al. 1998)
(Longtine, McKenzie et al. 1998)
(Goldstein and McCusker 1999)
Open Biosystems
(Mullen, Kaliraman et al. 2000)
(Mullen, Kaliraman et al. 2000)
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275
276
277
278
301
334
335
336
360
392
481
487
503
504
505
506
507
508
509
510
511
512
513
514
515
516
517
520
521
522
523
524
525
526
527
615

sgs1∆C200
SGS1
sgs1∆N158
sgs1∆N644
sgs1-hd.TRP1
sgs1∆C200.TRP1
sgs1∆C200.TRP1
sgs1∆N158.TRP1
pKHS276-SGS1.TRP1
pBDC
pRS415-SGS1
pOAD
pKHS360-sgs1-F30P
pKHS360-sgs1-I33P
pKHS360-sgs1-V29P
pKHS392-sgs1-1-347
pKHS392-sgs1-1-265
pKHS392-sgs1-1-265
pKHS392-sgs1-1-187
pKHS392-sgs1-1-187
pKHS392-sgs1-1-100
pKHS392-sgs1-1-100
pKHS392-sgs1-1-100
pKHS392-sgs1-1-100
pKHS392-sgs1-647-1447
pKHS392-sgs1-647-1447
pKHS392-sgs1-647-1447
pJG-4-5*-MLH1
pBC6, pJH1074
pJM100-SGS1
pJM100-SGS1
pJM100-SGS1
pKHS392-RECQL5
pKHS392-RECQL5
pKHS392-RECQL5
rad5 (C914,C917àAA) Ub ligase
mutant
616 Wt Rad5
617 rad5 (D681, E682 àAA) ATPase
mutant
619 2-Hyb. Prey pJG4-5* vector
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(Mullen, Kaliraman et al. 2000)
(Mullen, Kaliraman et al. 2000)
(Mullen, Kaliraman et al. 2000)
(Mullen, Kaliraman et al. 2000)
This study
This study
This study
This study
This study
(Uetz, Giot et al. 2000)
(Mullen, Kaliraman et al. 2000)
(Uetz, Giot et al. 2000)
This study
This study
This study
This study
This study
This study
This study
This study
This study
This study
This study
This study
This study
This study
This study
This study
This study
(Mullen, Kaliraman et al. 2000)
(Mullen, Kaliraman et al. 2000)
(Mullen, Kaliraman et al. 2000)
This study
This study
This study
(Blastyak, Pinter et al. 2007)
(Blastyak, Pinter et al. 2007)
(Blastyak, Pinter et al. 2007)
(Schmidt, Derry et al. 2002)

Plasmids (continued)
620 2-Hyb. Bait. pEG202 Vector
644 pR5-30-rad5D681A/E682A/C914A/C917A
645 pRS315-rrm3-N∆142
646 pRS315-rrm3-∆N186
647 pRS315-rrm3-∆212
648 pRS315-rrm3-K260A
649 pRS315-rrm3-K260D
650 pRS315-rrm3-D102P
651 pRS315-rrm3-S605A
652 pRS315-rrm3-S605D
653 pKHS620-rrm3-∆N186
654 pKHS620-rrm3-∆N212
655 pKHS620-rrm3-∆N230
656 pKHS619-ORC5
671 pKHS265-RECQL5.HIS3MX6

(Schmidt, Derry et al. 2002)
This study
This study
This study
This study
This study
This study
This study
This study
This study
This study
This study
This study
This study
This study
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Figure E.1: Permissions for content in Chapter Two provided by the Journal of
Molecular Biology and Elsevier.
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Figure E.2: Permissions for content in Appendix A provided by Eukaryotic Cell
and the American Society for Microbiology.
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Figure E.3: Permissions for content in Appendix B provided by PLOS ONE.
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